<!DOCTYPE html>
<!-- saved from url=(0044)https://dev.springer.com/documentation#/Meta -->
<html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <title>Springer API</title>

    
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

    <meta name="csrf-param" content="authenticity_token">
<meta name="csrf-token" content="wtHCcpzBAmRym/ex8N/g40mcao9camBPxkLiYkDU2djJ/6aGkc47kwnmBns2fDFxu+zmAyx9oB5o2QfWHwzw/w==">
    <link rel="stylesheet" type="text/css" media="screen" href="./Springer API_files/bootstrap.css">
    <link rel="stylesheet" type="text/css" media="screen" href="./Springer API_files/font-awesome.css">

    <script src="./Springer API_files/jquery.min.js"></script>

    <script src="./Springer API_files/3scale.js"></script>
    <script src="./Springer API_files/excanvas.compiled.js"></script>

    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6/html5shiv.min.js"></script>
      <script src="//cdnjs.cloudflare.com/ajax/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    
    <link rel="stylesheet" type="text/css" media="screen" href="./Springer API_files/default.css">

    
  </head>

  <body style="">
    <header role="banner">
      <nav class="navbar navbar-fixed-top navbar-inverse" role="navigation">
        <div class="container tabbed">
          <div class="navbar-header">
            <a class="navbar-brand" href="https://dev.springer.com/">Springer | BioMed Central</a>
          </div>
          <div class="navbar-collapse collapse">

  
    <ul class="nav navbar-nav">

      
        <li class="">
          <a href="https://dev.springer.com/admin/applications">Applications</a>
        </li>
      

      
      
        <li class="">
          <a href="https://dev.springer.com/buyer/stats">Statistics</a>
        </li>
      

      

      <li><a class="" href="https://dev.springer.com/docs">Documentation</a></li>

    </ul>

    <ul id="user_widget" class="nav navbar-nav navbar-right">
      <li class="">
        <a href="https://dev.springer.com/admin/messages/received">
          Messages
          
        </a>
      </li>
      <li class="">
        <a href="https://dev.springer.com/admin/account">
          <i class="icon-gears"></i>
          Settings
        </a>
      </li>
      <li>
      <a id="sign-out-button" class="pull-right sign-out" title="Logout adlowe88" href="https://dev.springer.com/logout">
          <i class="icon-signout"></i>
        </a>
      </li>
    </ul>

  
</div>

        </div>
      </nav>

      

        <div id="flash-messages">
          
        </div>
    </header>

    <main id="main-content" role="main">
      
        <div class="full">
          <div class="container">
            <script src="./Springer API_files/application.js"></script>
<link href="./Springer API_files/application.css" media="screen" rel="stylesheet">

<h1>Documentation</h1>

<p>Use our live documentation to learn about the Springer API.</p>

<div class="api-docs-wrap"><div id="apidocs-resources-container">
  <h2>Operations</h2>
  <ul id="apidocs-resources"><li class="resource" id="resource_Metadata">   <div class="apidocs-heading operation-heading">     <h2>       <a data-name="Metadata" href="https://dev.springer.com/documentation#/Metadata">Springer Metadata API</a>     </h2>   </div>   <ul class="endpoints" id="Metadata_endpoint_list" style=""><li class="endpoint">   <ul class="operations" id="Metadata_endpoint_operations"><li class="get operation" data-operation-id="0">   <div class="apidocs-heading" style="background-color:#BABBAD">     <div class="apidocs-bubble">       <div class="action">         <a class="toggle">Springer Metadata Service</a>       </div>     </div>     <div class="path-and-method">       <span class="path"><a>/metadata/{output}</a></span>       <span class="http_method"><a>GET</a></span>     </div>     <ul class="options" style="display:none">       <li>         <a>/metadata/{output}</a>       </li>     </ul>   </div>   <div class="content" data-operation-id="0" style="">          <h4>Description</h4>     <p>The Springer Metadata API allows users to retrieve metadata for more than 10 million online documents. 
    For testing the Springer Metadata API: 
    1.Pass your API Key value in the api_key field. 
    2.Pass the query string in the q field (e.g., keyword:saturn). 
    3. Indicate desired output format. 
    4. Amend the s and p parameters for pagination if desired. 
    4. Amend the s and p parameters for pagination if desired. 
    5. Click on 'Send Request' button. 
    6. Scroll down and you can see the result being generated.</p>               <form accept-charset="UTF-8" data-method="GET" data-host="http://api.springer.com" data-path="/metadata/{output}" action="https://dev.springer.com/documentation#" class="sandbox" method="post">       <div style="margin:0;padding:0;display:inline"></div>       <table class="fullwidth">         <thead>           <tr>             <th>Parameter</th>             <th>Value</th>             <th>Description</th>           </tr>         </thead>         <tbody id="Metadata_0_GET_params"><tr class="zebra">   <td class="">api_key</td>   <td>     <input data-threescale-name="user_keys" data-guid="1" data-param-type="query" minlength="0" name="api_key" data-original-name="api_key" type="text" value="">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Your API access key     </div>   </td> </tr><tr class="zebra">   <td class="">q</td>   <td>     <input data-threescale-name="q" data-guid="2" data-param-type="query" minlength="0" name="q" data-original-name="q" type="text" value="constraint:value">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Query String     </div>   </td> </tr><tr class="zebra">   <td class="">output</td>   <td>     <input data-guid="3" data-param-type="path" minlength="0" name="output" data-original-name="output" type="text" value="json">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Output/Result format as JSON or PAM     </div>   </td> </tr><tr class="zebra">   <td class="">s</td>   <td>     <input data-threescale-name="q" data-guid="4" data-param-type="query" minlength="0" name="s" data-original-name="s" type="text" value="1">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       The index of the first hit to return. If 0, treated as 1. The default is 1     </div>   </td> </tr><tr class="zebra">   <td class="">p</td>   <td>     <input data-threescale-name="q" data-guid="5" data-param-type="query" minlength="0" name="p" data-original-name="p" type="text" value="10">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       The maximum number of hits/results to return. The default is 10.     </div>   </td> </tr></tbody>       </table>       <div class="submit-bar">                    <button class="submit" name="commit" type="button">           <span>Send Request</span>         </button>                  <a href="https://dev.springer.com/documentation#" data-guid="0" class="hide-response" style="display:none;">HIDE RESPONSE</a>       </div>     </form>     <div class="response" data-guid="0" style="display:none">        <h4 class="request_heading">Request</h4>       <div class="block request_url"><pre class="prettyprint"></pre></div>        <h4 class="response_body_heading">Response Body</h4>       <div class="block response_body"><pre class="prettyprint"></pre></div>        <h4>Response Code</h4>       <div class="block response_code"><pre></pre></div>        <h4>Response Headers</h4>       <div class="block response_headers"><pre class="prettyprint"></pre></div>      </div>   </div> </li></ul> </li></ul> </li><li class="resource" id="resource_Meta">   <div class="apidocs-heading operation-heading">     <h2>       <a data-name="Meta" href="https://dev.springer.com/documentation#/Meta">Springer Meta API</a>     </h2>   </div>   <ul class="endpoints" id="Meta_endpoint_list" style=""><li class="endpoint">   <ul class="operations" id="Meta_endpoint_operations"><li class="get operation" data-operation-id="6">   <div class="apidocs-heading" style="background-color:#BABBAD">     <div class="apidocs-bubble">       <div class="action">         <a class="toggle">Springer Meta API Service</a>       </div>     </div>     <div class="path-and-method">       <span class="path"><a>/meta/v1/{output}</a></span>       <span class="http_method"><a>GET</a></span>     </div>     <ul class="options" style="display:none">       <li>         <a>/meta/v1/{output}</a>       </li>     </ul>   </div>   <div class="content" data-operation-id="6" style="">          <h4>Description</h4>     <p>The Springer Meta API allows users to retrieve metadata for more than 11 million online documents. 
    For testing the Springer Meta API: 
    1.Pass your API Key value in the api_key field. 
    2.Pass the query string in the q field (e.g., keyword:saturn). 
    3. Indicate desired output format. 
    4. Amend the s and p parameters for pagination if desired. 
    4. Amend the s and p parameters for pagination if desired. 
    5. Click on 'Send Request' button. 
    6. Scroll down and you can see the result being generated.</p>               <form accept-charset="UTF-8" data-method="GET" data-host="http://api.springer.com" data-path="/meta/v1/{output}" action="https://dev.springer.com/documentation#" class="sandbox" method="post">       <div style="margin:0;padding:0;display:inline"></div>       <table class="fullwidth">         <thead>           <tr>             <th>Parameter</th>             <th>Value</th>             <th>Description</th>           </tr>         </thead>         <tbody id="Meta_6_GET_params"><tr class="zebra">   <td class="">api_key</td>   <td>     <input data-threescale-name="api_key" data-guid="7" data-param-type="query" minlength="0" name="api_key" data-original-name="api_key" type="text" value="">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Your API access key     </div>   </td> </tr><tr class="zebra">   <td class="">q</td>   <td>     <input data-threescale-name="q" data-guid="8" data-param-type="query" minlength="0" name="q" data-original-name="q" type="text" value="constraint:value">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Query String     </div>   </td> </tr><tr class="zebra">   <td class="">output</td>   <td>     <input data-guid="9" data-param-type="path" minlength="0" name="output" data-original-name="output" type="text" value="json">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Output/Result format as JSON or PAM     </div>   </td> </tr><tr class="zebra">   <td class="">s</td>   <td>     <input data-threescale-name="q" data-guid="10" data-param-type="query" minlength="0" name="s" data-original-name="s" type="text" value="1">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       The index of the first hit to return. If 0, treated as 1. The default is 1     </div>   </td> </tr><tr class="zebra">   <td class="">p</td>   <td>     <input data-threescale-name="p" data-guid="11" data-param-type="query" minlength="0" name="p" data-original-name="p" type="text" value="10">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       The maximum number of hits/results to return. The default is 10.     </div>   </td> </tr></tbody>       </table>       <div class="submit-bar">                    <button class="submit" name="commit" type="button"><span>Send Request</span></button>                  <a href="https://dev.springer.com/documentation#" data-guid="6" class="hide-response" style="">HIDE RESPONSE</a>       </div>     </form>     <div class="response" data-guid="6" style="">        <h4 class="request_heading">Request</h4>       <div class="block request_url"><pre class="prettyprint">curl -v  -X GET "http://api.springer.com/meta/v1/json?api_key=b9ab99a51faec6511d70c08f878cfc61&amp;q=keyword%3Amedicine&amp;s=1&amp;p=10"</pre></div>        <h4 class="response_body_heading">Response Body</h4>       <div class="block response_body"><pre class="prettyprint">{
 "query": "keyword:medicine",
 "apiKey": "b9ab99a51faec6511d70c08f878cfc61",
 "result": [
  {
   "total": "12995",
   "start": "1",
   "pageLength": "10"
  }
 ],
 "records": [
  {
   "identifier": "doi:10.1007/978-3-642-40458-0_23-1",
   "url": [
    {
     "format": "html",
     "platform": "web",
     "value": "http://link.springer.com/openurl/fulltext?id=doi:10.1007/978-3-642-40458-0_23-1"
    },
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-3-642-40458-0_23-1"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-3-642-40458-0_23-1"
    }
   ],
   "title": "Human Capital",
   "creators": [
    {
     "creator": "Goldin, Claudia"
    }
   ],
   "publicationName": "Handbook of Cliometrics",
   "openaccess": "false",
   "doi": "10.1007/978-3-642-40458-0_23-1",
   "printIsbn": "",
   "electronicIsbn": "978-3-642-40458-0",
   "isbn": "",
   "publisher": "Springer",
   "publicationDate": "2021-01-01",
   "onlineDate": "2014-04-16",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2021 Springer-Verlag Berlin Heidelberg",
   "genre": "",
   "abstract": "AbstractHuman capital is the stock of skills that the labor force possesses. The flow of these skills is forthcoming when the return to investment exceeds the cost (both direct and indirect). Returns to these skills are private in the sense that an individual’s productive capacity increases with more of them. But there are often externalities that increase the productive capacity of others when human capital is increased. This essay discusses these concepts historically and focuses on two major components of human capital: education and training, and health. The institutions that encourage human capital investment are discussed, as is the role of human capital in economic growth. The notion that the study of human capital is inherently historical is emphasized and defended."
  },
  {
   "identifier": "doi:10.1007/978-3-319-03751-6_67-1",
   "url": [
    {
     "format": "html",
     "platform": "web",
     "value": "http://link.springer.com/openurl/fulltext?id=doi:10.1007/978-3-319-03751-6_67-1"
    },
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-3-319-03751-6_67-1"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-3-319-03751-6_67-1"
    }
   ],
   "title": "Plant polysaccharides and their effects on cell adhesion",
   "creators": [
    {
     "creator": "Xu, Xianxiang"
    }
   ],
   "publicationName": "Polysaccharides",
   "openaccess": "false",
   "doi": "10.1007/978-3-319-03751-6_67-1",
   "printIsbn": "",
   "electronicIsbn": "978-3-319-03751-6",
   "isbn": "",
   "publisher": "Springer",
   "publicationDate": "2021-01-01",
   "onlineDate": "2014-10-17",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2021 Springer International Publishing Switzerland",
   "genre": "",
   "abstract": "AbstractCell adhesion mediated by cell adhesion molecules (CAMs) constitutes essential life phenomenon. In inflammation, immunity, infection, tumor, cardiovascular injury, and wound healing, cell adhesion comes into being the basic physiological and pathological process. Intervening with cell adhesion has been the important therapeutic and prophylactic strategies for diseases. Accumulated evidence has indicated that plant polysaccharides especially those exacted from Chinese traditional and herbal medicine (most of plant medicine) displayed various pharmacological effects such as anti-inflammation, antitumor, anti-infection, immunomodulation, cardiovascular protective effects, and so on. Focusing on cell adhesion, further research is expected to reveal the therapeutic mechanism of plant polysaccharides in disease processes."
  },
  {
   "identifier": "doi:10.1007/978-3-319-64774-6_18",
   "url": [
    {
     "format": "html",
     "platform": "web",
     "value": "http://link.springer.com/openurl/fulltext?id=doi:10.1007/978-3-319-64774-6_18"
    },
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-3-319-64774-6_18"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-3-319-64774-6_18"
    }
   ],
   "title": "The Current State of Hospital Medicine: Trends in Compensation, Practice Patterns, Advanced Practice Providers, Malpractice, and Career Satisfaction",
   "creators": [
    {
     "creator": "Conrad, Kevin"
    },
    {
     "creator": "Valovska, Theodora"
    }
   ],
   "publicationName": "Clinical Approaches to Hospital Medicine",
   "openaccess": "false",
   "doi": "10.1007/978-3-319-64774-6_18",
   "printIsbn": "978-3-319-64773-9",
   "electronicIsbn": "978-3-319-64774-6",
   "isbn": "978-3-319-64773-9",
   "publisher": "Springer",
   "publicationDate": "2018-01-01",
   "onlineDate": "2017-08-22",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2018 Springer International Publishing AG",
   "genre": "",
   "abstract": "AbstractHospital medicine is approximately 20 years old. The term Hospitalist was first coined in a 1996 New England Journal of Medicine article written by Lee Goldman and Bob Wachter (Wachter N Engl J Med 335:514–517, 1996). It has been the fastest growing specialty in the history of medicine, with 50,000 current practicing Hospitalists in the United States. This represents a steady and slightly exponential growth of roughly 2850 new hospitalists per year for the past 15 years (Society of Hospital Medicines 2016 Report Based on 2015 Data), making it the largest subspecialty of Internal Medicine. Approximately 75% of all Hospitals in the US employ hospitalists, with the percentage increasing yearly. This chapter explores the growth and development of hospital medicine over the years, with a focus on compensation, practice patterns, AP Providers, malpractice, and career satisfaction."
  },
  {
   "identifier": "doi:10.1007/978-3-319-67349-3_14",
   "url": [
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-3-319-67349-3_14"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-3-319-67349-3_14"
    }
   ],
   "title": "Intelligent Internet Technology for Personalized Health-Saving Support",
   "creators": [
    {
     "creator": "Krut`ko, V. N."
    },
    {
     "creator": "Bolshakov, A. M."
    },
    {
     "creator": "Dontsov, V. I."
    },
    {
     "creator": "Mamikonova, O. A."
    },
    {
     "creator": "Markova, A. M."
    },
    {
     "creator": "Molodchenkov, A. I."
    },
    {
     "creator": "Potemkina, N. S."
    },
    {
     "creator": "Smirnov, I. V."
    }
   ],
   "publicationName": "Advances in Artificial Systems for Medicine and Education",
   "openaccess": "false",
   "doi": "10.1007/978-3-319-67349-3_14",
   "printIsbn": "978-3-319-67348-6",
   "electronicIsbn": "978-3-319-67349-3",
   "isbn": "978-3-319-67348-6",
   "publisher": "Springer",
   "publicationDate": "2018-01-01",
   "onlineDate": "2017-08-20",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2018 Springer International Publishing AG",
   "genre": "",
   "abstract": "AbstractMultifactorial nature of human health and need in personifying the approach to each person leads to the fact that full implementation of healthy life style (HLS) technologies is possible only on the basis of artificial intelligence technologies, widely implemented in the preventive medicine via modern Internet technologies. Modern computer systems allow considering simultaneously big data of separate factors in health assessing and selecting of individualized recommendations for personal HLS. This article presents a concept and a structure of intelligent Internet technology for personalized health-saving support, which allow assessing health and preparing individual optimal recommendations for HLS."
  },
  {
   "identifier": "doi:10.1007/978-3-319-62941-4_1",
   "url": [
    {
     "format": "html",
     "platform": "web",
     "value": "http://link.springer.com/openurl/fulltext?id=doi:10.1007/978-3-319-62941-4_1"
    },
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-3-319-62941-4_1"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-3-319-62941-4_1"
    }
   ],
   "title": "Precision Medicine in Lung Cancer",
   "creators": [
    {
     "creator": "Kerr, Keith M."
    },
    {
     "creator": "Laing, Gavin M."
    }
   ],
   "publicationName": "Precision Molecular Pathology of Lung Cancer",
   "openaccess": "false",
   "doi": "10.1007/978-3-319-62941-4_1",
   "printIsbn": "978-3-319-62940-7",
   "electronicIsbn": "978-3-319-62941-4",
   "isbn": "978-3-319-62940-7",
   "publisher": "Springer",
   "publicationDate": "2018-01-01",
   "onlineDate": "2017-08-14",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2018 Springer International Publishing AG",
   "genre": "",
   "abstract": "AbstractThe last 25 years have seen a remarkable change in the way we manage patients with lung cancer, especially those with advanced non-small cell lung cancer (NSCLC). A rather nihilistic approach, with poor therapy options, has been transformed by the availability of some very effective therapies, at least for some of our patients. Most of these therapies are effective against a particular molecular biological facet of the individual tumour. Patients who are likely to respond to these molecularly targeted treatments are selected on the basis of particular molecular characteristics identified at the time of pathological diagnosis. The identification of biomarkers for the selection of treatments has transformed the pathological diagnosis of NSCLC. These developments have, of course, implications for patients, oncologists and pathologists. In pathology, a new range of concepts and skills has been embraced, and for ‘traditional’ histo- and cytopathologists, there have been new opportunities to embrace molecular pathology as part of their diagnostic role. This has required a better understanding of the diagnostic techniques used in the pathology laboratory, as well as how our routine sample processing enhances or hinders them. Lung cancer pathologists have to be quite skilled in tissue management as our oncologists, and patients, require much more information from dwindling tissue resources. The value of performing tests to strict quality standards is ever more apparent. Precision medicine for patients with lung cancer is now a reality and has placed pathology, and pathologists, in the centre of the patient management process. A knowledge of the molecular pathology of lung cancer has become ever more important as pathologists take on new roles in diagnosis of lung cancer."
  },
  {
   "identifier": "doi:10.1007/978-3-319-64774-6_20",
   "url": [
    {
     "format": "html",
     "platform": "web",
     "value": "http://link.springer.com/openurl/fulltext?id=doi:10.1007/978-3-319-64774-6_20"
    },
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-3-319-64774-6_20"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-3-319-64774-6_20"
    }
   ],
   "title": "Tools for Applying Medical Knowledge",
   "creators": [
    {
     "creator": "Benson, Kjell"
    }
   ],
   "publicationName": "Clinical Approaches to Hospital Medicine",
   "openaccess": "false",
   "doi": "10.1007/978-3-319-64774-6_20",
   "printIsbn": "978-3-319-64773-9",
   "electronicIsbn": "978-3-319-64774-6",
   "isbn": "978-3-319-64773-9",
   "publisher": "Springer",
   "publicationDate": "2018-01-01",
   "onlineDate": "2017-08-22",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2018 Springer International Publishing AG",
   "genre": "",
   "abstract": "AbstractHospitalist physicians see patients at a unique moment of existential crisis in their lives as they encounter the collision of a serious illness, a complex medical system, and a vast quantity of scientific information. Knowledge of the origins of the medical tools that clinicians apply in helping patients allows for a more mindful approach to patients in these moments. This chapter reviews the main modalities of medical knowledge: practical wisdom, expert consensus, evidence-based medicine, and narrative medicine. The philosophy of science that undergirds these tools is explained. Finally, the use of narrative medicine sheds light on the existential moment of hospitalization, and highlights the ethical issues surrounding providing care on both individual and whole health system levels."
  },
  {
   "identifier": "doi:10.1007/978-1-4939-7456-6_16",
   "url": [
    {
     "format": "html",
     "platform": "web",
     "value": "http://link.springer.com/openurl/fulltext?id=doi:10.1007/978-1-4939-7456-6_16"
    },
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-1-4939-7456-6_16"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-1-4939-7456-6_16"
    }
   ],
   "title": "Metabolomics: Challenges and Opportunities in Systems Biology Studies",
   "creators": [
    {
     "creator": "Casadei, Luca"
    },
    {
     "creator": "Valerio, Mariacristina"
    },
    {
     "creator": "Manetti, Cesare"
    }
   ],
   "publicationName": "Systems Biology",
   "openaccess": "false",
   "doi": "10.1007/978-1-4939-7456-6_16",
   "printIsbn": "978-1-4939-7455-9",
   "electronicIsbn": "978-1-4939-7456-6",
   "isbn": "978-1-4939-7455-9",
   "publisher": "Springer",
   "publicationDate": "2018-01-01",
   "onlineDate": "2017-11-09",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2018 Springer Science+Business Media LLC",
   "genre": "",
   "abstract": "AbstractMetabolomics has the capability of providing predisposition, diagnostic, prognostic, and therapeutic biomarker profiles of individual patients, since a large number of metabolites can be measured in an unbiased manner from biological samples. In this setting, ^1H-Nuclear Magnetic Resonance (NMR) spectroscopy of biofluids such as plasma, urine, and fecal water offers the opportunity to identify patterns of biomarker changes that reflects the physiological or pathological status of an individual patient. In this chapter, we show as a metabolomics study can be used to diagnose a disease, classifying patients as healthy or as pathological taking into account individual variability."
  },
  {
   "identifier": "doi:10.1007/978-3-319-64771-5_15",
   "url": [
    {
     "format": "html",
     "platform": "web",
     "value": "http://link.springer.com/openurl/fulltext?id=doi:10.1007/978-3-319-64771-5_15"
    },
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-3-319-64771-5_15"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-3-319-64771-5_15"
    }
   ],
   "title": "Femoral Physeal Sparing/Transphyseal Tibial (Hybrid) Technique for ACL Reconstruction in Skeletally Immature Athletes",
   "creators": [
    {
     "creator": "Milewski, Matthew D."
    },
    {
     "creator": "Nissen, Carl W."
    }
   ],
   "publicationName": "The Pediatric Anterior Cruciate Ligament",
   "openaccess": "false",
   "doi": "10.1007/978-3-319-64771-5_15",
   "printIsbn": "978-3-319-64770-8",
   "electronicIsbn": "978-3-319-64771-5",
   "isbn": "978-3-319-64770-8",
   "publisher": "Springer",
   "publicationDate": "2018-01-01",
   "onlineDate": "2017-08-22",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2018 Springer International Publishing AG",
   "genre": "",
   "abstract": "AbstractSeveral techniques exist for physeal sparing or physeal respecting ACL reconstruction in the growing population of skeletally immature patients with this injury. We describe a physeal sparing femoral tunnel placement with a transphyseal tibial tunnel, a hybrid ACL reconstruction technique, that can be used in skeletally immature patients with 2 years of growth remaining. It allows for a more anatomic femoral tunnel location within the footprint and minimizes potential physeal injury to the femoral physis. A vertical transphyseal tibial tunnel minimizes physeal injury and maximizes graft within the tibial tunnel. Future studies will be needed to examine the long-term effects of these procedures and compare their functional outcomes with other techniques for skeletally immature athletes."
  },
  {
   "identifier": "doi:10.1007/978-981-10-3229-5_111",
   "url": [
    {
     "format": "html",
     "platform": "web",
     "value": "http://link.springer.com/openurl/fulltext?id=doi:10.1007/978-981-10-3229-5_111"
    },
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-981-10-3229-5_111"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-981-10-3229-5_111"
    }
   ],
   "title": "Design and Implementation of “Medicine Chest Butler” Mobile App",
   "creators": [
    {
     "creator": "Liu, Hengxin"
    },
    {
     "creator": "Chen, Jin"
    },
    {
     "creator": "Wang, Lujia"
    },
    {
     "creator": "Ji, Maolin"
    },
    {
     "creator": "Liu, Zeng"
    },
    {
     "creator": "Zhang, Hankun"
    }
   ],
   "publicationName": "Communications, Signal Processing, and Systems",
   "openaccess": "false",
   "doi": "10.1007/978-981-10-3229-5_111",
   "printIsbn": "978-981-10-3228-8",
   "electronicIsbn": "978-981-10-3229-5",
   "isbn": "978-981-10-3228-8",
   "publisher": "Springer",
   "publicationDate": "2018-01-01",
   "onlineDate": "2017-10-27",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2018 Springer Nature Singapore Pte Ltd.",
   "genre": "",
   "abstract": "AbstractMost family does not implement intelligent management of the most commonly used medicine. Little research teams designed the family medicine chest intelligent management. This article is based on this background, committed to the development of smart phone App managing medicine and cloud management platform software system. The mobile terminal will also develop Android and Apple’s dual-platform software. The medicine information is obtained by scanning the bar code. The backstage medicine information database maintenance and pharmaceutical science information releasing based on cloud-based platform architecture with more prominent security and scalability. The results show that the software can automatically remind medication and warn expired medicines. It can also well extend family health science knowledge."
  },
  {
   "identifier": "doi:10.1007/978-3-319-64771-5_1",
   "url": [
    {
     "format": "html",
     "platform": "web",
     "value": "http://link.springer.com/openurl/fulltext?id=doi:10.1007/978-3-319-64771-5_1"
    },
    {
     "format": "pdf",
     "platform": "web",
     "value": "http://link.springer.com/openurl/pdf?id=doi:10.1007/978-3-319-64771-5_1"
    },
    {
     "format": "",
     "platform": "",
     "value": "http://dx.doi.org/10.1007/978-3-319-64771-5_1"
    }
   ],
   "title": "Pediatric and Adolescent ACL Injury and Sports Medicine: The Early Years",
   "creators": [
    {
     "creator": "Stanitski, Carl L."
    }
   ],
   "publicationName": "The Pediatric Anterior Cruciate Ligament",
   "openaccess": "false",
   "doi": "10.1007/978-3-319-64771-5_1",
   "printIsbn": "978-3-319-64770-8",
   "electronicIsbn": "978-3-319-64771-5",
   "isbn": "978-3-319-64770-8",
   "publisher": "Springer",
   "publicationDate": "2018-01-01",
   "onlineDate": "2017-08-22",
   "printDate": "",
   "volume": "",
   "number": "",
   "startingPage": "",
   "copyright": "©2018 Springer International Publishing AG",
   "genre": "",
   "abstract": "AbstractSince the 1970s, sports medicine has grown rapidly into a multispecialty discipline with development of societies, courses, journals, and fellowships. With a major focus on understanding knee injuries, the normal function of the ACL was first defined and an appreciation of the functional instability that results from its compromise with onset of premature degenerative joint disease. Arthroscopy created a revolution in diagnosis and management of ACL injuries. Prior attitudes regarding the skeletally immature scholastic-aged athlete were twofold: no significant injuries occurred until skeletal maturity; children heal injuries without difficulty or sequelae. It always seemed to this author that the scholastic-aged athlete represented the largest group exposed to sports injuries, most of which were minor and resolved with limited treatment requirements. Recognition, however, of significant intra-articular injuries in the truly skeletally immature began to be reported and now is a fact of sports medicine. Management of ACL injury in the truly skeletally immature athlete was initially done nonoperatively because of fear of surgical damage to the femoral and tibial physes. With further observation of this treatment method’s outcomes, it was realized that attempts to return to play created additional instability and secondary intra-articular injury in an already functionally compromised knee. Patients need to be assessed for their physiologic maturity and not just their chronological age. Surgical methods were suggested with the use of various tissues, tunnels, and techniques. Reconstructions were based on physiologic maturity and were classified as physeal sparing, partial transphyseal, and complete transphyseal methods. Graduated rehab methods must be instituted with return to normal functional parameters prior to return to sport. Short time outcomes of most of these methods appear to be successful in preventing ongoing functional knee instability. In reported appropriately selected patients and surgical procedures, iatrogenic physeal injuries have been limited. The surgeon must act as a knee counselor relative to risks to the contralateral knee and ability to return to full activity and choice of sports. Pediatric and adolescent sports medicine initially emerged within the concept of “sports medicine” writ large. It is very rewarding to note that it has since developed into a bona fide multidisciplinary sub-subspecialty with practitioner fellowship trained in pediatric and sports medicine orthopedics."
  }
 ],
 "facets": [
  {
   "name": "subject",
   "values": [
    {
     "value": "Medicine &amp; Public Health",
     "count": "8486"
    },
    {
     "value": "Medicine/Public Health, general",
     "count": "2230"
    },
    {
     "value": "Internal Medicine",
     "count": "1956"
    },
    {
     "value": "Biomedicine",
     "count": "1363"
    },
    {
     "value": "Oncology",
     "count": "894"
    },
    {
     "value": "Emergency Medicine",
     "count": "850"
    },
    {
     "value": "Public Health",
     "count": "844"
    },
    {
     "value": "Life Sciences",
     "count": "736"
    },
    {
     "value": "General Practice / Family Medicine",
     "count": "695"
    },
    {
     "value": "Biomedicine general",
     "count": "637"
    },
    {
     "value": "Intensive / Critical Care Medicine",
     "count": "590"
    },
    {
     "value": "Pharmacology/Toxicology",
     "count": "584"
    },
    {
     "value": "Theory of Medicine/Bioethics",
     "count": "582"
    },
    {
     "value": "Complementary &amp; Alternative Medicine",
     "count": "501"
    },
    {
     "value": "Ethics",
     "count": "499"
    },
    {
     "value": "Cardiology",
     "count": "498"
    },
    {
     "value": "Pain Medicine",
     "count": "488"
    },
    {
     "value": "Chiropractic Medicine",
     "count": "461"
    },
    {
     "value": "Neurology",
     "count": "443"
    },
    {
     "value": "Imaging / Radiology",
     "count": "438"
    }
   ]
  },
  {
   "name": "keyword",
   "values": [
    {
     "value": "Evidence-based medicine",
     "count": "698"
    },
    {
     "value": "Personalized medicine",
     "count": "615"
    },
    {
     "value": "Regenerative medicine",
     "count": "588"
    },
    {
     "value": "Emergency medicine",
     "count": "525"
    },
    {
     "value": "Chinese medicine",
     "count": "509"
    },
    {
     "value": "Medicine",
     "count": "376"
    },
    {
     "value": "Precision medicine",
     "count": "249"
    },
    {
     "value": "Complementary and alternative medicine",
     "count": "238"
    },
    {
     "value": "Traditional Chinese medicine",
     "count": "237"
    },
    {
     "value": "Nuclear medicine",
     "count": "228"
    },
    {
     "value": "Herbal medicine",
     "count": "225"
    },
    {
     "value": "History of medicine",
     "count": "224"
    },
    {
     "value": "Evidenzbasierte Medizin",
     "count": "222"
    },
    {
     "value": "Notfallmedizin",
     "count": "220"
    },
    {
     "value": "Traditional medicine",
     "count": "190"
    },
    {
     "value": "Cancer",
     "count": "186"
    },
    {
     "value": "Complementary medicine",
     "count": "176"
    },
    {
     "value": "medicine",
     "count": "149"
    },
    {
     "value": "Tissue engineering",
     "count": "148"
    },
    {
     "value": "evidence-based medicine",
     "count": "146"
    }
   ]
  },
  {
   "name": "pub",
   "values": [
    {
     "value": "Chinese Journal of Integrative Medicine",
     "count": "635"
    },
    {
     "value": "BMC Complementary and Alternative Medicine",
     "count": "306"
    },
    {
     "value": "Journal of General Internal Medicine",
     "count": "295"
    },
    {
     "value": "EPMA Journal",
     "count": "144"
    },
    {
     "value": "Der Anaesthesist",
     "count": "143"
    },
    {
     "value": "Notfall + Rettungsmedizin",
     "count": "137"
    },
    {
     "value": "Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz",
     "count": "120"
    },
    {
     "value": "BMC Health Services Research",
     "count": "107"
    },
    {
     "value": "Supportive Care in Cancer",
     "count": "106"
    },
    {
     "value": "Trials",
     "count": "102"
    },
    {
     "value": "Medicine, Health Care and Philosophy",
     "count": "95"
    },
    {
     "value": "Der Gynäkologe",
     "count": "92"
    },
    {
     "value": "BMC Medical Education",
     "count": "90"
    },
    {
     "value": "International Journal of Clinical Pharmacy",
     "count": "86"
    },
    {
     "value": "Rechtsmedizin",
     "count": "81"
    },
    {
     "value": "Wiener Medizinische Wochenschrift",
     "count": "79"
    },
    {
     "value": "Der Urologe",
     "count": "78"
    },
    {
     "value": "Journal of Religion and Health",
     "count": "78"
    },
    {
     "value": "International Journal of Emergency Medicine",
     "count": "75"
    },
    {
     "value": "Journal of Digital Imaging",
     "count": "75"
    }
   ]
  },
  {
   "name": "year",
   "values": [
    {
     "value": "2021",
     "count": "2"
    },
    {
     "value": "2018",
     "count": "56"
    },
    {
     "value": "2017",
     "count": "1849"
    },
    {
     "value": "2016",
     "count": "1663"
    },
    {
     "value": "2015",
     "count": "1369"
    },
    {
     "value": "2014",
     "count": "1269"
    },
    {
     "value": "2013",
     "count": "1019"
    },
    {
     "value": "2012",
     "count": "877"
    },
    {
     "value": "2011",
     "count": "712"
    },
    {
     "value": "2010",
     "count": "491"
    },
    {
     "value": "2009",
     "count": "474"
    },
    {
     "value": "2008",
     "count": "457"
    },
    {
     "value": "2007",
     "count": "368"
    },
    {
     "value": "2006",
     "count": "316"
    },
    {
     "value": "2005",
     "count": "276"
    },
    {
     "value": "2004",
     "count": "263"
    },
    {
     "value": "2003",
     "count": "235"
    },
    {
     "value": "2002",
     "count": "194"
    },
    {
     "value": "2001",
     "count": "164"
    },
    {
     "value": "2000",
     "count": "150"
    }
   ]
  },
  {
   "name": "country",
   "values": [
    {
     "value": "United States",
     "count": "3103"
    },
    {
     "value": "Germany",
     "count": "2056"
    },
    {
     "value": "",
     "count": "1584"
    },
    {
     "value": "China",
     "count": "1280"
    },
    {
     "value": "United Kingdom",
     "count": "875"
    },
    {
     "value": "Italy",
     "count": "565"
    },
    {
     "value": "Canada",
     "count": "521"
    },
    {
     "value": "Japan",
     "count": "448"
    },
    {
     "value": "Australia",
     "count": "424"
    },
    {
     "value": "France",
     "count": "381"
    },
    {
     "value": "Switzerland",
     "count": "346"
    },
    {
     "value": "South Korea",
     "count": "231"
    },
    {
     "value": "Sweden",
     "count": "230"
    },
    {
     "value": "India",
     "count": "229"
    },
    {
     "value": "Austria",
     "count": "218"
    },
    {
     "value": "Spain",
     "count": "206"
    },
    {
     "value": "Belgium",
     "count": "169"
    },
    {
     "value": "Brazil",
     "count": "156"
    },
    {
     "value": "Israel",
     "count": "142"
    },
    {
     "value": "Denmark",
     "count": "137"
    }
   ]
  },
  {
   "name": "type",
   "values": [
    {
     "value": "Journal",
     "count": "10699"
    },
    {
     "value": "Book",
     "count": "2296"
    }
   ]
  }
 ]
}</pre></div>        <h4>Response Code</h4>       <div class="block response_code"><pre>200</pre></div>        <h4>Response Headers</h4>       <div class="block response_headers"><pre class="prettyprint">date: Tue, 05 Dec 2017 03:31:14 GMT
content-encoding: gzip
server: openresty/1.11.2.5
x-aspnet-version: 4.0.30319
x-powered-by: ASP.NET
content-type: text/html; charset=utf-8
access-control-allow-origin: *
cache-control: private
access-control-allow-credentials: true
connection: keep-alive
content-length: 7684
servernumber: 19
</pre></div>      </div>   </div> </li></ul> </li></ul> </li><li class="resource" id="resource_Openaccess">   <div class="apidocs-heading operation-heading">     <h2>       <a data-name="Openaccess" href="https://dev.springer.com/documentation#/Openaccess">Springer Openacces API</a>     </h2>   </div>   <ul class="endpoints" id="Openaccess_endpoint_list" style=""><li class="endpoint">   <ul class="operations" id="Openaccess_endpoint_operations"><li class="get operation" data-operation-id="15">   <div class="apidocs-heading" style="background-color:#BABBAD">     <div class="apidocs-bubble">       <div class="action">         <a class="toggle">Springer OpenAccess API Service</a>       </div>     </div>     <div class="path-and-method">       <span class="path"><a>/openaccess/{output}</a></span>       <span class="http_method"><a>GET</a></span>     </div>     <ul class="options" style="display:none">       <li>         <a>/openaccess/{output}</a>       </li>     </ul>   </div>   <div class="content" data-operation-id="15" style="">          <h4>Description</h4>     <p>The Springer OpenAccess API Provides metadata, full-text content, and images for over 80,000 open access articles from BioMed Central and SpringerOpen journals. 
    For testing the Springer OpenAccess API: 
    1.Pass your API Key value in the api_key field. 
    2.Pass the query string in the q field (e.g., keyword:saturn). 
    3. Indicate desired output format. 
    4. Amend the s and p parameters for pagination if desired. 
    4. Amend the s and p parameters for pagination if desired. 
    5. Click on 'Send Request' button. 
    6. Scroll down and you can see the result being generated.</p>               <form accept-charset="UTF-8" data-method="GET" data-host="http://api.springer.com" data-path="/openaccess/{output}" action="https://dev.springer.com/documentation#" class="sandbox" method="post">       <div style="margin:0;padding:0;display:inline"></div>       <table class="fullwidth">         <thead>           <tr>             <th>Parameter</th>             <th>Value</th>             <th>Description</th>           </tr>         </thead>         <tbody id="Openaccess_15_GET_params"><tr class="zebra">   <td class="">api_key</td>   <td>     <input data-threescale-name="api_key" data-guid="16" data-param-type="query" minlength="0" name="api_key" data-original-name="api_key" type="text" value="">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Your API access key     </div>   </td> </tr><tr class="zebra">   <td class="">q</td>   <td>     <input data-threescale-name="q" data-guid="17" data-param-type="query" minlength="0" name="q" data-original-name="q" type="text" value="constraint:value">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Query String     </div>   </td> </tr><tr class="zebra">   <td class="">output</td>   <td>     <input data-guid="18" data-param-type="path" minlength="0" name="output" data-original-name="output" type="text" value="app">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Output/Result format as JSON or PAM     </div>   </td> </tr><tr class="zebra">   <td class="">s</td>   <td>     <input data-threescale-name="q" data-guid="19" data-param-type="query" minlength="0" name="s" data-original-name="s" type="text" value="1">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       The index of the first hit to return. If 0, treated as 1. The default is 1     </div>   </td> </tr><tr class="zebra">   <td class="">p</td>   <td>     <input data-threescale-name="q" data-guid="20" data-param-type="query" minlength="0" name="p" data-original-name="p" type="text" value="10">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       The maximum number of hits/results to return. The default is 10.     </div>   </td> </tr></tbody>       </table>       <div class="submit-bar">                    <button class="submit" name="commit" type="button"><span>Send Request</span></button>                  <a href="https://dev.springer.com/documentation#" data-guid="15" class="hide-response" style="">HIDE RESPONSE</a>       </div>     </form>     <div class="response" data-guid="15" style="">        <h4 class="request_heading">Request</h4>       <div class="block request_url"><pre class="prettyprint">curl -v  -X GET "http://api.springer.com/openaccess/app?api_key=b9ab99a51faec6511d70c08f878cfc61&amp;q=keyword%3Alung+cancer&amp;s=1&amp;p=10"</pre></div>        <h4 class="response_body_heading">Response Body</h4>       <div class="block response_body"><pre class="prettyprint">&lt;?xml version="1.0"?&gt;
&lt;?xml-stylesheet type="text/xsl" href="/resources/spdi-open-app.xsl"?&gt;
&lt;response&gt;
  &lt;query&gt;keyword:lung cancer&lt;/query&gt;
  &lt;apiKey&gt;b9ab99a51faec6511d70c08f878cfc61&lt;/apiKey&gt;
  &lt;result&gt;
    &lt;total&gt;2258&lt;/total&gt;
    &lt;start&gt;1&lt;/start&gt;
    &lt;pageLength&gt;10&lt;/pageLength&gt;
    &lt;recordsDisplayed&gt;10&lt;/recordsDisplayed&gt;
  &lt;/result&gt;
  &lt;records&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;BioMed Central&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;London&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;BioMed Central&lt;/PublisherImprintName&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="Online"&gt;
        &lt;JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;13014&lt;/JournalID&gt;
          &lt;JournalElectronicISSN&gt;1748-717X&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;Radiation Oncology&lt;/JournalTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;Radiat Oncol&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCB" Type="Primary"&gt;Biomedicine&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCB11001" Priority="1" Type="Secondary"&gt;Cancer Research&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH33160" Priority="2" Type="Secondary"&gt;Oncology&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH29056" Priority="3" Type="Secondary"&gt;Radiotherapy&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH29005" Priority="4" Type="Secondary"&gt;Imaging / Radiology&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Biomedical and Life Sciences"&gt;SC3&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;Volume OutputMedium="Online"&gt;
          &lt;VolumeInfo TocLevels="0" VolumeType="Regular"&gt;
            &lt;VolumeIDStart&gt;12&lt;/VolumeIDStart&gt;
            &lt;VolumeIDEnd&gt;12&lt;/VolumeIDEnd&gt;
            &lt;VolumeIssueCount&gt;1&lt;/VolumeIssueCount&gt;
          &lt;/VolumeInfo&gt;
          &lt;Issue IssueType="Regular" OutputMedium="Online"&gt;
            &lt;IssueInfo IssueType="Regular" TocLevels="0"&gt;
              &lt;IssueIDStart&gt;1&lt;/IssueIDStart&gt;
              &lt;IssueIDEnd&gt;1&lt;/IssueIDEnd&gt;
              &lt;IssueArticleCount&gt;0&lt;/IssueArticleCount&gt;
              &lt;IssueHistory&gt;
                &lt;CoverDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                &lt;/CoverDate&gt;
                &lt;PricelistYear&gt;2017&lt;/PricelistYear&gt;
              &lt;/IssueHistory&gt;
              &lt;IssueCopyright&gt;
                &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
              &lt;/IssueCopyright&gt;
            &lt;/IssueInfo&gt;
            &lt;Article ID="s13014-017-0909-6" OutputMedium="Online"&gt;
              &lt;ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
                &lt;ArticleID&gt;909&lt;/ArticleID&gt;
                &lt;ArticleDOI&gt;10.1186/s13014-017-0909-6&lt;/ArticleDOI&gt;
                &lt;ArticleCitationID&gt;195&lt;/ArticleCitationID&gt;
                &lt;ArticleSequenceNumber&gt;195&lt;/ArticleSequenceNumber&gt;
                &lt;ArticleTitle Language="En" OutputMedium="All"&gt;Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer&lt;/ArticleTitle&gt;
                &lt;ArticleCategory&gt;Research&lt;/ArticleCategory&gt;
                &lt;ArticleCollection ID="AC_820c960a380f8d590fd2c54509d53172" Type="Regular"&gt;
                  &lt;ArticleCollectionTitle&gt;Clinical Radiation Oncology&lt;/ArticleCollectionTitle&gt;
                &lt;/ArticleCollection&gt;
                &lt;ArticleFirstPage&gt;1&lt;/ArticleFirstPage&gt;
                &lt;ArticleLastPage&gt;8&lt;/ArticleLastPage&gt;
                &lt;ArticleHistory&gt;
                  &lt;RegistrationDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;10&lt;/Month&gt;
                    &lt;Day&gt;31&lt;/Day&gt;
                  &lt;/RegistrationDate&gt;
                  &lt;Received&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;8&lt;/Month&gt;
                    &lt;Day&gt;21&lt;/Day&gt;
                  &lt;/Received&gt;
                  &lt;Accepted&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;10&lt;/Month&gt;
                    &lt;Day&gt;19&lt;/Day&gt;
                  &lt;/Accepted&gt;
                  &lt;OnlineDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;12&lt;/Month&gt;
                    &lt;Day&gt;2&lt;/Day&gt;
                  &lt;/OnlineDate&gt;
                &lt;/ArticleHistory&gt;
                &lt;ArticleFundingInformation&gt;
                  &lt;Fund&gt;
                    &lt;FunderName FundRefID="http://dx.doi.org/10.13039/501100001809"&gt;National Natural Science Foundation of China&lt;/FunderName&gt;
                    &lt;GrantNumber GrantRecipient="Au9" Type="FundRef"&gt;81272616&lt;/GrantNumber&gt;
                  &lt;/Fund&gt;
                &lt;/ArticleFundingInformation&gt;
                &lt;ArticleCopyright&gt;
                  &lt;CopyrightHolderName&gt;The Author(s).&lt;/CopyrightHolderName&gt;
                  &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                  &lt;License SubType="CC BY + CC0" Type="OpenAccess" Version="4.0"&gt;
                    &lt;SimplePara&gt;
                      &lt;Emphasis Type="Bold"&gt;Open Access&lt;/Emphasis&gt;This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;http://creativecommons.org/licenses/by/4.0/&lt;/RefSource&gt;
                        &lt;RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/&gt;
                      &lt;/ExternalRef&gt;), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;http://creativecommons.org/publicdomain/zero/1.0/&lt;/RefSource&gt;
                        &lt;RefTarget Address="http://creativecommons.org/publicdomain/zero/1.0/" TargetType="URL"/&gt;
                      &lt;/ExternalRef&gt;) applies to the data made available in this article, unless otherwise stated.
                    &lt;/SimplePara&gt;
                  &lt;/License&gt;
                &lt;/ArticleCopyright&gt;
                &lt;ArticleGrants Type="OpenChoice"&gt;
                  &lt;MetadataGrant Grant="OpenAccess"/&gt;
                  &lt;AbstractGrant Grant="OpenAccess"/&gt;
                  &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                  &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                  &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                  &lt;ESMGrant Grant="OpenAccess"/&gt;
                &lt;/ArticleGrants&gt;
              &lt;/ArticleInfo&gt;
              &lt;ArticleHeader&gt;
                &lt;AuthorGroup&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au1"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Juntao&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Ran&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;ranjt2014@126.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au2"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Jingbo&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;wangjingbo303@yahoo.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au3"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Nan&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Bi&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;binan_email@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au4"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Wei&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Jiang&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;jwmars@126.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au5"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Zongmei&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Zhou&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;zhouzongmei2013@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au6"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Zhouguang&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Hui&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;drdhuizg@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au7"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Jun&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Liang&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;liang23400@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au8"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Qinfu&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Feng&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;13811300221@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au9"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Luhua&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Phone&gt;(86) 010 8778 8799&lt;/Phone&gt;
                      &lt;Email&gt;wlhwq@yahoo.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Affiliation ID="Aff1"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0000 9889 6335&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.413106.1&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Radiation Oncology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;17 Panjiayuan Nanli, Chaoyang District&lt;/Street&gt;
                      &lt;City&gt;Beijing&lt;/City&gt;
                      &lt;Postcode&gt;100021&lt;/Postcode&gt;
                      &lt;Country Code="CN"&gt;People’s Republic of China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                &lt;/AuthorGroup&gt;
                &lt;Abstract ID="Abs1" Language="En" OutputMedium="All"&gt;
                  &lt;Heading&gt;Abstract&lt;/Heading&gt;
                  &lt;AbstractSection ID="ASec1"&gt;
                    &lt;Heading&gt;Background&lt;/Heading&gt;
                    &lt;Para ID="Par1"&gt;Heath-related quality of life (HRQoL) among survivors with unresectable locally-advanced non-small cell lung cancer (LA-NSCLC) treated with radiotherapy and chemotherapy still is not clear. The current study were performed to determine HRQoL for long-term survivors with unresectable LA-NSCLC and to identify risk factors for poor HRQoL.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec2"&gt;
                    &lt;Heading&gt;Methods&lt;/Heading&gt;
                    &lt;Para ID="Par2"&gt;Among patients with LA-NSCLC receiving radiotherapy and chemotherapy between January 2006 and December 2010, 82 long-term survivors beyond 5&nbsp;years were identified in this cross-sectional study. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 and the lung cancer-specific questionnaire QLQ-LC13 were employed to gather information on HRQoL. HRQoL scores were compared between different subgroups to analyze factors related to HRQoL.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec3"&gt;
                    &lt;Heading&gt;Results&lt;/Heading&gt;
                    &lt;Para ID="Par3"&gt;Fifty-five out of 82 (67%) long-term survivors completed the HRQoL survey. They reported a mild reduction in global health status and physical and emotional functioning. Fatigue, dyspnea, coughing, and financial difficulties ranked the highest scores in the symptom scales. Analysis of risk factors for HRQoL showed age, exercise, smoking status, and treatment regimen were associated with global health status and functional scores, while age, gender, radiation pneumonitis, weight loss, and exercise were associated with symptom scores.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec4"&gt;
                    &lt;Heading&gt;Conclusions&lt;/Heading&gt;
                    &lt;Para ID="Par4"&gt;This study provides the first description of the HRQoL of long-term LA-NSCLC survivors receiving radiotherapy and chemotherapy who may experience a relatively high HRQoL. Factors related to poorer HRQoL are potential targets for intervention.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                &lt;/Abstract&gt;
                &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                  &lt;Heading&gt;Keywords&lt;/Heading&gt;
                  &lt;Keyword&gt;Health-related quality of life&lt;/Keyword&gt;
                  &lt;Keyword&gt;Non-small cell lung cancer&lt;/Keyword&gt;
                  &lt;Keyword&gt;Survivor&lt;/Keyword&gt;
                  &lt;Keyword&gt;Radiotherapy&lt;/Keyword&gt;
                  &lt;Keyword&gt;Chemotherapy&lt;/Keyword&gt;
                &lt;/KeywordGroup&gt;
                &lt;AbbreviationGroup&gt;
                  &lt;Heading&gt;Abbreviations&lt;/Heading&gt;
                  &lt;DefinitionList&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;CCRT&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par5"&gt;Concurrent chemoradiotherapy&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;CT&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par6"&gt;Chemotherapy&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;EORTC&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par7"&gt;European Organization for Research and Treatment of Cancer&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;HRQoL&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par8"&gt;Heath-related quality of life&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;IQR&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par9"&gt;Interquartile range&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;LA-NSCLC&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par10"&gt;Locally-advanced non-small cell lung cancer&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;LCDY&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par11"&gt;Dyspnea in QLQ LC13&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;NRCMS&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par12"&gt;New rural cooperative medical scheme’&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;nSCG&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par13"&gt;Non-Survey completed group&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;NSCLC&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par14"&gt;Non-small cell lung cancer&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;QLQ&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par15"&gt;Quality of life questionnaire&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;QoL&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par16"&gt;Quality of life&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;RP&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par17"&gt;Radiation pneumonitis&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;RT&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par18"&gt;Radiotherapy&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;SCG&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par19"&gt;Survey completed group&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;SD&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par20"&gt;Standard deviation&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;URBMI&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par21"&gt;Urban resident basic medical insurance&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                  &lt;/DefinitionList&gt;
                &lt;/AbbreviationGroup&gt;
              &lt;/ArticleHeader&gt;
              &lt;Body&gt;
                &lt;Section1 ID="Sec1"&gt;
                  &lt;Heading&gt;Background&lt;/Heading&gt;
                  &lt;Para ID="Par22"&gt;For decades, health practitioners have improved the outcome of locally advanced NSCLC (LA-NSCLC) by using concurrent chemoradiotherapy. Thus, a substantial goal of LA-NSCLC management is to maintain or improve the survivors’ health-related quality of life (HRQoL). Information about the HRQoL of long-term LA-NSCLC survivors is essential to anticipate consequences and problems. Moreover, it is useful to analyze factors that affect HRQoL and find optimal intervention to improve HRQoL.&lt;/Para&gt;
                  &lt;Para ID="Par23"&gt;Long-term lung cancer survivors experienced quality of life (QoL) impairment in 35% of cases and reported declined QoL and a worsened symptom load [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]. A cross-sectional study of QoL showed that a distressed mood was the most important predictor of the QoL of long-term NSCLC survivors [
                    &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;]. Most patients in both studies were stageIand treated with surgery. However, little is known about the HRQoL status of long-term LA-NSCLC survivors who have survived beyond 5&nbsp;years receiving radiotherapy and chemotherapy. This study aimed to determine the HRQoL of long-term LA-NSCLC survivors receiving radiotherapy and chemotherapy and to explore the relationships between demographic, clinical characteristics, and HRQoL.
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec2"&gt;
                  &lt;Heading&gt;Methods&lt;/Heading&gt;
                  &lt;Section2 ID="Sec3"&gt;
                    &lt;Heading&gt;Patients&lt;/Heading&gt;
                    &lt;Para ID="Par24"&gt;Patients diagnosed with histologically/cytologically confirmed LA-NSCLC (stages IIIA or IIIB) and treated with radiotherapy in our department between January 2006 and December 2010 were reviewed in the current study. We defined patients who are still living at least five years after diagnosis with LA-NSCLC as long-term survivors. Patients’ demographics and clinical characteristics were uniformly collected from their medical records. Tumor stages of all patients were reclassified using the 7th edition of the American Joint Committee on Cancer Staging. Eligibility included histologically or cytologically confirmed NSCLC, older than age 18 at the time of diagnosis, and medical records indicating at least 60&nbsp;months of follow-up. No specific post-treatment rehabilitation program was provided for all eligible patients, but the smokers were encouraged to stop smoking. The protocol of this study was approved by the ethics committees of the institution.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec4"&gt;
                    &lt;Heading&gt;Assessment of HRQoL&lt;/Heading&gt;
                    &lt;Para ID="Par25"&gt;Health-related QoL was assessed using a validated, cancer-specific core questionnaire, the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 (version 3.0) and a lung-specific module, the EORTC QLQ LC-13 [
                      &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;]. Questions were scaled and scored using the recommended EORTC quality of life group procedures [
                      &lt;CitationRef CitationID="CR4"&gt;4&lt;/CitationRef&gt;]. All scores on the EORTC QLQ-C30 and the QLQ-LC 13 were transformed to a 0 to 100 scale according to the guidelines of EORTC. Higher scores for the global QL and functional domains indicate better global health and function, while higher scores for symptoms indicate greater symptom severity. Given that a 10-point change in each of the EORTC multi-item scales is generally considered to be a moderate or meaningful change [
                      &lt;CitationRef CitationID="CR5"&gt;5&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR6"&gt;6&lt;/CitationRef&gt;], for the single-item scales, four levels of responses were defined: not at all, a little, quite a bit, and very much. Demographic characteristics were collected at the instructions of the survey. Smoking status was classified as current, former, and never smoker. Pack years of smoking were calculated as the number of packs of cigarettes smoked per day during the years of smoking. Exercise was defined as at least 30&nbsp;min of moderate aerobic exercise a day, at least five days a week.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec5"&gt;
                    &lt;Heading&gt;Survey procedures&lt;/Heading&gt;
                    &lt;Para ID="Par26"&gt;Eligible patients were asked to sign the consent form if they would be interested in the survey and complete Chinese versions of the questionnaires, if feasible, during their latest visit to the hospital. Others were mailed a consent form, questionnaires, and a stamped envelope. After the letter, a trained interviewer telephoned the patient to ask if the survivor was interested in the survey. Those who agreed to take part in the survey either completed a letter in reply or responded through a trained interviewer via telephone for survivors who could not complete the questionnaires by themselves.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec6"&gt;
                    &lt;Heading&gt;Statistical analysis&lt;/Heading&gt;
                    &lt;Para ID="Par27"&gt;The chi-squared test was applied for categorical variables to evaluate whether survey respondents differed significantly from nonrespondents of all patients. Cumulative survival was estimated according to the Kaplan-Meier method. Descriptive statistics, as appropriate, were used to provide a profile of HRQoL. HRQoL data were analyzed using nonparametric methods because the data were not normally distributed. Univariate data were compared by applying the Mann-Whitney 
                      &lt;Emphasis Type="Italic"&gt;U&lt;/Emphasis&gt; test or the KrusKal-Wallis test. Statistical analyses were performed using statistical software SPSS 19.0. The level of statistical significance was set to 0.05.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec7"&gt;
                  &lt;Heading&gt;Results&lt;/Heading&gt;
                  &lt;Section2 ID="Sec8"&gt;
                    &lt;Heading&gt;Patient characteristics&lt;/Heading&gt;
                    &lt;Para ID="Par28"&gt;The records of 505 patients with LA-NSCLC who underwent radiotherapy and chemotherapy were retrospectively reviewed. Of the 82 patients who were still living at 5&nbsp;years or more after diagnosis, 55 patients completed the Chinese versions of the EORTC QLQ-C30 questionnaires and the QLQ-LC13 module. Patients’ characteristics are summarized in Table&nbsp;
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;. Those who completed the survey (Survey Completed Group, SCG) included more patients treated with concurrent chemoradiotherapy (CCRT) and higher objective response rates than those who did not complete the survey (non-Survey Completed Group, nSCG) (
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.05), but they did not differ with regard to other factors.
                      &lt;Table Float="Yes" ID="Tab1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Comparison of characteristics of patients between nSCG and SCG&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup cols="5"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                          &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Characteristics&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;nSCG (450) n (%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;SCG (55) n (%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt; value
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Age&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Mean&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;61&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;60&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.563&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;SD&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;11&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;10&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Gender&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Male&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;372 (82.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;45 (81.8%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.876&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Female&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;78 (17.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;10 (18.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;KPS Score
                                  &lt;Superscript&gt;a&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;90–100&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;116 (25.8%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;19 (34.5%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.165&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;60–80&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;334 (74.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;36 (65.5%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Histology&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Squamous&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;266 (59.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;28 (50.9%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.244&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Non-squamous&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;184 (40.9%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;27 (49.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Stages (AJCC 2002)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;IIIA&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;156 (34.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;25 (45.5%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.115&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;IIIB&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;294 (65.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;30 (54.5%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Smoking status&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Never&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;89 (19.8%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;13 (23.6%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.501&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Former/current&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;361 (80.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;42 (76.4%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Weight loss
                                  &lt;Superscript&gt;b&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;≥5 %&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;121 (26.9%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;15 (27.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.959&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;&amp;lt;5 %&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;328 (73.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;40 (72.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Regimens&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;RT&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;122 (27.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;5 (9.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.006&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;CRT&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;147 (32.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;18 (32.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;CCRT
                                  &lt;Superscript&gt;c&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;181 (40.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;32 (58.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;RT dose&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;&amp;lt;60Gy&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;138 (30.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;11 (20%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.102&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;≥60Gy&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;312 (69.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;44 (80%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;RT-technique&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;2D–RT&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;41 (9.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;2 (3.6%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.343&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3D–CRT&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;22 (4.9%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;2 (3.6%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;IMRT&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;387 (86%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;51 (92.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Response rate
                                  &lt;Superscript&gt;d&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;CR&nbsp;+&nbsp;PR&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;285 (64.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;43 (78.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.039&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;SD&nbsp;+&nbsp;PD&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;159 (35.8%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;12 (21.8%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Radiation esophagitis
                                  &lt;Superscript&gt;e&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;&amp;lt;grade 2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;269 (64.4%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;37 (67.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.670&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;≥grade 2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;149 (35.6%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;18 (32.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Radiation pneumonitis
                                  &lt;Superscript&gt;f&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;&amp;lt;grade 2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;330 (85.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;46 (83.6%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry align="char" char="." colname="c5"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;0.750&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;≥grade 2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;57 (14.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;9 (16.4%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"/&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Superscript&gt;a&lt;/Superscript&gt;one patient &amp;lt;80 in SCG, 
                            &lt;Superscript&gt;b&lt;/Superscript&gt;one patient without data of weight loss, 
                            &lt;Superscript&gt;c&lt;/Superscript&gt;CCRT including:induction chemotherapy&nbsp;+&nbsp;CCRT,CCRT&nbsp;+&nbsp;consolidation chemotherapy,induction&nbsp;+&nbsp;CCRT&nbsp;+&nbsp;consolidation chemotherapy and CCRT, 
                            &lt;Superscript&gt;d&lt;/Superscript&gt;six patients without data of response rate, 
                            &lt;Superscript&gt;e&lt;/Superscript&gt;32 patients without data of radiation esophagitis, 
                            &lt;Superscript&gt;f&lt;/Superscript&gt;63 patients without data of radiation pneumonitis. 
                            &lt;Emphasis Type="Italic"&gt;CCRT&lt;/Emphasis&gt; Concurrent chemo-radiotherapy, 
                            &lt;Emphasis Type="Italic"&gt;nSCG&lt;/Emphasis&gt; non-Survey completed group, 
                            &lt;Emphasis Type="Italic"&gt;RT&lt;/Emphasis&gt; Radiotherapy, 
                            &lt;Emphasis Type="Italic"&gt;SCG&lt;/Emphasis&gt; Survey completed group
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par29"&gt;The demographic characteristics at the time of the interview of the 55 patients in SCG group are listed in Table&nbsp;
                      &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt;. Thirty-one patients reported no comorbidities. Three patients had second primary cancer (lung cancer, rectal cancer, and bladder cancer, respectively), two patients had metastasis (brain and liver, respectively), and five patients received target therapy (3 with erlotinib and 2 with gefitinib). The majority (54/55, 98%) could perform their daily life activities by themselves (KPS&nbsp;≥&nbsp;80). They also reported their educational level, employment status, income per month, and exercise status. Main types of aerobic exercise reported were brisk walking, jogging, Tai chi, and Qigong. All 55 patients had health insurance.
                      &lt;Table Float="Yes" ID="Tab2"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 2&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Demographic characteristics of 55 long-term survivors&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup cols="2"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="char" char="(" colname="c2" colnum="2"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Characteristic&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;n (%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Comorbidities&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Emphysema/COPD&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4 (7.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Heart disease&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;7 (12.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Hypertension&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;11 (20%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Diabetes&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4 (7.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Cancer&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Second primary cancer&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3 (5.5%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Metastasis&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;2 (3.6%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Other comorbidities&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;5 (9.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Target therapy&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;5 (9.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Smoking status&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Never&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;13 (23.6%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Former&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;38 (69.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Current&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4 (7.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; &nbsp;&amp;lt;&nbsp;20 pack-y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;21 (38.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; &nbsp;≥&nbsp;20 pack-y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;34 (61.8%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Education&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Less than high school&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;21 (38.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; High school graduate or more&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;34 (61.8%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Employment status&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Employed&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;10 (18.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Retired and unemployed&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;45 (81.8%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Income per month&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; &nbsp;&amp;lt;&nbsp;3000&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;16 (29.1%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; &nbsp;≥&nbsp;3000&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;39 (70.9%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Medical insurance&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; URBMI&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;51 (92.7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; NRCMS&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4 (7.3%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Taking exercise&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; yes&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;45 (81.8%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; no&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;10 (18.2%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Emphasis Type="Italic"&gt;URBMI&lt;/Emphasis&gt; Urban resident basic medical insurance, 
                            &lt;Emphasis Type="Italic"&gt;NRCMS&lt;/Emphasis&gt; New rural cooperative medical scheme
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec9"&gt;
                    &lt;Heading&gt;Survival and compliance&lt;/Heading&gt;
                    &lt;Para ID="Par30"&gt;Of 505 patients, the median survival time was 21&nbsp;months (95% CI, 19.14 to 22.86&nbsp;months), and the overall 1, 2, and 5-year survival rates were 73.2%, 44.4%, and 17.1%, respectively. Because of death or no follow-up, only 55 of the 82 (67%) long-term survivors completed the survey. Fourteen patients died, including 2 patients who died from pancreatitis and a heart attack, respectively in the 5th year. Besides those patients, there were 9 patients lost to follow-up and 4 patients who did not want to complete the questionnaires.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec10"&gt;
                    &lt;Heading&gt;Health-related quality of life&lt;/Heading&gt;
                    &lt;Para ID="Par31"&gt;Self-reported HRQoL scores for the QLQ-C30 and the QLQ-LC13 are displayed in Table&nbsp;
                      &lt;InternalRef RefID="Tab3"&gt;3&lt;/InternalRef&gt;. The greatest impairment was seen in global health status (76.67 ± 15.91), followed by physical impairment (86.06 ± 14.53), and emotional (89.58 ± 14.65) functioning. There were relatively high levels of role, social, and cognitive functioning with scores above 90. Most symptom scores were very low, except for scores of fatigue (27.02 ± 15.72), dyspnea (24.85&nbsp;±&nbsp;19.48 in QLQ-C30; 18.08 ± 13.74 in QLQ-LC13), coughing (23.03 ± 19.11), and financial difficulties (14.55 ± 21.05). The patients of four levels of responses of single-item symptom scales are shown in Fig.&nbsp;
                      &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt;. The most prevalent symptoms were fatigue (49/55, 89%), dyspnea (QLQ-LC13, 48/55, 87.3%; QLQ-C30, 37/55, 67.3%), coughing (35/55, 63.6%), and financial difficulties (20/55, 36.4%).
                      &lt;Table Float="Yes" ID="Tab3"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 3&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;HRQoL Scores of Long-term LA-NSCLC Survivors&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup cols="4"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="char" char="(" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="char" char="(" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;QoL Scale&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Mean (SD)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Median (IQR)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Range&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c4" namest="c1"&gt;
                                &lt;SimplePara&gt;QLQ-C30&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Global health status/QoL&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;76.67 (15.91)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;83.33 (66.67–91.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(25–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Physical functioning&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;86.06 (14.53)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;93.33 (80.0–93.3)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(20–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Role functioning&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;91.21(17.53)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;100 (83.3–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Emotional functioning&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;89.58 (14.65)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;100 (75.0–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(50–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Cognitive functioning&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;94.24 (12.51)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;100 (100–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(33.3–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Social functioning&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;93.94 (13.75)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;100 (100–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(33.3–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Fatigue&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;27.02 (15.77)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;33.33 (22.22–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–100)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Nausea and vomiting&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.40 (2.99)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–22.22)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Pain&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;5.76 (12.92)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–66.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Dyspnea&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;24.85 (19.48)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;33.33 (0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–66.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Insomnia&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;6.67 (16.23)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–66.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Appetite loss&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;2.42 (8.74)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Constipation&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;2.42 (8.74)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Diarrhea&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.82 (7.64)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Financial difficulties&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;14.55 (21.05)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–66.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c4" namest="c1"&gt;
                                &lt;SimplePara&gt;QLQ LC-13&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Dyspnea&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;18.08 (13.74)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;11.11 (11.11–22.22)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–66.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Coughing&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;23.03 (19.11)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;33.33 (0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–66.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Hemoptysis&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4.24 (12.92)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–66.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Sore mouth&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0 (0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Dysphagia&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.82 (9.98)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–66.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Peripheral neuropathy&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;2.42 (8.74)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Alopecia&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;5.45 (14.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–66.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Pain in chest&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;2.42 (8.74)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Pain in arm/shoulder&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3.64 (10.49)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Pain in other parts&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.21 (6.30)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 (0–0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;(0–33.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Emphasis Type="Italic"&gt;IQR&lt;/Emphasis&gt; Interquartile range, 
                            &lt;Emphasis Type="Italic"&gt;SD&lt;/Emphasis&gt; Standard deviation
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Number of patients in four levels of responses of single-item symptom scales&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO1"&gt;
                          &lt;ImageObject Color="Color" FileRef="MediaObjects/13014_2017_909_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec11"&gt;
                    &lt;Heading&gt;Risk factors for poor HRQoL&lt;/Heading&gt;
                    &lt;Para ID="Par32"&gt;In global health status and functional scales, survivors of a younger age (≤60&nbsp;years old), exercise, without comorbidity, and never smoker were significantly associated with more favorable scores for global health status. Likely, those with age (≤60&nbsp;years old), exercise and without comorbidity had better physical, role and social functioning (
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt; &amp;lt; 0.05). In contrast, CCRT was negatively associated with emotional functioning (
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt; &amp;lt; 0.05) (Table&nbsp;
                      &lt;InternalRef RefID="Tab4"&gt;4&lt;/InternalRef&gt;). On the examination of the association between symptom load and the characteristics of survivors, fatigue was significantly negatively affected by weight loss &amp;lt;5% and lack of exercise (
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt; &amp;lt; 0.05), while dyspnea was significantly negatively affected by gender: male, with at least one comorbidity, radiation pneumonitis (RP, ≥ grade 2), and age (&amp;gt;60&nbsp;years old) (
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.05) (Table&nbsp;
                      &lt;InternalRef RefID="Tab5"&gt;5&lt;/InternalRef&gt;). HRQoL was not significantly affected by other factors.
                      &lt;Table Float="Yes" ID="Tab4"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 4&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Relationship between selected demographic/clinical features and global health status, functional scale scores, mean (SD)&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup cols="17"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="char" char="(" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="char" char="(" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="char" char="." colname="c4" colnum="4"/&gt;
                          &lt;colspec align="char" char="(" colname="c5" colnum="5"/&gt;
                          &lt;colspec align="char" char="(" colname="c6" colnum="6"/&gt;
                          &lt;colspec align="char" char="." colname="c7" colnum="7"/&gt;
                          &lt;colspec align="char" char="(" colname="c8" colnum="8"/&gt;
                          &lt;colspec align="char" char="(" colname="c9" colnum="9"/&gt;
                          &lt;colspec align="char" char="." colname="c10" colnum="10"/&gt;
                          &lt;colspec align="char" char="(" colname="c11" colnum="11"/&gt;
                          &lt;colspec align="char" char="(" colname="c12" colnum="12"/&gt;
                          &lt;colspec align="char" char="." colname="c13" colnum="13"/&gt;
                          &lt;colspec align="char" char="(" colname="c14" colnum="14"/&gt;
                          &lt;colspec align="char" char="(" colname="c15" colnum="15"/&gt;
                          &lt;colspec align="char" char="(" colname="c16" colnum="16"/&gt;
                          &lt;colspec align="char" char="." colname="c17" colnum="17"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry nameend="c3" namest="c2"&gt;
                                &lt;SimplePara&gt;Age&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c6" namest="c5"&gt;
                                &lt;SimplePara&gt;Exercise&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c9" namest="c8"&gt;
                                &lt;SimplePara&gt;Comorbidity&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c10" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c12" namest="c11"&gt;
                                &lt;SimplePara&gt;Smoking status&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c13" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c16" namest="c14"&gt;
                                &lt;SimplePara&gt;Regimens&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c17" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;≤60 (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;25)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;&amp;gt;60 (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;30)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Yes (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;45)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;No (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;10)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;Yes (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;24)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;No (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;31)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c11"&gt;
                                &lt;SimplePara&gt;Never (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;13)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c12"&gt;
                                &lt;SimplePara&gt;Former/current (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;42)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c14"&gt;
                                &lt;SimplePara&gt;RT (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;5)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c15"&gt;
                                &lt;SimplePara&gt;RT&nbsp;+&nbsp;CT (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;18)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c16"&gt;
                                &lt;SimplePara&gt;CCRT (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;32)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Global health status&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;82.64 (12.98)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;71.39 (16.48)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.011&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;79.81 (14.81)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;62.5 (13.18)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;69.79 (17.34)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;81.99 (12.56)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c10"&gt;
                                &lt;SimplePara&gt;0.007&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c11"&gt;
                                &lt;SimplePara&gt;85.71(12.42)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c12"&gt;
                                &lt;SimplePara&gt;73.58 (15.91)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c13"&gt;
                                &lt;SimplePara&gt;0.01&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c14"&gt;
                                &lt;SimplePara&gt;73.33 (21.57)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c15"&gt;
                                &lt;SimplePara&gt;79.63 (11.15)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c16"&gt;
                                &lt;SimplePara&gt;75.52 (17.45)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c17"&gt;
                                &lt;SimplePara&gt;0.775&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Physical functioning&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;93.06 (7.22)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;80.0 (16.33)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.000&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;88.59 (13.9)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;74.67 (12.09)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;80.28 (17.42)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;90.54 (10.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c10"&gt;
                                &lt;SimplePara&gt;0.007&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c11"&gt;
                                &lt;SimplePara&gt;90.95 (8.52)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c12"&gt;
                                &lt;SimplePara&gt;84.39 (15.82)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c13"&gt;
                                &lt;SimplePara&gt;0.162&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c14"&gt;
                                &lt;SimplePara&gt;78.67 (17.26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c15"&gt;
                                &lt;SimplePara&gt;85.56 (11.72)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c16"&gt;
                                &lt;SimplePara&gt;87.5 (15.59)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c17"&gt;
                                &lt;SimplePara&gt;0.293&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Role functioning&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;98.61 (4.71)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;85.0 (21.60)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;93.7 (17.51)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;80.0 (13.15)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.000&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;85.42 (22.69)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;95.70 (10.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c10"&gt;
                                &lt;SimplePara&gt;0.019&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c11"&gt;
                                &lt;SimplePara&gt;96.43 (9.65)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c12"&gt;
                                &lt;SimplePara&gt;89.43 (19.28)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c13"&gt;
                                &lt;SimplePara&gt;0.157&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c14"&gt;
                                &lt;SimplePara&gt;86.67 (18.26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c15"&gt;
                                &lt;SimplePara&gt;90.74 (13.06)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c16"&gt;
                                &lt;SimplePara&gt;92.19 (19.85)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c17"&gt;
                                &lt;SimplePara&gt;0.414&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Emotional functioning&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;90.97 (13.66)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;88.11 (15.63)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.492&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;90.59 (14.53)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;85.0 (15.11)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.110&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;87.22 (16.90)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;91.40 (12.64)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c10"&gt;
                                &lt;SimplePara&gt;0.284&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c11"&gt;
                                &lt;SimplePara&gt;91.07 (14.05)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c12"&gt;
                                &lt;SimplePara&gt;89.07 (14.99)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c13"&gt;
                                &lt;SimplePara&gt;0.619&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c14"&gt;
                                &lt;SimplePara&gt;95.0 (11.18)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c15"&gt;
                                &lt;SimplePara&gt;95.37 (9.58)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c16"&gt;
                                &lt;SimplePara&gt;85.47 (16.31)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c17"&gt;
                                &lt;SimplePara&gt;0.035&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Social functioning&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;100 (0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;88.89 (17.14)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;95.93 (12.39)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;85.0 (16.57)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.002&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;88.20 (18.04)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;98.39 (6.60)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c10"&gt;
                                &lt;SimplePara&gt;0.002&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c11"&gt;
                                &lt;SimplePara&gt;98.81 (4.45)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c12"&gt;
                                &lt;SimplePara&gt;92.28 (15.41)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c13"&gt;
                                &lt;SimplePara&gt;0.114&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c14"&gt;
                                &lt;SimplePara&gt;86.67 (21.73)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c15"&gt;
                                &lt;SimplePara&gt;94.44 (9.90)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c16"&gt;
                                &lt;SimplePara&gt;94.79 (14.32)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c17"&gt;
                                &lt;SimplePara&gt;0.395&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Emphasis Type="Italic"&gt;CCRT&lt;/Emphasis&gt; Concurrent chemoradiotherapy, 
                            &lt;Emphasis Type="Italic"&gt;CT&lt;/Emphasis&gt; Chemotherapy, 
                            &lt;Emphasis Type="Italic"&gt;RT&lt;/Emphasis&gt; Radiotherapy, 
                            &lt;Emphasis Type="Italic"&gt;SD&lt;/Emphasis&gt; Standard deviation
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                      &lt;Table Float="Yes" ID="Tab5"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 5&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Relationship between selected demographic/clinical features and symptom scale scores, mean (SD)&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup cols="19"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="char" char="(" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="char" char="(" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="char" char="." colname="c4" colnum="4"/&gt;
                          &lt;colspec align="char" char="(" colname="c5" colnum="5"/&gt;
                          &lt;colspec align="char" char="(" colname="c6" colnum="6"/&gt;
                          &lt;colspec align="char" char="." colname="c7" colnum="7"/&gt;
                          &lt;colspec align="char" char="(" colname="c8" colnum="8"/&gt;
                          &lt;colspec align="char" char="(" colname="c9" colnum="9"/&gt;
                          &lt;colspec align="char" char="." colname="c10" colnum="10"/&gt;
                          &lt;colspec align="char" char="(" colname="c11" colnum="11"/&gt;
                          &lt;colspec align="char" char="(" colname="c12" colnum="12"/&gt;
                          &lt;colspec align="char" char="." colname="c13" colnum="13"/&gt;
                          &lt;colspec align="char" char="(" colname="c14" colnum="14"/&gt;
                          &lt;colspec align="char" char="(" colname="c15" colnum="15"/&gt;
                          &lt;colspec align="char" char="." colname="c16" colnum="16"/&gt;
                          &lt;colspec align="char" char="(" colname="c17" colnum="17"/&gt;
                          &lt;colspec align="char" char="(" colname="c18" colnum="18"/&gt;
                          &lt;colspec align="char" char="." colname="c19" colnum="19"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry nameend="c3" namest="c2"&gt;
                                &lt;SimplePara&gt;Age&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c6" namest="c5"&gt;
                                &lt;SimplePara&gt;Gender&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c9" namest="c8"&gt;
                                &lt;SimplePara&gt;Comorbidity&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c10" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c12" namest="c11"&gt;
                                &lt;SimplePara&gt;Exercise&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c13" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c15" namest="c14"&gt;
                                &lt;SimplePara&gt;Weight loss (≥5%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c16" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c18" namest="c17"&gt;
                                &lt;SimplePara&gt;RP&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c19" morerows="1"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;≤60 (n&nbsp;=&nbsp;25)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;&amp;gt;60 (n&nbsp;=&nbsp;30)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Male (n&nbsp;=&nbsp;45)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Female (n&nbsp;=&nbsp;10)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;Yes (n&nbsp;=&nbsp;24)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;No (n&nbsp;=&nbsp;31)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c11"&gt;
                                &lt;SimplePara&gt;Yes (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;45)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c12"&gt;
                                &lt;SimplePara&gt;No (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;10)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c14"&gt;
                                &lt;SimplePara&gt;Yes (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;15)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c15"&gt;
                                &lt;SimplePara&gt;No (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;40)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c17"&gt;
                                &lt;SimplePara&gt;&amp;lt;grade 2 (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;46)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c18"&gt;
                                &lt;SimplePara&gt;≥grade 2 (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;9)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Fatigue&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;23.15 (13.48)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;30.28 (17.18)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.110&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;26.85 (16.6)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;27.78 (12.0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.491&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;29.98 (19.71)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;24.73 (11.73)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c10"&gt;
                                &lt;SimplePara&gt;0.190&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c11"&gt;
                                &lt;SimplePara&gt;25.68 (16.72)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c12"&gt;
                                &lt;SimplePara&gt;33.06 (8.73)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c13"&gt;
                                &lt;SimplePara&gt;0.026&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c14"&gt;
                                &lt;SimplePara&gt;17.04 (13.19)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c15"&gt;
                                &lt;SimplePara&gt;30.76 (15.14)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c16"&gt;
                                &lt;SimplePara&gt;0.001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c17"&gt;
                                &lt;SimplePara&gt;25.3 (12.45)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c18"&gt;
                                &lt;SimplePara&gt;35.8 (26.51)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c19"&gt;
                                &lt;SimplePara&gt;0.255&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;LCDY&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;10.88 (9.62)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;24.07 (14.02)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.000&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;19.88 (13.74)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;10.0 (11.05)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.019&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;25.00 (15.46)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;12.72 (9.43)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c10"&gt;
                                &lt;SimplePara&gt;0.001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c11"&gt;
                                &lt;SimplePara&gt;16.42 (12.64)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c12"&gt;
                                &lt;SimplePara&gt;25.56 (16.6)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c13"&gt;
                                &lt;SimplePara&gt;0.064&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c14"&gt;
                                &lt;SimplePara&gt;20.74 (9.26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c15"&gt;
                                &lt;SimplePara&gt;17.08 (15.06)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c16"&gt;
                                &lt;SimplePara&gt;0.118&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c17"&gt;
                                &lt;SimplePara&gt;15.34 (9.74)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c18"&gt;
                                &lt;SimplePara&gt;32.1 (21.83)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c19"&gt;
                                &lt;SimplePara&gt;0.018&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Emphasis Type="Italic"&gt;LCDY&lt;/Emphasis&gt; Dyspnea in QLQ LC13, 
                            &lt;Emphasis Type="Italic"&gt;RP&lt;/Emphasis&gt; Radiation pneumonitis, 
                            &lt;Emphasis Type="Italic"&gt;SD&lt;/Emphasis&gt; Standard deviation
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec12"&gt;
                  &lt;Heading&gt;Discussion&lt;/Heading&gt;
                  &lt;Para ID="Par33"&gt;Obtaining a satisfactory level of HRQoL is a fundamental goal of the therapy for LA-NSCLC patients. To better understand HRQoL in long-term LA-NSCLC survivors, based on QLQ-C30 and QLQ-LC13 using the most frequently used instruments in patients with lung cancer [
                    &lt;CitationRef CitationID="CR7"&gt;7&lt;/CitationRef&gt;], we report the patient-reported HRQoL outcomes from the cross-sectional study for long-term LA-NSCLC survivors treated with radiotherapy and chemotherapy. Our findings suggest that long-term LA-NSCLC survivors have a relatively high HRQoL, while the long-term NSCLC survivors reported a slight reduction in global health status, physical and emotional functioning, and the predominant symptom load includes fatigue, dyspnea, coughing, and financial difficulties.
                  &lt;/Para&gt;
                  &lt;Para ID="Par34"&gt;Our study shows that the 5-year overall survival rate of all patients was 17.1%; this figure is comparable with other studies [
                    &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;]. Survivors who completed the survey have a higher proportion of CCRT, and an objective response rate may result from a strong association between survival and treatment effect [
                    &lt;CitationRef CitationID="CR10"&gt;10&lt;/CitationRef&gt;]. Several studies have documented the impact of cancer diagnosis and treatment on HRQoL in patients and short-term survivors with LA-NSCLC [
                    &lt;CitationRef AdditionalCitationIDS="CR12" CitationID="CR11"&gt;11&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR13"&gt;13&lt;/CitationRef&gt;]. It is possible that the HRQoL of long-term LA-NSCLC survivors may differ from those experienced around diagnosis and treatment. Baseline global health status and functioning scores in two studies [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR13"&gt;13&lt;/CitationRef&gt;] were lower than the current finding. Besides, this study found that long-term survivors of LA-NSCLC had a stable or slight decline in global health status and functioning scores; in contrast, for patients who just finished treatment or short-term survivors, global health status and all functioning scores except for emotional functioning declined significantly [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR13"&gt;13&lt;/CitationRef&gt;]. The worsening of emotional functioning of long-term survivors is presumably an effect of a long-term burden on health, financial status, and their families. Furthermore, our study indicated that fatigue, dyspnea, coughing, and financial difficulties were the most frequent and high-score symptoms, while a high proportion of patients who had just finished treatment or short-term survivors experienced fatigue, loss of appetite, respiratory problems, cough, pain, and blood in sputum [
                    &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;]. These differences may relate to the symptoms associated with lung cancer, chemotherapy, and around the time of radiotherapy that were significant during treatment but later improved [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;]. Financial problems are more common among the long-term survivors possibly due to long-term medical expenses though most of the patients have health insurance.
                  &lt;/Para&gt;
                  &lt;Para ID="Par35"&gt;According to our assessment of the risk factors for a poor HRQoL in the present study, among long-term survivors, the HRQoL reported by younger survivors (≤60&nbsp;years old) had significantly better scores in their global health status, physical, role and social functioning, and dyspnea than the older patients. The study [
                    &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;] conducted by Lemonnier et al. also found that older age was associated with low HRQoL. In addition, our study indicated that exercise had a positive effect on global health status, physical, role and social functioning, and fatigue; the increasing number of evidence also suggests that exercise may be able to enhance cancer survivorship [
                    &lt;CitationRef CitationID="CR17"&gt;17&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR18"&gt;18&lt;/CitationRef&gt;]. Survivors treated with CCRT and with a smoking history had lower scores on emotional functioning and global health status, respectively, while patients with comorbidities had significantly more disruption in global health, functional scales, and dyspnea. These findings suggest that treatment regimen, tobacco use, and comorbidities have a long-term effect on HRQoL. As expected, survivors with RP (≥ grade 2) during or after radiotherapy had significantly higher dyspnea scores. Our results suggest that the risk factors of HRQoL include general (age), lifestyle (exercise), side effect (RP), and treatment (CCRT), which should be emphasized to further understand mechanisms and lead to tailored intervention strategies to improve HRQoL. In this study, smoking status was only associated with global health, but the symptom burden, particularly dyspnea and cough, continued partly due to a relatively small number of survivors who continued to smoke.
                  &lt;/Para&gt;
                  &lt;Para ID="Par36"&gt;Several limitations should be considered when interpreting these results. First, our results have a potential bias in follow-up. Of the 82 patients, there were 4 patients (5%) who declined to answer the survey and 9 patients (11%) were lost to follow-up. It is generally accepted that those with advanced cancer do not complete surveys, leaving only those in better health to provide data. Hence, our results may overestimate HRQoL in these patients. Second, in this cross-sectional study, we did not observe longitudinal HRQoL, dynamic time-dependent changes. Thus, we could not define any change in HRQoL, and further studies are warranted. Finally, the number of patients was relatively small, thus limiting the statistical power of subgroup analyses and not correcting for multivariate comparisons.&lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec13"&gt;
                  &lt;Heading&gt;Conclusions&lt;/Heading&gt;
                  &lt;Para ID="Par37"&gt;Long-term LA-NSCLC survivors treated with radiotherapy and chemotherapy have a relatively high HRQoL, with slight limitations in global health status and physical and emotional functioning and a higher symptom load of fatigue, dyspnea, coughing, and financial difficulties. Information about HRQoL of long-term LA-NSCLC survivors can be contributed to rehabilitation programs and long-term surveillance. Future prospective studies need to consider the long-term change of HRQoL and explore potential interventions.&lt;/Para&gt;
                &lt;/Section1&gt;
              &lt;/Body&gt;
              &lt;BodyRef FileRef="BodyRef/PDF/13014_2017_Article_909.pdf" PDFType="Typeset" TargetType="OnlinePDF"/&gt;
              &lt;ArticleBackmatter&gt;
                &lt;Acknowledgments&gt;
                  &lt;Heading&gt;Acknowledgements&lt;/Heading&gt;
                  &lt;SimplePara&gt;Not applicable.&lt;/SimplePara&gt;
                  &lt;FormalPara ID="FPar1" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Funding&lt;/Heading&gt;
                    &lt;Para ID="Par38"&gt;This work was founded by the National Natural Science Foundation of China (No.81272616).&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar2" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Availability of data and materials&lt;/Heading&gt;
                    &lt;Para ID="Par39"&gt;The datasets generated or analysed during the current study are available from the corresponding author on reasonable request.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Acknowledgments&gt;
                &lt;AuthorContribution&gt;
                  &lt;Heading&gt;Authors’ contributions&lt;/Heading&gt;
                  &lt;SimplePara&gt;LW was responsible for management of the project, quality assessment, review, and approval of the manuscript. JR and LW were responsible for conception, research goals and aims. JR, JW, NB and WJ contributed to design of methodology, writing of the protocol, data analysis and interpretation. All authors were involved in recruitment and treatment of patients. JR, JW, NB and LW contributed to write, review and edit the completed report. All authors read and approved the final manuscript.&lt;/SimplePara&gt;
                &lt;/AuthorContribution&gt;
                &lt;Ethics&gt;
                  &lt;FormalPara ID="FPar3" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Ethics approval and consent to participate&lt;/Heading&gt;
                    &lt;Para ID="Par40"&gt;This study was approved by the ethics committees of the institution and in accordance with the Declaration of Helsinki and current ethics guidelines.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar4" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Consent for publication&lt;/Heading&gt;
                    &lt;Para ID="Par41"&gt;Not applicable.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar5" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Competing interests&lt;/Heading&gt;
                    &lt;Para ID="Par42"&gt;The authors declare that they have no competing interests.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar6" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Publisher’s Note&lt;/Heading&gt;
                    &lt;Para ID="Par43"&gt;Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Ethics&gt;
                &lt;Bibliography ID="Bib1"&gt;
                  &lt;Heading&gt;References&lt;/Heading&gt;
                  &lt;Citation ID="CR1"&gt;
                    &lt;CitationNumber&gt;1.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cheville&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wampfler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Quality of life and symptom burden among long-term lung cancer survivors&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;7&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;64&lt;/FirstPage&gt;
                      &lt;LastPage&gt;70&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/JTO.0b013e3182397b3e&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22134070&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3241852&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Yang P, Cheville AL, Wampfler JA, et al. Quality of life and symptom burden among long-term lung cancer survivors. J Thorac Oncol. 2012;7:64–70.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR2"&gt;
                    &lt;CitationNumber&gt;2.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sarna&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Padilla&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Holmes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2002&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Quality of life of long-term survivors of non-small-cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;20&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2920&lt;/FirstPage&gt;
                      &lt;LastPage&gt;2929&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.2002.09.045&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;12089220&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Sarna L, Padilla G, Holmes C, et al. Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol. 2002;20:2920–9.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR3"&gt;
                    &lt;CitationNumber&gt;3.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Aaronson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ahmedzai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bergman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;1993&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Natl Cancer Inst&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;85&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;365&lt;/FirstPage&gt;
                      &lt;LastPage&gt;376&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK3s7msVarsQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1093/jnci/85.5.365&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;8433390&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR4"&gt;
                    &lt;CitationNumber&gt;4.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Fayers PM, Aaronson NK, Bjordal K, et al. EORTCS QLQ-C30 scoring manual. 3rd ed. Brussels: EORTC; 2001.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR5"&gt;
                    &lt;CitationNumber&gt;5.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Osoba&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rodrigues&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Myles&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;1998&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Interpreting the significance of changes in health-related quality-of-life scores&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;139&lt;/FirstPage&gt;
                      &lt;LastPage&gt;144&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK1c7gtFKrtw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.1998.16.1.139&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;9440735&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–44.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR6"&gt;
                    &lt;CitationNumber&gt;6.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Osoba&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bezjak&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brundage&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the National Cancer Institute of Canada clinical trials group&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;41&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;280&lt;/FirstPage&gt;
                      &lt;LastPage&gt;287&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.ejca.2004.10.017&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;15661554&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Osoba D, Bezjak A, Brundage M, et al. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of the National Cancer Institute of Canada clinical trials group. Eur J Cancer. 2005;41:280–7.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR7"&gt;
                    &lt;CitationNumber&gt;7.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Damm&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Roeske&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jacob&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Health-related quality of life questionnaires in lung cancer trials: a systematic literature review&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Health Econ Rev&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;3&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;15&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1186/2191-1991-3-15&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23680096&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3666900&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Damm K, Roeske N, Jacob C. Health-related quality of life questionnaires in lung cancer trials: a systematic literature review. Health Econ Rev. 2013;3:15.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR8"&gt;
                    &lt;CitationNumber&gt;8.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Curran&lt;/FamilyName&gt;
                        &lt;Suffix&gt;Jr&lt;/Suffix&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Paulus&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Langer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Natl Cancer Inst&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;103&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1452&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1460&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXht12rsrnF&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1093/jnci/djr325&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21903745&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3186782&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Curran WJ Jr, Paulus R, Langer CJ, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011;103:1452–60.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR9"&gt;
                    &lt;CitationNumber&gt;9.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fournel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Robinet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Thomas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 study&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;23&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;5910&lt;/FirstPage&gt;
                      &lt;LastPage&gt;5917&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD2MXhtVKgtbzP&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.2005.03.070&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16087956&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Fournel P, Robinet G, Thomas P, et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 study. J Clin Oncol. 2005;23:5910–7.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR10"&gt;
                    &lt;CitationNumber&gt;10.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Blumenthal&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Karuri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;33&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1008&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1014&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.2014.59.0489&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25667291&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4356710&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Blumenthal GM, Karuri SW, Zhang H, et al. Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses. J Clin Oncol. 2015;33:1008–14.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR11"&gt;
                    &lt;CitationNumber&gt;11.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hallqvist&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bergman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nyman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiother Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;104&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;39&lt;/FirstPage&gt;
                      &lt;LastPage&gt;44&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.radonc.2012.05.006&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22727262&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hallqvist A, Bergman B, Nyman J. Health related quality of life in locally advanced NSCLC treated with high dose radiotherapy and concurrent chemotherapy or cetuximab--pooled results from two prospective clinical trials. Radiother Oncol. 2012;104:39–44.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR12"&gt;
                    &lt;CitationNumber&gt;12.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Auchter&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scholtens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Adak&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2001&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern cooperative oncology group&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int J Radiat Oncol Biol Phys&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;50&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1199&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1206&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3MvjslKrsQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S0360-3016(01)01604-2&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;11483329&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Auchter RM, Scholtens D, Adak S, et al. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern cooperative oncology group. Int J Radiat Oncol Biol Phys. 2001;50:1199–206.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR13"&gt;
                    &lt;CitationNumber&gt;13.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Langendijk&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Aaronson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;de Jong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2001&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;19&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2123&lt;/FirstPage&gt;
                      &lt;LastPage&gt;2133&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3M3mtFOisw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.2001.19.8.2123&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;11304764&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Langendijk JA, Aaronson NK, de Jong JM, et al. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol. 2001;19:2123–33.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR14"&gt;
                    &lt;CitationNumber&gt;14.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Iyer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Taylor-Stokes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Roughley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Lung Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;81&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;288&lt;/FirstPage&gt;
                      &lt;LastPage&gt;293&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.lungcan.2013.03.008&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23561304&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Iyer S, Taylor-Stokes G, Roughley A. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. 2013;81:288–93.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR15"&gt;
                    &lt;CitationNumber&gt;15.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Iyer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Roughley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rider&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Support Care Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;22&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;181&lt;/FirstPage&gt;
                      &lt;LastPage&gt;187&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00520-013-1959-4&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24026981&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Iyer S, Roughley A, Rider A, et al. The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study. Support Care Cancer. 2014;22:181–7.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR16"&gt;
                    &lt;CitationNumber&gt;16.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lemonnier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Baumann&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jolly&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Solitary pulmonary nodules: consequences for patient quality of life&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Qual Life Res&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;20&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;101&lt;/FirstPage&gt;
                      &lt;LastPage&gt;109&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s11136-010-9719-0&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20694803&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lemonnier I, Baumann C, Jolly D, et al. Solitary pulmonary nodules: consequences for patient quality of life. Qual Life Res. 2011;20:101–9.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR17"&gt;
                    &lt;CitationNumber&gt;17.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Leach&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Devonish&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bebb&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Exercise preferences, levels and quality of life in lung cancer survivors&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Support Care Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;23&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;3239&lt;/FirstPage&gt;
                      &lt;LastPage&gt;3247&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BC2MjgtV2msQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00520-015-2717-6&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25832895&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Leach HJ, Devonish JA, Bebb DG, et al. Exercise preferences, levels and quality of life in lung cancer survivors. Support Care Cancer. 2015;23:3239–47.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR18"&gt;
                    &lt;CitationNumber&gt;18.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ferrer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Huedo-Medina&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Johnson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Ann Behav Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;41&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;32&lt;/FirstPage&gt;
                      &lt;LastPage&gt;47&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s12160-010-9225-1&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20931309&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3712334&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Ferrer RA, Huedo-Medina TB, Johnson BT, et al. Exercise interventions for cancer survivors: a meta-analysis of quality of life outcomes. Ann Behav Med. 2011;41:32–47.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                &lt;/Bibliography&gt;
              &lt;/ArticleBackmatter&gt;
            &lt;/Article&gt;
          &lt;/Issue&gt;
        &lt;/Volume&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-12-04T13:04:09.198273+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Ran, Juntao&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Wang, Jingbo&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Bi, Nan&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Jiang, Wei&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Zhou, Zongmei&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Hui, Zhouguang&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Liang, Jun&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Feng, Qinfu&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Wang, Luhua&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution geo="116.4073950,39.9042110"&gt;
            &lt;meta:OrgName&gt;National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;116.4073950,39.9042110#National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College&lt;/meta:GeoOrg&gt;
            &lt;meta:Country/&gt;&lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-02&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-12-03T05:08:10&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1186/s13014-017-0909-6&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;1748-717X&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;BioMed Central&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;Radiation Oncology&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;Radiation Oncology&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCB" Type="Primary"&gt;Biomedicine&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCB11001" Priority="1" Type="Secondary"&gt;Cancer Research&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH33160" Priority="2" Type="Secondary"&gt;Oncology&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH29056" Priority="3" Type="Secondary"&gt;Radiotherapy&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH29005" Priority="4" Type="Secondary"&gt;Imaging / Radiology&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:VolumeId&gt;12&lt;/meta:VolumeId&gt;
        &lt;meta:IssueId&gt;1&lt;/meta:IssueId&gt;
        &lt;meta:ArticleSequenceNumber&gt;195&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;Springer Vienna&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;Vienna&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;SpringerMedizin&lt;/PublisherImprintName&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="All"&gt;
        &lt;JournalInfo JournalProductType="NonStandardArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;12254&lt;/JournalID&gt;
          &lt;JournalDOI&gt;10.1007/12254.1865-5076&lt;/JournalDOI&gt;
          &lt;JournalPrintISSN&gt;1865-5041&lt;/JournalPrintISSN&gt;
          &lt;JournalElectronicISSN&gt;1865-5076&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;memo - Magazine of European Medical Oncology&lt;/JournalTitle&gt;
          &lt;JournalSubTitle&gt;An International Journal for Oncology and Haematology Professionals&lt;/JournalSubTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;memo&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH33160" Priority="1" Type="Secondary"&gt;Oncology&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH00007" Priority="2" Type="Secondary"&gt;Medicine/Public Health, general&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Medicine"&gt;SC11&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;JournalOnlineFirst&gt;
          &lt;Article ID="s12254-017-0373-x" OutputMedium="All"&gt;
            &lt;ArticleInfo ArticleType="ReviewPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
              &lt;ArticleID&gt;373&lt;/ArticleID&gt;
              &lt;ArticleDOI&gt;10.1007/s12254-017-0373-x&lt;/ArticleDOI&gt;
              &lt;ArticleTitle Language="En"&gt;ASCO update: lung cancer&lt;/ArticleTitle&gt;
              &lt;ArticleCategory&gt;short review&lt;/ArticleCategory&gt;
              &lt;ArticleFirstPage&gt;1&lt;/ArticleFirstPage&gt;
              &lt;ArticleLastPage&gt;4&lt;/ArticleLastPage&gt;
              &lt;ArticleHistory&gt;
                &lt;RegistrationDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;10&lt;/Day&gt;
                &lt;/RegistrationDate&gt;
                &lt;Received&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;8&lt;/Month&gt;
                  &lt;Day&gt;16&lt;/Day&gt;
                &lt;/Received&gt;
                &lt;Accepted&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;10&lt;/Day&gt;
                &lt;/Accepted&gt;
                &lt;OnlineDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                  &lt;Day&gt;1&lt;/Day&gt;
                &lt;/OnlineDate&gt;
              &lt;/ArticleHistory&gt;
              &lt;ArticleFundingInformation&gt;
                &lt;Fund&gt;
                  &lt;FunderName&gt;Medical University of Graz&lt;/FunderName&gt;
                  &lt;FundingNote&gt;Open access funding provided by Medical University of Graz.&lt;/FundingNote&gt;
                &lt;/Fund&gt;
              &lt;/ArticleFundingInformation&gt;
              &lt;ArticleCopyright&gt;
                &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                &lt;License SubType="CC BY" Type="OpenAccess" Version="4.0"&gt;
                  &lt;SimplePara&gt;
                    &lt;Emphasis Type="Bold"&gt;Open Access.&lt;/Emphasis&gt; This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
                    &lt;ExternalRef&gt;
                      &lt;RefSource&gt;http://creativecommons.org/licenses/by/4.0/&lt;/RefSource&gt;
                      &lt;RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/&gt;
                    &lt;/ExternalRef&gt;), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
                  &lt;/SimplePara&gt;
                &lt;/License&gt;
              &lt;/ArticleCopyright&gt;
              &lt;ArticleGrants Type="OpenChoice"&gt;
                &lt;MetadataGrant Grant="OpenAccess"/&gt;
                &lt;AbstractGrant Grant="OpenAccess"/&gt;
                &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                &lt;ESMGrant Grant="OpenAccess"/&gt;
              &lt;/ArticleGrants&gt;
            &lt;/ArticleInfo&gt;
            &lt;ArticleHeader&gt;
              &lt;AuthorGroup&gt;
                &lt;Author AffiliationIDS="Aff1"&gt;
                  &lt;AuthorName DisplayOrder="Western"&gt;
                    &lt;Prefix&gt;PD Dr.&lt;/Prefix&gt;
                    &lt;GivenName&gt;Gudrun&lt;/GivenName&gt;
                    &lt;FamilyName&gt;Absenger&lt;/FamilyName&gt;
                  &lt;/AuthorName&gt;
                &lt;/Author&gt;
                &lt;Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1"&gt;
                  &lt;AuthorName DisplayOrder="Western"&gt;
                    &lt;Prefix&gt;OA. Dr.&lt;/Prefix&gt;
                    &lt;GivenName&gt;Jasmin&lt;/GivenName&gt;
                    &lt;FamilyName&gt;Terzic&lt;/FamilyName&gt;
                  &lt;/AuthorName&gt;
                  &lt;Contact&gt;
                    &lt;Email&gt;jasminalija.terzic@klinikum-graz.at&lt;/Email&gt;
                  &lt;/Contact&gt;
                &lt;/Author&gt;
                &lt;Author AffiliationIDS="Aff1"&gt;
                  &lt;AuthorName DisplayOrder="Western"&gt;
                    &lt;Prefix&gt;Ass. Dr.&lt;/Prefix&gt;
                    &lt;GivenName&gt;Angelika&lt;/GivenName&gt;
                    &lt;FamilyName&gt;Bezan&lt;/FamilyName&gt;
                  &lt;/AuthorName&gt;
                &lt;/Author&gt;
                &lt;Affiliation ID="Aff1"&gt;
                  &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0000 9937 5566&lt;/OrgID&gt;
                  &lt;OrgID Level="Institution" Type="GRID"&gt;grid.411580.9&lt;/OrgID&gt;
                  &lt;OrgDivision&gt;Klinische Abteilung für Onkologie&lt;/OrgDivision&gt;
                  &lt;OrgName&gt;LKH-Univ. Klinikum Graz&lt;/OrgName&gt;
                  &lt;OrgAddress&gt;
                    &lt;Street&gt;Auenbruggerplatz&nbsp;15&lt;/Street&gt;
                    &lt;Postcode&gt;8036&lt;/Postcode&gt;
                    &lt;City&gt;Graz&lt;/City&gt;
                    &lt;Country Code="AT"&gt;Austria&lt;/Country&gt;
                  &lt;/OrgAddress&gt;
                &lt;/Affiliation&gt;
              &lt;/AuthorGroup&gt;
              &lt;Abstract ID="Abs1" Language="En" OutputMedium="All"&gt;
                &lt;Heading&gt;Summary&lt;/Heading&gt;
                &lt;Para&gt;In the past few years there have been major changes in the treatment landscape in oncology; lung cancer is affected by those changes like almost no other solid tumor. The rise of further second- and third-line tyrosine kinase inhibitors offers sequential therapy for patients with mutated non-small-cell lung cancer. Immunotherapy has found its way into clinical routine and presents us with new challenges in managing side effects, evaluating treatment response and deciding on how long we treat our patients. The treatment algorithm of lung cancer has changed in the last month and further practice-changing trials are coming up, so treating lung cancer patients shows nowadays a&nbsp;more challenging perspective with the possibility of subsequently applied individual therapies. This article provides a&nbsp;brief overview of the highlights presented at the ASCO (American Society of Clinical Oncology) annual meeting this year in Chicago.&lt;/Para&gt;
              &lt;/Abstract&gt;
              &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                &lt;Heading&gt;Keywords&lt;/Heading&gt;
                &lt;Keyword&gt;Carcinoma, non-small-cell lung&lt;/Keyword&gt;
                &lt;Keyword&gt;Carcinoma, small-cell lung&lt;/Keyword&gt;
                &lt;Keyword&gt;Lung neoplasms&lt;/Keyword&gt;
                &lt;Keyword&gt;Immunotherapy&lt;/Keyword&gt;
                &lt;Keyword&gt;Treatment algorithms&lt;/Keyword&gt;
              &lt;/KeywordGroup&gt;
            &lt;/ArticleHeader&gt;
            &lt;Body&gt;
              &lt;Section1 ID="Sec1"&gt;
                &lt;Heading&gt;Non-small-cell lung cancer (NSCLC)&lt;/Heading&gt;
                &lt;Section2 ID="Sec2"&gt;
                  &lt;Heading&gt;EGFR-mutated NSCLC&lt;/Heading&gt;
                  &lt;Para&gt;Approximately 11% of Caucasian patients with NSCLC harbor activating EGFR (epidermal growth factor receptor) mutations and first-line treatment with EGFR-targeted tyrosine kinase inhibitors (TKI) have been proven to be superior in comparison to chemotherapy in patients with metastatic disease [
                    &lt;CitationRef AdditionalCitationIDS="CR2" CitationID="CR1"&gt;1&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;]. In the adjuvant setting, the current standard of care is adjuvant chemotherapy. The Chinese CTONG trial compared adjuvant TKI therapy with gefitinib for two years to the standard of care with 4&nbsp;cycles of cisplatin/vinorelbine in patients with EGFR-mutated lung cancer. The median disease-free survival was statistically significant better in the gefitinib arm (28.7&nbsp;months vs 18&nbsp;months, HR 0.60, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;= 0.005) and thereby the study met its primary endpoint. However, when adjuvant treatment with gefitinib was stopped after 24&nbsp;months, the Kaplan–Meier curves converged again so gefitinib maybe just delays recurrence instead of leading to higher cure rates. In all, 65% of patients had N2 disease; in the smaller proportion of patients with N1 disease there was no statistically significant difference between the two treatment arms in subgroup analysis. Further follow-up needs to be awaited for overall survival analysis. Up to now, these data are too immature to change the standard of care.
                  &lt;/Para&gt;
                  &lt;Para&gt;The phase&nbsp;III ARCHER trial randomized patients with EGFR-mutated lung cancer to first-line treatment with either dacomitinib, a&nbsp;second generation EGFR-targeted TKI or gefitinib as the standard of care. With a&nbsp;longer median progression-free survival (PFS) of 14.7&nbsp;months in the dacomitinib arm versus 9.2&nbsp;months in the gefitinib arm the primary endpoint was met (HR 0.59, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt; 0.0001). However, in this trial patients with brain metastases were excluded which seems not practicable because the central nervous system (CNS) is a&nbsp;common site for metastases in EGFR-mutated patients. Furthermore, the incidence of severe adverse events was more frequent in the dacomitinib arm (acne and diarrhea), requiring dose reduction in 66.1% of patients vs 8% in the control arm. In addition, the study included mainly Asian patients (74.9%) and in the subgroup analysis of non-Asian patients there was no significant difference in PFS.
                  &lt;/Para&gt;
                  &lt;Para&gt;Osimertinib, a&nbsp;third generation TKI is approved for treatment of patients with advanced EGFR T790M-mutant NSCLC who had progressive disease after EGFR-targeted TKI therapy. In a&nbsp;prespecified subgroup analysis of the AURA 3&nbsp;trial in patients with brain metastases, osimertinib showed an CNS overall response rate (ORR) of 70% compared to 31% with platinum-based doublet chemotherapy (OR 5.13, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;= 0.015). The median PFS in the CNS was significantly longer with osimertinib than with chemotherapy (11.7&nbsp;months vs 5.6&nbsp;months; HR 0.32, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;= 0.004). These results underline the value of osimertinib as second-line treatment in EGFR T790M mutated patients. In addition, the FLAURA trial, presented at this year’s EMSO meeting, compares osimertinib with two first generation TKIs (gefitinib or erlotinib) in treatment naïve patients with EGFR exon 19 or 21&nbsp;mutations. The primary endpoint of the study was met; the median progression-free-survival was 18.9&nbsp;months compared to 10.2&nbsp;months (HR 0.46, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt; 0.0001). The benefit in progression-free survival was consistent across all subgroups, including patients with and without brain metastases.
                  &lt;/Para&gt;
                &lt;/Section2&gt;
                &lt;Section2 ID="Sec3"&gt;
                  &lt;Heading&gt;ALK-mutated NSCLC&lt;/Heading&gt;
                  &lt;Para&gt;NSCLC with EML4-ALK translocation (echinoderm microtubule associated protein-like4 anaplastic lymphoma kinase) can be found in around 5% of lung cancer patients and is characterized by a&nbsp;high risk of developing brain metastases. In the phase&nbsp;III ALEX trial, treatment naïve patients with stage IIIB or IV&nbsp;NSCLC with ALK rearrangement were randomly assigned to receive alectinib, a&nbsp;second generation ALK inhibitor or crizotinib, the current standard of care. Alectinib extended the median time to progression by about 15&nbsp;months (median PFS 25.7 vs 10.4&nbsp;months) and thereby reduced the risk of cancer progression by 53% (HR 0.47, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt; 0.0001) (Fig.&nbsp;
                    &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt;). Overall survival analysis is currently considered immature. While both treatments cross the blood–brain barrier, alectinib was more effective in preventing brain metastases. At 12&nbsp;months, the incidence of brain metastases was much lower with alectinib than with crizotinib (9% vs 41%, HR 0.16, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt; 0.0001). These results go along with the J‑ALEX trial involving Japanese treatment naïve patients with ALK-positive disease [
                    &lt;CitationRef CitationID="CR4"&gt;4&lt;/CitationRef&gt;]. In addition, alectinib showed a&nbsp;more favorable safety profile. Taken together alectinib seems to be the new standard of care for first-line treatment of patients with ALK-positive NSCLC [
                    &lt;CitationRef CitationID="CR5"&gt;5&lt;/CitationRef&gt;].
                    &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Fig. 1&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;Progression-free survival primary endpoint (ITT Population) [
                            &lt;CitationRef CitationID="CR5"&gt;5&lt;/CitationRef&gt;]
                          &lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;MediaObject&gt;
                        &lt;ImageObject Color="Color" FileRef="MediaObjects/12254_2017_373_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Figure&gt;
                  &lt;/Para&gt;
                &lt;/Section2&gt;
              &lt;/Section1&gt;
              &lt;Section1 ID="Sec4"&gt;
                &lt;Heading&gt;Immune checkpoint inhibition&lt;/Heading&gt;
                &lt;Para&gt;The ASCO (American Society of Clinical Oncology) 2017 was not the meeting of large Phase&nbsp;III trials in immunotherapy. Beside updates of the practice changing trials like the Keynote&nbsp;024, managing therapies with immune checkpoint inhibitors was an important topic. Trials discuss questions like treatment duration and dealing with patients who developed immune-related adverse effects (irAE).&lt;/Para&gt;
              &lt;/Section1&gt;
              &lt;Section1 ID="Sec5"&gt;
                &lt;Heading&gt;Updated results: Keynote&nbsp;024 and Keynote&nbsp;021&lt;/Heading&gt;
                &lt;Para&gt;Julie R.&nbsp;Brahmer reported updated OS and PFS2 of the Keynote&nbsp;024 trial based on 19-month median follow-up. The phase&nbsp;III trial compared pembrolizumab with the investigator’s choice of chemotherapy as first-line treatment for patients with advanced NSCLC and PD-L1-tumor proportion score (TPS)&nbsp;≥ 50% [
                  &lt;CitationRef CitationID="CR6"&gt;6&lt;/CitationRef&gt;]. Preliminary data presented at ESMO last year showed a&nbsp;significant improvement in PFS for pembrolizumab. PFS2 is defined as “time from randomization to objective tumor progression on next-line treatment or death from any cause.” Median PFS2 was substantially improved for pembrolizumab (18.3. vs. 8.6&nbsp;months, HR 0.54). Survival showed an 18-month OS rate of 61.2% in the pembrolizumab group compared to 43.0% in the chemotherapy group. This data support the use of pembrolizumab for first-line treatment in patients with NSCLC PD-L1-TPS&nbsp;≥ 50%.
                &lt;/Para&gt;
                &lt;Para&gt;The randomized phase&nbsp;II Keynote&nbsp;021 trial showed that adding pembrolizumab as third agent to carboplatin/pemetrexed in the first-line advanced NSCLC setting significantly improve ORR (55% vs 29%, 
                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;= 0.0016) and PFS (HR 0.53, 
                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;= 0.01) [
                  &lt;CitationRef CitationID="CR7"&gt;7&lt;/CitationRef&gt;]. The toxicity profile, especially grade 3–4&nbsp;AEs, was manageable (39% vs. 26%). Notablely, PD-L1 negative patients showed a&nbsp;response of approximately 60%. This highlights that the combination of a&nbsp;checkpoint inhibitor and chemotherapy is safe and promising and led to FDA approval of the combination of pembrolizumab and chemotherapy as first-line treatment.
                &lt;/Para&gt;
              &lt;/Section1&gt;
              &lt;Section1 ID="Sec6"&gt;
                &lt;Heading&gt;Treatment beyond progression and managing side effects&lt;/Heading&gt;
                &lt;Para&gt;The phase&nbsp;III OAK trial enrolled 1225 patients with previously treated NSCLC and randomized them to intravenous atezolizumab (1200 mg every 3&nbsp;weeks) or docetaxel (75 mg/m
                  &lt;Superscript&gt;2&lt;/Superscript&gt; every 3&nbsp;weeks; [
                  &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;]). The data were already presented at the last ESMO meeting at Copenhagen with a&nbsp;meaningful survival benefit of atezolizumab over chemotherapy. This year’s ASCO meeting addressed the question of atezolizumab treatment beyond progression (TBP) defined by post progressive disease (PD) tumor regression, OS and safety. Post-PD-regression can result from response due to tumor immune infiltration or delayed response, reducing reliability of RECIST&nbsp;1.1 as an indicator of treatment failure. Atezolizumab beyond progression showed subsequent response in 7% of patients and stable disease in 49% of patients. The study showed that continuing atezolizumab beyond PD was associated with a&nbsp;prolonged clinical benefit, 12.7&nbsp;months OS compared with 8.8&nbsp;months OS for those patients treated with other anticancer treatments post PD. These data support the treatment strategy of continuing atezolizumab beyond PD until loss of clinical benefit in patients, regardless of the level of PD-L1 expression.
                &lt;/Para&gt;
                &lt;Para&gt;In melanoma, a&nbsp;correlation between development of irSE (immune-related side effects) and clinical benefit has been suggested. Owen et&nbsp;al. assessed this question for NSCLC patients treated with nivolumab in a&nbsp;retrospective review and found that patients with irSE had longer median OS (13.2 vs 5.8&nbsp;months, 
                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;= 0.018; [
                  &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;]). Another trial evaluated restart of immunotherapy after Grade&nbsp;2 or higher irAE. In patients who develop irAEs, re-treatment with anti-PD (L)-1 therapy was associated with recurrent or new irAEs in half of the patients, and was more common in early onset irAEs [
                  &lt;CitationRef CitationID="CR10"&gt;10&lt;/CitationRef&gt;].
                &lt;/Para&gt;
              &lt;/Section1&gt;
              &lt;Section1 ID="Sec7"&gt;
                &lt;Heading&gt;Small cell lung cancer (SCLC)&lt;/Heading&gt;
                &lt;Para&gt;The CheckMate&nbsp;032 phase&nbsp;I/II study showed that the treatment with nivolumab alone or in combination with ipilimumab resulted in durable responses in patients with previously treated SCLC. In the non-randomized cohort of this trial, the median OS was 4.1&nbsp;months for patients receiving monotherapy and 7.8&nbsp;months for the combination arm, resulting in a&nbsp;higher incidence of adverse events. At 2&nbsp;years, 26% of patients in the combination arm and 14% of patients receiving monotherapy were still alive. Responses were seen regardless of platinum sensitivity or PD-L1 status. Based on these findings nivolumab with or without ipilimumab was recently added to the National Comprehensive Cancer Network® Guidelines for the treatment of extensive stage (ES)-SCLC. The combination of these two immunotherapies could be applied if there is a&nbsp;relapse of the disease &amp;lt;6&nbsp;months.&lt;/Para&gt;
                &lt;Para&gt;At this year’s ASCO meeting, the presented data of the randomized Phase&nbsp;II cohort were 3‑month PFS and OS (PFS 18% for nivolumab and 30% for the combination arm). This is too early for interpretation but ORR of the randomized cohort was equal to the phase 1&nbsp;cohort so maybe we will see promising results later this year.&lt;/Para&gt;
              &lt;/Section1&gt;
              &lt;Section1 ID="Sec8"&gt;
                &lt;Heading&gt;Maintenance therapy with pembrolizumab&lt;/Heading&gt;
                &lt;Para&gt;In patients with ES-SCLC, median PFS after initial chemotherapy lies usually around 2&nbsp;months. The phase&nbsp;II trial by Gadgeel et&nbsp;al. investigated if PFS could be extended by maintenance therapy with pembrolizumab. With only a&nbsp;median PFS of 1.4&nbsp;months the study did not achieve the primary endpoint. However, exploratory analysis showed that patients with higher PD-L1 expression at the stromal interface had better outcomes. Further trials are needed to define the role of pembrolizumab in this setting.&lt;/Para&gt;
                &lt;Para&gt;The ECOG-ACRIN 2511 study evaluated the combination of the PARP-inhibitor&nbsp;(enzyme poly ADP ribose polymerase) veliparib with cisplatin/etoposide doublet as first-line treatment in ES-SCLC. Median PFS was 6.1&nbsp;months for patients receiving veliparib and 5.5&nbsp;months for patients receiving placebo (unstratified HR: 0.75; 1‑sided 
                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;= 0.06). Unfortunately, no biomarker analyses were planned so the question remains if analyzing gene signatures for DNA repair could define a&nbsp;subgroup of patients who benefit significantly.
                &lt;/Para&gt;
              &lt;/Section1&gt;
            &lt;/Body&gt;
            &lt;BodyRef FileRef="BodyRef/PDF/12254_2017_Article_373.pdf" OutputMedium="All" PDFType="Typeset" TargetType="OnlinePDF"/&gt;
            &lt;ArticleBackmatter&gt;
              &lt;FundingInformation&gt;
                &lt;Heading&gt;Funding&lt;/Heading&gt;
                &lt;SimplePara&gt;Open access funding provided by Medical University of Graz.&lt;/SimplePara&gt;
              &lt;/FundingInformation&gt;
              &lt;Ethics&gt;
                &lt;FormalPara ID="FPar1" OutputMedium="All" RenderingStyle="Style1"&gt;
                  &lt;Heading&gt;Conflict of interest&lt;/Heading&gt;
                  &lt;Para&gt;G.&nbsp;Absenger, J.&nbsp;Terzic, and A.&nbsp;Bezan declare that they have no competing interests.&lt;/Para&gt;
                &lt;/FormalPara&gt;
              &lt;/Ethics&gt;
              &lt;Bibliography ID="Bib1"&gt;
                &lt;Heading&gt;References&lt;/Heading&gt;
                &lt;Citation ID="CR1"&gt;
                  &lt;CitationNumber&gt;1.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;LV&lt;/Initials&gt;
                      &lt;FamilyName&gt;Sequist&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;JC&lt;/Initials&gt;
                      &lt;FamilyName&gt;Yang&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;N&lt;/Initials&gt;
                      &lt;FamilyName&gt;Yamamoto&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;K&lt;/Initials&gt;
                      &lt;FamilyName&gt;O’Byrne&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;V&lt;/Initials&gt;
                      &lt;FamilyName&gt;Hirsh&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;T&lt;/Initials&gt;
                      &lt;FamilyName&gt;Mok&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Etal/&gt;
                    &lt;Year&gt;2013&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;31&lt;/VolumeID&gt;
                    &lt;IssueID&gt;27&lt;/IssueID&gt;
                    &lt;FirstPage&gt;3327&lt;/FirstPage&gt;
                    &lt;LastPage&gt;3334&lt;/LastPage&gt;
                    &lt;Occurrence Type="COI"&gt;
                      &lt;Handle&gt;1:CAS:528:DC%2BC3sXhs1KrsrzP&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="DOI"&gt;
                      &lt;Handle&gt;10.1200/JCO.2012.44.2806&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="PID"&gt;
                      &lt;Handle&gt;23816960&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Sequist LV, Yang JC, Yamamoto N, O’Byrne K, Hirsh V, Mok T, et&nbsp;al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. J&nbsp;Clin Oncol. 2013;31(27):3327–34.&lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
                &lt;Citation ID="CR2"&gt;
                  &lt;CitationNumber&gt;2.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;R&lt;/Initials&gt;
                      &lt;FamilyName&gt;Rosell&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;E&lt;/Initials&gt;
                      &lt;FamilyName&gt;Carcereny&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;R&lt;/Initials&gt;
                      &lt;FamilyName&gt;Gervais&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Etal/&gt;
                    &lt;Year&gt;2012&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a&nbsp;multicentre, open-label, randomized phase 3 trial&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;Lancet Oncol&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;13&lt;/VolumeID&gt;
                    &lt;IssueID&gt;3&lt;/IssueID&gt;
                    &lt;FirstPage&gt;239&lt;/FirstPage&gt;
                    &lt;LastPage&gt;246&lt;/LastPage&gt;
                    &lt;Occurrence Type="COI"&gt;
                      &lt;Handle&gt;1:CAS:528:DC%2BC38XjsVCgsbk%3D&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="DOI"&gt;
                      &lt;Handle&gt;10.1016/S1470-2045(11)70393-X&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="PID"&gt;
                      &lt;Handle&gt;22285168&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Rosell R, Carcereny E, Gervais R, et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a&nbsp;multicentre, open-label, randomized phase 3 trial. Lancet Oncol. 2012;13(3):239–46.&lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
                &lt;Citation ID="CR3"&gt;
                  &lt;CitationNumber&gt;3.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;T&lt;/Initials&gt;
                      &lt;FamilyName&gt;Mitsudomi&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;S&lt;/Initials&gt;
                      &lt;FamilyName&gt;Morita&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;Y&lt;/Initials&gt;
                      &lt;FamilyName&gt;Yatabe&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;S&lt;/Initials&gt;
                      &lt;FamilyName&gt;Negoro&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;I&lt;/Initials&gt;
                      &lt;FamilyName&gt;Okamoto&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;J&lt;/Initials&gt;
                      &lt;FamilyName&gt;Tsurutani&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Etal/&gt;
                    &lt;Year&gt;2010&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;Lancet Oncol&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;11&lt;/VolumeID&gt;
                    &lt;IssueID&gt;2&lt;/IssueID&gt;
                    &lt;FirstPage&gt;121&lt;/FirstPage&gt;
                    &lt;LastPage&gt;128&lt;/LastPage&gt;
                    &lt;Occurrence Type="COI"&gt;
                      &lt;Handle&gt;1:CAS:528:DC%2BC3cXhtlGgtbo%3D&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="DOI"&gt;
                      &lt;Handle&gt;10.1016/S1470-2045(09)70364-X&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="PID"&gt;
                      &lt;Handle&gt;20022809&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Mitsudomi T, Morita S, Yatabe Y, Negoro S, Okamoto I, Tsurutani J, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol. 2010;11(2):121–8.&lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
                &lt;Citation ID="CR4"&gt;
                  &lt;CitationNumber&gt;4.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;T&lt;/Initials&gt;
                      &lt;FamilyName&gt;Hida&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;H&lt;/Initials&gt;
                      &lt;FamilyName&gt;Nokihara&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;M&lt;/Initials&gt;
                      &lt;FamilyName&gt;Kondo&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;YH&lt;/Initials&gt;
                      &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;K&lt;/Initials&gt;
                      &lt;FamilyName&gt;Azuma&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;T&lt;/Initials&gt;
                      &lt;FamilyName&gt;Seto&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Etal/&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;Lancet&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;390&lt;/VolumeID&gt;
                    &lt;IssueID&gt;10089&lt;/IssueID&gt;
                    &lt;FirstPage&gt;29&lt;/FirstPage&gt;
                    &lt;LastPage&gt;39&lt;/LastPage&gt;
                    &lt;Occurrence Type="COI"&gt;
                      &lt;Handle&gt;1:CAS:528:DC%2BC2sXns1yhsb8%3D&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="DOI"&gt;
                      &lt;Handle&gt;10.1016/S0140-6736(17)30565-2&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="PID"&gt;
                      &lt;Handle&gt;28501140&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Hida T, Nokihara H, Kondo M, Kim YH, Azuma K, Seto T, et al. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial. Lancet. 2017;390(10089):29–39.&lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
                &lt;Citation ID="CR5"&gt;
                  &lt;CitationNumber&gt;5.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;S&lt;/Initials&gt;
                      &lt;FamilyName&gt;Peters&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;DR&lt;/Initials&gt;
                      &lt;FamilyName&gt;Camidge&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;AT&lt;/Initials&gt;
                      &lt;FamilyName&gt;Shaw&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;S&lt;/Initials&gt;
                      &lt;FamilyName&gt;Gadgeel&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;JS&lt;/Initials&gt;
                      &lt;FamilyName&gt;Ahn&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;DW&lt;/Initials&gt;
                      &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Etal/&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;N. Engl. J. Med.&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;377&lt;/VolumeID&gt;
                    &lt;FirstPage&gt;829&lt;/FirstPage&gt;
                    &lt;BibArticleDOI&gt;10.1056/NEJMoa1704795&lt;/BibArticleDOI&gt;
                    &lt;Occurrence Type="COI"&gt;
                      &lt;Handle&gt;1:CAS:528:DC%2BC2sXhsFSju7nL&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="DOI"&gt;
                      &lt;Handle&gt;10.1056/NEJMoa1704795&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="PID"&gt;
                      &lt;Handle&gt;28586279&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Peters S, Camidge DR, Shaw AT, Gadgeel S, Ahn JS, Kim DW, et al. Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer. N Engl J Med. 2017;377:829. 
                    &lt;ExternalRef&gt;
                      &lt;RefSource&gt;https://doi.org/10.1056/NEJMoa1704795&lt;/RefSource&gt;
                      &lt;RefTarget Address="10.1056/NEJMoa1704795" TargetType="DOI"/&gt;
                    &lt;/ExternalRef&gt;.
                  &lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
                &lt;Citation ID="CR6"&gt;
                  &lt;CitationNumber&gt;6.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;M&lt;/Initials&gt;
                      &lt;FamilyName&gt;Reck&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;D&lt;/Initials&gt;
                      &lt;FamilyName&gt;Rodríguez-Abreu&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;A&lt;/Initials&gt;
                      &lt;FamilyName&gt;Robinson Get&lt;/FamilyName&gt;
                      &lt;Particle&gt;al&lt;/Particle&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Year&gt;2016&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer: an international, randomized, open-label, phase 3 trial&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;N Engl J Med&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;375&lt;/VolumeID&gt;
                    &lt;FirstPage&gt;1823&lt;/FirstPage&gt;
                    &lt;LastPage&gt;1833&lt;/LastPage&gt;
                    &lt;Occurrence Type="COI"&gt;
                      &lt;Handle&gt;1:CAS:528:DC%2BC28XhvF2ks77I&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="DOI"&gt;
                      &lt;Handle&gt;10.1056/NEJMoa1606774&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="PID"&gt;
                      &lt;Handle&gt;27718847&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Reck M, Rodríguez-Abreu D, al Robinson Get A. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer: an international, randomized, open-label, phase 3 trial. N&nbsp;Engl J Med. 2016;375:1823–33.&lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
                &lt;Citation ID="CR7"&gt;
                  &lt;CitationNumber&gt;7.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;CJ&lt;/Initials&gt;
                      &lt;FamilyName&gt;Langer&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;S&lt;/Initials&gt;
                      &lt;FamilyName&gt;Gadgeel&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;H&lt;/Initials&gt;
                      &lt;FamilyName&gt;Borghaei&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Etal/&gt;
                    &lt;Year&gt;2016&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a&nbsp;randomised, phase 2 cohort of the open-label KEYNOTE-021 study&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;Lancet Oncol&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                    &lt;IssueID&gt;11&lt;/IssueID&gt;
                    &lt;FirstPage&gt;1497&lt;/FirstPage&gt;
                    &lt;LastPage&gt;1508&lt;/LastPage&gt;
                    &lt;Occurrence Type="COI"&gt;
                      &lt;Handle&gt;1:CAS:528:DC%2BC28Xhs1GnurrI&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="DOI"&gt;
                      &lt;Handle&gt;10.1016/S1470-2045(16)30498-3&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="PID"&gt;
                      &lt;Handle&gt;27745820&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Langer CJ, Gadgeel S, Borghaei H, et al. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a&nbsp;randomised, phase 2 cohort of the open-label KEYNOTE-021 study. Lancet Oncol. 2016;17(11):1497–508.&lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
                &lt;Citation ID="CR8"&gt;
                  &lt;CitationNumber&gt;8.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;A&lt;/Initials&gt;
                      &lt;FamilyName&gt;Rittmeyer&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;F&lt;/Initials&gt;
                      &lt;FamilyName&gt;Barlesi&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;D&lt;/Initials&gt;
                      &lt;FamilyName&gt;Waterkamp&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;K&lt;/Initials&gt;
                      &lt;FamilyName&gt;Park&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Etal/&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a&nbsp;phase 3, open-label, multicentre randomised controlled trial&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;Lancet&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;389&lt;/VolumeID&gt;
                    &lt;IssueID&gt;10066&lt;/IssueID&gt;
                    &lt;FirstPage&gt;255&lt;/FirstPage&gt;
                    &lt;LastPage&gt;265&lt;/LastPage&gt;
                    &lt;Occurrence Type="DOI"&gt;
                      &lt;Handle&gt;10.1016/S0140-6736(16)32517-X&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                    &lt;Occurrence Type="PID"&gt;
                      &lt;Handle&gt;27979383&lt;/Handle&gt;
                    &lt;/Occurrence&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Rittmeyer A, Barlesi F, Waterkamp D, Park K, et al. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a&nbsp;phase 3, open-label, multicentre randomised controlled trial. Lancet. 2017;389(10066):255–65.&lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
                &lt;Citation ID="CR9"&gt;
                  &lt;CitationNumber&gt;9.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;DH&lt;/Initials&gt;
                      &lt;FamilyName&gt;Owen&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;L&lt;/Initials&gt;
                      &lt;FamilyName&gt;Wei&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;MA&lt;/Initials&gt;
                      &lt;FamilyName&gt;Villalona-Calero&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;EM&lt;/Initials&gt;
                      &lt;FamilyName&gt;Bertino&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Etal/&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Impact of immune-related adverse events (irAE) on overall survival (OS) in patients treated with immunotherapy for non-small cell lung cancer (NSCLC)&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;35&lt;/VolumeID&gt;
                    &lt;FirstPage&gt;abstr 9080&lt;/FirstPage&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Owen DH, Wei L, Villalona-Calero MA, Bertino EM, et al. Impact of immune-related adverse events (irAE) on overall survival (OS) in patients treated with immunotherapy for non-small cell lung cancer (NSCLC). J&nbsp;Clin Oncol. 2017;35:abstr 9080.&lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
                &lt;Citation ID="CR10"&gt;
                  &lt;CitationNumber&gt;10.&lt;/CitationNumber&gt;
                  &lt;BibArticle&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;F&lt;/Initials&gt;
                      &lt;FamilyName&gt;Santini&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;H&lt;/Initials&gt;
                      &lt;FamilyName&gt;Rizvi&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;O&lt;/Initials&gt;
                      &lt;FamilyName&gt;Wilkins&lt;/FamilyName&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;BibAuthorName&gt;
                      &lt;Initials&gt;M&lt;/Initials&gt;
                      &lt;FamilyName&gt;Voorthuysen&lt;/FamilyName&gt;
                      &lt;Particle&gt;van&lt;/Particle&gt;
                    &lt;/BibAuthorName&gt;
                    &lt;Etal/&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;ArticleTitle Language="--"&gt;Safety of retreatment with immunotherapy after immune-related toxicity in patients with lung cancers treated with anti-PD(L)-1 therapy&lt;/ArticleTitle&gt;
                    &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                    &lt;VolumeID&gt;35&lt;/VolumeID&gt;
                    &lt;FirstPage&gt;abstr 9012&lt;/FirstPage&gt;
                  &lt;/BibArticle&gt;
                  &lt;BibUnstructured&gt;Santini F, Rizvi H, Wilkins O, van Voorthuysen M, et al. Safety of retreatment with immunotherapy after immune-related toxicity in patients with lung cancers treated with anti-PD(L)-1 therapy. J&nbsp;Clin Oncol. 2017;35:abstr 9012.&lt;/BibUnstructured&gt;
                &lt;/Citation&gt;
              &lt;/Bibliography&gt;
            &lt;/ArticleBackmatter&gt;
          &lt;/Article&gt;
        &lt;/JournalOnlineFirst&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-12-04T13:44:32.600296+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Absenger, Gudrun&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Terzic, Jasmin&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Bezan, Angelika&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;LKH-Univ. Klinikum Graz&lt;/meta:OrgName&gt;
            &lt;meta:Country&gt;Austria&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-01&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-12-02T06:08:21&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1007/s12254-017-0373-x&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;ASCO update: lung cancer&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;1865-5076&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;Springer&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;memo - Magazine of European Medical Oncology&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;memo - Magazine of European Medical Oncology&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH33160" Priority="1" Type="Secondary"&gt;Oncology&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH00007" Priority="2" Type="Secondary"&gt;Medicine/Public Health, general&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:ArticleSequenceNumber&gt;9999&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;Springer International Publishing&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;Cham&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;Springer&lt;/PublisherImprintName&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="Online"&gt;
        &lt;JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;41824&lt;/JournalID&gt;
          &lt;JournalElectronicISSN&gt;2510-3636&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;European Journal of Hybrid Imaging&lt;/JournalTitle&gt;
          &lt;JournalSubTitle&gt;EJNMMI Multimodality Journal&lt;/JournalSubTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;European J Hybrid Imaging&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH29005" Priority="1" Type="Secondary"&gt;Imaging / Radiology&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Medicine"&gt;SC11&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;Volume OutputMedium="Online"&gt;
          &lt;VolumeInfo TocLevels="0" VolumeType="Regular"&gt;
            &lt;VolumeIDStart&gt;1&lt;/VolumeIDStart&gt;
            &lt;VolumeIDEnd&gt;1&lt;/VolumeIDEnd&gt;
            &lt;VolumeIssueCount&gt;1&lt;/VolumeIssueCount&gt;
          &lt;/VolumeInfo&gt;
          &lt;Issue IssueType="Regular" OutputMedium="Online"&gt;
            &lt;IssueInfo IssueType="Regular" TocLevels="0"&gt;
              &lt;IssueIDStart&gt;1&lt;/IssueIDStart&gt;
              &lt;IssueIDEnd&gt;1&lt;/IssueIDEnd&gt;
              &lt;IssueArticleCount&gt;0&lt;/IssueArticleCount&gt;
              &lt;IssueHistory&gt;
                &lt;CoverDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                &lt;/CoverDate&gt;
                &lt;PricelistYear&gt;2017&lt;/PricelistYear&gt;
              &lt;/IssueHistory&gt;
              &lt;IssueCopyright&gt;
                &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
              &lt;/IssueCopyright&gt;
            &lt;/IssueInfo&gt;
            &lt;Article ID="s41824-017-0013-z" OutputMedium="Online"&gt;
              &lt;ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
                &lt;ArticleID&gt;13&lt;/ArticleID&gt;
                &lt;ArticleDOI&gt;10.1186/s41824-017-0013-z&lt;/ArticleDOI&gt;
                &lt;ArticleCitationID&gt;8&lt;/ArticleCitationID&gt;
                &lt;ArticleSequenceNumber&gt;8&lt;/ArticleSequenceNumber&gt;
                &lt;ArticleTitle Language="En" OutputMedium="All"&gt;Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation&lt;/ArticleTitle&gt;
                &lt;ArticleCategory&gt;Original article&lt;/ArticleCategory&gt;
                &lt;ArticleFirstPage&gt;1&lt;/ArticleFirstPage&gt;
                &lt;ArticleLastPage&gt;10&lt;/ArticleLastPage&gt;
                &lt;ArticleHistory&gt;
                  &lt;RegistrationDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;9&lt;/Month&gt;
                    &lt;Day&gt;18&lt;/Day&gt;
                  &lt;/RegistrationDate&gt;
                  &lt;Received&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;5&lt;/Month&gt;
                    &lt;Day&gt;11&lt;/Day&gt;
                  &lt;/Received&gt;
                  &lt;Accepted&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;9&lt;/Month&gt;
                    &lt;Day&gt;18&lt;/Day&gt;
                  &lt;/Accepted&gt;
                  &lt;OnlineDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;12&lt;/Month&gt;
                    &lt;Day&gt;1&lt;/Day&gt;
                  &lt;/OnlineDate&gt;
                &lt;/ArticleHistory&gt;
                &lt;ArticleFundingInformation&gt;
                  &lt;Fund&gt;
                    &lt;FunderName FundRefID="http://dx.doi.org/10.13039/100000054"&gt;National Cancer Institute&lt;/FunderName&gt;
                    &lt;GrantNumber GrantRecipient="Au9" Type="FundRef"&gt;R21 CA181885&lt;/GrantNumber&gt;
                  &lt;/Fund&gt;
                &lt;/ArticleFundingInformation&gt;
                &lt;ArticleCopyright&gt;
                  &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                  &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                  &lt;License SubType="CC BY" Type="OpenAccess" Version="4.0"&gt;
                    &lt;SimplePara&gt;
                      &lt;Emphasis Type="Bold"&gt;Open Access&lt;/Emphasis&gt;This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;http://creativecommons.org/licenses/by/4.0/&lt;/RefSource&gt;
                        &lt;RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/&gt;
                      &lt;/ExternalRef&gt;), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
                    &lt;/SimplePara&gt;
                  &lt;/License&gt;
                &lt;/ArticleCopyright&gt;
                &lt;ArticleGrants Type="OpenChoice"&gt;
                  &lt;MetadataGrant Grant="OpenAccess"/&gt;
                  &lt;AbstractGrant Grant="OpenAccess"/&gt;
                  &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                  &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                  &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                  &lt;ESMGrant Grant="OpenAccess"/&gt;
                &lt;/ArticleGrants&gt;
              &lt;/ArticleInfo&gt;
              &lt;ArticleHeader&gt;
                &lt;AuthorGroup&gt;
                  &lt;Author AffiliationIDS="Aff1" EqualContribution="Yes" ID="Au1"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Brittany&lt;/GivenName&gt;
                      &lt;GivenName&gt;Z.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Dashevsky&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff2" ID="Au2"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Chenpeng&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff3 Aff4" EqualContribution="Yes" ID="Au3"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Li&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Yan&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au4"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Cindy&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Yuan&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au5"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Lingyun&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Xiong&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff5 Aff7" ID="Au6"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Yongmei&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff6" ID="Au7"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Haiyan&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff7 Aff8" CorrespondingAffiliationID="Aff8" ID="Au8"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Feng-Ming&lt;/GivenName&gt;
                      &lt;GivenName&gt;Spring&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Kong&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Phone&gt;317-944-2524&lt;/Phone&gt;
                      &lt;Email&gt;fskong@iupui.edu&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au9" ORCID="http://orcid.org/0000-0002-9583-8185"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Yonglin&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Pu&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Phone&gt;773-834-7629&lt;/Phone&gt;
                      &lt;Email&gt;ypu@radiology.bsd.uchicago.edu&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Affiliation ID="Aff1"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 1936 7822&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.170205.1&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Radiology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;University Of Chicago&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;5841 S. Maryland Ave. MC 2026&lt;/Street&gt;
                      &lt;City&gt;Chicago&lt;/City&gt;
                      &lt;State&gt;IL&lt;/State&gt;
                      &lt;Postcode&gt;60637&lt;/Postcode&gt;
                      &lt;Country Code="US"&gt;USA&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff2"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 0368 8293&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.16821.3c&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Nuclear Medicine, RenJi Hospital, School of Medicine&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Shanghai Jiao Tong University&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Shanghai&lt;/City&gt;
                      &lt;Country Code="CN"&gt;China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff3"&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.415946.b&lt;/OrgID&gt;
                    &lt;OrgName&gt;Department of Radiation Oncology, Linyi People’s Hospital&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Linyi&lt;/City&gt;
                      &lt;State&gt;Shandong&lt;/State&gt;
                      &lt;Country Code="CN"&gt;China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff4"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 1761 1174&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.27255.37&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Cell Biology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Shandong University&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Jinan&lt;/City&gt;
                      &lt;State&gt;Shandong&lt;/State&gt;
                      &lt;Country Code="CN"&gt;China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff5"&gt;
                    &lt;OrgDivision&gt;Department of Thoracic Oncology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;China West University Hospital&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;Shichuan&lt;/Street&gt;
                      &lt;City&gt;Chengdu&lt;/City&gt;
                      &lt;Country Code="CN"&gt;China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff6"&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.263452.4&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Nuclear Medicine&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;First Hospital of Shanxi Medical University and Molecular Imaging Precision Medical Collaborative Innovation Center, Shanxi Medical University&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Taiyuan&lt;/City&gt;
                      &lt;Postcode&gt;030001&lt;/Postcode&gt;
                      &lt;State&gt;Shanxi&lt;/State&gt;
                      &lt;Country Code="CN"&gt;China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff7"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0001 2287 3919&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.257413.6&lt;/OrgID&gt;
                    &lt;OrgName&gt;Radiation Oncology, Medical and Molecular Genetics, Indiana University School of Medicine&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Indianapolis&lt;/City&gt;
                      &lt;Country Code="US"&gt;USA&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff8"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0001 2287 3919&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.257413.6&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Radiation Oncology, Simon Cancer Center&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Indiana University School of Medicine&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;535 Barnhill Drive&lt;/Street&gt;
                      &lt;City&gt;Indianapolis&lt;/City&gt;
                      &lt;State&gt;IN&lt;/State&gt;
                      &lt;Postcode&gt;46202&lt;/Postcode&gt;
                      &lt;Country Code="US"&gt;USA&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                &lt;/AuthorGroup&gt;
                &lt;Abstract ID="Abs1" Language="En" OutputMedium="All"&gt;
                  &lt;Heading&gt;Abstract&lt;/Heading&gt;
                  &lt;AbstractSection ID="ASec1"&gt;
                    &lt;Heading&gt;Purpose&lt;/Heading&gt;
                    &lt;Para ID="Par1"&gt;TNM Stage 3B encompasses a wide range of primary tumor and nodal metastatic tumor burden. This study aimed to evaluate the prognostic value of quantitative FDG PET/CT parameters in patients with newly diagnosed Stage 3B Non-Small Cell Lung Cancer (NSCLC).&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec2"&gt;
                    &lt;Heading&gt;Materials and Methods&lt;/Heading&gt;
                    &lt;Para ID="Par2"&gt;Institutional review board approved retrospective study identified patients diagnosed with Stage 3B NSCLC (8
                      &lt;Superscript&gt;th&lt;/Superscript&gt; edition TNM classification) on baseline FDG PET/CT at two medical centers (Medical centers A and B), between Feb 2004 and Dec 2014. Patients were excluded if they had prior NSCLC treatment or recent diagnosis of a second primary cancer. Quantitative FDG PET/CT parameters including whole body metabolic tumor volume (MTVwb), total lesion glycolysis (TLGwb), and maximum standardized uptake value (SUVmaxwb) were measured from baseline PET/CT using Edge method with Mimvista software. The primary endpoint was overall survival (OS). Cox proportional hazard regression and Kaplan-Meier overall survival analyses were used to test for an association between OS and quantitative FDG PET/CT parameters. The distributions of MTVwb, TLGwb, SUVmaxwb were skewed, so a natural logarithm transformation was applied and the transformed variables [(ln(MTVwb), ln(TLGwb), and ln(SUVmaxwb)] were used in the analysis.
                    &lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec3"&gt;
                    &lt;Heading&gt;Results&lt;/Heading&gt;
                    &lt;Para ID="Par3"&gt;The training set included 110 patients from center A with Stage 3B NSCLC. 78.2% of patients expired during follow-up. Median OS was 14 months. 1-year, 2-year, and 5-year OS was 56.5%, 34.6% and 13.9%, respectively. Univariate Cox regression analysis showed no significant difference in OS on the basis of age, gender, histology, ln(TLGwb), or ln(SUVmaxwb). ln(MTVwb) was positively associated with OS [hazard ratio (HR) of 1.23, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt; = 0.037]. This association persisted on multivariate Cox regression analysis (HR 1.28, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt; = 0.043), with adjustments for age, gender, treatment and tumor histology. External validation with 44 patients from center B confirmed increasing MTVwb was associated significantly worse OS. An MTVwb cut-off point of 85.6 mL significantly stratified Stage 3B NSCLC patient prognosis.
                    &lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec4"&gt;
                    &lt;Heading&gt;Conclusion&lt;/Heading&gt;
                    &lt;Para ID="Par4"&gt;MTVwb is a prognostic marker for OS in patients with Stage 3B NSCLC, independent of age, gender, treatment, and tumor histology.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                &lt;/Abstract&gt;
                &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                  &lt;Heading&gt;Keywords&lt;/Heading&gt;
                  &lt;Keyword&gt;Lung cancer&lt;/Keyword&gt;
                  &lt;Keyword&gt;Tumor volume&lt;/Keyword&gt;
                  &lt;Keyword&gt;FDG, PET/CT&lt;/Keyword&gt;
                &lt;/KeywordGroup&gt;
                &lt;AbbreviationGroup&gt;
                  &lt;Heading&gt;Abbreviations&lt;/Heading&gt;
                  &lt;DefinitionList&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;AJCC&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par5"&gt;American Joint Committee on Cancer&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;CT&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par6"&gt;Computed tomography&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;FDG&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par7"&gt;2-deoxy-2-[18F]fluoro-D-glucose&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;HR&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par8"&gt;Hazard ratio&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;IASLC&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par9"&gt;International Association for the Study of Lung Cancer&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;MBq&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par10"&gt;Megabecquerel&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;MTVwb&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par11"&gt;Whole-body metabolic tumor volume&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;NSCLC&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par12"&gt;Non-small cell lung cancer&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;OS&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par13"&gt;Overall survival&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;PET&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par14"&gt;Positron emission tomography&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;SUVmaxwb&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par15"&gt;Maximum standardized uptake value&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;TLGwb&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par16"&gt;Whole body total lesion glycolysis&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;TNM&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par17"&gt;Tumor-node-metastases&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                    &lt;DefinitionListEntry&gt;
                      &lt;Term&gt;UICC&lt;/Term&gt;
                      &lt;Description&gt;
                        &lt;Para ID="Par18"&gt;Union for International Cancer Control&lt;/Para&gt;
                      &lt;/Description&gt;
                    &lt;/DefinitionListEntry&gt;
                  &lt;/DefinitionList&gt;
                &lt;/AbbreviationGroup&gt;
              &lt;/ArticleHeader&gt;
              &lt;Body&gt;
                &lt;Section1 ID="Sec1"&gt;
                  &lt;Heading&gt;Introduction&lt;/Heading&gt;
                  &lt;Para ID="Par19"&gt;Lung cancer is the leading cause of cancer death within the United States (Siegel et al., 
                    &lt;CitationRef CitationID="CR1"&gt;2016&lt;/CitationRef&gt;). The TNM staging system developed by the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) is the primary means for classifying patient disease status and predicting patient prognosis, with the most recent 8
                    &lt;Superscript&gt;th&lt;/Superscript&gt; edition recently introduced by the International Association for the Study of Lung Cancer (IASLC) (Detterbeck et al., 
                    &lt;CitationRef CitationID="CR2"&gt;2016&lt;/CitationRef&gt;; Asamura et al., 
                    &lt;CitationRef CitationID="CR3"&gt;2015&lt;/CitationRef&gt;; Rami-Porta et al., 
                    &lt;CitationRef CitationID="CR4"&gt;2015&lt;/CitationRef&gt;; Goldstraw et al., 
                    &lt;CitationRef CitationID="CR5"&gt;2016&lt;/CitationRef&gt;). Stage 3B Non-small Cell Lung Cancer (NSCLC) now comprises patients without distant metastases (M0) who have stage T3 or T4 primary disease, with ipsilateral mediastinal and/or subcarinal nodal metastases (N2), as well as patients with T1 or T2 primary disease with metastases in scalene, supraclavicular, contralateral mediastinal or contralateral hilar lymph nodes (N3). In other words, Stage 3B encompasses a wide range of primary tumor burden, including patients with primary tumors ranging from &amp;lt;1&nbsp;cm (T1a) to ≥7&nbsp;cm (T4) in greatest dimension and N0 to N3 nodal metastases.
                  &lt;/Para&gt;
                  &lt;Para ID="Par20"&gt;For patients with locally advanced lung cancer, fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) enables detection of CT-occult, metabolically active tumor. Maximum standardized uptake value (SUVmax) is an established measurement of maximal tumor metabolic activity and facilitates identification of tumor metastases, but it fails to take into account total tumor abundance/burden. Quantitative FDG measurements, namely the amount of whole body metabolic tumor volume (MTVwb) and total lesion glycolysis (TLGwb), may be used to quantify both total tumor burden and metabolic activity. These parameters have been found to be associated with OS for both surgical and non-surgical NSCLC patients, after adjusting for clinical stage (Liao et al., 
                    &lt;CitationRef CitationID="CR6"&gt;2012a&lt;/CitationRef&gt;; Zhang et al., 
                    &lt;CitationRef CitationID="CR7"&gt;2013a&lt;/CitationRef&gt;; Zhang et al., 
                    &lt;CitationRef CitationID="CR8"&gt;2013b&lt;/CitationRef&gt;). These PET/CT metrics have yet to be evaluated for Stage 3B NSCLC patients (Ohri et al., 
                    &lt;CitationRef CitationID="CR9"&gt;2015&lt;/CitationRef&gt;).
                  &lt;/Para&gt;
                  &lt;Para ID="Par21"&gt;Patients with Stage 3B NSCLC are rarely surgical candidates due to mediastinal invasion or extensive nodal disease, and are routinely treated with combined radiation and chemotherapy, though options are constantly evolving to cater to a more individualized patient-centered therapeutic approach (Rocco et al., 
                    &lt;CitationRef CitationID="CR10"&gt;2016&lt;/CitationRef&gt;). The overall survival (OS) of Stage 3B NSCLC patients at 2 and 5&nbsp;years is 44% and 26%, respectively (Goldstraw et al., 
                    &lt;CitationRef CitationID="CR5"&gt;2016&lt;/CitationRef&gt;). If we can identify additional prognostic markers for these patients, we may be able to better stratify Stage 3B NSCLC patients, and determine who is more likely to benefit from more aggressive therapy.
                  &lt;/Para&gt;
                  &lt;Para ID="Par22"&gt;Here we aimed to evaluate the prognostic value of MTVwb, TLGwb, and SUVmaxwb, on baseline FDG PET/CT in patients with Stage 3B NSCLC.&lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec2"&gt;
                  &lt;Heading&gt;Materials and methods&lt;/Heading&gt;
                  &lt;Para ID="Par23"&gt;This Health Insurance Portability and Accountability Act compliant retrospective study received institutional review board approval. The need for informed consent was waived.&lt;/Para&gt;
                  &lt;Section2 ID="Sec3"&gt;
                    &lt;Heading&gt;Patient cohort&lt;/Heading&gt;
                    &lt;Para ID="Par24"&gt;Utilizing a retrospective search of our health information system, patients were included if they met both of the following inclusion criteria: a. diagnosed with Stage 3B NSCLC in accordance with the 8
                      &lt;Superscript&gt;th&lt;/Superscript&gt; edition of the TNM classification system; and b. received baseline staging PET/CT between February 2004 and Dec 2014. Patients were excluded if they either: 1. received prior lung cancer treatment, including chemotherapy, radiation, or surgery; or 2. had a second primary cancer diagnosed from 5&nbsp;years before to 2&nbsp;months after the FDG PET/CT scan conducted for NSCLC diagnosis and staging. 110 consecutive patients were identified from center A and served as the training set. The external validation set included 44 patients managed and imaged at institution B from 2008 to 2014. These patients received a FDG PET/CT within 3&nbsp;months of starting radiation therapy.
                    &lt;/Para&gt;
                    &lt;Para ID="Par25"&gt;Patient demographics, clinical information, and follow-up were collected from the health information system. Patients were censored at date of last contact.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec4"&gt;
                    &lt;Heading&gt;PET/CT acquisition&lt;/Heading&gt;
                    &lt;Para ID="Par26"&gt;Imaging was performed on a Siemens mCT scanner (Siemens Healthcare, Knoxville, Tenn) or Reveal HD scanner (CTI, Knoxville, Tenn). All patients fasted for a minimum of 4&nbsp;h prior to imaging, confirmed by fingerstick serum blood glucose levels &amp;lt;200&nbsp;mg/dl. Patients were injected with 370-555&nbsp;MBq 
                      &lt;Superscript&gt;18&lt;/Superscript&gt;F–FDG. At center A (the training dataset), whole body PET/CT imaging was acquired approximately 90&nbsp;min later. At center B (the validation dataset), patients were scanned approximately 60&nbsp;min later. Concomitant low-dose non-contrast or diagnostic CT extending from the skull base to thighs was performed for anatomic localization and attenuation correction.
                    &lt;/Para&gt;
                    &lt;Para ID="Par27"&gt;PET/CT tumor volume, SUVmaxwb, MTVwb, and TLGwb were measured using the PET Edge tool of MIMvista software as illustrated in Fig.&nbsp;
                      &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt;, using semi-automated tumor segmentation, as previously described (Liao et al., 
                      &lt;CitationRef CitationID="CR6"&gt;2012a&lt;/CitationRef&gt;).
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Whole-body PET images of a 59&nbsp;year-old male with newly diagnosed squamous cell carcinoma, stage IIIB (T4N2M0). This study was performed for initial staging. Colored regions of interest (ROIs) show the tumor contours. The MTVwb in mL is the sum of tumor volumes in all ROIs. Axial image (
                              &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt;), sagittal image (
                              &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt;), coronal image (
                              &lt;Emphasis Type="Bold"&gt;c&lt;/Emphasis&gt;) and maximal intensity projection image (
                              &lt;Emphasis Type="Bold"&gt;d&lt;/Emphasis&gt;)
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO1"&gt;
                          &lt;ImageObject Color="Color" FileRef="MediaObjects/41824_2017_13_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par28"&gt;Briefly, SUVmax for each tumor lesion was defined as: 
                      &lt;InlineEquation ID="IEq1"&gt;
                        &lt;InlineMediaObject&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="41824_2017_13_Article_IEq1.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/&gt;
                        &lt;/InlineMediaObject&gt;
                        &lt;EquationSource Format="MATHML"&gt;
                          &lt;math display="inline" xmlns:xlink="http://www.w3.org/1999/xlink"&gt;
                            &lt;mfrac&gt;
                              &lt;mrow&gt;
                                &lt;mtext&gt;decayed corrected activity&lt;/mtext&gt;
                                &lt;mo stretchy="true"&gt;/&lt;/mo&gt;
                                &lt;mtext&gt;tissue volume&lt;/mtext&gt;
                              &lt;/mrow&gt;
                              &lt;mrow&gt;
                                &lt;mtext&gt;injected dose&lt;/mtext&gt;
                                &lt;mo stretchy="true"&gt;/&lt;/mo&gt;
                                &lt;mtext&gt;injected weight&lt;/mtext&gt;
                              &lt;/mrow&gt;
                            &lt;/mfrac&gt;
                          &lt;/math&gt;
                        &lt;/EquationSource&gt;
                        &lt;EquationSource Format="TEX"&gt;$$ \frac{\mathrm{decayed}\  \mathrm{corrected}\  \mathrm{activity}/\mathrm{tissue}\  \mathrm{volume}}{\mathrm{injected}\  \mathrm{dose}/\mathrm{injected}\  \mathrm{weight}} $$&lt;/EquationSource&gt;
                      &lt;/InlineEquation&gt;. SUVmaxwb was taken to be the largest SUVmax among all tumor lesions identified on baseline staging PET/CT. MTVwb was defined as the total segmented volume of all FDG-avid tumors in the body. TLG for a single tumor lesion is the product of MTV and the average SUV for the lesion. TLGwb was calculated as the sum of the TLGs of all segmented tumor.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec5"&gt;
                    &lt;Heading&gt;Statistical analysis&lt;/Heading&gt;
                    &lt;Para ID="Par29"&gt;Statistical analyses were performed using Stata Software version 14. OS was considered the primary endpoint and defined as the time from baseline PET/CT to time of any cause mortality. Analysis was conducted using natural-logarithm transformed values of the PET parameters [(ln(MTVwb), ln(TLGwb), and ln(SUVmaxwb)] in order to achieve a near-normal distribution of independent variables. Univariate and multivariate analyses were performed with Cox proportional hazard regression models to test for an association with the primary end point, OS. 
                      &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt;-value of &amp;lt;0.05 from a two-tailed test was considered significant. Survival curves were plotted using the Kaplan-Meier method.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec6"&gt;
                  &lt;Heading&gt;Results&lt;/Heading&gt;
                  &lt;Section2 ID="Sec7"&gt;
                    &lt;Heading&gt;Model fitting&lt;/Heading&gt;
                    &lt;Para ID="Par30"&gt;The model was fitted using the training dataset of 110 patients with Stage 3B NSCLC (41% adenocarcinoma; 32% squamous cell; 27% other histologic sub-type) who met the inclusion criteria, with patient characteristics summarized in Table&nbsp;
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;. The median patient age was 67.3 (range 31.4–83.9) years. There were 47 Caucasian patients, 60 African American patients and 3 Asian patients. The majority of patients (69%) were managed non-surgically (with chemotherapy and/or radiation), while 22% received surgical treatment, and 9% did not treatment. 86/110 patients expired during follow-up. The median OS was 14&nbsp;months. 1-year, 2-year, and 5-year OS was 56.5%, 34.6% and 13.9%, respectively. The median follow-up among survivors was 26.0&nbsp;months (inter-quartile range 13.6 to 57.1&nbsp;months).
                      &lt;Table Float="Yes" ID="Tab1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Characteristics of patients from the University of Chicago&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup align="left" cols="3"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="char" char="." colname="c3" colnum="3"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Clinical and PET Parameters&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Number of patients&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Percentage&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c3" namest="c1"&gt;
                                &lt;SimplePara&gt;Gender&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Male&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;47&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;43%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Female&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;63&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;57%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c3" namest="c1"&gt;
                                &lt;SimplePara&gt;Race&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Caucasian&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;47&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;43%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; African American&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;60&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;55%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Asian&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;3%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c3" namest="c1"&gt;
                                &lt;SimplePara&gt;Treatment&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Surgically&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;24&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;22%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Non-surgically&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;76&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;69%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; None&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;10&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;9%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c3" namest="c1"&gt;
                                &lt;SimplePara&gt;Histological subtype&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Adenocarcinoma&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;45&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;41%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Squamous cell&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;35&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;32%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Other types
                                  &lt;Superscript&gt;a&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;30&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;27%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Age (Median and range, years)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;67.3(31.4–83.9)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; &amp;gt;65&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;44&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;40%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; &amp;lt;65&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;66&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;60%&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;MTVwb (Median and range, ml)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;85.6(3.2–1261.4)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;TLGwb (Median and range, ml)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;485.5(12.1–4921.0)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;SUVmaxwb (Median and range)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;13.07(3.5–42.9)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Emphasis Type="Italic"&gt;MTVwb&lt;/Emphasis&gt; whole-body metabolic tumor volume, 
                            &lt;Emphasis Type="Italic"&gt;SUVmaxwb&lt;/Emphasis&gt; whole-body maximum standardized uptake value, 
                            &lt;Emphasis Type="Italic"&gt;TLGwb&lt;/Emphasis&gt; whole-body total lesion glycolysis
                          &lt;/SimplePara&gt;
                          &lt;SimplePara&gt;
                            &lt;Superscript&gt;a&lt;/Superscript&gt;Other histological subtypes including large cell (
                            &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;7), NSCLC not otherwise specified (
                            &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;21) and neuroendocrine tumor (
                            &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2)
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par31"&gt;Univariate Cox regression analysis showed no significant difference in OS on the basis of age, gender, or histology (Table&nbsp;
                      &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt;). Surgical treatment (24/110 patients) was associated with improved OS, as compared to the no treatment and non-surgical treatment groups. Some of the PET/CT variables, ln(TLG
                      &lt;Subscript&gt;WB&lt;/Subscript&gt;) and ln(SUV
                      &lt;Subscript&gt;WB&lt;/Subscript&gt;), were not associated with OS.
                      &lt;Table Float="Yes" ID="Tab2"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 2&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Univariate Cox regression analyses&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup align="left" cols="4"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="center" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="center" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="char" char="." colname="c4" colnum="4"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Hazard ratio&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;95% CI&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt;-value
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Age (per 1&nbsp;year increase)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.02&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0 .99 -1.034&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.171&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c4" namest="c1"&gt;
                                &lt;SimplePara&gt;Gender&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Female&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Reference&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                              &lt;entry colname="c4"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Male&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.19&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.78–1.83&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.419&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c4" namest="c1"&gt;
                                &lt;SimplePara&gt;Histology&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Adenocarcinoma&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Reference&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                              &lt;entry colname="c4"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Squamous&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.37&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.83–2.26&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.218&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; other types&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.33&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.78 2.27&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.303&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c4" namest="c1"&gt;
                                &lt;SimplePara&gt;Treatment&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Non-surgical (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;76)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Reference&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                              &lt;entry colname="c4"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Surgical (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;24)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.22 -0.71&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.002&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; No treatment (
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;10)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.99&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.47 -2.1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.986&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;ln(MTV
                                  &lt;Subscript&gt;wb&lt;/Subscript&gt;)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.23&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;1.01–1.49&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.037&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;ln(TLG
                                  &lt;Subscript&gt;wb&lt;/Subscript&gt;)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.13&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.95–1.34&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.175&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;In(SUVmaxwb)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.91&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.57–1.43&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.67&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;Note: ln(MTVwb), ln(TLGwb) and ln(SUVmaxwb) are continuous variables. ln&nbsp;=&nbsp;natural logarithmic transformation&lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par32"&gt;However, ln(MTVwb) was positively associated with OS, with a hazard ratio (HR) of 1.23 with 95% confidence interval (95% CI) of 1.01–1.49, (
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.037). This association persisted on multivariate Cox regression analysis with a HR of 1.28 (95% CI =1.01–1.64, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.043), after adjustment for age, gender, treatment and tumor histology (Table&nbsp;
                      &lt;InternalRef RefID="Tab3"&gt;3&lt;/InternalRef&gt;).
                      &lt;Table Float="Yes" ID="Tab3"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 3&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Multivariate Cox regression analyses of whole cohort&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup align="left" cols="4"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="center" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="char" char="–" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="char" char="." colname="c4" colnum="4"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Variables&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Hazard ratio&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;95% CI&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt;-value
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;ln(MTVwb)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.28&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;1.01–1.64&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.043&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c4" namest="c1"&gt;
                                &lt;SimplePara&gt;Treatment&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Non-surgical&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Reference&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                              &lt;entry colname="c4"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Surgical&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.41&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.22–0.76&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.004&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry align="center" colname="c1"&gt;
                                &lt;SimplePara&gt; No treatment&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.34&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.59–3.02&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.48&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;Additional adjustments were made for age, gender, treatment and tumor histology&lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par33"&gt;The training dataset was segmented by the median MTVwb of 85.6&nbsp;mL, Kaplan-Meier survival curves (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig2"&gt;2&lt;/InternalRef&gt;) demonstrate decreased OS among patients with MTVwb greater than or equal to the median, when compared to those patients with MTVwb less than the median (
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.021). The median OS was 9.5&nbsp;months in patients with MTVwb greater than or equal to the median, while the median OS was 17.3&nbsp;months in patients with MTVwb less than the median.
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig2"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 2&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Kaplan-Meier overall survival curves of the training dataset of 110 patients with TNM Stage 3B NSCLC, stratified by the median MTVwb of 85.6&nbsp;mL. The dashed line indicates patient group with MTVwb greater than or equal to 85.6&nbsp;ml with median OS of 9.5&nbsp;months. The solid line indicates patient group with MTVwb less than 85.6&nbsp;ml with median OS of 17.3&nbsp;months. The difference is statistically significant with 
                              &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.02
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO2"&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/41824_2017_13_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec8"&gt;
                    &lt;Heading&gt;Model validation&lt;/Heading&gt;
                    &lt;Para ID="Par34"&gt;To validate the model, a separate analysis was performed using a dataset of 44 patients who were imaged and managed from medical center B. These 44 patients received radiation-based treatment. The median OS was 20&nbsp;months and 1-year, 2-year, and 5-year OS was 60%, 45% and 38%, respectively. 24/44 patients (55%) expired during follow-up. The median follow-up among survivors was 30.7&nbsp;months (inter-quartile range 12.7 o 49.1&nbsp;months).&lt;/Para&gt;
                    &lt;Para ID="Par35"&gt;With a univariate Cox regression model, there was significant positive correlation of ln(MTVwb) with OS, HR of 1.83 (95% CI&nbsp;=&nbsp;1.14–2.94, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.012). For 7 of 44 patients, the SUVmax and TLGwb were not available due to missing accurate weight information during PET/CT acquisition. Univariate Cox regression analysis in the remaining 37 patients demonstrated no statistically significant association of ln(TLGwb) (HR&nbsp;=&nbsp;1.37, 95% CI&nbsp;=&nbsp;0.94–2.00, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.1) and ln(SUVmaxwb) (HR&nbsp;=&nbsp;1.30, 95% CI&nbsp;=&nbsp;0.53–3.17, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.57) with OS. After adjusting for tumor histology, there remained significant positive correlation with ln(MTVwb) and OS, with HR of 1.78 (95% CI&nbsp;=&nbsp;1.01–2.90, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.02). The results provided further evidence for the prognostic value of ln(MTVwb). Kaplan-Meier survival curves with groups defined by the median MTVwb from the training set (85.6&nbsp;mL) further demonstrated significantly lower OS among patients with MTVwb ≥85.6&nbsp;mL, when compared to those with MTVwb &amp;lt;85.6 mL (
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.028; Fig.&nbsp;
                      &lt;InternalRef RefID="Fig3"&gt;3&lt;/InternalRef&gt;). The median OS was 13.9&nbsp;months in patients MTVwb ≥85.6&nbsp;mL. For patients with MTVwb &amp;lt;85.6 mL, the median OS could not be determined because more than 50% of patients were alive at the last follow-up (median follow-up of 30.7&nbsp;months).
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig3"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 3&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Kaplan-Meier overall survival curves of the validation dataset of 44 patients with TNM stage 3B NSCLC, stratified by the median MTVwb of the training dataset, 85.6&nbsp;mL. The dashed line represents the patient group with MTVwb ≥85.6&nbsp;ml with median OS of 13.9&nbsp;months. The solid line represents the patient group with MTVwb &amp;lt;85.6&nbsp;ml with median OS not reached during follow-up period. The groups were significantly different with 
                              &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.03
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO3"&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/41824_2017_13_Fig3_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec9"&gt;
                  &lt;Heading&gt;Discussion&lt;/Heading&gt;
                  &lt;Para ID="Par36"&gt;Quantitative PET/CT parameters are increasingly used to better stratify patients with cancer. Multiple studies have evaluated the association of primary tumor and whole body MTV, TLG, and SUVmax with respect to OS, though this has yet to be evaluated for Stage 3B NSCLC (8
                    &lt;Superscript&gt;th&lt;/Superscript&gt; edition TNM classification) (Liao et al., 
                    &lt;CitationRef CitationID="CR6"&gt;2012a&lt;/CitationRef&gt;; Zhang et al., 
                    &lt;CitationRef CitationID="CR7"&gt;2013a&lt;/CitationRef&gt;; Zhang et al., 
                    &lt;CitationRef CitationID="CR8"&gt;2013b&lt;/CitationRef&gt;; Ohri et al., 
                    &lt;CitationRef CitationID="CR9"&gt;2015&lt;/CitationRef&gt;; Liao et al., 
                    &lt;CitationRef CitationID="CR11"&gt;2012b&lt;/CitationRef&gt;; Chung et al., 
                    &lt;CitationRef CitationID="CR12"&gt;2014&lt;/CitationRef&gt;; Im et al., 
                    &lt;CitationRef CitationID="CR13"&gt;2015&lt;/CitationRef&gt;; Hyun et al., 
                    &lt;CitationRef CitationID="CR14"&gt;2013&lt;/CitationRef&gt;; Hyun et al., 
                    &lt;CitationRef CitationID="CR15"&gt;2014&lt;/CitationRef&gt;; Carvalho et al., 
                    &lt;CitationRef CitationID="CR16"&gt;2013&lt;/CitationRef&gt;; Kim et al., 
                    &lt;CitationRef CitationID="CR17"&gt;2012&lt;/CitationRef&gt;; Abelson et al., 
                    &lt;CitationRef CitationID="CR18"&gt;2012&lt;/CitationRef&gt;; Satoh et al., 
                    &lt;CitationRef CitationID="CR19"&gt;2014&lt;/CitationRef&gt;; Winther-Larsen et al., 
                    &lt;CitationRef CitationID="CR20"&gt;2016&lt;/CitationRef&gt;; Yoo et al., 
                    &lt;CitationRef CitationID="CR21"&gt;2012&lt;/CitationRef&gt;; Zhu et al., 
                    &lt;CitationRef CitationID="CR22"&gt;2016&lt;/CitationRef&gt;; Vu et al., 
                    &lt;CitationRef CitationID="CR23"&gt;2013&lt;/CitationRef&gt;; Lee et al., 
                    &lt;CitationRef CitationID="CR24"&gt;2007&lt;/CitationRef&gt;). We sought to better delineate prognosis among patients with Stage 3B NSCLC by utilizing MTVwb, SUVmaxwb, and TLGwb.
                  &lt;/Para&gt;
                  &lt;Para ID="Par37"&gt;Among patients with Stage 3B NSCLC, greater MTVwb was associated with shorter OS, independent of age, sex, and histology. This was further validated by an external dataset of 44 patients treated with radiation-based treatment at outside hospitals. Other studies have shown that OS significantly decreases with every 1&nbsp;cm increase in primary tumor burden and with increasing number and extent of nodal metastases, which prompted recent changes to the TNM classification (Asamura et al., 
                    &lt;CitationRef CitationID="CR3"&gt;2015&lt;/CitationRef&gt;; Goldstraw et al., 
                    &lt;CitationRef CitationID="CR5"&gt;2016&lt;/CitationRef&gt;). Thus, it is not surprising that quantitative PET/CT measures of whole body tumor burden are similarly associated with OS.
                  &lt;/Para&gt;
                  &lt;Para ID="Par38"&gt;Here we did not find a significant association between SUVmaxwb or TLGwb and OS in patients with Stage 3B NSCLC. SUVmaxwb is a maximum single voxel measurement, so it may not be representative of the entire disease process. Additionally, SUVmaxwb is not representative of the total extent of tumor burden. Though TLGwb incorporates MTVwb, it was not statistically significantly associated with OS in this sample of patients with Stage 3B NSCLC, despite the estimated HR of 1.13. The lack of statistical significance is most likely due to the small sample size in this study, as opposed to a true lack of association with survival.&lt;/Para&gt;
                  &lt;Para ID="Par39"&gt;Among the Stage 3B NSCLC patients in the training cohort, the 2-year and 5-year OS was 34.6% and 13.9%, lower than the survival observed in the IASLC database (44% and 26%, respectively) (Goldstraw et al., 
                    &lt;CitationRef CitationID="CR5"&gt;2016&lt;/CitationRef&gt;). However, our validation dataset had 2- and 5-year survival of 45%, 38%, which is more similar to the IASLC database. One explanation for the difference in OS may be related to socioeconomic status: Center A serves a predominantly low-income neighborhood, a factor that has been previously associated with worse OS (Aldrich et al., 
                    &lt;CitationRef CitationID="CR26"&gt;2013&lt;/CitationRef&gt;). Furthermore, the training dataset included 10 patients who had no treatment, which is likely to lower OS.
                  &lt;/Para&gt;
                  &lt;Para ID="Par40"&gt;The training dataset had a significantly higher proportion of African American patients (55%) than other studies, like the 1996–2007 Florida Cancer Data System registry of 98,541 patients with NSCLC, which was only 7.4% African American (Tannenbaum et al., 
                    &lt;CitationRef CitationID="CR25"&gt;2014&lt;/CitationRef&gt;). Although our study included a disproportionate number of African Americans compared to both other registries and the national population, prior work by Aldrich et al., has shown that lung cancer survival is independent of race, when adjusting for stage and socioeconomic status (Aldrich et al., 
                    &lt;CitationRef CitationID="CR26"&gt;2013&lt;/CitationRef&gt;).
                  &lt;/Para&gt;
                  &lt;Section2 ID="Sec10"&gt;
                    &lt;Heading&gt;Limitations&lt;/Heading&gt;
                    &lt;Para ID="Par41"&gt;Due to the retrospective design of this study, it was not possible to control the type of surgery, chemotherapy or radiation that patients received. Treatment for each patient was determined at the discretion of the surgeon and oncologist and, ultimately, by the patient. In addition, PET/CT has limited sensitivity to detect lesions which are less than 1&nbsp;cm in diameter or which have low metabolic uptake, likely resulting in a slight under measurement of MTVwb and TLGwb. Since patients in the validation dataset were exclusively treated with radiation-based treatment, and the significant association between OS and MTVwb persists, this strongly suggests the robust prognostic value of MTVwb.&lt;/Para&gt;
                    &lt;Para ID="Par42"&gt;In summary, among patients with Stage 3B NSCLC increasing MTVwb measured on baseline FDG PET/CT is associated with worse OS in both univariate and multivariate cox regression analysis, as seen in both the training and validation datasets. Currently, PET/CT volumetric parameters do not affect clinical management, but hopefully the developing knowledge regarding the values of these measurements may allow more targeted treatment for patients with more or less aggressive disease. Regardless, identifying which patients are more likely to survive to 2 or 5&nbsp;years may be extremely valuable to patients, who may be planning the final months or years of their life.&lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec11"&gt;
                  &lt;Heading&gt;Conclusion&lt;/Heading&gt;
                  &lt;Para ID="Par43"&gt;MTVwb is a prognostic marker for OS in patients with Stage 3B NSCLC, independent of age, gender, treatment, and tumor histology.&lt;/Para&gt;
                &lt;/Section1&gt;
              &lt;/Body&gt;
              &lt;BodyRef FileRef="BodyRef/PDF/41824_2017_Article_13.pdf" PDFType="Typeset" TargetType="OnlinePDF"/&gt;
              &lt;ArticleBackmatter&gt;
                &lt;Acknowledgments&gt;
                  &lt;Heading&gt;Acknowledgements&lt;/Heading&gt;
                  &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                  &lt;FormalPara ID="FPar1" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Funding&lt;/Heading&gt;
                    &lt;Para ID="Par44"&gt;This work was supported in part by a grant (R21 CA181885) from the National Cancer Institute of the National Institutes of Health.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar2" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Availability of data and materials&lt;/Heading&gt;
                    &lt;Para ID="Par45"&gt;The data supporting the findings can be found in the corresponding author’s institution.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Acknowledgments&gt;
                &lt;AuthorContribution&gt;
                  &lt;Heading&gt;Authors’ contributions&lt;/Heading&gt;
                  &lt;SimplePara&gt;Guarantors of integrity of entire study: BZD, F-MK and YP. Study concepts/study design or data acquisition or data analysis/interpretation: all authors; Manuscript drafting or manuscript revision for important intellectual content: all authors. Approval of final version of submitted manuscript: all authors; Agrees to ensure any questions related to the work are appropriately resolved by all authors; Literature research: BZD, F-MK and YP. Clinical studies: CZ, LX, HL, LY, YL, YP. Statistical analysis: YP and F-MK. Manuscript editing: all authors.&lt;/SimplePara&gt;
                &lt;/AuthorContribution&gt;
                &lt;Ethics&gt;
                  &lt;FormalPara ID="FPar3" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Ethics approval and consent to participate&lt;/Heading&gt;
                    &lt;Para ID="Par46"&gt;This study was approved by our Institutional Review Board of the University of Chicago, which waived the requirement for informed consent and all methods were carried out in accordance with relevant guidelines and regulations.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar4" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Consent for publication&lt;/Heading&gt;
                    &lt;Para ID="Par47"&gt;N/A&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar5" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Competing interests&lt;/Heading&gt;
                    &lt;Para ID="Par48"&gt;The authors declare that they have no competing interests.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar6" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Publisher’s Note&lt;/Heading&gt;
                    &lt;Para ID="Par49"&gt;Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Ethics&gt;
                &lt;Bibliography ID="Bib1"&gt;
                  &lt;Heading&gt;References&lt;/Heading&gt;
                  &lt;Citation ID="CR1"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Siegel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Miller&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jemal&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Cancer statistics, 2016&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;CA Cancer J Clin&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;66&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;7&lt;/FirstPage&gt;
                      &lt;LastPage&gt;30&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3322/caac.21332&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26742998&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR2"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Detterbeck&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chansky&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Groome&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;11&lt;/VolumeID&gt;
                      &lt;IssueID&gt;9&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1433&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1446&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jtho.2016.06.028&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27448762&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Detterbeck FC, Chansky K, Groome P et al (2016) The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer. J Thorac Oncol 11(9):1433–1446&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR3"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Asamura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chansky&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Crowley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;IssueID&gt;12&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1675&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1684&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhvF2it7rO&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/JTO.0000000000000678&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26709477&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Asamura H, Chansky K, Crowley J et al (2015) The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 10(12):1675–1684&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR4"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rami-Porta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bolejack&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Crowley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;IssueID&gt;7&lt;/IssueID&gt;
                      &lt;FirstPage&gt;990&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1003&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/JTO.0000000000000559&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26134221&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Rami-Porta R, Bolejack V, Crowley J et al (2015) The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 10(7):990–1003&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR5"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Goldstraw&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chansky&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Crowley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;11&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;39&lt;/FirstPage&gt;
                      &lt;LastPage&gt;51&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jtho.2015.09.009&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26762738&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Goldstraw P, Chansky K, Crowley J et al (2016) The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 11(1):39–51&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR6"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liao&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Penney&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wroblewski&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Nucl Med Mol Imaging&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;39&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;27&lt;/FirstPage&gt;
                      &lt;LastPage&gt;38&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXhsFOgt7bN&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00259-011-1934-6&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21946983&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Liao S, Penney BC, Wroblewski K et al (2012a) Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 39(1):27–38&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR7"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wroblewski&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liao&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Acad Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;20&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;32&lt;/FirstPage&gt;
                      &lt;LastPage&gt;40&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.acra.2012.07.002&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22999369&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Zhang H, Wroblewski K, Liao S et al (2013a) Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Acad Radiol 20(1):32–40&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR8"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wroblewski&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Appelbaum&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int J Comput Assist Radiol Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;8&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;181&lt;/FirstPage&gt;
                      &lt;LastPage&gt;191&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s11548-012-0749-7&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22644386&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Zhang H, Wroblewski K, Appelbaum D, Pu Y (2013b) Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer. Int J Comput Assist Radiol Surg 8(2):181–191&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR9"&gt;
                    &lt;BibUnstructured&gt;Ohri N, Duan F, Machtay M et al (2015) Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235. J Natl Cancer Inst 107(4):djv004. 
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402361/pdf/djv004.pdf&lt;/RefSource&gt;
                        &lt;RefTarget Address="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402361/pdf/djv004.pdf" TargetType="URL"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR10"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rocco&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Morabito&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Leone&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Muto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fiore&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Budillon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Management of non-small cell lung cancer in the era of personalized medicine&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int J Biochem Cell Biol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;78&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;173&lt;/FirstPage&gt;
                      &lt;LastPage&gt;179&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xht1aitbrE&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.biocel.2016.07.011&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27425397&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Rocco G, Morabito A, Leone A, Muto P, Fiore F, Budillon A (2016) Management of non-small cell lung cancer in the era of personalized medicine. Int J Biochem Cell Biol 78:173–179&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR11"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liao&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Penney&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Suzuki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Acad Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;19&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;69&lt;/FirstPage&gt;
                      &lt;LastPage&gt;77&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.acra.2011.08.020&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22142679&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Liao S, Penney BC, Zhang H, Suzuki K, Pu Y (2012b) Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. Acad Radiol 19(1):69–77&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR12"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chung&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;So&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Cancer Res Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;140&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;89&lt;/FirstPage&gt;
                      &lt;LastPage&gt;98&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhsleltLzL&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00432-013-1545-7&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24194352&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Chung HW, Lee KY, Kim HJ, Kim WS, So Y (2014) FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma. J Cancer Res Clin Oncol 140(1):89–98&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR13"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Im&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pak&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cheon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Nucl Med Mol Imaging&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;42&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;241&lt;/FirstPage&gt;
                      &lt;LastPage&gt;251&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXhsFelu7%2FF&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00259-014-2903-7&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25193652&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Im HJ, Pak K, Cheon GJ et al (2015) Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging 42(2):241–251&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR14"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hyun&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Choi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Ann Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;257&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;364&lt;/FirstPage&gt;
                      &lt;LastPage&gt;370&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/SLA.0b013e318262a6ec&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22968069&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hyun SH, Choi JY, Kim K et al (2013) Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection. Ann Surg 257(2):364–370&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR15"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hyun&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ahn&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Nucl Med Mol Imaging&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;41&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;50&lt;/FirstPage&gt;
                      &lt;LastPage&gt;58&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhtlSitbzO&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00259-013-2530-8&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23948859&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hyun SH, Ahn HK, Kim H et al (2014) Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 41(1):50–58&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR16"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carvalho&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Leijenaar&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ER&lt;/Initials&gt;
                        &lt;FamilyName&gt;Velazquez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Acta Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;52&lt;/VolumeID&gt;
                      &lt;IssueID&gt;7&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1398&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1404&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3109/0284186X.2013.812795&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24047338&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4464799&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Carvalho S, Leijenaar RT, Velazquez ER et al (2013) Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer. Acta Oncol 52(7):1398–1404&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR17"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;IJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pak&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nucl Med Commun&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;33&lt;/VolumeID&gt;
                      &lt;IssueID&gt;6&lt;/IssueID&gt;
                      &lt;FirstPage&gt;613&lt;/FirstPage&gt;
                      &lt;LastPage&gt;620&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/MNM.0b013e328351d4f5&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22407127&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kim K, Kim SJ, Kim IJ, Kim YS, Pak K, Kim H (2012) Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer. Nucl Med Commun 33(6):613–620&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR18"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Abelson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Murphy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Trakul&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Lung Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;78&lt;/VolumeID&gt;
                      &lt;IssueID&gt;3&lt;/IssueID&gt;
                      &lt;FirstPage&gt;219&lt;/FirstPage&gt;
                      &lt;LastPage&gt;224&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.lungcan.2012.08.016&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23009727&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Abelson JA, Murphy JD, Trakul N et al (2012) Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer 78(3):219–224&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR19"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Satoh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Onishi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nambu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Araki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;270&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;275&lt;/FirstPage&gt;
                      &lt;LastPage&gt;281&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1148/radiol.13130652&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24029640&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Satoh Y, Onishi H, Nambu A, Araki T (2014) Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value. Radiology 270(1):275–281&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR20"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Winther-Larsen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fledelius&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sorensen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Meldgaard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Lung Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;94&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;81&lt;/FirstPage&gt;
                      &lt;LastPage&gt;87&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.lungcan.2016.01.024&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26973211&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Winther-Larsen A, Fledelius J, Sorensen BS, Meldgaard P (2016) Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib. Lung Cancer 94:81–87&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR21"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yoo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nucl Med Mol Imaging&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;46&lt;/VolumeID&gt;
                      &lt;IssueID&gt;4&lt;/IssueID&gt;
                      &lt;FirstPage&gt;286&lt;/FirstPage&gt;
                      &lt;LastPage&gt;293&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XhslCgtb7F&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s13139-012-0165-5&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24900076&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4043070&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Yoo SW, Kim J, Chong A et al (2012) Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer. Nucl Med Mol Imaging 46(4):286–293&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR22"&gt;
                    &lt;BibUnstructured&gt;Zhu X, Liao C, Penney BC et al (2017) Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer. Nucl Med Commun 38(2):185–192&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR23"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matthews&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Franceschi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TV&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bilfinger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moore&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prognostic value of metabolic tumor volume and total lesion glycolysis from (1)(8)F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nucl Med Commun&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;34&lt;/VolumeID&gt;
                      &lt;IssueID&gt;10&lt;/IssueID&gt;
                      &lt;FirstPage&gt;959&lt;/FirstPage&gt;
                      &lt;LastPage&gt;963&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhtlensrzN&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/MNM.0b013e32836491a9&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23921784&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Vu CC, Matthews R, Kim B, Franceschi D, Bilfinger TV, Moore WH (2013) Prognostic value of metabolic tumor volume and total lesion glycolysis from (1)(8)F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Nucl Med Commun 34(10):959–963&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR24"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Weerasuriya&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lavori&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2007&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Metabolic tumor burden predicts for disease progression and death in lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int J Radiat Oncol Biol Phys&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;69&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;328&lt;/FirstPage&gt;
                      &lt;LastPage&gt;333&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.ijrobp.2007.04.036&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;17869659&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lee P, Weerasuriya DK, Lavori PW et al (2007) Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys 69(2):328–333&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR25"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tannenbaum&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Koru-Sengul&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhao&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Miao&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Byrne&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cancer J&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;20&lt;/VolumeID&gt;
                      &lt;IssueID&gt;4&lt;/IssueID&gt;
                      &lt;FirstPage&gt;237&lt;/FirstPage&gt;
                      &lt;LastPage&gt;245&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/PPO.0000000000000058&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25098282&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Tannenbaum SL, Koru-Sengul T, Zhao W, Miao F, Byrne MM (2014) Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status. Cancer J 20(4):237–245&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR26"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Aldrich&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grogan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Munro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Signorello&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Blot&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Stage-adjusted lung cancer survival does not differ between low-income Blacks and Whites&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;8&lt;/VolumeID&gt;
                      &lt;IssueID&gt;10&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1248&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1254&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/JTO.0b013e3182a406f6&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24457235&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3901948&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Aldrich MC, Grogan EL, Munro HM, Signorello LB, Blot WJ (2013) Stage-adjusted lung cancer survival does not differ between low-income Blacks and Whites. J Thorac Oncol 8(10):1248–1254&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                &lt;/Bibliography&gt;
              &lt;/ArticleBackmatter&gt;
            &lt;/Article&gt;
          &lt;/Issue&gt;
        &lt;/Volume&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-12-04T14:05:29.071867+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Dashevsky, Brittany Z.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Zhang, Chenpeng&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Yan, Li&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Yuan, Cindy&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Xiong, Lingyun&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Liu, Yongmei&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Liu, Haiyan&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Kong, Feng-Ming Spring&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Pu, Yonglin&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution geo="-87.5996710,41.7895723"&gt;
            &lt;meta:OrgName&gt;University Of Chicago&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;-87.5996710,41.7895723#University Of Chicago&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;United States&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="121.4296032,31.1993538"&gt;
            &lt;meta:OrgName&gt;Shanghai Jiao Tong University&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;121.4296032,31.1993538#Shanghai Jiao Tong University&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;China&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;Department of Radiation Oncology, Linyi People’s Hospital&lt;/meta:OrgName&gt;
            &lt;meta:Country&gt;China&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="117.0601336,36.6721003,0"&gt;
            &lt;meta:OrgName&gt;Shandong University&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;117.0601336,36.6721003,0#Shandong University&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;China&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;China West University Hospital&lt;/meta:OrgName&gt;
            &lt;meta:Country&gt;China&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;First Hospital of Shanxi Medical University and Molecular Imaging Precision Medical Collaborative Innovation Center, Shanxi Medical University&lt;/meta:OrgName&gt;
            &lt;meta:Country&gt;China&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;Radiation Oncology, Medical and Molecular Genetics, Indiana University School of Medicine&lt;/meta:OrgName&gt;
            &lt;meta:Country&gt;United States&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="-86.1648200,39.7816050"&gt;
            &lt;meta:OrgName&gt;Indiana University School of Medicine&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;-86.1648200,39.7816050#Indiana University School of Medicine&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;United States&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-01&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-12-01T05:37:15&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1186/s41824-017-0013-z&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;2510-3636&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;Springer&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;European Journal of Hybrid Imaging&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;European Journal of Hybrid Imaging&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH29005" Priority="1" Type="Secondary"&gt;Imaging / Radiology&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:VolumeId&gt;1&lt;/meta:VolumeId&gt;
        &lt;meta:IssueId&gt;1&lt;/meta:IssueId&gt;
        &lt;meta:ArticleSequenceNumber&gt;8&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;Springer US&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;New York&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;Springer&lt;/PublisherImprintName&gt;
        &lt;PublisherURL&gt;http://www.springer-ny.com&lt;/PublisherURL&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="All"&gt;
        &lt;JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;10637&lt;/JournalID&gt;
          &lt;JournalDOI&gt;10.1007/10637.1573-0646&lt;/JournalDOI&gt;
          &lt;JournalPrintISSN&gt;0167-6997&lt;/JournalPrintISSN&gt;
          &lt;JournalElectronicISSN&gt;1573-0646&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;Investigational New Drugs&lt;/JournalTitle&gt;
          &lt;JournalSubTitle&gt;Novel Anti-Cancer Therapeutics and Therapies&lt;/JournalSubTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;Invest New Drugs&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH33160" Priority="1" Type="Secondary"&gt;Oncology&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCB21007" Priority="2" Type="Secondary"&gt;Pharmacology/Toxicology&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Medicine"&gt;SC11&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;Volume OutputMedium="All"&gt;
          &lt;VolumeInfo TocLevels="0" VolumeType="Regular"&gt;
            &lt;VolumeIDStart&gt;35&lt;/VolumeIDStart&gt;
            &lt;VolumeIDEnd&gt;35&lt;/VolumeIDEnd&gt;
            &lt;VolumeIssueCount&gt;6&lt;/VolumeIssueCount&gt;
          &lt;/VolumeInfo&gt;
          &lt;Issue IssueType="Regular" OutputMedium="All"&gt;
            &lt;IssueInfo IssueType="Regular" TocLevels="0"&gt;
              &lt;IssueIDStart&gt;6&lt;/IssueIDStart&gt;
              &lt;IssueIDEnd&gt;6&lt;/IssueIDEnd&gt;
              &lt;IssueArticleCount&gt;20&lt;/IssueArticleCount&gt;
              &lt;IssueHistory&gt;
                &lt;OnlineDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;18&lt;/Day&gt;
                &lt;/OnlineDate&gt;
                &lt;PrintDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;18&lt;/Day&gt;
                &lt;/PrintDate&gt;
                &lt;CoverDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                &lt;/CoverDate&gt;
                &lt;PricelistYear&gt;2017&lt;/PricelistYear&gt;
              &lt;/IssueHistory&gt;
              &lt;IssueCopyright&gt;
                &lt;CopyrightHolderName&gt;Springer Science+Business Media, LLC, part of Springer Nature&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
              &lt;/IssueCopyright&gt;
            &lt;/IssueInfo&gt;
            &lt;Article ID="s10637-017-0471-y" OutputMedium="All"&gt;
              &lt;ArticleInfo ArticleType="Report" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
                &lt;ArticleID&gt;471&lt;/ArticleID&gt;
                &lt;ArticleDOI&gt;10.1007/s10637-017-0471-y&lt;/ArticleDOI&gt;
                &lt;ArticleSequenceNumber&gt;18&lt;/ArticleSequenceNumber&gt;
                &lt;ArticleTitle Language="En"&gt;Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab&lt;/ArticleTitle&gt;
                &lt;ArticleCategory&gt;SHORT REPORT&lt;/ArticleCategory&gt;
                &lt;ArticleFirstPage&gt;839&lt;/ArticleFirstPage&gt;
                &lt;ArticleLastPage&gt;841&lt;/ArticleLastPage&gt;
                &lt;ArticleHistory&gt;
                  &lt;RegistrationDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;4&lt;/Month&gt;
                    &lt;Day&gt;25&lt;/Day&gt;
                  &lt;/RegistrationDate&gt;
                  &lt;Received&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;3&lt;/Month&gt;
                    &lt;Day&gt;21&lt;/Day&gt;
                  &lt;/Received&gt;
                  &lt;Accepted&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;4&lt;/Month&gt;
                    &lt;Day&gt;25&lt;/Day&gt;
                  &lt;/Accepted&gt;
                  &lt;OnlineDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;5&lt;/Month&gt;
                    &lt;Day&gt;2&lt;/Day&gt;
                  &lt;/OnlineDate&gt;
                &lt;/ArticleHistory&gt;
                &lt;ArticleCopyright&gt;
                  &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                  &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                  &lt;License SubType="CC BY" Type="OpenAccess" Version="4.0"&gt;
                    &lt;SimplePara&gt;
                      &lt;Emphasis Type="Bold"&gt;Open Access&lt;/Emphasis&gt; This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
                    &lt;/SimplePara&gt;
                  &lt;/License&gt;
                &lt;/ArticleCopyright&gt;
                &lt;ArticleGrants Type="OpenChoice"&gt;
                  &lt;MetadataGrant Grant="OpenAccess"/&gt;
                  &lt;AbstractGrant Grant="OpenAccess"/&gt;
                  &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                  &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                  &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                  &lt;ESMGrant Grant="OpenAccess"/&gt;
                &lt;/ArticleGrants&gt;
              &lt;/ArticleInfo&gt;
              &lt;ArticleHeader&gt;
                &lt;AuthorGroup&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au1"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Nobuaki&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Mamesaya&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au2" ORCID="http://orcid.org/0000-0003-0590-9259"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Hirotsugu&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Kenmotsu&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Phone&gt;+81-55-989-5222&lt;/Phone&gt;
                      &lt;Email&gt;h.kenmotsu@scchr.jp&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au3"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Toshiaki&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Takahashi&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Affiliation ID="Aff1"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 1774 9501&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.415797.9&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Division of Thoracic Oncology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Shizuoka Cancer Center Hospital&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun&lt;/Street&gt;
                      &lt;City&gt;Shizuoka&lt;/City&gt;
                      &lt;Postcode&gt;411-8777&lt;/Postcode&gt;
                      &lt;Country Code="JP"&gt;Japan&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                &lt;/AuthorGroup&gt;
                &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                  &lt;Heading&gt;Keywords&lt;/Heading&gt;
                  &lt;Keyword&gt;Lung cancer&lt;/Keyword&gt;
                  &lt;Keyword&gt;EGFR mutation&lt;/Keyword&gt;
                  &lt;Keyword&gt;EGFR tyrosine kinase inhibitor&lt;/Keyword&gt;
                  &lt;Keyword&gt;Anti-PD1 antibody&lt;/Keyword&gt;
                  &lt;Keyword&gt;Interstitial lung disease&lt;/Keyword&gt;
                  &lt;Keyword&gt;Rechallenge&lt;/Keyword&gt;
                &lt;/KeywordGroup&gt;
              &lt;/ArticleHeader&gt;
              &lt;Body&gt;
                &lt;Para ID="Par1"&gt;Dear Editor:&lt;/Para&gt;
                &lt;Para ID="Par2"&gt;We have already reported a case of a 38-year-old woman with advanced non-small cell lung cancer harboring a sensitive epidermal growth factor receptor (EGFR) L858R mutation with T790&nbsp;M who was treated with osimertinib, a third generation EGFR-tyrosine kinase inhibitor (EGFR-TKI), which induced interstitial lung disease (ILD) after treatment with nivolumab [
                  &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]. In that report, we mentioned that an anti-programmed cell death-1 (anti-PD1) antibody therapies may be a risk factor for EGFR-TKI-induced ILD. Herein, we describe the clinical course of a patient who was successfully treated with osimertinib rechallenge after osimertinib-induced ILD following treatment with nivolumab.
                &lt;/Para&gt;
                &lt;Para ID="Par3"&gt;In our patient, osimertinib-induced ILD improved within 2&nbsp;months after discontinuing osimertinib. She was treated with a combination of docetaxel and ramucirumab (10&nbsp;mg/kg, up to four cycles), as sixth-line chemotherapy, from August 2016, and then she received gemcitabine monotherapy (up to two cycles). However, no significant response was observed in any conventional chemotherapy, and tumor-related pain became worsen regardless of the administration of oxycodone. Therefore, osimertinib rechallenge was considered based on the expected clinical benefit of its antitumor efficacy over the risk of osimertinib-induced ILD recurrence. Although the risk of drug-induced ILD recurrence may be increased by rechallenge, we considered that the interaction between EGFR-TKI and the anti-PD1 antibody was decreased, because the interval from treatment with nivolumab had been more than 6&nbsp;month. After obtaining informed consent, a rechallenge of osimertinib (80&nbsp;mg, once daily) was started as eighth-line treatment for 8&nbsp;months after the last initiation of nivolumab. One week after the re-administration of osimertinib concurrently without a steroid, her symptom (right chest pain) improved, and right tumor shadows were shrinking, as indicated by the chest radiograph (Fig. 
                  &lt;InternalRef RefID="Fig1"&gt;1a&lt;/InternalRef&gt;, b). Furthermore, 3&nbsp;months after treatment with osimertinib, the chest computed tomography scan showed a remarkable antitumor response with improvement in right pleural thickening without evidence of the recurrence of osimertinib-induced ILD (e.g., bilateral diffuse, faint, ground-glass opacities or consolidation) (Fig. 
                  &lt;InternalRef RefID="Fig1"&gt;1c&lt;/InternalRef&gt;, d). Now, she continues to receive treatment with osimertinib.
                  &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                    &lt;Caption Language="En"&gt;
                      &lt;CaptionNumber&gt;Fig. 1&lt;/CaptionNumber&gt;
                      &lt;CaptionContent&gt;
                        &lt;SimplePara&gt;Chest radiographs before and after treatment. 
                          &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt; Solid tumors with intrapulmonary metastasis have aggressive regrowth. 
                          &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt; Remarkable shrinkage of tumors after osimertinib rechallenge treatment within 1&nbsp;week. 
                          &lt;Emphasis Type="Bold"&gt;c&lt;/Emphasis&gt; Solid tumors with intrapulmonary metastasis and no evidence of preexisting interstitial pneumonia before osimertinib rechallenge treatment. 
                          &lt;Emphasis Type="Bold"&gt;d&lt;/Emphasis&gt; Remarkable shrinkage of tumors after osimertinib rechallenge treatment without evidence of the recurrence of osimertinib-induced interstitial lung disease
                        &lt;/SimplePara&gt;
                      &lt;/CaptionContent&gt;
                    &lt;/Caption&gt;
                    &lt;MediaObject ID="MO1"&gt;
                      &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/10637_2017_471_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                    &lt;/MediaObject&gt;
                  &lt;/Figure&gt;
                &lt;/Para&gt;
                &lt;Para ID="Par4"&gt;To our knowledge, this is the first case report of a successful osimertinib rechallenge following osimertinib-induced ILD after treatment with nivolumab. The strategy for treating lung cancer harboring a sensitive EGFR mutation is preferentially to administer EGFR-TKI. However, most patients unfortunately acquire resistance to EGFR-TKI. Several conventional chemotherapies or anti-PD1 therapies, in general, are initiated after resistance without a T790&nbsp;M mutation to the first or second generation EGFR-TKI or the acquisition of osimertinib-resistance. In particular, PD1 antibody therapies are expecting to be one of the potential salvage chemotherapies. Kotake et al. reported a high frequency of osimertinib-induced ILD after immediate prior treatment with nivolumab in a series of 19 patients with EGFR-T790&nbsp;M mutation-positive advanced non-small cell lung cancer who acquired resistance with the T790&nbsp;M mutation [
                  &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;]. They also showed that the administration interval between prior nivolumab and osimertinib tended to be shorter in patients with ILD than in those without ILD. However, it is unknown how long of an interval is safe for ILD due to the synergistic reaction between osimertinib and nivolumab. Brahmer et al. reported that the nivolumab serum half-life concentration (t1/2) was approximately 12&nbsp;days (3&nbsp;mg/kg dose), according to flow cytometric methods used to evaluate the pharmacodynamics of infused nivolumab [
                  &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;]. In addition, they showed that estimating the plateau PD-1 occupancy on circulating CD3
                  &lt;Superscript&gt;+&lt;/Superscript&gt; T cells after one infusion was observed at 4 to 24&nbsp;h and ≥57&nbsp;days. These data showed the high affinity of nivolumab for PD-1 in vitro, which suggests that sufficient concentrations persist to plateau PD-1 occupancy, even when nivolumab serum levels are undetectable (&amp;lt;1.2&nbsp;μg/mL). However, it is unknown whether these findings in circulating lymphocytes reflect PD-1 occupancy on lymphocytes in the tumor or other normal tissues relating to antitumor activity or the development of immune-related adverse effects. This case report suggests that even if patients receive nivolumab therapy, a long interval from the last administration of nivolumab may reduce the risk of osimertinib-induced ILD.
                &lt;/Para&gt;
              &lt;/Body&gt;
              &lt;BodyRef FileRef="BodyRef/PDF/10637_2017_Article_471.pdf" TargetType="OnlinePDF"/&gt;
              &lt;ArticleBackmatter&gt;
                &lt;Acknowledgments&gt;
                  &lt;Heading&gt;Acknowledgements&lt;/Heading&gt;
                  &lt;SimplePara&gt;The authors were responsible for all content and editorial decisions and received no honoraria related to the development of this publication. All authors contributed to the writing and reviewing of all drafts of this manuscript and approved the final draft.&lt;/SimplePara&gt;
                &lt;/Acknowledgments&gt;
                &lt;Ethics&gt;
                  &lt;Heading&gt;Compliance with ethical standards&lt;/Heading&gt;
                  &lt;FormalPara ID="FPar1" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Conflicts of interest&lt;/Heading&gt;
                    &lt;Para ID="Par5"&gt;NM has no conflicts of interest to declare. HK received grants and honoraria from AstraZeneca K.K. and personal fees from Ono Pharmaceutical Co., Ltd. TT received grants and honoraria from AstraZeneca K.K., and grants and honoraria from Ono Pharmaceutical Co., Ltd.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar2" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Funding&lt;/Heading&gt;
                    &lt;Para ID="Par6"&gt;No funding was received for this report.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar3" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Ethical approval&lt;/Heading&gt;
                    &lt;Para ID="Par7"&gt;All procedures performed in the human participant were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar4" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Informed consent&lt;/Heading&gt;
                    &lt;Para ID="Par8"&gt;Informed consent was obtained from the patient.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Ethics&gt;
                &lt;Bibliography ID="Bib1"&gt;
                  &lt;Heading&gt;References&lt;/Heading&gt;
                  &lt;Citation ID="CR1"&gt;
                    &lt;CitationNumber&gt;1.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mamesaya&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kenmotsu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Katsumata&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nakajima&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Endo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takahashi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2017&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibody&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Investig New Drugs&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;35&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;105&lt;/FirstPage&gt;
                      &lt;LastPage&gt;107&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1007/s10637-016-0389-9&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2sXitFGmtbs%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s10637-016-0389-9&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Mamesaya N, Kenmotsu H, Katsumata M, Nakajima T, Endo M, Takahashi T (2017) Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibody. Investig New Drugs 35:105–107. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1007/s10637-016-0389-9&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1007/s10637-016-0389-9" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR2"&gt;
                    &lt;CitationNumber&gt;2.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kotake&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Murakami&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kenmotsu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Naito&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takahashi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Ann Oncol&lt;/JournalTitle&gt;
                      &lt;BibArticleDOI&gt;10.1093/annonc/mdw647&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27056996&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kotake M, Murakami H, Kenmotsu H, Naito T, Takahashi T (2016) High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy. Ann Oncol. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1093/annonc/mdw647&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1093/annonc/mdw647" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR3"&gt;
                    &lt;CitationNumber&gt;3.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brahmer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Drake&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wollner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;28&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;3167&lt;/FirstPage&gt;
                      &lt;LastPage&gt;3175&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1200/JCO.2009.26.7609&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXpslajtLw%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.2009.26.7609&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20516446&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4834717&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Brahmer JR, Drake CG, Wollner I et al (2010) Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 28:3167–3175. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1200/JCO.2009.26.7609&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1200/JCO.2009.26.7609" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                &lt;/Bibliography&gt;
              &lt;/ArticleBackmatter&gt;
            &lt;/Article&gt;
          &lt;/Issue&gt;
        &lt;/Volume&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-11-19T16:14:56.657178+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Mamesaya, Nobuaki&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Kenmotsu, Hirotsugu&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Takahashi, Toshiaki&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution geo="138.3827596,34.9755620,0"&gt;
            &lt;meta:OrgName&gt;Shizuoka Cancer Center Hospital&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;138.3827596,34.9755620,0#Shizuoka Cancer Center Hospital&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Japan&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-01&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-11-19T05:10:43&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1007/s10637-017-0471-y&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;1573-0646&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;Springer&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;Investigational New Drugs&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;Investigational New Drugs&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH33160" Priority="1" Type="Secondary"&gt;Oncology&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCB21007" Priority="2" Type="Secondary"&gt;Pharmacology/Toxicology&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:VolumeId&gt;35&lt;/meta:VolumeId&gt;
        &lt;meta:IssueId&gt;6&lt;/meta:IssueId&gt;
        &lt;meta:ArticleSequenceNumber&gt;18&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;Springer US&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;New York&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;Springer&lt;/PublisherImprintName&gt;
        &lt;PublisherURL&gt;http://www.springer-ny.com&lt;/PublisherURL&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="All"&gt;
        &lt;JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;11764&lt;/JournalID&gt;
          &lt;JournalDOI&gt;10.1007/11764.1932-2267&lt;/JournalDOI&gt;
          &lt;JournalPrintISSN&gt;1932-2259&lt;/JournalPrintISSN&gt;
          &lt;JournalElectronicISSN&gt;1932-2267&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;Journal of Cancer Survivorship&lt;/JournalTitle&gt;
          &lt;JournalSubTitle&gt;Research and Practice&lt;/JournalSubTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;J Cancer Surviv&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH27002" Priority="1" Type="Secondary"&gt;Public Health&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH33160" Priority="2" Type="Secondary"&gt;Oncology&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH27010" Priority="3" Type="Secondary"&gt;Health Promotion and Disease Prevention&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH28009" Priority="4" Type="Secondary"&gt;Health Informatics&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH65000" Priority="5" Type="Secondary"&gt;Quality of Life Research&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH51000" Priority="6" Type="Secondary"&gt;Primary Care Medicine&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Medicine"&gt;SC11&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;Volume OutputMedium="All"&gt;
          &lt;VolumeInfo TocLevels="0" VolumeType="Regular"&gt;
            &lt;VolumeIDStart&gt;11&lt;/VolumeIDStart&gt;
            &lt;VolumeIDEnd&gt;11&lt;/VolumeIDEnd&gt;
            &lt;VolumeIssueCount&gt;6&lt;/VolumeIssueCount&gt;
          &lt;/VolumeInfo&gt;
          &lt;Issue IssueType="Regular" OutputMedium="All"&gt;
            &lt;IssueInfo IssueType="Regular" TocLevels="0"&gt;
              &lt;IssueIDStart&gt;6&lt;/IssueIDStart&gt;
              &lt;IssueIDEnd&gt;6&lt;/IssueIDEnd&gt;
              &lt;IssueTitle Language="En"&gt;Includes a Special Section on Digital Technology and Cancer Survivorship&lt;/IssueTitle&gt;
              &lt;IssueArticleCount&gt;16&lt;/IssueArticleCount&gt;
              &lt;IssueHistory&gt;
                &lt;OnlineDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;4&lt;/Day&gt;
                &lt;/OnlineDate&gt;
                &lt;PrintDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;4&lt;/Day&gt;
                &lt;/PrintDate&gt;
                &lt;CoverDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                &lt;/CoverDate&gt;
                &lt;PricelistYear&gt;2017&lt;/PricelistYear&gt;
              &lt;/IssueHistory&gt;
              &lt;IssueCopyright&gt;
                &lt;CopyrightHolderName&gt;Springer Science+Business Media, LLC&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
              &lt;/IssueCopyright&gt;
            &lt;/IssueInfo&gt;
            &lt;IssueHeader&gt;
              &lt;EditorGroup&gt;
                &lt;Editor&gt;
                  &lt;EditorName DisplayOrder="Western"&gt;
                    &lt;GivenName&gt;Kate&lt;/GivenName&gt;
                    &lt;FamilyName&gt;Absolom&lt;/FamilyName&gt;
                  &lt;/EditorName&gt;
                &lt;/Editor&gt;
                &lt;Editor&gt;
                  &lt;EditorName DisplayOrder="Western"&gt;
                    &lt;GivenName&gt;Patricia&lt;/GivenName&gt;
                    &lt;FamilyName&gt;Holch&lt;/FamilyName&gt;
                  &lt;/EditorName&gt;
                &lt;/Editor&gt;
                &lt;Editor&gt;
                  &lt;EditorName DisplayOrder="Western"&gt;
                    &lt;GivenName&gt;Ziv&lt;/GivenName&gt;
                    &lt;FamilyName&gt;Amir&lt;/FamilyName&gt;
                  &lt;/EditorName&gt;
                &lt;/Editor&gt;
              &lt;/EditorGroup&gt;
            &lt;/IssueHeader&gt;
            &lt;Article ID="s11764-017-0611-6" OutputMedium="All"&gt;
              &lt;ArticleInfo ArticleType="OriginalPaper" ContainsESM="Yes" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
                &lt;ArticleID&gt;611&lt;/ArticleID&gt;
                &lt;ArticleDOI&gt;10.1007/s11764-017-0611-6&lt;/ArticleDOI&gt;
                &lt;ArticleSequenceNumber&gt;7&lt;/ArticleSequenceNumber&gt;
                &lt;ArticleTitle Language="En"&gt;Ambulant monitoring and web-accessible home-based exercise program during outpatient follow-up for resected lung cancer survivors: actual use and feasibility in clinical practice&lt;/ArticleTitle&gt;
                &lt;ArticleFirstPage&gt;720&lt;/ArticleFirstPage&gt;
                &lt;ArticleLastPage&gt;731&lt;/ArticleLastPage&gt;
                &lt;ArticleHistory&gt;
                  &lt;RegistrationDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;2&lt;/Month&gt;
                    &lt;Day&gt;24&lt;/Day&gt;
                  &lt;/RegistrationDate&gt;
                  &lt;Received&gt;
                    &lt;Year&gt;2016&lt;/Year&gt;
                    &lt;Month&gt;8&lt;/Month&gt;
                    &lt;Day&gt;22&lt;/Day&gt;
                  &lt;/Received&gt;
                  &lt;Accepted&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;2&lt;/Month&gt;
                    &lt;Day&gt;24&lt;/Day&gt;
                  &lt;/Accepted&gt;
                  &lt;OnlineDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;4&lt;/Month&gt;
                    &lt;Day&gt;10&lt;/Day&gt;
                  &lt;/OnlineDate&gt;
                &lt;/ArticleHistory&gt;
                &lt;ArticleFundingInformation&gt;
                  &lt;Fund&gt;
                    &lt;FunderName FundRefID="http://dx.doi.org/10.13039/501100004622"&gt;KWF Kankerbestrijding&lt;/FunderName&gt;
                    &lt;GrantNumber Type="FundRef"&gt;2010-4854&lt;/GrantNumber&gt;
                  &lt;/Fund&gt;
                &lt;/ArticleFundingInformation&gt;
                &lt;ArticleCopyright&gt;
                  &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                  &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                  &lt;License SubType="CC BY" Type="OpenAccess" Version="4.0"&gt;
                    &lt;SimplePara&gt;
                      &lt;Emphasis Type="Bold"&gt;Open Access&lt;/Emphasis&gt; This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
                    &lt;/SimplePara&gt;
                  &lt;/License&gt;
                &lt;/ArticleCopyright&gt;
                &lt;ArticleGrants Type="OpenChoice"&gt;
                  &lt;MetadataGrant Grant="OpenAccess"/&gt;
                  &lt;AbstractGrant Grant="OpenAccess"/&gt;
                  &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                  &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                  &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                  &lt;ESMGrant Grant="OpenAccess"/&gt;
                &lt;/ArticleGrants&gt;
              &lt;/ArticleInfo&gt;
              &lt;ArticleHeader&gt;
                &lt;AuthorGroup&gt;
                  &lt;Author AffiliationIDS="Aff1 Aff2" CorrespondingAffiliationID="Aff1" ID="Au1"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;J.G.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Timmerman&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Phone&gt;+31 (0)88 0875777&lt;/Phone&gt;
                      &lt;Email&gt;j.g.timmerman@utwente.nl&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au2"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;M.G.H.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Dekker-van Weering&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;m.dekker@rrd.nl&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff3" ID="Au3"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;M.M.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Stuiver&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;m.stuiver@nki.nl&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff3" ID="Au4"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;W.G.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Groen&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;w.groen@nki.nl&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff3" ID="Au5"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;M.W.J.M.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Wouters&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;m.wouters@nki.nl&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au6"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;T.M.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Tönis&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1 Aff2" ID="Au7"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;H.J.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Hermens&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;h.hermens@rrd.nl&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff2 Aff4" ID="Au8"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;M.M.R.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Vollenbroek-Hutten&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;m.m.r.hutten@utwente.nl&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Affiliation ID="Aff1"&gt;
                    &lt;OrgDivision&gt;Roessingh Research and Development&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Telemedicine Group&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Enschede&lt;/City&gt;
                      &lt;Country Code="NL"&gt;The Netherlands&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff2"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 0399 8953&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.6214.1&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Faculty of Electrical Engineering, Mathematics and Computer Science, Telemedicine Group&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;University of Twente&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Enschede&lt;/City&gt;
                      &lt;Country Code="NL"&gt;The Netherlands&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff3"&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.430814.a&lt;/OrgID&gt;
                    &lt;OrgName&gt;The Netherlands Cancer Institute&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Amsterdam&lt;/City&gt;
                      &lt;Country Code="NL"&gt;The Netherlands&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff4"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 0502 0983&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.417370.6&lt;/OrgID&gt;
                    &lt;OrgName&gt;Ziekenhuis Groep Twente&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Almelo&lt;/City&gt;
                      &lt;Country Code="NL"&gt;The Netherlands&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                &lt;/AuthorGroup&gt;
                &lt;Abstract ID="Abs1" Language="En" OutputMedium="All"&gt;
                  &lt;Heading&gt;Abstract&lt;/Heading&gt;
                  &lt;AbstractSection ID="ASec1"&gt;
                    &lt;Heading&gt;Purpose&lt;/Heading&gt;
                    &lt;Para ID="Par1"&gt;The aim of this study is to evaluate the feasibility of a telehealthcare application for operable lung cancer (OLC) patients, consisting of ambulant symptom and physical activity monitoring (S&amp;amp;PAM) and a web-accessible home-based exercise program (WEP), and identify possible barriers for successful adoption and implementation.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec2"&gt;
                    &lt;Heading&gt;Methods&lt;/Heading&gt;
                    &lt;Para ID="Par2"&gt;A two-stage mixed methods design was used, in which 22 OLC patients and their treating healthcare professionals (HCPs) participated from pre-surgery to three (stage 1; 
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;10) or six (stage 2; 
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;12) months post-surgery. Actual use and acceptability (usability, usefulness, and satisfaction) were evaluated.
                    &lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec3"&gt;
                    &lt;Heading&gt;Results&lt;/Heading&gt;
                    &lt;Para ID="Par3"&gt;Seventeen OLC patients (age (SD): 59 (8) years; 8 female) actively used the modules. S&amp;amp;PAM use varied from 1 to 11 monitoring days prior to outpatient consultations. Patients used WEP most frequently during the first 5&nbsp;weeks, with an average of four logins a week. Fifty-eight percent used WEP beyond 7&nbsp;weeks. No adverse situations occurred, and patients felt confident using the applications.&lt;/Para&gt;
                    &lt;Para ID="Par4"&gt;Perceived added value included active lifestyle promotion, decreased anxiety, and accessibility to specialized HCPs. Physiotherapists used WEP as intended. Contrarily, physicians scarcely used information from S&amp;amp;PAM. To promote future adoption, strategies should focus on high-level patient tailoring of the technology, and formalization of including the applications in the clinical workflow.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec4"&gt;
                    &lt;Heading&gt;Conclusions&lt;/Heading&gt;
                    &lt;Para ID="Par5"&gt;Ambulant monitoring and web-accessible home exercise is clinically feasible for OLC patients. However, low level of adoption by referring physicians may hamper successful implementation.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec5"&gt;
                    &lt;Heading&gt;Implications for cancer survivors&lt;/Heading&gt;
                    &lt;Para ID="Par6"&gt;Patients perceived both ambulant monitoring and web-accessible exercise as an added value to regular care and feasible to use in the period before and after lung resection.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                &lt;/Abstract&gt;
                &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                  &lt;Heading&gt;Keywords&lt;/Heading&gt;
                  &lt;Keyword&gt;Lung cancer&lt;/Keyword&gt;
                  &lt;Keyword&gt;Telehealthcare&lt;/Keyword&gt;
                  &lt;Keyword&gt;Cancer survivorship&lt;/Keyword&gt;
                  &lt;Keyword&gt;Rehabilitation&lt;/Keyword&gt;
                  &lt;Keyword&gt;Feasibility&lt;/Keyword&gt;
                  &lt;Keyword&gt;Implementation&lt;/Keyword&gt;
                &lt;/KeywordGroup&gt;
                &lt;ArticleNote Type="ESMHint"&gt;
                  &lt;Heading&gt;Electronic supplementary material&lt;/Heading&gt;
                  &lt;SimplePara&gt;The online version of this article (doi:
                    &lt;ExternalRef&gt;
                      &lt;RefSource&gt;10.1007/s11764-017-0611-6&lt;/RefSource&gt;
                      &lt;RefTarget Address="10.1007/s11764-017-0611-6" TargetType="DOI"/&gt;
                    &lt;/ExternalRef&gt;) contains supplementary material, which is available to authorized users.
                  &lt;/SimplePara&gt;
                &lt;/ArticleNote&gt;
              &lt;/ArticleHeader&gt;
              &lt;Body&gt;
                &lt;Section1 ID="Sec1"&gt;
                  &lt;Heading&gt;Introduction&lt;/Heading&gt;
                  &lt;Para ID="Par7"&gt;Lung cancer is associated with high symptom burden and high level of unmet needs during and after treatment [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]. Although lung resection has the best treatment outcomes in terms of survival in early stage lung cancer, resected patients are faced with an additional worsening of physical fitness, lung function, quality of life, and symptoms such as pain or fatigue following surgery [
                    &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR4"&gt;4&lt;/CitationRef&gt;]. Good quality survivorship care post-surgery is essential to optimize recovery and prevent rehospitalization. Physical training and ambulant symptom monitoring might promote recovery and optimize treatment outcome [
                    &lt;CitationRef CitationID="CR5"&gt;5&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;], yet availability and accessibility of such non-invasive interventions specifically adapted for operable lung cancer (OLC) patients remains extremely low [
                    &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par8"&gt;Telehealthcare, defined as delivery of care by a healthcare professional over a distance using information and communication technologies (ICT) [
                    &lt;CitationRef CitationID="CR10"&gt;10&lt;/CitationRef&gt;], is hypothesized to be a promising method to improve both the accessibility and quality of post-surgery cancer rehabilitation. Studies in various cancer diagnoses showed beneficial effects of telehealthcare on physical fitness, symptom management, and patient empowerment through frequent health monitoring, home-based exercise programs, and tailored information on disease and treatment [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;]. Using the internet, smartphones, and sensors, telehealthcare services are accessible on patients’ demand, wherever and whenever they need, providing timely support and promoting health-related self-management behaviors. Currently, evidence is emerging that telehealthcare applications are also acceptable for OLC patients and clinically safe [
                    &lt;CitationRef CitationID="CR13"&gt;13&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par9"&gt;However, showing acceptability and clinical safety is not sufficient for successful adoption and widespread use in everyday care [
                    &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR17"&gt;17&lt;/CitationRef&gt;]. The context of use is considered important as well [
                    &lt;CitationRef CitationID="CR18"&gt;18&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR17"&gt;17&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR19"&gt;19&lt;/CitationRef&gt;], which means that insight in acceptability and use 
                    &lt;Emphasis Type="Italic"&gt;within&lt;/Emphasis&gt; this context is of utmost importance to make the potential of telehealthcare come true.
                  &lt;/Para&gt;
                  &lt;Para ID="Par10"&gt;Therefore, the primary aim of this study was to evaluate the feasibility of a telehealthcare application when used in clinical practice. Research questions to be answered were: (1) how do patients and HCPs use the application during outpatient follow-up in terms of frequency and duration; and (2) is the application acceptable for patients and HCPs as offered. A secondary aim was to identify factors for successful adoption and implementation following the staged approach of Jansen-Kosterink and Vollenbroek-Hutten [
                    &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;]. By doing so, essential factors can be detected in an early phase, which enables efficient modification of the application before larger-scale implementation.
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec2"&gt;
                  &lt;Heading&gt;Methods&lt;/Heading&gt;
                  &lt;Para ID="Par11"&gt;A repeated-measures, single-arm, mixed-methods feasibility study was performed from January 2014 to January 2016. The study was approved by the Institutional Review Board Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital (NL44192.031.13/N13POR), and all participants provided informed consent prior to participation in the study. The staged approach was used to guide the evaluation [
                    &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;], resulting in a stage 1—optimization of usability for use in clinical practice—and a stage 2—evaluation of clinical feasibility—study.
                  &lt;/Para&gt;
                  &lt;Section2 ID="Sec3"&gt;
                    &lt;Heading&gt;Sample and setting&lt;/Heading&gt;
                    &lt;Para ID="Par12"&gt;Participants were recruited from the Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands, between January–May 2014 (stage 1) and January–July 2015 (stage 2). Eligible participants were Dutch-speaking adults aged 18&nbsp;years or older, diagnosed with primary non-small lung cancer (NSCLC) and scheduled for curative lung resection. Participants were identified during the multidisciplinary meeting at the NKI, and patients’ treating oncologist validated eligibility. A study information letter was sent to eligible patients, after which patients were contacted by the first author. When interested, a first appointment was scheduled at the NKI prior to surgery.&lt;/Para&gt;
                    &lt;Para ID="Par13"&gt;Participants were excluded if they had no access to a computer or internet, were unable to walk independently with or without walking aid (e.g., cane), exhibited severe cognitive disorders or emotional instability, or suffered from uncontrolled comorbidities. HCPs (oncologists, surgeons, physiotherapists) involved in the care of the included patient were also recruited.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec4"&gt;
                    &lt;Heading&gt;Intervention&lt;/Heading&gt;
                    &lt;Para ID="Par14"&gt;The telehealthcare application, called the 
                      &lt;Emphasis Type="Italic"&gt;Remote Monitoring and Treatment (RMT) application&lt;/Emphasis&gt;, has been described previously [
                      &lt;CitationRef CitationID="CR20"&gt;20&lt;/CitationRef&gt;]. Briefly, it consists of two modules: (1) a symptom and physical activity monitoring (S&amp;amp;PAM) system, and (2) a web-accessible exercise program (WEP) with remote supervision by a physiotherapist.
                    &lt;/Para&gt;
                    &lt;Para ID="Par15"&gt;
                      &lt;Emphasis Type="Italic"&gt;The S&amp;amp;PAM module&lt;/Emphasis&gt; aims to increase insight in the severity of and change in self-reported symptoms, well-being, and daily physical activity. The system consists of an android smartphone—used as input device for self-rated symptom severity (pain, dyspnea, fatigue; scored by moving slider between 0 (‘no [symptom] at all’) to 10 (‘extremely/a lot of [symptom]’)), mood (
                      &lt;Emphasis Type="Italic"&gt;valence&lt;/Emphasis&gt;, 
                      &lt;Emphasis Type="Italic"&gt;calmness&lt;/Emphasis&gt;, 
                      &lt;Emphasis Type="Italic"&gt;energetic arousal&lt;/Emphasis&gt;; scored from 0 (e.g., ‘tense’)—6 (e.g., ‘calm’) [
                      &lt;CitationRef CitationID="CR21"&gt;21&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR22"&gt;22&lt;/CitationRef&gt;]), weight, and pain medication use—and three on-body sensors, i.e., an accelerometer, heart rate sensor, and an oxygen saturation sensor (Fig. 
                      &lt;InternalRef RefID="Fig1"&gt;1a&lt;/InternalRef&gt;). The symptom scores are combined with physiological parameters from the sensors and summarized into graphs, accessible for both patients and HCPs via a web portal, which is integrated with existing electronic medical records (EMRs) at the hospital.
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;The remote monitoring and treatment (RMT) service for lung cancer patients. 
                              &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt; The symptom and physical activity monitoring (S&amp;amp;PAM) system consisting of a smartphone, heart rate sensor, pulse oximeter, and accelerometer. 
                              &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt; Example exercise of the web-accessible home-based exercise program (WEP) including a movie and written instructions as displayed in the online portal
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO1"&gt;
                          &lt;ImageObject Color="Color" FileRef="MediaObjects/11764_2017_611_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par16"&gt;
                      &lt;Emphasis Type="Italic"&gt;The WEP module&lt;/Emphasis&gt; aims at improving physical fitness of the patient by means of an online, tailored exercise program, which is based on patients’ fitness and goals—assessed during a face-to-face intake—and is performed at home. Each exercise is illustrated by a movie with spoken instructions, and supported by written text (Fig. 
                      &lt;InternalRef RefID="Fig1"&gt;1b&lt;/InternalRef&gt;). Progress is monitored via patient self-report (number of exercises successfully completed, and the experienced difficulty of the exercise) and automatically logged information on use (frequency, duration of login, number of page, and exercise views). If a patient experiences problems with exercise execution (e.g., unclear how to perform an exercise or non-acute bodily pain related to the exercise program), the patient can click a button on the web portal reading “cannot perform exercise, report to therapist”, which results in a standardized email sent to the responsible physiotherapist with instructions to contact the patient. For acute physical problems, the patient is instructed to contact his/her GP.
                    &lt;/Para&gt;
                    &lt;Para ID="Par17"&gt;The modules were accessible for patients via ‘MyAVL’, the interactive patient portal from the NKI [
                      &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;] but ran on the Continuous Care and Coaching Platform hosted at the research institute [
                      &lt;CitationRef CitationID="CR19"&gt;19&lt;/CitationRef&gt;].
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec5"&gt;
                    &lt;Heading&gt;Study procedures&lt;/Heading&gt;
                    &lt;Section3 ID="Sec6"&gt;
                      &lt;Heading&gt;Stage 1 study: preparation of the RMT application for clinical use&lt;/Heading&gt;
                      &lt;Para ID="Par18"&gt;To optimize usability of the application for clinical use, the RMT application was offered to a small sample of operable NSCLC patients and their HCPs at the NKI from pre-surgery to 3&nbsp;months post-surgery.&lt;/Para&gt;
                      &lt;Para ID="Par19"&gt;Patients, pulmonologists, and physiotherapists participated in telephone or face-to-face semi-structured interview to evaluate satisfaction 3&nbsp;months post-surgery. All interviews were performed by the first author and lasted between 15 and 30&nbsp;min. Participants were asked to describe how they used the application, what they thought of the ease of use, and if they had experienced any problems (e.g., technical) using the application. Their comments resulted in a list of critical requirements for adaptation of the RMT application. Results are summarized in this article and adaptations were realized before start of the stage 2 study.&lt;/Para&gt;
                    &lt;/Section3&gt;
                    &lt;Section3 ID="Sec7"&gt;
                      &lt;Heading&gt;Stage 2 study: evaluation of clinical feasibility of the RMT application in clinical care&lt;/Heading&gt;
                      &lt;Para ID="Par20"&gt;Before start of the study, thoracic surgeons and pulmonologists of the NKI were given a 30-min presentation about content and possible benefits of the S&amp;amp;PAM module, where in the EMRs the data could be found and how these should be interpreted. Physiotherapists of the NKI were familiarized with the WEP portal during a 2-h workshop. Additionally, a paper manual was provided. Telephone and email support for the use of the modules was also available for both patients and HCPs.&lt;/Para&gt;
                    &lt;/Section3&gt;
                    &lt;Section3 ID="Sec8"&gt;
                      &lt;Heading&gt;Study protocol&lt;/Heading&gt;
                      &lt;Para ID="Par21"&gt;The study protocol is summarized in Fig. 
                        &lt;InternalRef RefID="Fig2"&gt;2&lt;/InternalRef&gt;.
                        &lt;Figure Category="Standard" Float="Yes" ID="Fig2"&gt;
                          &lt;Caption Language="En"&gt;
                            &lt;CaptionNumber&gt;Fig. 2&lt;/CaptionNumber&gt;
                            &lt;CaptionContent&gt;
                              &lt;SimplePara&gt;Study protocol stage 1 and stage 2 study. Stage 1 ran from 2&nbsp;weeks prior surgery (t0) to 3&nbsp;months post-surgery (t2) only. 
                                &lt;Emphasis Type="Italic"&gt;S&amp;amp;PAM&lt;/Emphasis&gt; symptom and physical activity monitoring module; 
                                &lt;Emphasis Type="Italic"&gt;WEP&lt;/Emphasis&gt; web-accessible home exercise program; 
                                &lt;Emphasis Type="Italic"&gt;UTAUT&lt;/Emphasis&gt; unified theory of acceptance and use of technology
                              &lt;/SimplePara&gt;
                            &lt;/CaptionContent&gt;
                          &lt;/Caption&gt;
                          &lt;MediaObject ID="MO2"&gt;
                            &lt;ImageObject Color="Color" FileRef="MediaObjects/11764_2017_611_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                          &lt;/MediaObject&gt;
                        &lt;/Figure&gt;
                      &lt;/Para&gt;
                      &lt;FormalPara ID="FPar1" RenderingStyle="Style1"&gt;
                        &lt;Heading&gt;Pre-surgery (t0)&lt;/Heading&gt;
                        &lt;Para ID="Par22"&gt;At baseline, patients received the system for the S&amp;amp;PAM module, oral instructions, and a paper manual. Patients were asked to use the system in the period 
                          &lt;Emphasis Type="Italic"&gt;before&lt;/Emphasis&gt; surgery for a minimum of 3&nbsp;days a week, preferably for 2&nbsp;weeks. The first week following the appointment, the investigator checked if scores were displayed in the EMR, and when necessary, encouraged the patient to complete measurements before surgery.
                        &lt;/Para&gt;
                      &lt;/FormalPara&gt;
                      &lt;FormalPara ID="FPar2" RenderingStyle="Style1"&gt;
                        &lt;Heading&gt;Post-surgery&lt;/Heading&gt;
                        &lt;Para ID="Par23"&gt;Outpatient appointments with the physician (thoracic surgeon or pulmonologists) and the physiotherapist were scheduled at 1&nbsp;month post-surgery, as per usual care. After hospital discharge, the patients were contacted by the investigator and reminded to use the S&amp;amp;PAM system for a minimum of 3&nbsp;days a week, preferably all weeks until the 1-month physician appointment at the hospital (t1).&lt;/Para&gt;
                      &lt;/FormalPara&gt;
                      &lt;FormalPara ID="FPar3" RenderingStyle="Style1"&gt;
                        &lt;Heading&gt;First month post-surgery (t1)&lt;/Heading&gt;
                        &lt;Para ID="Par24"&gt;Two days before the outpatient visit, physicians received an email with a reminder that additional information from the S&amp;amp;PAM system was available in the EMRs, including instructions where and how to access this information. Patients returned the S&amp;amp;PAM system during their visit to the hospital.&lt;/Para&gt;
                        &lt;Para ID="Par25"&gt;During the physiotherapist consultation, patients received user instruction for the WEP portal, including a personal login and a paper manual. A brief and individualized assessment of the patient’s fitness level was made, after clarifying individual exercise goals and preferences. A tailored exercise program was then constructed by the physiotherapist and made accessible to the patient within the first week following the appointment. The exercise program was adjusted at least once a month. If needed, the physiotherapist could adjust the program more often. No specific guidelines were given regarding the number or content of contacts between patients and the physiotherapists. Contact between patient and therapist was possible via chat messages on the portal. More complex issues, such as problems with performing exercises or changes in health, could be discussed by telephone or email. The WEP module was offered until 6&nbsp;months post-surgery.&lt;/Para&gt;
                      &lt;/FormalPara&gt;
                      &lt;FormalPara ID="FPar4" RenderingStyle="Style1"&gt;
                        &lt;Heading&gt;Three and 6&nbsp;months post-surgery (t2 and t3)&lt;/Heading&gt;
                        &lt;Para ID="Par26"&gt;Three weeks prior to the 3 and 6&nbsp;months follow-up, the S&amp;amp;PAM system was again sent to the patients by the investigator, including written instructions for use. Patients were asked to use the system prior to their appointment for 3&nbsp;days a week during 2&nbsp;weeks. Two days before the appointment, physicians received a reminder that monitoring data was available for this patient in the EMR. Again, instructions were included where and how to access this information. Patients returned the S&amp;amp;PAM system during their follow-up visits to the hospital.&lt;/Para&gt;
                        &lt;Para ID="Par27"&gt;Dropout was defined as a patient who did not attend the final measurement at t3. Every patient was contacted to determine their reason(s) for dropping out.&lt;/Para&gt;
                      &lt;/FormalPara&gt;
                    &lt;/Section3&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec9"&gt;
                    &lt;Heading&gt;Data collection&lt;/Heading&gt;
                    &lt;Section3 ID="Sec10"&gt;
                      &lt;Heading&gt;Patient characteristics&lt;/Heading&gt;
                      &lt;Para ID="Par28"&gt;At baseline, demographics such as sex, age, marital status, education level, and employment status were collected via a questionnaire. Experience with internet and computer technology was self-reported in terms of frequency and duration. Clinical information (diagnosis, cancer stage, treatment details, number of comorbidities, lung function) were obtained from the hospital medical records.&lt;/Para&gt;
                    &lt;/Section3&gt;
                    &lt;Section3 ID="Sec11"&gt;
                      &lt;Heading&gt;Actual use&lt;/Heading&gt;
                      &lt;FormalPara ID="FPar5" RenderingStyle="Style1"&gt;
                        &lt;Heading&gt;Symptom and physical activity monitoring&lt;/Heading&gt;
                        &lt;Para ID="Par29"&gt;To reflect use of the S&amp;amp;PAM module, the following measures were logged, extracted from the database, and further analyzed:
                          &lt;UnorderedList Mark="None"&gt;
                            &lt;ItemContent&gt;
                              &lt;Para ID="Par30"&gt;
                                &lt;Emphasis Type="Italic"&gt;Patients:&lt;/Emphasis&gt;
                                &lt;UnorderedList Mark="Bullet"&gt;
                                  &lt;ItemContent&gt;
                                    &lt;Para ID="Par31"&gt;The number of days that patients used the monitoring system, calculated as the number of days that data were available from the system (accelerometer or symptom scores) expressed over all periods together as well as per treatment period (pre-surgery, first month following surgery, prior to 3&nbsp;months consultation, and prior to 6&nbsp;months consultation).&lt;/Para&gt;
                                  &lt;/ItemContent&gt;
                                  &lt;ItemContent&gt;
                                    &lt;Para ID="Par32"&gt;Frequency (number) and duration (minutes) of login on the S&amp;amp;PAM portal expressed over all periods together.&lt;/Para&gt;
                                  &lt;/ItemContent&gt;
                                &lt;/UnorderedList&gt;
                              &lt;/Para&gt;
                            &lt;/ItemContent&gt;
                          &lt;/UnorderedList&gt;
                        &lt;/Para&gt;
                        &lt;Para ID="Par33"&gt;
                          &lt;UnorderedList Mark="None"&gt;
                            &lt;ItemContent&gt;
                              &lt;Para ID="Par34"&gt;
                                &lt;Emphasis Type="Italic"&gt;Physicians:&lt;/Emphasis&gt;
                                &lt;UnorderedList Mark="Bullet"&gt;
                                  &lt;ItemContent&gt;
                                    &lt;Para ID="Par35"&gt;Frequency (number) and duration (minutes) of login expressed over all weeks together.&lt;/Para&gt;
                                  &lt;/ItemContent&gt;
                                &lt;/UnorderedList&gt;
                              &lt;/Para&gt;
                            &lt;/ItemContent&gt;
                          &lt;/UnorderedList&gt;
                        &lt;/Para&gt;
                      &lt;/FormalPara&gt;
                      &lt;FormalPara ID="FPar6" RenderingStyle="Style1"&gt;
                        &lt;Heading&gt;Web-accessible home-based exercise program&lt;/Heading&gt;
                        &lt;Para ID="Par36"&gt;For the WEP module, the following use measures were evaluated:
                          &lt;UnorderedList Mark="None"&gt;
                            &lt;ItemContent&gt;
                              &lt;Para ID="Par37"&gt;
                                &lt;Emphasis Type="Italic"&gt;Patients:&lt;/Emphasis&gt;
                                &lt;UnorderedList Mark="Bullet"&gt;
                                  &lt;ItemContent&gt;
                                    &lt;Para ID="Par38"&gt;Number of weeks patients used the service, measured as number of weeks from the first to the last week that a patient logged in on the portal&lt;/Para&gt;
                                  &lt;/ItemContent&gt;
                                  &lt;ItemContent&gt;
                                    &lt;Para ID="Par39"&gt;Frequency (number) of logins per week&lt;/Para&gt;
                                  &lt;/ItemContent&gt;
                                  &lt;ItemContent&gt;
                                    &lt;Para ID="Par40"&gt;Average duration (minutes) of login per session&lt;/Para&gt;
                                  &lt;/ItemContent&gt;
                                  &lt;ItemContent&gt;
                                    &lt;Para ID="Par41"&gt;Reason for ending service (provided by patients through self-reported)&lt;/Para&gt;
                                  &lt;/ItemContent&gt;
                                &lt;/UnorderedList&gt;
                              &lt;/Para&gt;
                            &lt;/ItemContent&gt;
                            &lt;ItemContent&gt;
                              &lt;Para ID="Par42"&gt;
                                &lt;Emphasis Type="Italic"&gt;Physiotherapists:&lt;/Emphasis&gt;
                                &lt;UnorderedList Mark="Bullet"&gt;
                                  &lt;ItemContent&gt;
                                    &lt;Para ID="Par43"&gt;The frequency (number) and duration (minutes) of login expressed over all weeks together were logged.&lt;/Para&gt;
                                  &lt;/ItemContent&gt;
                                  &lt;ItemContent&gt;
                                    &lt;Para ID="Par44"&gt;Time needed to perform the first consultation (including instruction), setting up and adapting a tailored exercise program, as recorded by the therapist per patient.&lt;/Para&gt;
                                  &lt;/ItemContent&gt;
                                &lt;/UnorderedList&gt;
                              &lt;/Para&gt;
                            &lt;/ItemContent&gt;
                          &lt;/UnorderedList&gt;
                        &lt;/Para&gt;
                      &lt;/FormalPara&gt;
                    &lt;/Section3&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec12"&gt;
                  &lt;Heading&gt;Acceptability&lt;/Heading&gt;
                  &lt;Para ID="Par45"&gt;A combination of quantitative and qualitative measures was used to measure acceptability of the S&amp;amp;PAM and WEP modules in both patients and HCPs.&lt;/Para&gt;
                  &lt;FormalPara ID="FPar7" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Patients&lt;/Heading&gt;
                    &lt;Para ID="Par46"&gt;An 
                      &lt;Emphasis Type="Italic"&gt;online questionnaire&lt;/Emphasis&gt; based on the Unified Theory of Acceptance and Use of Technology (UTAUT) [
                      &lt;CitationRef CitationID="CR23"&gt;23&lt;/CitationRef&gt;] was administered at pre- (t0) and post-intervention (t3). The modules (S&amp;amp;PAM and WEP) were evaluated independent from each other in the questionnaire. Scores prior to surgery give an indication about the 
                      &lt;Emphasis Type="Italic"&gt;expectations&lt;/Emphasis&gt; patients had about the RMT service, while the scores at study completion represent their 
                      &lt;Emphasis Type="Italic"&gt;experiences&lt;/Emphasis&gt; or 
                      &lt;Emphasis Type="Italic"&gt;acceptability&lt;/Emphasis&gt; of the RMT service. The questionnaire evaluated the components 
                      &lt;Emphasis Type="Italic"&gt;effort expectancy&lt;/Emphasis&gt; or usability, 
                      &lt;Emphasis Type="Italic"&gt;performance expectancy&lt;/Emphasis&gt; or usefulness, 
                      &lt;Emphasis Type="Italic"&gt;social influence&lt;/Emphasis&gt;, 
                      &lt;Emphasis Type="Italic"&gt;behavioral intention to use&lt;/Emphasis&gt;. Facilitation conditions were measured in terms of 
                      &lt;Emphasis Type="Italic"&gt;perceived self-efficacy&lt;/Emphasis&gt;. Computer availability and internet access were inclusion criteria for participation and therefore not measured as part of facilitation conditions. 
                      &lt;Emphasis Type="Italic"&gt;Attitude&lt;/Emphasis&gt; and 
                      &lt;Emphasis Type="Italic"&gt;satisfaction&lt;/Emphasis&gt; were added, as they are hypothesized to influence intention to use and actual use [
                      &lt;CitationRef CitationID="CR24"&gt;24&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR18"&gt;18&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR25"&gt;25&lt;/CitationRef&gt;]. Each item was phrased as a statement, and scored on a 7-point Likert scale (from completely disagree to completely agree). Negative phrased items were transformed so that a higher score indicated higher expectation/experience. For each component, the item scores were summed, and the average score was taken as the final outcome measure.
                    &lt;/Para&gt;
                    &lt;Para ID="Par47"&gt;At the end of the study, 
                      &lt;Emphasis Type="Italic"&gt;a patient focus group&lt;/Emphasis&gt; was performed by the investigator. Discussion focused on usability and perceived usefulness of the application for resected lung cancer patients, patients’ motivation for use, and if they thought the application should be part of standard care for resected lung cancer patients (intention to use). The first aim was to generate input for improvement of the application itself. The secondary aims were to gather information about the clinical value of the application as well as influencing factors that motivate or hamper patients to use these kinds of applications. The focus group was recorded with permission of the participants and notes were taken.
                    &lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar8" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Healthcare professionals (HCPs)&lt;/Heading&gt;
                    &lt;Para ID="Par48"&gt;Acceptability of the S&amp;amp;PAM module was evaluated via an online questionnaire at the end of the study (January 2016). The questionnaire was send to 16 HCPs that are involved in the outpatient care of operable lung cancer patients (two specialized oncology nurses, four thoracic surgeons, ten pulmonologists).&lt;/Para&gt;
                    &lt;Para ID="Par49"&gt;If an HCP indicated that he/she had not used the results of the S&amp;amp;PAM module, reasons for non-use were registered as well as the expected usefulness of symptom monitoring in clinical care for lung cancer patients.&lt;/Para&gt;
                    &lt;Para ID="Par50"&gt;A focus group with physiotherapists who used the WEP module was performed by the first author at the end of the study to evaluate acceptability of the WEP module in terms of usability, usefulness, satisfaction, and intention to keep using the module.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;Section2 ID="Sec13"&gt;
                    &lt;Heading&gt;Data analysis&lt;/Heading&gt;
                    &lt;Para ID="Par51"&gt;IBM’s Statistical Package for the Social Sciences (SPSS, 23) was used for the statistical analyses. Demographic, patient expectation and experience (UTAUT components) were calculated as frequencies (percentage), medians, and interquartile ranges.&lt;/Para&gt;
                    &lt;Para ID="Par52"&gt;For evaluating the actual use of the web portals of S&amp;amp;PAM and WEP all logins less than 2&nbsp;min in duration were excluded from analysis. Following, logins that occurred on the same day were considered a single session and duration of these sessions were summed. Means, standard deviations, and ranges were calculated of the use measures. For visualization of actual use, dot plots were generated capturing each individual use values, means, and 95% confidence intervals (95% CI). CI’s were calculated using the 
                      &lt;Emphasis Type="Italic"&gt;t&lt;/Emphasis&gt;-distribution due to small sample size.
                    &lt;/Para&gt;
                    &lt;Para ID="Par53"&gt;For qualitative insight into feasibility and acceptability, notes of the focus groups were combined with results of the questionnaire to highlight the most important aspects. Responses on the HCPs questionnaire were summarized using descriptive statistics.&lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec14"&gt;
                  &lt;Heading&gt;Results&lt;/Heading&gt;
                  &lt;Section2 ID="Sec15"&gt;
                    &lt;Heading&gt;Stage 1 study&lt;/Heading&gt;
                    &lt;Para ID="Par54"&gt;The RMT service was offered to 10 patients (60% female; median age (IQR): 56.6 (52.8–62.8) years), of which eight patients used one or both modules of the RMT service. Seven physicians were involved in the care of these patients (three surgeons, four pulmonologists). Detailed description of patient characteristics can be found in Online Resource 
                      &lt;InternalRef RefID="MOESM1"&gt;1&lt;/InternalRef&gt;. In post-intervention, patients indicated good usability and usefulness, confidence in using the modules (‘self-efficacy’), and a positive attitude and intention to use the modules (i.e., all components a median score of &amp;gt;5 out of 7). Overall, patients felt satisfied with the modules, rating the S&amp;amp;PAM and WEP modules with a 5.3 (4.5–6.5) and a 5.6 (4.5–6.9), respectively (out of 7). Four patients (two female) and four HCPs (two physiotherapists, two pulmonologists) participated in the semi-structured interviews. Two patients declined participation in a personal interview, but gave written comments on the questions from the interview. From the interviews and written comments, eight critical issues were extracted for the S&amp;amp;PAM and five critical issues for the WEP module. Critical issues and the functional requirements for adaptations have been summarized in Online Resource 
                      &lt;InternalRef RefID="MOESM2"&gt;2&lt;/InternalRef&gt;.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec16"&gt;
                    &lt;Heading&gt;Stage 2 study&lt;/Heading&gt;
                    &lt;Section3 ID="Sec17"&gt;
                      &lt;Heading&gt;Sample&lt;/Heading&gt;
                      &lt;Para ID="Par55"&gt;Eighteen NSCLC patients scheduled for curative lung resection were approached for participation. Twelve patients agreed to participate (33% female; median age (IQR): 59.5 (54.5–66.0) years); a consent rate of 67%. Detailed description of patient characteristics can be found in the Online Resource 
                        &lt;InternalRef RefID="MOESM1"&gt;1&lt;/InternalRef&gt;. Most important reasons for refusal were surgery before enrollment could take place (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2), too little experience with computers/internet (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2), or emotional burden (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;1). Following enrollment, four patients dropped out of the study, three prior to intervention, and one after 2&nbsp;months of participation. Reasons for dropout were cancelation of the surgery (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2), emotional burden (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;1), or complications following surgery (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;1). Internet experience was high in this sample, with all patients indicating using the internet almost every day for more than 3&nbsp;years. Twelve physicians were involved in the care of enrolled patients (four surgeons, eight pulmonologists).
                      &lt;/Para&gt;
                    &lt;/Section3&gt;
                    &lt;Section3 ID="Sec18"&gt;
                      &lt;Heading&gt;Actual use of the modules&lt;/Heading&gt;
                    &lt;/Section3&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec19"&gt;
                  &lt;Heading&gt;Ambulant symptom and physical activity monitoring (S&amp;amp;PAM)&lt;/Heading&gt;
                  &lt;FormalPara ID="FPar9" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Ambulant S&amp;amp;PAM system&lt;/Heading&gt;
                    &lt;Para ID="Par56"&gt;All patients used the S&amp;amp;PAM system at least once, resulting in 179 monitoring days. On average, patients used the system between 5 to 6&nbsp;days per treatment period (i.e., pre-surgery, 1, 3, and 6&nbsp;months post-surgery (Fig. 
                      &lt;InternalRef RefID="Fig3"&gt;3a&lt;/InternalRef&gt;).
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig3"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 3&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Use of the RMT application. 
                              &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt; S&amp;amp;PAM: number of days with physical activity data (
                              &lt;Emphasis Type="Italic"&gt;dots&lt;/Emphasis&gt;) and symptom scores (
                              &lt;Emphasis Type="Italic"&gt;crosses&lt;/Emphasis&gt;); 
                              &lt;Emphasis Type="Italic"&gt;PS&lt;/Emphasis&gt; post-surgery. WEP: 
                              &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt; frequency of login on the WEP portal per training week; 
                              &lt;Emphasis Type="Bold"&gt;c&lt;/Emphasis&gt; average duration of login per session per training week. 
                              &lt;Emphasis Type="Italic"&gt;Training week 1&lt;/Emphasis&gt; indicates the first week that a patient logged in on the web portal. A patient data point is represented by a 
                              &lt;Emphasis Type="Italic"&gt;dot/cross&lt;/Emphasis&gt;. Data points that overlap each other are visualized with 
                              &lt;Emphasis Type="Italic"&gt;larger dots/cross&lt;/Emphasis&gt;; the more overlapping points the 
                              &lt;Emphasis Type="Italic"&gt;larger the dot/cross&lt;/Emphasis&gt;. The average (
                              &lt;Emphasis Type="Italic"&gt;horizontal lines&lt;/Emphasis&gt;) and 95% CI (
                              &lt;Emphasis Type="Italic"&gt;vertical lines&lt;/Emphasis&gt;; calculated with 
                              &lt;Emphasis Type="Italic"&gt;t&lt;/Emphasis&gt;-distribution) are given
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO3"&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/11764_2017_611_Fig3_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par57"&gt;During the study, in three patients, heartrate and oxygen saturation monitoring was removed from the system. One patient experienced problems with attachment of the heartrate sensor because of his thorax wound post-surgery. One patient was anxious about using these sensors and for the other patient there simply was no sensor available. Technical issues were reported by six patients, but all issues could be resolved remotely. Most often reported was a loss of connection between the pulse oximeter and the smartphone during increased physical activity (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;4). Two patients indicated problems rating the symptoms on the smartphone prior to surgery (t0). As can be seen from Fig. 
                      &lt;InternalRef RefID="Fig3"&gt;3c&lt;/InternalRef&gt;, there are in general fewer days with PA data than there are for subjective symptoms. This was caused by low quality data in terms of missing data points.
                    &lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar10" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Web portal&lt;/Heading&gt;
                    &lt;Para ID="Par58"&gt;In total, patients logged in 28 times on the portal to view the results of the symptom monitoring. Nine patients logged in at least once. Mean duration of login was 8&nbsp;min (min-max: 2–35&nbsp;min). On average, patients clicked on 11 different pages per session (SD&nbsp;=&nbsp;12 page clicks). Patients looked most to the pages containing the detailed information about heart rate and oxygen saturation (40% of all page clicks), followed by the summary of symptom scores and daily activity (33% of all page clicks).&lt;/Para&gt;
                    &lt;Para ID="Par59"&gt;Of the 12 physicians involved, only three physicians logged in on the portal (once each), with an average login time of 12&nbsp;min.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec20"&gt;
                  &lt;Heading&gt;Web-accessible home-based exercise program (WEP)&lt;/Heading&gt;
                  &lt;Para ID="Par60"&gt;Eight patients (67%) used the exercise portal at least 1&nbsp;week following lung resection. Patients started 4 (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;3), 5 (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2), 6 (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2), or 7 (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;1) weeks following resection. Use of the portal in terms frequency of use per week and average duration per session are visualized in Fig. 
                    &lt;InternalRef RefID="Fig3"&gt;3b&lt;/InternalRef&gt;/c. Patients used the exercise portal most frequently in their first 5&nbsp;weeks of use. Seven patients (58%) used the portal for 7&nbsp;weeks or longer. During the program, none of the patients used the shortcut button to indicate difficulty in exercise performance or reported an acute, serious problem as a result of the exercise program. Twenty percent of all sessions lasted 20&nbsp;min or longer; while the majority of all sessions (66%) lasted less than 10&nbsp;min.
                  &lt;/Para&gt;
                  &lt;Para ID="Par61"&gt;Half of the patients reported that after some weeks practicing at home, they printed the exercise program and performed the exercises at a local fitness center (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;3) or community center (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;1). Reasons for exercising in these centers were availability of better equipment (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;1), support from trainer (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;1), and ‘used to go to the fitness center prior to surgery’(
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2). Reasons for ending were that patients felt that they had reached their fitness goals and were fit enough to pick up their usual exercise activities (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;5), outpatient follow-up ended (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;1), or that exercises were too easy (
                    &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2).
                  &lt;/Para&gt;
                  &lt;Para ID="Par62"&gt;Two physiotherapists participated in the study. They logged in 46 times during the study, with a total duration of 805&nbsp;min. Time investment per patient was as follows (mean&nbsp;±&nbsp;SD): intake with the patients 60&nbsp;±&nbsp;7&nbsp;min (including 30&nbsp;min consultation part of ‘standard’ care), first set-up of exercise program 35&nbsp;±&nbsp;9&nbsp;min, and adaptation of the training program 19&nbsp;±&nbsp;7&nbsp;min.&lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec21"&gt;
                  &lt;Heading&gt;Acceptability&lt;/Heading&gt;
                  &lt;Para ID="Par63"&gt;Eight patients completed the online questionnaire at both t0 and t3, and six of these patients participated in the patient focus group. Dot plots of the results from the online patient questionnaire can be found in Online Resource 
                    &lt;InternalRef RefID="MOESM3"&gt;3&lt;/InternalRef&gt;. Seven HCPs completed the online questionnaire; five pulmonologists and two specialized oncology nurses.
                  &lt;/Para&gt;
                  &lt;Section2 ID="Sec22"&gt;
                    &lt;Heading&gt;Ambulant symptom and physical activity monitoring (S&amp;amp;PAM)&lt;/Heading&gt;
                    &lt;FormalPara ID="FPar11" RenderingStyle="Style1"&gt;
                      &lt;Heading&gt;Patients&lt;/Heading&gt;
                      &lt;Para ID="Par64"&gt;At t0, patient expectations were generally high (medians &amp;gt;5 out of a score of 7), with the exception of usability (median (IQR): 4.3(4.0–6.0)), and all patients had a positive intention to use the S&amp;amp;PAM module.&lt;/Para&gt;
                      &lt;Para ID="Par65"&gt;Following the intervention (t3), most patients indicated that the monitoring system had good usability and all felt competent using the module (that is, score &amp;gt;5 on perceived self-efficacy). Patients felt satisfied with the module and had the opinion that the module should be offered by the hospital to all eligible OLC patients as part of standard care (median satisfaction score =6.0 (IQR&nbsp;=&nbsp;5.6–6.2); median intention to use score =6.0 (IQR&nbsp;=&nbsp;5.0–6.8), respectively). On average, scores for usefulness indicated that patients experienced benefit using the system during treatment. Nevertheless, three patients scored rather low on usefulness (score between 3 and 4). Qualitative data show that they were disappointed with the lack of feedback from their physician on the results of the S&amp;amp;PAM, which made the module less useful, and, as a consequence, decreased motivation to use the S&amp;amp;PAM system. During the focus group, this decline in motivation was confirmed by all other patients. As a result, patients felt no need to extend measurements beyond the prescribed frequency. Next to that, patients also requested tailoring of the monitoring protocol in terms of monitoring frequency and sensors employed, based on their individual pattern of recovery and needs.&lt;/Para&gt;
                      &lt;Para ID="Par66"&gt;Patients mentioned several points of improvements regarding usability. Connection problems between pulse oximeter sensor and smartphone during activity (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;4), and difficulty understanding visualization of the results on the portal (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;4) were the aspects mentioned most often.
                      &lt;/Para&gt;
                    &lt;/FormalPara&gt;
                    &lt;FormalPara ID="FPar12" RenderingStyle="Style1"&gt;
                      &lt;Heading&gt;Healthcare professionals&lt;/Heading&gt;
                      &lt;Para ID="Par67"&gt;The majority of the HCPs (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;5) expected added value of a symptom monitoring system in the care for lung cancer patients in that it might improve insight into the capacity, symptoms, and daily activity, and with this information, improve treatment choices. Most HCPs reported that they would use the S&amp;amp;PAM during chemo (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;4). But in their opinion, also surgery (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;3), concurrent (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2), and radiation therapy (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2) might benefit from the use of the S&amp;amp;PAM module.
                      &lt;/Para&gt;
                      &lt;Para ID="Par68"&gt;Yet, only two pulmonologists who completed the online questionnaire indicated to be aware that their patients had used the S&amp;amp;PAM module. None of these HCPs actually checked the results of the monitoring in the EMRs. Reasons mentioned for not using the information from S&amp;amp;PAM were unawareness that a specific patient participated in the study, lack of time to check the information, and non-compatibility with the content and process of their work.&lt;/Para&gt;
                      &lt;Para ID="Par69"&gt;From a HCP perspective, most relevant to optimize future use was to emphasize and improve HCPs’ perception of the added value of the symptom monitoring system (
                        &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;7).
                      &lt;/Para&gt;
                    &lt;/FormalPara&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec23"&gt;
                  &lt;Heading&gt;Web-accessible home-based exercise program (WEP)&lt;/Heading&gt;
                  &lt;FormalPara ID="FPar13" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Patients&lt;/Heading&gt;
                    &lt;Para ID="Par70"&gt;Prior to intervention (t0), expectation scores were high with all UTAUT components median scores higher than 5, and all patients had the intention to use the WEP module as much as needed.&lt;/Para&gt;
                    &lt;Para ID="Par71"&gt;In the following use, most patients were satisfied with usability of the module, except for two (score &amp;lt;5) since the program was difficult to access on mobile phone, which hampered execution of the program on a different location than home. Nonetheless, all patients felt confident in their ability to use the module (“self-efficacy”).&lt;/Para&gt;
                    &lt;Para ID="Par72"&gt;Seven patients found the WEP module useful (score &amp;gt;5 out of 7), but one patient scored extremely low (2 out of 7). During the focus group, this patient indicated a lack of interaction with the physiotherapist, insufficient tailoring of the exercises, and lack of insight in progression as most important reasons for dissatisfaction. The majority of patients (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;7) had the opinion that the module should be accessible to all operable lung cancer patients (score ≥5 on intention to use).
                    &lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar14" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Physiotherapists&lt;/Heading&gt;
                    &lt;Para ID="Par73"&gt;Overall, physiotherapists indicated satisfaction and voiced a positive intention to keep using the WEP module. Therapists found it easy to provide user instruction to the patient, due to the simplicity of the patient portal. However, some suggestions for improvement were given for the therapist portal, including navigation between the summary of patient reported progress and corresponding exercises (to quickly adapt instructions based on the progress), and rearrangement of visualization of the chats (i.e., all the chats into one ‘chat-roll’ with a clear mark for messages that have been read).&lt;/Para&gt;
                    &lt;Para ID="Par74"&gt;Regarding usefulness, therapists believed that the module might contribute to improved accessibility of a cancer rehabilitation program and support of patients towards an active lifestyle by decreasing anxiety for physical activity. For improvement, a smartphone-supported application was considered likely to improve accessibility even more. In general, the necessary time investments were regarded acceptable to the therapists. It appeared critical to instruct the patient when and for what to use the chat function of the module as to prevent unmanageable number of messages.&lt;/Para&gt;
                    &lt;Para ID="Par75"&gt;To ensure successful implementation of the module, therapists advised a more blended care approach, that is, a combination of supervised and home-based training as to facilitate adequate evaluation of patients’ fitness and optimize program tailoring. Also, official (organizational) agreements are needed to ensure financing of the treatment and time to use the module next to face-to-face patientcare.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec24"&gt;
                  &lt;Heading&gt;Discussion&lt;/Heading&gt;
                  &lt;Para ID="Par76"&gt;This study aimed to evaluate the clinical feasibility in terms of actual use and acceptability of a telehealthcare application, the Remote Monitoring and Treatment (RMT) application, for lung cancer patients treated with lung resection when used in daily clinical practice. Our findings suggest that the use of remote monitoring and treatment is feasible to lung cancer patients when offered pre- and post-surgery. Patients actively used the modules prior and following surgery, and perceived both modules as a beneficial contribution to their care. Also, the continuous treatment and involvement of ‘experts’ from the cancer institute, who were expected to be better informed about cancer and the treatment patients had received, was seen as a big advantage of using ICT-supported rehabilitation. These results are in line with previous studies that showed willingness of lung cancer patients to exercise at home following surgery [
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;] or daily rate symptoms on a smartphone during radiotherapy [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par77"&gt;During the study, several issues emerged that need consideration for successful patient adoption. One of the important factors observed is usability of the RMT application. Results show that participants felt confident using on-body sensors, a smartphone, and corresponding protocols. This positive attitude might have been facilitated by a perceived usefulness of the system as well as a flexible monitoring protocol (e.g., change to a different monitoring protocol that did not include heart rate and pulse oximeter sensor) and availability of (paper) manual and a ‘helpdesk’. These factors have previously been linked to the acceptance of personal health devices in patients with chronic conditions [
                    &lt;CitationRef CitationID="CR26"&gt;26&lt;/CitationRef&gt;]. Unfortunately, the S&amp;amp;PAM module suffered from loss of connection between the pulse oximeter and the smartphone during performing physical activities. Patients felt annoyed by this problem and it resulted in loss of data for the HCPs. Although SpO
                    &lt;Subscript&gt;2&lt;/Subscript&gt; is considered clinically relevant both pre- and post-surgery for lung cancer patients [
                    &lt;CitationRef CitationID="CR27"&gt;27&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR28"&gt;28&lt;/CitationRef&gt;], it should only be included in the monitoring protocol when the sensor’s performance is adequate and reliable in the ambulant setting. Also, previous studies have shown the added value of S&amp;amp;PAM without SpO
                    &lt;Subscript&gt;2&lt;/Subscript&gt; measurement [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;]. Therefore, we recommend that only patients at risk for desaturation should be offered the pulse oximeter [
                    &lt;CitationRef CitationID="CR28"&gt;28&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par78"&gt;For the WEP, the main usability issue reported was accessibility of the program from a mobile platform such as a smartphone. Providing the program on smartphone or tablet may facilitate patient use, due to accessibility at various locations which is preferred by patients (e.g., fitness center, local therapist, or communal centers), but also accessibility by broader (e.g., elderly) population due to increasing number of people possessing tablets rather than desktops [
                    &lt;CitationRef CitationID="CR29"&gt;29&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par79"&gt;Another factor that influences patient use is motivation. For both modules, patients explicitly reported a perceived decline in motivation towards the end of the study, caused by a lack of sufficient feedback by physicians and the system, and insufficient tailoring of the modules to the needs and capacity of the patients. In agreement, Hoaas et al. recently reported that providing patients with (objective) signs of improvements as well as treatment tailoring in terms of individual goal setting were seen as most important for COPD patients maintaining motivation to participate in a long-term telerehabilitation program [
                    &lt;CitationRef CitationID="CR18"&gt;18&lt;/CitationRef&gt;]. Lack of motivation is not unique to the use of telehealthcare applications, but has been the object of evaluation in other, not ICT-related, interventions that focus on behavior change, such as promoting physical exercise [
                    &lt;CitationRef CitationID="CR30"&gt;30&lt;/CitationRef&gt;]. Tailoring, or personalization, of treatment, and feedback is considered beneficial for treatment compliance and long-term behavior change [
                    &lt;CitationRef CitationID="CR31"&gt;31&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR32"&gt;32&lt;/CitationRef&gt;]. Evidence is growing that shows the potential and unique capability of technology to provide high level of personalization through monitor on an individual level and translate this complex gathering of information into tailored feedback and treatment [
                    &lt;CitationRef CitationID="CR33"&gt;33&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR35"&gt;35&lt;/CitationRef&gt;]. Adding a gaming layer (‘serious gaming’), a virtual coach, or social component such as online group-based exercise to the program, may further enhance motivation [
                    &lt;CitationRef CitationID="CR35"&gt;35&lt;/CitationRef&gt;]. Given the fast technological developments, we should strive for an individual, holistic approach that takes into account the complex interaction between the patient—including his/her health, norms, beliefs, and goals—the context and changes herein. For our RMT application, this means that we should utilize information about the patient (such as age, sex, cancer stage, experience with technology), his/her treatment (including treatment phase, care processes) to tailor the intervention protocol, and adapt the protocol frequently based on newly acquired information. Next to tailoring, other motivational strategies have been reported by our patients and HCPs that might improve the use and adherence of the RMT service. The most promising improvements were providing feedback about health and recovery via a smartphone app instead of a web-based portal since it is readily available and more user-friendly; and a more blended treatment approach, that is combining face-to-face consultation with home-based treatment as to optimize continuous tuning of the treatment to the patient.
                  &lt;/Para&gt;
                  &lt;Para ID="Par80"&gt;In contrast with the overall positive findings regarding feasibility and acceptability from patients, the findings from HCPs were mixed. From the HCPs’ perspective, both modules were regarded beneficial and a valuable addition to care for operable lung cancer patients. However, evaluation of HCP satisfaction with the S&amp;amp;PAM module was unsuccessful, since physicians that completed the questionnaire all indicated non-use of the module. Since HCPs play a key role in making innovations available to patients and the influence they may have on the adoption and adherence of patients [
                    &lt;CitationRef CitationID="CR20"&gt;20&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR17"&gt;17&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR36"&gt;36&lt;/CitationRef&gt;], active involvement of HCPs is regarded crucial for successful implementation of telehealthcare and should be given more attention. In line with a recent publication of Vollenbroek et al. [
                    &lt;CitationRef CitationID="CR17"&gt;17&lt;/CitationRef&gt;], our results also show that a process of co-creation of the telehealthcare applications and protocols that are considered useful for their patients, it was clearly not enough for physicians to actually start using these modules as part of their daily practice. Interestingly, in our study, large variation was observed in HCPs using the modules. Physiotherapists that participated in the study showed high level of involvement, while physicians hardly used the information from the S&amp;amp;PAM module in their patients’ consultation. Research suggests that ease of use, perceived usefulness, and organizational- and work-related factors play an important role in HCP adoption [
                    &lt;CitationRef CitationID="CR37"&gt;37&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR19"&gt;19&lt;/CitationRef&gt;]. In our current study, it is difficult to draw firm conclusions about facilitating and impeding factors due to the small sample size. However, since ease of use and perceived usefulness of symptom monitoring were rated positive in our current and previous study by HCPs [
                    &lt;CitationRef CitationID="CR20"&gt;20&lt;/CitationRef&gt;], the low use in clinical practice suggest a role of these work- and organization-related factors. For example, for the WEP module, the physiotherapists explicitly reserved time in their schedule for usage of the module, and they were solely responsible for the content of the exercise program and also served as the primary contact for patients regarding the WEP module. In contrast, no explicit agreements were made with physicians in terms of their role and responsibilities, and no time was reserved for learning and working with the S&amp;amp;PAM. Another issue might be that only few patients used the S&amp;amp;PAM, causing that usage of the monitoring data was not part of their daily routine. Lastly, the intervention protocol lacked clear guidelines how the modules and the results generated, should be integrated with hospital-based care. For example, specific cut-off scores for symptom levels were lacking, as was a clear protocol for handling alarming results of the S&amp;amp;PAM such as high pain scores.
                  &lt;/Para&gt;
                  &lt;Para ID="Par81"&gt;This study provides valuable insight in how adoption and implementation of the RMT application in clinical practice can be promoted. While the technology can be further improved, we believe that integration of the RMT application with existing care processes is of paramount importance. This is in line with the work of Jansen-Kosterink, who states that it is not the technology, but the way the technology is embedded in care processes (‘service configuration’) that defines the service [
                    &lt;CitationRef CitationID="CR38"&gt;38&lt;/CitationRef&gt;]. Therefore, implementation strategies should focus on formalization of the tasks and processes needed for usage of telehealthcare in practice, which should include the availability of time, funding and creating leadership [
                    &lt;CitationRef CitationID="CR37"&gt;37&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR19"&gt;19&lt;/CitationRef&gt;], and education of all involved personnel about the benefits of the service, as well as defining clinical protocols for the resulting information. Additionally, a stage 3 (large-scale) evaluation study is needed to evaluate effectiveness (clinical outcomes), adoption, adherence, and cost-effectiveness when used in clinical practice [
                    &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec25"&gt;
                  &lt;Heading&gt;Strengths and limitations&lt;/Heading&gt;
                  &lt;Para ID="Par82"&gt;This study is one of the few that evaluated feasibility of ambulant symptom monitoring and web-accessible home-based exercise in clinical practice for lung cancer patients that underwent lung resection. We used the staged approach, resulting in a two-stage study, that allows for gradual development and fine-tuning between technology and clinical context. Several limitations of our study need consideration. First, our convenience sample might have resulted in inclusion of ‘enthusiasts’, resulting in higher IT literacy and levels of use. Also, patients with complications or who experience high levels of stress as a result of diagnosis are less likely to participate in the study. Exclusion due to lack of experience with or access to IT is a well-known barrier for successful adoption and implementation of telehealthcare in the elderly [
                    &lt;CitationRef CitationID="CR39"&gt;39&lt;/CitationRef&gt;]. Currently, there are no reliable data available on IT literacy for this specific subgroup of patients, but the low percentage (i.e., 11%) of patients excluded in the current study for this reason probably is a too optimistic figure for the population as a whole. On the other hand, the number of chronically ill and elderly that have access to the internet and own a smartphone or tablet is increasing fast in the Netherlands [
                    &lt;CitationRef CitationID="CR29"&gt;29&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR40"&gt;40&lt;/CitationRef&gt;]. For example, in 2016, 82% of chronically ill patients were estimated to have internet access [
                    &lt;CitationRef CitationID="CR40"&gt;40&lt;/CitationRef&gt;], and 63% of people 65+ years used a smartphone [
                    &lt;CitationRef CitationID="CR41"&gt;41&lt;/CitationRef&gt;]. These numbers suggest that a lack of IT literacy as a barrier for participation will decrease in the upcoming years for elderly and chronically ill patients.
                  &lt;/Para&gt;
                  &lt;Para ID="Par83"&gt;Second, the first author performed several research activities, including recruitment, S&amp;amp;PAM instruction, and leading the patient focus group. Therefore, patients might have been less willing to report negative comments during the focus group. However, the questionnaires were completed anonymously and resulted in better rating of the modules than the results during the focus group, suggesting that this effect can largely be ignored. Lastly, in the present study, we did not report effect of the intervention on treatment outcome and patients’ health or costs of the intervention. Although patients experienced the intervention as a beneficial addition to their treatment, additional research is needed to confirm clinical effect and cost-effectiveness objectively and in a larger sample.&lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec26"&gt;
                  &lt;Heading&gt;Conclusion&lt;/Heading&gt;
                  &lt;Para ID="Par84"&gt;Our study demonstrates that remote monitoring and treatment is feasible to lung cancer patients when offered pre- and post-surgery. Patients actively used the ambulant symptom monitoring and web-based exercise modules prior and following surgery, and perceived both the modules as a beneficial contribution to their care. However, we also showed that a low level of adoption by referring physicians may hamper successful implementation.&lt;/Para&gt;
                  &lt;Para ID="Par85"&gt;A stage 3 (large-scale) evaluation study is needed, with focus on both involvement of HCPs through organizational formalization and adequate education, as well as promotion of patient motivation through individual tailoring of treatment content and feedback. Following the staged approach, outcome should evaluate clinical effect (in relation to the goal of each module), costs (in time and money), and factors that determine use and effect in both HCPs and patients.&lt;/Para&gt;
                &lt;/Section1&gt;
              &lt;/Body&gt;
              &lt;BodyRef FileRef="BodyRef/PDF/11764_2017_Article_611.pdf" TargetType="OnlinePDF"/&gt;
              &lt;ArticleBackmatter&gt;
                &lt;Acknowledgments&gt;
                  &lt;Heading&gt;Acknowledgements&lt;/Heading&gt;
                  &lt;SimplePara&gt;The authors want to thank all patients and healthcare professionals from the Netherlands Cancer Institute for their participation in the study. We want to thank Dennis Hofs and Boris van Schooten (Roessingh Research and Development, The Netherlands) for their contribution in the technical development, adaptation, and support of the RMT application. We also want to acknowledge the contributions of Mirka Evers (Roessingh Research and Development, The Netherlands), and students who helped to collect the data for this study.&lt;/SimplePara&gt;
                  &lt;SimplePara&gt;This research was funded by Alpe d’HuZes, a foundation which is part of the Dutch Cancer Society (KWF Kankerbestrijding) (grant number 2010-4854). This study was part of the A-CaRe Program, 
                    &lt;ExternalRef&gt;
                      &lt;RefSource&gt;www.a-care.org&lt;/RefSource&gt;
                      &lt;RefTarget Address="http://www.a-care.org" TargetType="URL"/&gt;
                    &lt;/ExternalRef&gt;. The authors acknowledge the A-CaRe2Move Research Group.
                  &lt;/SimplePara&gt;
                &lt;/Acknowledgments&gt;
                &lt;Ethics&gt;
                  &lt;Heading&gt;Compliance with ethical standards&lt;/Heading&gt;
                  &lt;FormalPara ID="FPar15" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Conflict of interest&lt;/Heading&gt;
                    &lt;Para ID="Par86"&gt;The authors declare that they have no conflict of interest.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar16" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Ethical approval&lt;/Heading&gt;
                    &lt;Para ID="Par87"&gt;All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. According to guidelines of the CCMO, no ethical approval was needed.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar17" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Informed consent&lt;/Heading&gt;
                    &lt;Para ID="Par88"&gt;Informed consent was obtained from all patients included in the study.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar18" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Consent for publication&lt;/Heading&gt;
                    &lt;Para ID="Par89"&gt;Explicit consent for publication was obtained from the person displayed in Fig. 
                      &lt;InternalRef RefID="Fig1"&gt;1b&lt;/InternalRef&gt;.
                    &lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar19" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Availability of data and materials&lt;/Heading&gt;
                    &lt;Para ID="Par90"&gt;Data are available on request.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Ethics&gt;
                &lt;Appendix ID="App1" OutputMedium="Online"&gt;
                  &lt;Section1 ID="Sec27"&gt;
                    &lt;Heading&gt;Electronic supplementary material&lt;/Heading&gt;
                    &lt;Para ID="Par91"&gt;
                      &lt;MediaObject ID="MOESM1"&gt;
                        &lt;DataObject FileRef="MediaObjects/11764_2017_611_MOESM1_ESM.docx"&gt;
                          &lt;Caption Language="En"&gt;
                            &lt;CaptionNumber&gt;Online Resource 1&lt;/CaptionNumber&gt;
                            &lt;CaptionContent&gt;
                              &lt;SimplePara&gt;(DOCX 21&nbsp;kb)&lt;/SimplePara&gt;
                            &lt;/CaptionContent&gt;
                          &lt;/Caption&gt;
                        &lt;/DataObject&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par92"&gt;
                      &lt;MediaObject ID="MOESM2"&gt;
                        &lt;DataObject FileRef="MediaObjects/11764_2017_611_MOESM2_ESM.docx"&gt;
                          &lt;Caption Language="En"&gt;
                            &lt;CaptionNumber&gt;Online Resource 2&lt;/CaptionNumber&gt;
                            &lt;CaptionContent&gt;
                              &lt;SimplePara&gt;(DOCX 22&nbsp;kb)&lt;/SimplePara&gt;
                            &lt;/CaptionContent&gt;
                          &lt;/Caption&gt;
                        &lt;/DataObject&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par93"&gt;
                      &lt;MediaObject ID="MOESM3"&gt;
                        &lt;DataObject FileRef="MediaObjects/11764_2017_611_MOESM3_ESM.docx"&gt;
                          &lt;Caption Language="En"&gt;
                            &lt;CaptionNumber&gt;Online Resource 3&lt;/CaptionNumber&gt;
                            &lt;CaptionContent&gt;
                              &lt;SimplePara&gt;(DOCX 57&nbsp;kb)&lt;/SimplePara&gt;
                            &lt;/CaptionContent&gt;
                          &lt;/Caption&gt;
                        &lt;/DataObject&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Para&gt;
                  &lt;/Section1&gt;
                &lt;/Appendix&gt;
                &lt;Bibliography ID="Bib1"&gt;
                  &lt;Heading&gt;References&lt;/Heading&gt;
                  &lt;Citation ID="CR1"&gt;
                    &lt;CitationNumber&gt;1.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maguire&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Papadopoulou&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kotronoulas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Simpson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;McPhelim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Irvine&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;A systematic review of supportive care needs of people living with lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Oncol Nurs&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;IssueID&gt;4&lt;/IssueID&gt;
                      &lt;FirstPage&gt;449&lt;/FirstPage&gt;
                      &lt;LastPage&gt;464&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.ejon.2012.10.013&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23246484&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Maguire R, Papadopoulou C, Kotronoulas G, Simpson MF, McPhelim J, Irvine L. A systematic review of supportive care needs of people living with lung cancer. Eur J Oncol Nurs. 2013;17(4):449–64.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR2"&gt;
                    &lt;CitationNumber&gt;2.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brunelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xiume&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Refai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Salati&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marasco&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sciarra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2007&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Evaluation of expiratory volume, diffusion capacity, and exercise tolerance following major lung resection: a prospective follow-up analysis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Chest&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;131&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;141&lt;/FirstPage&gt;
                      &lt;LastPage&gt;147&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1378/chest.06-1345&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;17218568&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Brunelli A, Xiume F, Refai M, Salati M, Marasco R, Sciarra V, et al. Evaluation of expiratory volume, diffusion capacity, and exercise tolerance following major lung resection: a prospective follow-up analysis. Chest. 2007a;131(1):141–7.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR3"&gt;
                    &lt;CitationNumber&gt;3.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brunelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Socci&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Refai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Salati&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xiume&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sabbatini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2007&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Quality of life before and after major lung resection for lung cancer: a prospective follow-up analysis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Ann Thorac Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;84&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;410&lt;/FirstPage&gt;
                      &lt;LastPage&gt;416&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.athoracsur.2007.04.019&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;17643607&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Brunelli A, Socci L, Refai M, Salati M, Xiume F, Sabbatini A. Quality of life before and after major lung resection for lung cancer: a prospective follow-up analysis. Ann Thorac Surg. 2007b;84(2):410–6.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR4"&gt;
                    &lt;CitationNumber&gt;4.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sarna&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ME&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cooley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brown&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chernecky&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Elashoff&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kotlerman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2008&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Symptom severity 1 to 4 months after thoracotomy for lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Crit Care&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;IssueID&gt;5&lt;/IssueID&gt;
                      &lt;FirstPage&gt;455&lt;/FirstPage&gt;
                      &lt;LastPage&gt;467&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;18776002&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;BibComments&gt;
                        &lt;Emphasis Type="Bold"&gt;quiz 68&lt;/Emphasis&gt;
                      &lt;/BibComments&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Sarna L, Cooley ME, Brown JK, Chernecky C, Elashoff D, Kotlerman J. Symptom severity 1 to 4 months after thoracotomy for lung cancer. Am J Crit Care. 2008;17(5):455–67. 
                      &lt;Emphasis Type="Bold"&gt;quiz 68&lt;/Emphasis&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR5"&gt;
                    &lt;CitationNumber&gt;5.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Ni HJ, Pudasaini B, Yuan XT, Li HF, Shi L, Yuan P. Exercise Training for Patients Pre- and Postsurgically Treated for Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysis. Integr Cancer Ther. 2016
                      &lt;Emphasis Type="Bold"&gt;.&lt;/Emphasis&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR6"&gt;
                    &lt;CitationNumber&gt;6.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cavalheri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tahirah&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nonoyama&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jenkins&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hill&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Exercise training for people following lung resection for non-small cell lung cancer—a Cochrane systematic review&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cancer Treat Rev&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;40&lt;/VolumeID&gt;
                      &lt;IssueID&gt;4&lt;/IssueID&gt;
                      &lt;FirstPage&gt;585&lt;/FirstPage&gt;
                      &lt;LastPage&gt;594&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.ctrv.2013.11.001&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24268442&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Cavalheri V, Tahirah F, Nonoyama M, Jenkins S, Hill K. Exercise training for people following lung resection for non-small cell lung cancer—a Cochrane systematic review. Cancer Treat Rev. 2014;40(4):585–94.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR7"&gt;
                    &lt;CitationNumber&gt;7.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Crandall&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maguire&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Campbell&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kearney&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Exercise intervention for patients surgically treated for Non-Small Cell Lung Cancer (NSCLC): a systematic review&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Surg Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;23&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;17&lt;/FirstPage&gt;
                      &lt;LastPage&gt;30&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.suronc.2014.01.001&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24529937&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Crandall K, Maguire R, Campbell A, Kearney N. Exercise intervention for patients surgically treated for Non-Small Cell Lung Cancer (NSCLC): a systematic review. Surg Oncol. 2014;23(1):17–30.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR8"&gt;
                    &lt;CitationNumber&gt;8.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cleeland&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;XS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Q&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mendoza&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wright&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Berry&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;29&lt;/VolumeID&gt;
                      &lt;IssueID&gt;8&lt;/IssueID&gt;
                      &lt;FirstPage&gt;994&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1000&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.2010.29.8315&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21282546&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3068055&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, et al. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol. 2011;29(8):994–1000.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR9"&gt;
                    &lt;CitationNumber&gt;9.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rueda&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sola&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pascual&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Subirana&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Non-invasive interventions for improving well-being and quality of life in patients with lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cochrane Database Syst Rev&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;9&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;CD004282&lt;/FirstPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Rueda JR, Sola I, Pascual A, Subirana CM. Non-invasive interventions for improving well-being and quality of life in patients with lung cancer. Cochrane Database Syst Rev. 2011;9:CD004282.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR10"&gt;
                    &lt;CitationNumber&gt;10.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;McLean&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Protti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sheikh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Telehealthcare for long term conditions&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;BMJ&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;342&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;d120&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1136/bmj.d120&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21292710&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;McLean S, Protti D, Sheikh A. Telehealthcare for long term conditions. BMJ. 2011;342:d120.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR11"&gt;
                    &lt;CitationNumber&gt;11.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maguire&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ream&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Richardson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Connaghan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Johnston&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kotronoulas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Development of a novel remote patient monitoring system: the advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cancer Nurs&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;38&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;E37&lt;/FirstPage&gt;
                      &lt;LastPage&gt;E47&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/NCC.0000000000000150&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24836956&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Maguire R, Ream E, Richardson A, Connaghan J, Johnston B, Kotronoulas G, et al. Development of a novel remote patient monitoring system: the advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy. Cancer Nurs. 2015;38(2):E37–47.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR12"&gt;
                    &lt;CitationNumber&gt;12.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kuijpers&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Groen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oldenburg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wouters&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Aaronson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Harten&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Development of MijnAVL, an interactive portal to empower breast and lung cancer survivors: an iterative
                        &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Multi-Stakeholder Approach
                      &lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;JMIR Res Protoc&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;4&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e14&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2196/resprot.3796&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25614924&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4319089&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kuijpers W, Groen WG, Oldenburg HS, Wouters MW, Aaronson NK, van Harten WH. Development of MijnAVL, an interactive portal to empower breast and lung cancer survivors: an iterative
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Multi-Stakeholder Approach. JMIR Res Protoc. 2015;4(1):e14.
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR13"&gt;
                    &lt;CitationNumber&gt;13.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dickinson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hall&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sinclair&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bond&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Murchie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Using technology to deliver cancer follow-up: a systematic review&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;BMC Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;311&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1186/1471-2407-14-311&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24885758&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4101828&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Dickinson R, Hall S, Sinclair JE, Bond C, Murchie P. Using technology to deliver cancer follow-up: a systematic review. BMC Cancer. 2014;14(1):311.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR14"&gt;
                    &lt;CitationNumber&gt;14.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Groen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kuijpers&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oldenburg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wouters&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Aaronson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Harten&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Empowerment of cancer survivors through information technology: an integrative review&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Med Internet Res&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;IssueID&gt;11&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e270&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2196/jmir.4818&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26614438&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4704924&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Groen WG, Kuijpers W, Oldenburg HS, Wouters MW, Aaronson NK, van Harten WH. Empowerment of cancer survivors through information technology: an integrative review. J Med Internet Res. 2015;17(11):e270.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR15"&gt;
                    &lt;CitationNumber&gt;15.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoffman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brintnall&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brown&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Eye&lt;/FamilyName&gt;
                        &lt;Particle&gt;von&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jones&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Alderink&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Virtual reality bringing a new reality to postthoracotomy lung cancer patients via a home-based exercise intervention targeting fatigue while undergoing adjuvant treatment&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cancer Nurs&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;37&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;23&lt;/FirstPage&gt;
                      &lt;LastPage&gt;33&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/NCC.0b013e318278d52f&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23348662&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hoffman AJ, Brintnall RA, Brown JK, von Eye A, Jones LW, Alderink G, et al. Virtual reality bringing a new reality to postthoracotomy lung cancer patients via a home-based exercise intervention targeting fatigue while undergoing adjuvant treatment. Cancer Nurs. 2014;37(1):23–33.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR16"&gt;
                    &lt;CitationNumber&gt;16.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Jansen-Kosterink S
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Vollenbroek-Hutten M. A Renewed Framework for the Evaluation of Telemedicine. 8th International Conference on eHealth, Telemedicine, and Social Medicine: eTELEMED 2016; April 24–28, 2016; Venice, Italy 2016.
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR17"&gt;
                    &lt;CitationNumber&gt;17.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Vollenbroek-Hutten M
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Tabak M
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Jansen-Kosterink S
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Dekker M, editors. From telemedicine technology to telemedicine services. Proceedings of the 3rd 2015 Workshop on ICTs for improving Patients Rehabilitation Research Techniques; 2015: ACM.
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR18"&gt;
                    &lt;CitationNumber&gt;18.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoaas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Andreassen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lien&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hjalmarsen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zanaboni&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Adherence and factors affecting satisfaction in long-term telerehabilitation for patients with chronic obstructive pulmonary disease: a mixed methods study&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;BMC Med Inform Decis Mak&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;26&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1186/s12911-016-0264-9&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26911326&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4766676&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hoaas H, Andreassen HK, Lien LA, Hjalmarsen A, Zanaboni P. Adherence and factors affecting satisfaction in long-term telerehabilitation for patients with chronic obstructive pulmonary disease: a mixed methods study. BMC Med Inform Decis Mak. 2016;16:26.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR19"&gt;
                    &lt;CitationNumber&gt;19.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Judi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Razak&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sha’ari&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mohamed&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Feasibility and critical success factors in implementing telemedicine&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Inf Technol J&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;8&lt;/VolumeID&gt;
                      &lt;IssueID&gt;3&lt;/IssueID&gt;
                      &lt;FirstPage&gt;326&lt;/FirstPage&gt;
                      &lt;LastPage&gt;332&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3923/itj.2009.326.332&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Judi HM, Razak A, Sha’ari N, Mohamed H. Feasibility and critical success factors in implementing telemedicine. Inf Technol J. 2009;8(3):326–32.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR20"&gt;
                    &lt;CitationNumber&gt;20.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Timmerman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tönis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MGH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dekker-van Weering&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stuiver&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MWJM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wouters&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Harten&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Co-creation of an ICT-supported cancer rehabilitation application for resected lung cancer survivors: design and evaluation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;BMC Health Serv Res&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1&lt;/FirstPage&gt;
                      &lt;LastPage&gt;11&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1186/s12913-016-1385-7&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Timmerman JG, Tönis TM, Dekker-van Weering MGH, Stuiver MM, Wouters MWJM, van Harten WH, et al. Co-creation of an ICT-supported cancer rehabilitation application for resected lung cancer survivors: design and evaluation. BMC Health Serv Res. 2016;16(1):1–11.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR21"&gt;
                    &lt;CitationNumber&gt;21.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kanning&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Using objective, real-time measures to investigate the effect of actual physical activity on affective states in everyday life differentiating the contexts of working and leisure time in a sample with students&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Front Psychol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;3&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;602&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23346064&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kanning M. Using objective, real-time measures to investigate the effect of actual physical activity on affective states in everyday life differentiating the contexts of working and leisure time in a sample with students. Front Psychol. 2012;3:602.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR22"&gt;
                    &lt;CitationNumber&gt;22.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wilhelm&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schoebi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2007&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Assessing mood in daily life: structural validity, sensitivity to change, and reliability of a short-scale to measure three basic dimensions of mood&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Psychol Assess&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;23&lt;/VolumeID&gt;
                      &lt;IssueID&gt;4&lt;/IssueID&gt;
                      &lt;FirstPage&gt;258&lt;/FirstPage&gt;
                      &lt;LastPage&gt;267&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1027/1015-5759.23.4.258&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Wilhelm P, Schoebi D. Assessing mood in daily life: structural validity, sensitivity to change, and reliability of a short-scale to measure three basic dimensions of mood. Eur J Psychol Assess. 2007;23(4):258–67.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR23"&gt;
                    &lt;CitationNumber&gt;23.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Venkatesh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Morris&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gordon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Davis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2003&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;User acceptance of information technology: toward a unified view&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;MIS Q&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;27&lt;/VolumeID&gt;
                      &lt;IssueID&gt;3&lt;/IssueID&gt;
                      &lt;FirstPage&gt;425&lt;/FirstPage&gt;
                      &lt;LastPage&gt;478&lt;/LastPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Venkatesh V, Morris MG, Gordon BD, Davis FD. User acceptance of information technology: toward a unified view. MIS Q. 2003;27(3):425–78.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR24"&gt;
                    &lt;CitationNumber&gt;24.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ajzen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1991&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The theory of planned behavior&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Organ Behav Hum Decis Process&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;50&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;179&lt;/FirstPage&gt;
                      &lt;LastPage&gt;211&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/0749-5978(91)90020-T&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR25"&gt;
                    &lt;CitationNumber&gt;25.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Hu PJ-H, editor. Evaluating telemedicine systems success: a revised model. System Sciences, 2003. Proceedings of the 36th Annual Hawaii International Conference on; 2003: IEEE.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR26"&gt;
                    &lt;CitationNumber&gt;26.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sun&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rau&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The acceptance of personal health devices among patients with chronic conditions&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int J Med Inform&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;84&lt;/VolumeID&gt;
                      &lt;IssueID&gt;4&lt;/IssueID&gt;
                      &lt;FirstPage&gt;288&lt;/FirstPage&gt;
                      &lt;LastPage&gt;297&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.ijmedinf.2015.01.002&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25655783&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Sun N, Rau PL. The acceptance of personal health devices among patients with chronic conditions. Int J Med Inform. 2015;84(4):288–97.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR27"&gt;
                    &lt;CitationNumber&gt;27.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brunelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Refai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xiume&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Salati&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marasco&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sciarra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2008&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Oxygen desaturation during maximal stair-climbing test and postoperative complications after major lung resections&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Cardiothorac Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;33&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;77&lt;/FirstPage&gt;
                      &lt;LastPage&gt;82&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.ejcts.2007.09.028&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;17983763&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Brunelli A, Refai M, Xiume F, Salati M, Marasco R, Sciarra V, et al. Oxygen desaturation during maximal stair-climbing test and postoperative complications after major lung resections. Eur J Cardiothorac Surg. 2008;33(1):77–82.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR28"&gt;
                    &lt;CitationNumber&gt;28.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brunelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Al Refai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Monteverde&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Borri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Salati&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fianchini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2003&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Predictors of exercise oxygen desaturation following major lung resection&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Cardiothorac Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;24&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;145&lt;/FirstPage&gt;
                      &lt;LastPage&gt;148&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S1010-7940(03)00175-1&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;12853059&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Brunelli A, Al Refai M, Monteverde M, Borri A, Salati M, Fianchini A. Predictors of exercise oxygen desaturation following major lung resection. Eur J Cardiothorac Surg. 2003;24(1):145–8.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR29"&gt;
                    &lt;CitationNumber&gt;29.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;CBS. ICT, kennis en economie 2016. In: Zaken MvE, editor. Den Haag: CBS; 2016.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR30"&gt;
                    &lt;CitationNumber&gt;30.&lt;/CitationNumber&gt;
                    &lt;BibChapter&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Courneya&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Karvinen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JKH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vallance&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2007&lt;/Year&gt;
                      &lt;NoChapterTitle/&gt;
                      &lt;BibEditorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Feuerstein&lt;/FamilyName&gt;
                      &lt;/BibEditorName&gt;
                      &lt;Eds/&gt;
                      &lt;BookTitle&gt;Exercise motivation and behavior change handbook of cancer survivorship&lt;/BookTitle&gt;
                      &lt;PublisherName&gt;Springer&lt;/PublisherName&gt;
                      &lt;PublisherLocation&gt;US&lt;/PublisherLocation&gt;
                      &lt;FirstPage&gt;113&lt;/FirstPage&gt;
                      &lt;LastPage&gt;132&lt;/LastPage&gt;
                    &lt;/BibChapter&gt;
                    &lt;BibUnstructured&gt;Courneya KS, Karvinen KH, Vallance JKH. Exercise motivation and behavior change handbook of cancer survivorship. In: Feuerstein M, editor. . US: Springer; 2007. p. 113–32.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR31"&gt;
                    &lt;CitationNumber&gt;31.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pinto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ciccolo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Physical activity motivation and cancer survivorship&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Recent Results Cancer Res&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;186&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;367&lt;/FirstPage&gt;
                      &lt;LastPage&gt;387&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/978-3-642-04231-7_16&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21113773&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Pinto BM, Ciccolo JT. Physical activity motivation and cancer survivorship. Recent Results Cancer Res. 2011;186:367–87.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR32"&gt;
                    &lt;CitationNumber&gt;32.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Achterkamp R
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Dekker-Van Weering MG
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Evering RM
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Tabak M
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Timmerman JG
                      &lt;Emphasis Type="Bold"&gt;,&lt;/Emphasis&gt; Hermens HJ et al. Strategies to improve effectiveness of physical activity coaching systems: Development of personas for providing tailored feedback. Health Inform J. 2016
                      &lt;Emphasis Type="Bold"&gt;.&lt;/Emphasis&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR33"&gt;
                    &lt;CitationNumber&gt;33.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Op den Akker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cabrita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Op den Akker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;VM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jones&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hermens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Tailored motivational message generation: a model and practical framework for real-time physical activity coaching&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Biomed Inform&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;55&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;104&lt;/FirstPage&gt;
                      &lt;LastPage&gt;115&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jbi.2015.03.005&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25843359&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Op den Akker H, Cabrita M, Op den Akker R, Jones VM, Hermens HJ. Tailored motivational message generation: a model and practical framework for real-time physical activity coaching. J Biomed Inform. 2015;55:104–15.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR34"&gt;
                    &lt;CitationNumber&gt;34.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wolvers&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FZ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bruggeman-Everts&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ML&lt;/Initials&gt;
                        &lt;FamilyName&gt;Van der Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Van de Schoot&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vollenbroek-Hutten&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Effectiveness, mediators, and effect predictors of internet interventions for chronic cancer-related fatigue: the design and an analysis plan of a 3-armed randomized controlled trial&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;JMIR Res Protoc&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;4&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e77&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2196/resprot.4363&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26104114&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4526958&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Wolvers M, Bruggeman-Everts FZ, Van der Lee ML, Van de Schoot R, Vollenbroek-Hutten MM. Effectiveness, mediators, and effect predictors of internet interventions for chronic cancer-related fatigue: the design and an analysis plan of a 3-armed randomized controlled trial. JMIR Res Protoc. 2015;4(2):e77.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR35"&gt;
                    &lt;CitationNumber&gt;35.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Op den Akker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;VM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jones&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hermens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Tailoring real-time physical activity coaching systems: a literature survey and model&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;User Model User-Adap Inter&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;24&lt;/VolumeID&gt;
                      &lt;IssueID&gt;5&lt;/IssueID&gt;
                      &lt;FirstPage&gt;351&lt;/FirstPage&gt;
                      &lt;LastPage&gt;392&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s11257-014-9146-y&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Op den Akker H, Jones VM, Hermens HJ. Tailoring real-time physical activity coaching systems: a literature survey and model. User Model User-Adap Inter. 2014;24(5):351–92.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR36"&gt;
                    &lt;CitationNumber&gt;36.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Broens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Huis in’t Veld&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vollenbroek-Hutten&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hermens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Halteren&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nieuwenhuis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2007&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Determinants of successful telemedicine implementations: a literature study&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Telemed Telecare&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;13&lt;/VolumeID&gt;
                      &lt;IssueID&gt;6&lt;/IssueID&gt;
                      &lt;FirstPage&gt;303&lt;/FirstPage&gt;
                      &lt;LastPage&gt;309&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1258/135763307781644951&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;17785027&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Broens TH, Huis in’t Veld RM, Vollenbroek-Hutten MM, Hermens HJ, van Halteren AT, Nieuwenhuis LJ. Determinants of successful telemedicine implementations: a literature study. J Telemed Telecare. 2007;13(6):303–9.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR37"&gt;
                    &lt;CitationNumber&gt;37.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dyk&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;A review of telehealth service implementation frameworks&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int J Environ Res Public Health&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;11&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1279&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1298&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3390/ijerph110201279&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24464237&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3945538&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;van Dyk L. A review of telehealth service implementation frameworks. Int J Environ Res Public Health. 2014;11(2):1279–98.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR38"&gt;
                    &lt;CitationNumber&gt;38.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Jansen-Kosterink SM. The added value of telemedicine services for physical rehabilitation. Enschede: University of Twente; 2014
                      &lt;Emphasis Type="Bold"&gt;.&lt;/Emphasis&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR39"&gt;
                    &lt;CitationNumber&gt;39.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Heart&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kalderon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Older adults: are they ready to adopt health-related ICT?&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int J Med Inform&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;82&lt;/VolumeID&gt;
                      &lt;IssueID&gt;11&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e209&lt;/FirstPage&gt;
                      &lt;LastPage&gt;ee31&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.ijmedinf.2011.03.002&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21481631&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Heart T, Kalderon E. Older adults: are they ready to adopt health-related ICT? Int J Med Inform. 2013;82(11):e209–e31.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR40"&gt;
                    &lt;CitationNumber&gt;40.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Krijgsman J, Peeters J, Waverijn G, Van Lettow B, Van der Hoek L, De Jong J et al. ‘Omdat ik het belangrijk vind om goed voor mezelf te zorgen’- rapportage eHealth-doelstellingen 2016. Den Haag &amp;amp; Utrecht: Nictiz &amp;amp; Nivel2016.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR41"&gt;
                    &lt;CitationNumber&gt;41.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Bosman R, Bruyckere SD. Dutch Smartphone User - 2016 Q1: Telecompaper 2016.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                &lt;/Bibliography&gt;
              &lt;/ArticleBackmatter&gt;
            &lt;/Article&gt;
          &lt;/Issue&gt;
        &lt;/Volume&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-11-05T15:10:53.629392+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Timmerman, J.G.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Dekker-van Weering, M.G.H.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Stuiver, M.M.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Groen, W.G.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Wouters, M.W.J.M.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Tönis, T.M.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Hermens, H.J.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Vollenbroek-Hutten, M.M.R.&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution geo="6.8936619,52.2215372"&gt;
            &lt;meta:OrgName&gt;Telemedicine Group&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;6.8936619,52.2215372#Telemedicine Group&lt;/meta:GeoOrg&gt;
            &lt;meta:Country/&gt;&lt;/meta:Institution&gt;
          &lt;meta:Institution geo="6.8936619,52.2215372,0"&gt;
            &lt;meta:OrgName&gt;University of Twente&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;6.8936619,52.2215372,0#University of Twente&lt;/meta:GeoOrg&gt;
            &lt;meta:Country/&gt;&lt;/meta:Institution&gt;
          &lt;meta:Institution geo="4.8909347,52.3738007,0"&gt;
            &lt;meta:OrgName&gt;The Netherlands Cancer Institute&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;4.8909347,52.3738007,0#The Netherlands Cancer Institute&lt;/meta:GeoOrg&gt;
            &lt;meta:Country/&gt;&lt;/meta:Institution&gt;
          &lt;meta:Institution geo="6.7927725,52.2574121"&gt;
            &lt;meta:OrgName&gt;Ziekenhuis Groep Twente&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;6.7927725,52.2574121#Ziekenhuis Groep Twente&lt;/meta:GeoOrg&gt;
            &lt;meta:Country/&gt;&lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-01&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-11-05T05:13:23&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1007/s11764-017-0611-6&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;Ambulant monitoring and web-accessible home-based exercise program during outpatient follow-up for resected lung cancer survivors: actual use and feasibility in clinical practice&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;1932-2267&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;Springer&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;Journal of Cancer Survivorship&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;Journal of Cancer Survivorship&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH27002" Priority="1" Type="Secondary"&gt;Public Health&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH33160" Priority="2" Type="Secondary"&gt;Oncology&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH27010" Priority="3" Type="Secondary"&gt;Health Promotion and Disease Prevention&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH28009" Priority="4" Type="Secondary"&gt;Health Informatics&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH65000" Priority="5" Type="Secondary"&gt;Quality of Life Research&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH51000" Priority="6" Type="Secondary"&gt;Primary Care Medicine&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:VolumeId&gt;11&lt;/meta:VolumeId&gt;
        &lt;meta:IssueId&gt;6&lt;/meta:IssueId&gt;
        &lt;meta:ArticleSequenceNumber&gt;7&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;BioMed Central&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;London&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;BioMed Central&lt;/PublisherImprintName&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="Online"&gt;
        &lt;JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;40644&lt;/JournalID&gt;
          &lt;JournalElectronicISSN&gt;1470-7330&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;Cancer Imaging&lt;/JournalTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;Cancer Imaging&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH33160" Priority="1" Type="Secondary"&gt;Oncology&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCB11001" Priority="2" Type="Secondary"&gt;Cancer Research&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH29005" Priority="3" Type="Secondary"&gt;Imaging / Radiology&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH29048" Priority="4" Type="Secondary"&gt;Nuclear Medicine&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Medicine"&gt;SC11&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;Volume OutputMedium="Online"&gt;
          &lt;VolumeInfo TocLevels="0" VolumeType="Regular"&gt;
            &lt;VolumeIDStart&gt;17&lt;/VolumeIDStart&gt;
            &lt;VolumeIDEnd&gt;17&lt;/VolumeIDEnd&gt;
            &lt;VolumeIssueCount&gt;1&lt;/VolumeIssueCount&gt;
          &lt;/VolumeInfo&gt;
          &lt;Issue IssueType="Regular" OutputMedium="Online"&gt;
            &lt;IssueInfo IssueType="Regular" TocLevels="0"&gt;
              &lt;IssueIDStart&gt;1&lt;/IssueIDStart&gt;
              &lt;IssueIDEnd&gt;1&lt;/IssueIDEnd&gt;
              &lt;IssueArticleCount&gt;0&lt;/IssueArticleCount&gt;
              &lt;IssueHistory&gt;
                &lt;CoverDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                &lt;/CoverDate&gt;
                &lt;PricelistYear&gt;2017&lt;/PricelistYear&gt;
              &lt;/IssueHistory&gt;
              &lt;IssueCopyright&gt;
                &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
              &lt;/IssueCopyright&gt;
            &lt;/IssueInfo&gt;
            &lt;Article ID="s40644-017-0131-7" OutputMedium="Online"&gt;
              &lt;ArticleInfo ArticleType="OriginalPaper" ContainsESM="Yes" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
                &lt;ArticleID&gt;131&lt;/ArticleID&gt;
                &lt;ArticleDOI&gt;10.1186/s40644-017-0131-7&lt;/ArticleDOI&gt;
                &lt;ArticleCitationID&gt;29&lt;/ArticleCitationID&gt;
                &lt;ArticleSequenceNumber&gt;28&lt;/ArticleSequenceNumber&gt;
                &lt;ArticleTitle Language="En" OutputMedium="All"&gt;3.0T MRI for long-term observation of lung nodules post cryoablation: a pilot study&lt;/ArticleTitle&gt;
                &lt;ArticleCategory&gt;Research article&lt;/ArticleCategory&gt;
                &lt;ArticleFirstPage&gt;1&lt;/ArticleFirstPage&gt;
                &lt;ArticleLastPage&gt;10&lt;/ArticleLastPage&gt;
                &lt;ArticleHistory&gt;
                  &lt;RegistrationDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;11&lt;/Month&gt;
                    &lt;Day&gt;17&lt;/Day&gt;
                  &lt;/RegistrationDate&gt;
                  &lt;Received&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;5&lt;/Month&gt;
                    &lt;Day&gt;2&lt;/Day&gt;
                  &lt;/Received&gt;
                  &lt;Accepted&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;11&lt;/Month&gt;
                    &lt;Day&gt;17&lt;/Day&gt;
                  &lt;/Accepted&gt;
                  &lt;OnlineDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;12&lt;/Month&gt;
                    &lt;Day&gt;1&lt;/Day&gt;
                  &lt;/OnlineDate&gt;
                &lt;/ArticleHistory&gt;
                &lt;ArticleFundingInformation&gt;
                  &lt;Fund&gt;
                    &lt;FunderName&gt;National Natural and Science Fund of China&lt;/FunderName&gt;
                    &lt;GrantNumber Type="FundRef"&gt;81372370&lt;/GrantNumber&gt;
                  &lt;/Fund&gt;
                &lt;/ArticleFundingInformation&gt;
                &lt;ArticleCopyright&gt;
                  &lt;CopyrightHolderName&gt;The Author(s).&lt;/CopyrightHolderName&gt;
                  &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                  &lt;License SubType="CC BY + CC0" Type="OpenAccess" Version="4.0"&gt;
                    &lt;SimplePara&gt;
                      &lt;Emphasis Type="Bold"&gt;Open Access&lt;/Emphasis&gt;This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;http://creativecommons.org/licenses/by/4.0/&lt;/RefSource&gt;
                        &lt;RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/&gt;
                      &lt;/ExternalRef&gt;), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;http://creativecommons.org/publicdomain/zero/1.0/&lt;/RefSource&gt;
                        &lt;RefTarget Address="http://creativecommons.org/publicdomain/zero/1.0/" TargetType="URL"/&gt;
                      &lt;/ExternalRef&gt;) applies to the data made available in this article, unless otherwise stated.
                    &lt;/SimplePara&gt;
                  &lt;/License&gt;
                &lt;/ArticleCopyright&gt;
                &lt;ArticleGrants Type="OpenChoice"&gt;
                  &lt;MetadataGrant Grant="OpenAccess"/&gt;
                  &lt;AbstractGrant Grant="OpenAccess"/&gt;
                  &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                  &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                  &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                  &lt;ESMGrant Grant="OpenAccess"/&gt;
                &lt;/ArticleGrants&gt;
              &lt;/ArticleInfo&gt;
              &lt;ArticleHeader&gt;
                &lt;AuthorGroup&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au1"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Jing&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Li&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;lijingqingqing@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au2"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Jinrong&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Qu&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;qjryq@126.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au3"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Hongkai&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;zhk625@sina.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au4"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Yingshu&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;wys1285@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au5"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Lin&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Zheng&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;hyzhenglin@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au6"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Xiang&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Geng&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;gengxiang19861@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au7"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Yan&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Zhao&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;zhaoyan10211@163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au8" ORCID="http://orcid.org/0000-0002-4036-2191"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Hailiang&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Li&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Phone&gt;(+86)13903861969&lt;/Phone&gt;
                      &lt;Email&gt;cjr.lihailiang@vip.163.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Affiliation ID="Aff1"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 1799 4638&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.414008.9&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Radiology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;127 Dongming Road, Jinshui District&lt;/Street&gt;
                      &lt;City&gt;Zhengzhou&lt;/City&gt;
                      &lt;State&gt;Henan Province&lt;/State&gt;
                      &lt;Postcode&gt;450008&lt;/Postcode&gt;
                      &lt;Country Code="CN"&gt;China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                &lt;/AuthorGroup&gt;
                &lt;Abstract ID="Abs1" Language="En" OutputMedium="All"&gt;
                  &lt;Heading&gt;Abstract&lt;/Heading&gt;
                  &lt;AbstractSection ID="ASec1"&gt;
                    &lt;Heading&gt;Background&lt;/Heading&gt;
                    &lt;Para ID="Par1"&gt;The purpose of this study was to use serial magnetic resonance imaging (MRI) examinations to observe changes in malignant lung tumors over time post-cryoablation.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec2"&gt;
                    &lt;Heading&gt;Methods&lt;/Heading&gt;
                    &lt;Para ID="Par2"&gt;The study protocol was approved by Institutional Review Board, and written informed consent was obtained from each participant in accordance with the Declaration of Helsinki. Patients with primary or metastatic lung tumors eligible for cryoablation were included in this prospective study. Cryoablation was performed according to standard procedures. Unenhanced and dynamic contrast-enhanced MRI scans were performed pre-cryoablation and at 1&nbsp;day, 1&nbsp;week, and 3-, 6-, and 12&nbsp;months after cryoablation. At each time point, the signal intensity of the ablated zone on both T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI images, and volume and characteristics of the ablation zone were examined, and changes over time analyzed.
                    &lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec3"&gt;
                    &lt;Heading&gt;Results&lt;/Heading&gt;
                    &lt;Para ID="Par3"&gt;A total of 26 nodules in 23 patients were included in the study. The mean patient age was 53.7 ± 13.6&nbsp;years, and 57.7% were males. Ablation zone volume increased to 1&nbsp;week after the procedure, and then returned to baseline by 3&nbsp;months. Cavitation post-cryoablation was found in 34.6% (9/26) of the nodules 1&nbsp;month after treatment. Two types of time-signal intensity curves post-cryoablation were found: a straight line representing no definite enhancement from 1-day to 1-month, and an inflow curve representing mild delayed enhancement from month 3 to month 12. Local progression was associated with an incomplete hypointense rim around the ablation zone and absence of cavitation post-treatment.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec4"&gt;
                    &lt;Heading&gt;Conclusions&lt;/Heading&gt;
                    &lt;Para ID="Par4"&gt;Characteristic changes are present on MRI after cryoablation of lung tumors. A complete hypointense rim and cavitation may be signs of adequate treatment and that local tumor progression is less likely.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                &lt;/Abstract&gt;
                &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                  &lt;Heading&gt;Keywords&lt;/Heading&gt;
                  &lt;Keyword&gt;Lung cancer&lt;/Keyword&gt;
                  &lt;Keyword&gt;Magnetic resonance imaging&lt;/Keyword&gt;
                  &lt;Keyword&gt;Percutaneous cryotherapy&lt;/Keyword&gt;
                &lt;/KeywordGroup&gt;
                &lt;ArticleNote Type="ESMHint"&gt;
                  &lt;Heading&gt;Electronic supplementary material&lt;/Heading&gt;
                  &lt;SimplePara&gt;The online version of this article (doi:
                    &lt;ExternalRef&gt;
                      &lt;RefSource&gt;10.1186/s40644-017-0131-7&lt;/RefSource&gt;
                      &lt;RefTarget Address="10.1186/s40644-017-0131-7" TargetType="DOI"/&gt;
                    &lt;/ExternalRef&gt;) contains supplementary material, which is available to authorized users.
                  &lt;/SimplePara&gt;
                &lt;/ArticleNote&gt;
              &lt;/ArticleHeader&gt;
              &lt;Body&gt;
                &lt;Section1 ID="Sec1"&gt;
                  &lt;Heading&gt;Background&lt;/Heading&gt;
                  &lt;Para ID="Par5"&gt;Lung cancer is the most common cancer worldwide, and is the leading cause of cancer-related death in both men and women [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]. Surgical resection is the standard treatment for early-stage patients. However, patients with advanced stage disease and those with significant comorbidities may not be eligible for surgery. Metastases is the second most common pulmonary malignancy, and resectability depends on many factors [
                    &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;]. Nonsurgical candidates are usually managed with systemic chemotherapy; however, side effects can be severe and not all tumors respond to chemotherapy [
                    &lt;CitationRef AdditionalCitationIDS="CR4" CitationID="CR3"&gt;3&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR5"&gt;5&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par6"&gt;Cryoablation of a tumor can reduce its size, or completely eliminate it, and can thus alleviate symptoms and improve survival [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR6"&gt;6&lt;/CitationRef&gt;]. Cryosurgery is commonly used for the treatment of prostate and liver tumors [
                    &lt;CitationRef CitationID="CR7"&gt;7&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;]. Although percutaneous cryoablation of tumors in the thorax was first reported in 2005 [
                    &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;], and it has been shown to be safe and effective for lung tumors [
                    &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR5"&gt;5&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR10"&gt;10&lt;/CitationRef&gt;], it is still not widely used for lung malignancies [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;]. No tissue is removed during cryoablation; thus, imaging is necessary to determine if the extent of ablation is adequate, and to determine how the lesion has responded to the treatment. Imaging studies are mainly utilized for intra-operative guidance, and there is only 1 report on application of computed tomography (CT) for determination of the ablated zone and the examination of serial post-ablative changes [
                    &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;]. While the study showed that CT was useful for examining changes following cryoablation, the large radiation dose from multiple CT scans cannot be ignored.
                  &lt;/Para&gt;
                  &lt;Para ID="Par7"&gt;Magnetic resonance imaging (MRI) has advanced such that artifacts due to breathing and heart function can be reduced or eliminated, and MRI is frequently used for the diagnosis of thoracic disease [
                    &lt;CitationRef CitationID="CR13"&gt;13&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;]. MRI has been shown to clearly reflect changes in the ablation zone after radiofrequency ablation of liver lesions [
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;]. Unlike CT, MRI is not associated with ionizing radiation. However, there is currently only 1 report of MR-guided cryoablation for lung cancer [
                    &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;], and data of long-term changes of the ablation zone using MRI are not available.
                  &lt;/Para&gt;
                  &lt;Para ID="Par8"&gt;We hypothesized that MRI can identify changes in the ablation zone after radiofrequency ablation of lung tumors, and thus may be useful for monitoring treatment effectiveness. Thus, the purpose of this study was to use serial MRI examinations to observe changes in malignant lung tumors over time post-cryoablation, and correlate these changes with the effects of treatment.&lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec2"&gt;
                  &lt;Heading&gt;Methods&lt;/Heading&gt;
                  &lt;Section2 ID="Sec3"&gt;
                    &lt;Heading&gt;Patients&lt;/Heading&gt;
                    &lt;Para ID="Par9"&gt;The study protocol was approved by Institutional Review Board, and written informed consent was obtained from each participant in accordance with the Declaration of Helsinki.&lt;/Para&gt;
                    &lt;Para ID="Par10"&gt;This prospective study included patients with primary or metastatic lung cancer who received cryoablation from December 2013 to December 2015. Malignancy was diagnosed by a tissue specimen obtained via percutaneous or transbronchial lung biopsy, or clinical changes in the nodule such as rapid enlargement or glucose uptake on positron emission tomography (PET/CT). Other inclusion criteria were 1) newly diagnosed and had received no prior treatment; 2) were judged able to tolerate general anesthesia and the cryoablation procedure; 3) had a single nodule in the target lobe; 4) nodule size &amp;lt;4&nbsp;cm and no invasion into the adjacent structure; and 5) can complete the entire MRI scanning plan. Patients were excluded if 1) they had more than 1 tumor in the target lobe or had received prior therapy; 2) image quality was too poor to meet diagnostic requirements; 3) significant comorbidities or vital organ failure were present; and 4) nodule size &amp;gt;4&nbsp;cm, or invasion into mediastinal structures, chest wall, segmental bronchi, vessels, or nerves.&lt;/Para&gt;
                    &lt;Para ID="Par11"&gt;During the post ablation follow-up period, progression was diagnosed by biopsy only if the patient was able to tolerate the procedure, or changes in the nodule such as rapid enlargement or increased glucose uptake were identified on positron emission tomography (PET/CT).&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec4"&gt;
                    &lt;Heading&gt;Cryoablation protocol&lt;/Heading&gt;
                    &lt;Para ID="Par12"&gt;Cryoablation was performed under general anesthesia and CT guidance. All procedures were performed with a percutaneous cryoablation device utilizing 1.7 mm diameter cryoprobe and an Ar-He cryosurgery unit (CryoHit type; Galil Medical, Yokneam, Israel). The target lung nodule was identified, and a 3-dimensional (3D) treatment plan was designed based on 16 slice helical CT images (Light Speed; GE Medical Systems, Milwaukee, WI). The criteria for effective treatment were an ice hockey puck zone 1&nbsp;cm or more from the edge of the target nodule, and the frozen range after 1 single procedure covered more than 80% of the lesion. The needle interval was set to 2&nbsp;cm when using 2 needles so that the ice ball produced by each needle slightly overlapped and formed a seamless large frozen ball. The number of needles used depended on the size of the tumor.&lt;/Para&gt;
                    &lt;Para ID="Par13"&gt;After the skin was prepped and draped, 1% lidocaine was injected subcutaneous from the skin to the pleura. A 21-gauge guide needle was inserted along the planned optimized path using scout CT images. The needle position was confirmed in the targeting area by repeat CT scanning, then the 17-gauge stainless steel cryoablation probes consisting of an external sheath and inner-guide needle was inserted. The guide needle was removed after confirming the position, and the cryoprobe was introduced through the external sheath. The needle always penetrated the tumor, and the tip of the needle was placed at the far end of the lesion. Freeze-thaw cycles were then performed. A single cycle consisted of a 10&nbsp;min freezing period in which the local temperature decreased to minus 170&nbsp;°C due to argon gas rapid expansion, and a 2-min re-warming period in which the local temperature increased to plus 20&nbsp;°C as a result of helium rapid expansion. Generally, a single procedure consisted of 2 freeze-thaw cycles; however, in the case of large tumors multiple cycles were performed.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec5"&gt;
                    &lt;Heading&gt;MRI scanning program and parameters&lt;/Heading&gt;
                    &lt;Para ID="Par14"&gt;All patients received chest unenhanced and dynamic enhanced MR scans pre-cryoablation, and at 1&nbsp;day, 1&nbsp;week, and 1, 3, 6, and 12&nbsp;months after the procedure. Scanning was done with a 3.0T MR scanner (SignaHDx; GE Healthcare, Waukesha, WI), using a TORSO coil. Patients were in the supine position, foot ahead. Imaging was performed from the apex to the top of the diaphragm, including the target lung nodule. Six different sequences were used, and the sequences and parameters are summarized in Additional&nbsp;file&nbsp;
                      &lt;InternalRef RefID="MOESM1"&gt;1&lt;/InternalRef&gt;: Table S1.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec6"&gt;
                    &lt;Heading&gt;Image analysis&lt;/Heading&gt;
                    &lt;Para ID="Par15"&gt;The size of the ablation zone was measured in 3 dimensions on each imaging study. In prior studies, the post-ablation zone was characterized by regional ground-glass opacity on CT images [
                      &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR17"&gt;17&lt;/CitationRef&gt;]. As MRI characteristics of the ablation zone for pulmonary nodules are not available, we referred to studies of MRI characteristics after cryoablation for liver tumors [
                      &lt;CitationRef CitationID="CR18"&gt;18&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR19"&gt;19&lt;/CitationRef&gt;]. The ablation zone was defined as an area of high signal intensity on both T1WI and T2WI images, and no enhancement, which histologically represents the region of coagulative necrosis. Tumor volume (lesion length × lesion width × lesion height)/2) was recorded for each ablation zone. Each diameter was measured 3 times by an independent radiologist, and the average value was used for further calculations.
                    &lt;/Para&gt;
                    &lt;Para ID="Par16"&gt;All MRI images at each time point were analyzed by 2 radiologists with more than 5&nbsp;years of MRI diagnostic experience. Analyses were done independently and blindly. If there were inconsistencies at the final review of all of the analysis, a third highly qualified radiologist with more than 10&nbsp;years of MRI diagnostic experience reviewed the imaging studies and made the final determination.&lt;/Para&gt;
                    &lt;Para ID="Par17"&gt;Signal intensity of the ablation zone on T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI images were observed carefully, and changing characteristics and time-signal intensity changes were recorded. There are no standard criteria or quantitative parameters of T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI sequences for evaluating lung nodule post-cryoablation. However, a 5-point grading scale method has been proven to be effective and reliable for subjectively evaluating image quality, and to compare different technologies in tumor diagnosis [
                      &lt;CitationRef CitationID="CR20"&gt;20&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR21"&gt;21&lt;/CitationRef&gt;]. Thus, we applied a 5-point grading scale ranging from 1 (low) to 5 (high) on both T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI images for scoring signal intensity of the ablation zone. The scoring criteria were: On T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI images, lung parenchyma background was scored as 1 point, muscle signals as 3 points, fat tissue signal intensity as 5 points, signal intensity between lung parenchyma and muscle as 2 points, between muscle and fat tissues as 4 points (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig1"&gt;1a&lt;/InternalRef&gt;). On T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI images, lung parenchyma background was scored as 1 point, muscle signals as 3 points, water-like high signal intensity as 5 points, signals between parenchyma and muscles as 2 points, and between muscle and water as 4 points (Fig. 
                      &lt;InternalRef RefID="Fig1"&gt;1b&lt;/InternalRef&gt;). The ablation zone on T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI images at 1-day post-cryotherapy often showed heterogeneous signal intensity. When this occurred, the scores were determined by the dominant signals at the largest part of the ablation zone. Accompanying signs were also observed, including inflammation, atelectasis, and pleural effusion. Inflammation was identified as a large flake appearance with blurred margins, slightly high T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI signals with bronchial low signal intensity inside, and marked enhancement and blood vessels penetrating signs. Atelectasis was identified as a reduced wedge shape of a segment or lobe, slightly high signal intensity on T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI images without a bronchial low signal intensity inside, and significantly enhanced with a clear and straight border. Pleural effusion was identified by a crescent or ribbon-like intra-thoracic water-like signal intensity.
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Changes in volume (
                              &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt;) and T
                              &lt;Subscript&gt;1&lt;/Subscript&gt;WI (
                              &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt;) and T
                              &lt;Subscript&gt;2&lt;/Subscript&gt;WI score (
                              &lt;Emphasis Type="Bold"&gt;c&lt;/Emphasis&gt;) during the study period (
                              &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt; = 26 nodules). Nodule volume data are presented as a box plot: 1st quartile (top of the box), median (line shown in box), 3rd quartile (bottom of the box), and examined Friedman’s test. T
                              &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                              &lt;Subscript&gt;2&lt;/Subscript&gt;WI data are presented as mean ± standard deviation, and tested by linear mixed model. Letters denote significant difference between the given time and baseline
                              &lt;Superscript&gt;a&lt;/Superscript&gt;, day 1
                              &lt;Superscript&gt;b&lt;/Superscript&gt;, week 1
                              &lt;Superscript&gt;c&lt;/Superscript&gt;, or 1&nbsp;month 
                              &lt;Superscript&gt;d&lt;/Superscript&gt; (
                              &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt; &amp;lt; 0.002). Volume (cm
                              &lt;Superscript&gt;3&lt;/Superscript&gt;)
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO1"&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/40644_2017_131_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par18"&gt;Dynamic enhanced sequences, including mask phase, were transmitted to a Work Station 4.5, and processed by the SER software package. A region of interest (ROI) was placed in the aorta, and in the largest cross-section of the ablation zone on the same slice. Time-signal intensity curves were automatically generated.&lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec7"&gt;
                  &lt;Heading&gt;Statistical analysis&lt;/Heading&gt;
                  &lt;Para ID="Par19"&gt;Mean and standard deviation were computed for age, nodule volume, T
                    &lt;Subscript&gt;1&lt;/Subscript&gt;WI, and T
                    &lt;Subscript&gt;2&lt;/Subscript&gt;WI, and age range was reported as well. Categorical variables were summarized as frequency and percentage. Inter-rater reliability for T
                    &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                    &lt;Subscript&gt;2&lt;/Subscript&gt;WI analysis was examined by weighted Kappa. Five levels of agreement were defined according to the Kappa statistic: poor (κ &amp;lt; 0.2), fair (0.2 ≤ κ &amp;lt; 0.4), moderate (0.4 ≤ κ &amp;lt;0.6), good (0.6 ≤ κ &amp;lt; 0.8), and very good (0.8 ≤ κ ≤ 1.00). Nodule volume at various time points were presented as a box plot: 1st quartile (top of the box), median (line shown in box), 3rd quartile (bottom of the box). Data on nodule volume were examined by Friedman’s test, while the time trends of T
                    &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                    &lt;Subscript&gt;2&lt;/Subscript&gt;WI signal intensity were presented as line charts and examined using a linear mixed model. If the time effect was significant, post-hoc tests were implemented using Bonferroni’s correction method. To compare differences in T
                    &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                    &lt;Subscript&gt;2&lt;/Subscript&gt;WI signal intensity between patients with and without local tumor progression, the Mann-Whitney U test was also performed. A value of 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt; &amp;lt; 0.05 was considered statistical significant; the significance level was adjusted to 0.002 (0.05/21) if post-hoc tests were required. All statistical analyses were performed with PASW statistical software (version 21.0, IBM Corp., Armonk, NY, USA).
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec8"&gt;
                  &lt;Heading&gt;Results&lt;/Heading&gt;
                  &lt;Section2 ID="Sec9"&gt;
                    &lt;Heading&gt;Patients&lt;/Heading&gt;
                    &lt;Para ID="Par20"&gt;Data of 26 nodules from 23 patients were used for the analysis (Table&nbsp;
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;). The mean patient age was 53.7 ± 13.6 (range: 25–78) years, and 57.7% were males. Of the 23 patients, 12 were lost to follow-up at 18&nbsp;months, and another 5 were lost at 24&nbsp;months.
                      &lt;Table Float="Yes" ID="Tab1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Characteristics of 26 nodules in 23 patients&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup cols="3"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="char" char="(" colname="c3" colnum="3"/&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Age, years&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"/&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;53.7 ± 13.6 (25–78)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Gender&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Female&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;11 (42.3)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Male&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;15 (57.7)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Metastasis&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;No&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;11 (42.3)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Yes&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;15 (57.7)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Histological type&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Adenocarcinoma&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;22 (84.6)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Squamous cell carcinoma&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;4 (15.4)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Local progression&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;No&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;20 (76.9)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Yes&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;6 (23.1)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;Age reported as mean ± standard deviation with (range); other data reported as number (percentage)&lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec10"&gt;
                    &lt;Heading&gt;Volume change characteristics&lt;/Heading&gt;
                    &lt;Para ID="Par21"&gt;Changes in nodule volume through the study period are illustrated in Fig. 
                      &lt;InternalRef RefID="Fig1"&gt;1a&lt;/InternalRef&gt;. The volume was increased at post-procedure day 1, then became smaller gradually at 1&nbsp;week and 1&nbsp;month, and then reduced in size to the baseline value at 3&nbsp;months and remained at that size until the 12th month examination.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec11"&gt;
                    &lt;Heading&gt;Cavity formation&lt;/Heading&gt;
                    &lt;Para ID="Par22"&gt;Other MRI findings such as cavitation and complications are summarized in Table&nbsp;
                      &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt;. Cavitation post-cryoablation was found in 34.6% (9/26) of the nodules 1&nbsp;month after treatment, but no further cavitation was noted as time progressed. Six of the 9 cases of cavitation were resolved at 3&nbsp;months, and the others were resolved by 6&nbsp;months. Interestingly, none of the patients with cavitation post-cryoablation developed local tumor progression.
                      &lt;Table Float="Yes" ID="Tab2"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 2&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;MRI findings and complications (26 nodules)&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup cols="6"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                          &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                          &lt;colspec align="left" colname="c6" colnum="6"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Post-cryoablation cavitation&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Time-intensity curve type
                                  &lt;Superscript&gt;a&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Consolidation&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Atelectasis&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Pneumothorax&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Baseline&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Vary&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Day 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;42.3% (11/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;30.8% (8/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;26.9% (7/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Week 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;26.9% (7/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;7.7% (2/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3.8% (1/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Month 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;34.6% (9/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;7.7% (2/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;3.8% (1/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Month 3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;11.5% (3/26)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Month 6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Month 12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Superscript&gt;a&lt;/Superscript&gt;Two classifications of time-intensity curve: 1, no definite enhancement as a straight line; 2, mild delayed enhancement as an inflow curve
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par23"&gt;Consolidation, atelectasis, and pneumothorax were found in 42.3%, 30.8%, and 26.9% of nodules 1&nbsp;day after the treatment, respectively. No consolidation or atelectasis was observed after 3&nbsp;months, and pneumothoraces were resolved by 1&nbsp;month.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec12"&gt;
                    &lt;Heading&gt;Changes of signal intensity&lt;/Heading&gt;
                    &lt;Para ID="Par24"&gt;The inter-rater reliability with regard to observation of T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI signal intensity are reported in Table&nbsp;
                      &lt;InternalRef RefID="Tab3"&gt;3&lt;/InternalRef&gt;. Regardless of time, the inter-rater reliability of T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI were good or very good, except that T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI measured at month 6 only achieved moderate reliability. Changes in T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI are illustrated in Fig. 
                      &lt;InternalRef RefID="Fig1"&gt;1b and c&lt;/InternalRef&gt;. The T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI score increased from 2.87 at baseline to the peak of 4.58 at week 1, then declined to around 3 after 3&nbsp;months (Fig. 
                      &lt;InternalRef RefID="Fig1"&gt;1b&lt;/InternalRef&gt;). A similar trend was found for T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI, except the T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI score significantly decreased to 3.2 at 1&nbsp;month, and then leveled off to around 2.9 at 6&nbsp;months (Fig. 
                      &lt;InternalRef RefID="Fig1"&gt;1c&lt;/InternalRef&gt;).
                      &lt;Table Float="Yes" ID="Tab3"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 3&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Inter-rater reliability for T
                              &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                              &lt;Subscript&gt;2&lt;/Subscript&gt;WI
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup cols="5"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                          &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry nameend="c3" namest="c2"&gt;
                                &lt;SimplePara&gt;T
                                  &lt;Subscript&gt;1&lt;/Subscript&gt;WI
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c5" namest="c4"&gt;
                                &lt;SimplePara&gt;T
                                  &lt;Subscript&gt;2&lt;/Subscript&gt;WI
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Time&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Weighted Kappa&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;95% CI&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Weighted Kappa&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;95% CI&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Baseline&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.943&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.831–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.824&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.593–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Day 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.750&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.446–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.800&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.533–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Week 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.878&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.706–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;1.000&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(1.000–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Month 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.930&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.794–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.885&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.665–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Month 3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.875&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.704–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.898&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.702–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Month 6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.829&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.595–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.500&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.076–0.924)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Month 12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.000&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(1.000–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.776&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.357–1.000)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Emphasis Type="Italic"&gt;CI&lt;/Emphasis&gt; confidence interval
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec13"&gt;
                    &lt;Heading&gt;Enhancement characteristics&lt;/Heading&gt;
                    &lt;Para ID="Par25"&gt;Lung nodules exhibited different enhancement characteristics pre-cryoablation. The majority (73.1%, 19/26) exhibited moderate persistent enhancement, and the time-intensity curve was plateau (type II). However, there were 2 types of time-signal intensity curves post-cryoablation: a straight line representing no definite enhancement from 1-day to 1-month, and an inflow curve representing mild delayed enhancement from month 3 to month 12 (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig2"&gt;2&lt;/InternalRef&gt;). Images of a progressive lesion are shown in Fig.&nbsp;
                      &lt;InternalRef RefID="Fig3"&gt;3&lt;/InternalRef&gt;.
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig2"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 2&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Post-contrast images of venous phase (
                              &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt;), T
                              &lt;Subscript&gt;1&lt;/Subscript&gt;WI (
                              &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt;), and T
                              &lt;Subscript&gt;2&lt;/Subscript&gt;WI (
                              &lt;Emphasis Type="Bold"&gt;c&lt;/Emphasis&gt;) of a non-progressive lesion. At the early stage (1&nbsp;day, 1-month and 3-month), there was no definite enhancement in the ablation zone; later, mild enhancement was noted. Similarly, at the early stage the time-signal curve was a straight line type, and later became an inflow type
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO2"&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/40644_2017_131_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig3"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 3&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Post-contrast images of venous phase (
                              &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt;), T
                              &lt;Subscript&gt;1&lt;/Subscript&gt;WI (
                              &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt;), and T
                              &lt;Subscript&gt;2&lt;/Subscript&gt;WI (
                              &lt;Emphasis Type="Bold"&gt;c&lt;/Emphasis&gt;) of a progressive lesion. Progression was noted at 3&nbsp;months postoperatively. Images obtained at 1&nbsp;week and 1&nbsp;month postoperatively showed an unclear and incomplete hypointense rim, especially the T
                              &lt;Subscript&gt;2&lt;/Subscript&gt;WI images
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO3"&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/40644_2017_131_Fig3_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec14"&gt;
                    &lt;Heading&gt;Local tumor progression&lt;/Heading&gt;
                    &lt;Para ID="Par26"&gt;At 12&nbsp;months after treatment, 4 nodules showed local tumor progression. At 18&nbsp;months after treatment, and additional 2 nodules developed local progression. A difference in T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI signal intensity between patients with and without local tumor progression was found; however, the difference was no longer statistically significant after 1&nbsp;week. A difference in T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI signal intensity was also noted after treatment, but the difference became none significant at 6&nbsp;months. At 3&nbsp;months after treatment the ablation zone in 22.7% (5/22) of nodules remain round or nodule-like in the non-progression group, and at 12&nbsp;months 77.3% (17/22) of ablation zones had streaks and or a patch shape.
                    &lt;/Para&gt;
                    &lt;Para ID="Par27"&gt;Of 6 patients that developed local tumor progression, 4 were male and adenocarcinoma was the histological type in 4 cases. Complications like consolidation, atelectasis, and pneumothorax occurred within 1&nbsp;week to 3&nbsp;months after treatment (Table&nbsp;
                      &lt;InternalRef RefID="Tab4"&gt;4&lt;/InternalRef&gt;). Two patients received treatment with embedded 
                      &lt;Superscript&gt;125&lt;/Superscript&gt;I particles, 2 a second cyroablation, and 2 local radiotherapy. The ablation zone in the 6 patients with progression showed an incomplete ring at 1&nbsp;week and 3&nbsp;months on T
                      &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                      &lt;Subscript&gt;2&lt;/Subscript&gt;WI images, suggesting that this finding early post-cryoablation may be an indicator for progression.
                      &lt;Table Float="Yes" ID="Tab4"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 4&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Characteristics of 6 patients with local tumor progression&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup cols="7"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                          &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                          &lt;colspec align="left" colname="c6" colnum="6"/&gt;
                          &lt;colspec align="left" colname="c7" colnum="7"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"/&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Patient 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Patient 2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Patient 3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Patient 4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Patient 5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;Patient 6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Age, years&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;25&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;57&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;62&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;56&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;55&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;57&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Gender&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;M&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;F&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;M&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;M&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;F&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;M&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Number of treated nodules&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Histological type&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;AD&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;SCC&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;AD&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;AD&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;AD&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;SCC&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Metastasis&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c7" namest="c1"&gt;
                                &lt;SimplePara&gt;Volume, cm
                                  &lt;Superscript&gt;3&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Baseline&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.46&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;14.91&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;5.66&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;1.52&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0.25&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;4.20&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Day 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;29.71&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;51.89&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;124.71&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;29.74&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;46.37&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;35.34&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Week 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;16.09&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;47.05&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;95.47&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;22.46&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;26.04&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;26.84&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;7.15&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;23.25&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;27.84&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;8.54&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;20.39&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;9.98&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;1.37&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;7.95&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;8.72&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;1.37&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;5.92&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;7.30&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.52&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;5.83&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;1.82&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;4.54&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;3.56&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.46&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;4.83&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c7" namest="c1"&gt;
                                &lt;SimplePara&gt;T1WI&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Baseline&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Day 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Week 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c7" namest="c1"&gt;
                                &lt;SimplePara&gt;T2WI&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Baseline&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Day 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Week 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Post-cryoablation cavitation&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c7" namest="c1"&gt;
                                &lt;SimplePara&gt;Consolidation&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Baseline&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Day 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Week 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c7" namest="c1"&gt;
                                &lt;SimplePara&gt;Atelectasis&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Baseline&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Day 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Week 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c7" namest="c1"&gt;
                                &lt;SimplePara&gt;Pneumothorax&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Baseline&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Day 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Week 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Y&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Month 12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;N&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;N/A&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Emphasis Type="Italic"&gt;AD&lt;/Emphasis&gt; adenocarcinoma, 
                            &lt;Emphasis Type="Italic"&gt;N&lt;/Emphasis&gt; no, 
                            &lt;Emphasis Type="Italic"&gt;N/A&lt;/Emphasis&gt; not available, 
                            &lt;Emphasis Type="Italic"&gt;SC&lt;/Emphasis&gt; squamous cell carcinoma, 
                            &lt;Emphasis Type="Italic"&gt;Y&lt;/Emphasis&gt; yes
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec15"&gt;
                  &lt;Heading&gt;Discussion&lt;/Heading&gt;
                  &lt;Para ID="Par28"&gt;A number of studies have shown that cryoablation is an effective treatment for primary lung tumors and pulmonary metastasis [
                    &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR4"&gt;4&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR22"&gt;22&lt;/CitationRef&gt;]. However, familiarity with the post-procedural findings, and the ability to discriminate them from local progression, is critically important.
                  &lt;/Para&gt;
                  &lt;Para ID="Par29"&gt;Our study showed there are characteristic changes of lung nodules after cryotherapy. There is an early increase in volume of the ablated zone that peaks at 1&nbsp;day after the procedure, remains consistent to 1&nbsp;week, and then gradually declines to the baseline size at 3&nbsp;months. The volume increase at 1&nbsp;day is secondary to ice ball formation and acute lung changes in the target region. However, the reason why the signal is heterogeneous at 1&nbsp;day post-cryoablation is not clear. Heterogeneous signals can reflect post-cryoablation complications; a high signal on T
                    &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                    &lt;Subscript&gt;2&lt;/Subscript&gt;WI images can be due to alveolar hemorrhage, which is suggestive of small vessel rupture, whereas a low signal in the outer periphery may be the result of alveolar wall collapse and small bronchi rupture. In an animal study, Romaneehsen et al. [
                    &lt;CitationRef CitationID="CR23"&gt;23&lt;/CitationRef&gt;] showed that a volume decrease at 1&nbsp;week after cryoablation was associated with a reduction or disappearance of a low signal region in the outer periphery, which is suggestive that tissue repair begins in the outer region. A signal increase in the core of the ablated zone has been shown by animal experiments to be secondary to coagulation necrosis [
                    &lt;CitationRef CitationID="CR23"&gt;23&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR24"&gt;24&lt;/CitationRef&gt;]. This findings has also been found in radiofrequency ablation in the liver [
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par30"&gt;The persistent initial volume increase is secondary to the mobilization of macrophages and neutrophils into the cryoablation zone as part of the post-cryoablation immunologic cascade, which leads to tumor lysis and ensuing tissue repair [
                    &lt;CitationRef CitationID="CR24"&gt;24&lt;/CitationRef&gt;]. Subsequently, as the concentration of cellular debris, macrophages, and neutrophils decreases, there is steady reduction in the volume of the cryoablation zone [
                    &lt;CitationRef CitationID="CR24"&gt;24&lt;/CitationRef&gt;], as noted in our study. It is unclear why there is an increase of T
                    &lt;Subscript&gt;2&lt;/Subscript&gt;WI signal intensity in the ablated zone at 1-month post-cryoablation, as there is no relevant literature on the topic. It may secondary to stromal hyperplasia, which is abundant in newly developing small vessels and new fibrous tissue, thus reflecting tissue repair [
                    &lt;CitationRef CitationID="CR6"&gt;6&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR24"&gt;24&lt;/CitationRef&gt;]. The continuous decrease of signal intensity on T
                    &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                    &lt;Subscript&gt;2&lt;/Subscript&gt;WI images in the ablated zone from 3&nbsp;months onward may represent repair and fibrosis.
                  &lt;/Para&gt;
                  &lt;Para ID="Par31"&gt;In our study, at 1&nbsp;day, 1- week, and 1&nbsp;month post-cryoablation, the ablated zone showed no enhancement, which may be due to complex changes related to cell necrosis [
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR23"&gt;23&lt;/CitationRef&gt;]. From 3&nbsp;months onward mild enhancement was note in nodules that did not develop local progression. This is consistent with CT findings of lung nodules post-ablation [
                    &lt;CitationRef CitationID="CR6"&gt;6&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par32"&gt;The local progression rate in our study during a 12-month follow-up period was lower than that reported by Liu et al. [
                    &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;] and Inoue et al. [
                    &lt;CitationRef CitationID="CR10"&gt;10&lt;/CitationRef&gt;] Most nodules (73.7%) in our study had a diameter &amp;lt; 30&nbsp;mm, and approximately 30% had a diameter of 30–40&nbsp;mm; thus, they were relatively small. The low progression rate in this study may due to the limited sample size, size of the nodules, or the histological cancer types.
                  &lt;/Para&gt;
                  &lt;Para ID="Par33"&gt;The presence of hypointense rim as a “ring” appears to be critically important, as suggested from study of radiofrequency ablation [
                    &lt;CitationRef CitationID="CR25"&gt;25&lt;/CitationRef&gt;]. In this study, the hypointense rim was present at 1-week and 1-month post-cryoablation, and was a complete rim in 84.6% of nodules and incomplete in 15.4%. Although statistical comparative analysis in the progression group could not be performed due to the small sample size, all cases with local progression exhibited an incomplete ring at the ablation zone at 1&nbsp;week and 3&nbsp;months on T
                    &lt;Subscript&gt;1&lt;/Subscript&gt;WI and T
                    &lt;Subscript&gt;2&lt;/Subscript&gt;WI images, suggesting that this finding early post-cryoablation may be an indicator for progression.
                  &lt;/Para&gt;
                  &lt;Para ID="Par34"&gt;Studies of radiofrequency ablation indicate the presence of cavitation is a very important predictor of prognosis [
                    &lt;CitationRef CitationID="CR6"&gt;6&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;]. We found cavitation in approximately 30% of nodules after treatment, which is similar to the 35% reported by Ito et al. [
                    &lt;CitationRef CitationID="CR26"&gt;26&lt;/CitationRef&gt;], but lower than the 53% reported by Chaudhry et al. [
                    &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;]. The spectrum of pulmonary nodules in our study was similar to that of the study by Ito et al., but different from that of Chaudhry et al. who only included patients with stage I non-small cell lung cancer. None of the patients who developed tumor progression had evidence of cavitation, suggesting that cavitation may predict a good clinical outcome. In our study, the ablated zone in approximately 77% of patients without local progression eventually developed streaks and a patch shape, and the other cases remained round or nodule shaped. Chaudhry et al. [
                    &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;] found that shape change in the ablated occurred up to 6&nbsp;months after treatment, and then remains stable to 12&nbsp;months after cryoablation.
                  &lt;/Para&gt;
                  &lt;Para ID="Par35"&gt;While the current study focused on MRI changes, other studies examined CT and PET/CT for the evaluation of nodules post ablation. Abtin et al. [
                    &lt;CitationRef CitationID="CR6"&gt;6&lt;/CitationRef&gt;] examined CT, PET, and dual-modality imaging with combined PET and CT (PET/CT) for their value in identifying partial ablation, tumor recurrence, and progression in lung nodules treated with RFA. The authors divided post ablation into 3 periods: early (up to 1&nbsp;week), intermediate (&amp;gt; 1&nbsp;week to 2&nbsp;months), and late (&amp;gt; 2&nbsp;months). Imaging features that were suggestive of residual or recurrent disease included 1) increasing contrast agent uptake in the ablation zone (&amp;gt;180&nbsp;s on dynamic images), nodular enhancement &amp;gt;10&nbsp;mm, central enhancement &amp;gt;15 HU, and enhancement greater than baseline any time after ablation; 2) growth of the ablation zone after 3&nbsp;months as compared with baseline, peripheral nodular growth, and change from ground-glass opacity to solid opacity; 3) increased metabolic activity beyond 2&nbsp;months, residual activity centrally or at the ablated tumor, and development of nodular activity.
                  &lt;/Para&gt;
                  &lt;Para ID="Par36"&gt;There are limitations to what we consider a preliminary study. The sample size was small, the nodules were extremely heterogeneous, i.e., they were both primary and metastatic cancer and the histological type varied, and because of patients lost to follow-up only data up to 12&nbsp;months could be analyzed. We could not correlate MRI findings with histopathological changes as performing repeat biopsies solely for the purposes of research is not ethical. We did not examine DWI sequence data and ADC values, which have been proven a reliable for the diagnosis of pulmonary nodules [
                    &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR27"&gt;27&lt;/CitationRef&gt;], and evaluation of therapeutic response [
                    &lt;CitationRef CitationID="CR21"&gt;21&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR28"&gt;28&lt;/CitationRef&gt;]. These examinations were not performed because there were artifacts on DWI images at 1&nbsp;day and 1&nbsp;week post-cryoablation, and putting the ROI in the correct place was difficult due to cavity formation. The method of evaluating the effect of cryoablation, tissue changes, and local residual tumor and local tumor progression was subjective, and was based on CT observations of lung tumors and MRI observations of liver tumors, changes to lung tumors that have been cryoablated identified by MRI may not correspond. Positron emission thermography (PET)-CT may have provided greater value and more objective data with respect to examining serial changes in the tumors. However, PET is not generally covered by insurance (only 7 patients in the current study received PET-CT as part of their initial work-up), and our budget did not allow for us to perform the procedure on all patients, and there is the concern of ionizing radiation with repeated CT scanning. We did not compare MRI and CT data, as study has evaluated the value of CT, MRI, and histological examination after cryoablation of renal tumors and concluded that MRI is superior to CT [
                    &lt;CitationRef CitationID="CR29"&gt;29&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec16"&gt;
                  &lt;Heading&gt;Conclusions&lt;/Heading&gt;
                  &lt;Para ID="Par37"&gt;The results of this study showed there are characteristic changes that can be identified on MRI after cryoablation of lung tumors. A complete hypointense rim at 1&nbsp;week and 1&nbsp;month post-cryoablation, and cavitation in the ablation zone at 1&nbsp;month post-cryoablation may be signs of adequate treatment and that local tumor progression is less likely. Though we consider this a preliminary study, the results suggest that MRI may be a good method to follow the results of cryoablation of lung tumors.&lt;/Para&gt;
                &lt;/Section1&gt;
              &lt;/Body&gt;
              &lt;BodyRef FileRef="BodyRef/PDF/40644_2017_Article_131.pdf" PDFType="Typeset" TargetType="OnlinePDF"/&gt;
              &lt;ArticleBackmatter&gt;
                &lt;Acknowledgments&gt;
                  &lt;Heading&gt;Acknowledgements&lt;/Heading&gt;
                  &lt;SimplePara&gt;None&lt;/SimplePara&gt;
                  &lt;FormalPara ID="FPar1" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Funding&lt;/Heading&gt;
                    &lt;Para ID="Par38"&gt;National Natural and Science Fund of China (NO. 81372370).&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar2" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Availability of data and materials&lt;/Heading&gt;
                    &lt;Para ID="Par39"&gt;Not applicable&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Acknowledgments&gt;
                &lt;AuthorContribution&gt;
                  &lt;Heading&gt;Authors’ contributions&lt;/Heading&gt;
                  &lt;SimplePara&gt;JL: manuscript preparation, literature research, and data analysis. JQ: study concepts; definition of intellectual content, literature research, study design, manuscript editing and data analysis. HZ: data acquisition. YW: data acquisition. LZ: clinical studies. XG: clinical studies. YZ: statistical analysis. HL: guarantor of integrity of the entire study, manuscript review, study concepts, definition of intellectual content, literature research, and data analysis. All authors read and approved the final manuscript.&lt;/SimplePara&gt;
                &lt;/AuthorContribution&gt;
                &lt;Ethics&gt;
                  &lt;FormalPara ID="FPar3" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Ethics approval and consent to participate&lt;/Heading&gt;
                    &lt;Para ID="Par40"&gt;The study protocol was approved by Institutional Review Board, and written informed consent was obtained from each participant in accordance with the Declaration of Helsinki.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar4" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Consent for publication&lt;/Heading&gt;
                    &lt;Para ID="Par41"&gt;Not applicable&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar5" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Competing interests&lt;/Heading&gt;
                    &lt;Para ID="Par42"&gt;The authors declare that they have no competing interests.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar6" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Publisher’s Note&lt;/Heading&gt;
                    &lt;Para ID="Par43"&gt;Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Ethics&gt;
                &lt;Appendix ID="App1" OutputMedium="Online"&gt;
                  &lt;Section1 ID="Sec22"&gt;
                    &lt;Heading&gt;Additional file&lt;/Heading&gt;
                    &lt;Para ID="Par57"&gt;
                      &lt;MediaObject ID="MOESM1"&gt;
                        &lt;DataObject FileRef="MediaObjects/40644_2017_131_MOESM1_ESM.docx"&gt;
                          &lt;Caption Language="En"&gt;
                            &lt;CaptionNumber&gt;Additional file 1:&lt;/CaptionNumber&gt;
                            &lt;CaptionContent&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Bold"&gt;Table S1&lt;/Emphasis&gt;. Magnetic resonance sequences and parameters. (DOCX 18 kb)
                              &lt;/SimplePara&gt;
                            &lt;/CaptionContent&gt;
                          &lt;/Caption&gt;
                        &lt;/DataObject&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Para&gt;
                  &lt;/Section1&gt;
                &lt;/Appendix&gt;
                &lt;Bibliography ID="Bib1"&gt;
                  &lt;Heading&gt;References&lt;/Heading&gt;
                  &lt;Citation ID="CR1"&gt;
                    &lt;CitationNumber&gt;1.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tomic&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Podgaetz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Andrade&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dincer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Cryotechnology in diagnosing and treating lung diseases&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Bronchology Interv Pulmonol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;22&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;76&lt;/FirstPage&gt;
                      &lt;LastPage&gt;84&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/LBR.0000000000000103&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25590490&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Tomic R, Podgaetz E, Andrade RS, Dincer HE. Cryotechnology in diagnosing and treating lung diseases. J Bronchology Interv Pulmonol. 2015;22:76–84.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR2"&gt;
                    &lt;CitationNumber&gt;2.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Davidson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nwogu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brentjens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Anderson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2001&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The surgical management of pulmonary metastasis: current concepts&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Surg Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;35&lt;/FirstPage&gt;
                      &lt;LastPage&gt;42&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3Mnntlylsg%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S0960-7404(01)00013-5&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;11719027&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Davidson RS, Nwogu CE, Brentjens MJ, Anderson TM. The surgical management of pulmonary metastasis: current concepts. Surg Oncol. 2001;10:35–42.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR3"&gt;
                    &lt;CitationNumber&gt;3.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yamauchi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Izumi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kawamura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nakatsuka&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yashiro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tsukada&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Inoue&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Asakura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nomori&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Percutaneous cryoablation of pulmonary metastases from colorectal cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;PLoS One&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;6&lt;/VolumeID&gt;
                      &lt;BibArticleNumber&gt;e27086&lt;/BibArticleNumber&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXhsFKhsrfM&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1371/journal.pone.0027086&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22096520&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3212539&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Yamauchi Y, Izumi Y, Kawamura M, Nakatsuka S, Yashiro H, Tsukada N, Inoue M, Asakura K, Nomori H. Percutaneous cryoablation of pulmonary metastases from colorectal cancer. PLoS One. 2011;6:e27086.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR4"&gt;
                    &lt;CitationNumber&gt;4.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Macbeth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Russell&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Treasure&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Cryotherapy for lung metastases: a justifiable procedure?&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;e120&lt;/FirstPage&gt;
                      &lt;LastPage&gt;e121&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/JTO.0000000000000694&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26709487&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Macbeth F, Russell C, Treasure T. Cryotherapy for lung metastases: a justifiable procedure? J Thorac Oncol. 2015;10:e120–1.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR5"&gt;
                    &lt;CitationNumber&gt;5.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kawamura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Izumi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tsukada&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Asakura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sugiura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yashiro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nakano&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nakatsuka&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kuribayashi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kobayashi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2006&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Cardiovasc Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;131&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1007&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1013&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jtcvs.2005.12.051&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16678583&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kawamura M, Izumi Y, Tsukada N, Asakura K, Sugiura H, Yashiro H, Nakano K, Nakatsuka S, Kuribayashi S, Kobayashi K. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg. 2006;131:1007–13.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR6"&gt;
                    &lt;CitationNumber&gt;6.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Abtin FG, Eradat J, Gutierrez AJ, Lee C, Fishbein MC, Suh RD. Radiofrequency ablation of lung tumors: imaging features of the post ablation zone. Radiographics. 2012;32:947–69.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR7"&gt;
                    &lt;CitationNumber&gt;7.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bahn&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Badalament&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kumar&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Greski&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chernick&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2002&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Urology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;60&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;3&lt;/FirstPage&gt;
                      &lt;LastPage&gt;11&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S0090-4295(02)01678-3&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;12206842&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60:3–11.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR8"&gt;
                    &lt;CitationNumber&gt;8.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                        &lt;Suffix&gt;Jr&lt;/Suffix&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mahvi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chosy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Onik&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Littrup&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scanlan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1997&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Hepatic cryosurgery with intraoperative US guidance&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;202&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;624&lt;/FirstPage&gt;
                      &lt;LastPage&gt;632&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1148/radiology.202.3.9051005&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;9051005&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lee FT Jr, Mahvi DM, Chosy SG, Onik GM, Wong WS, Littrup PJ, Scanlan KA. Hepatic cryosurgery with intraoperative US guidance. Radiology. 1997;202:624–32.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR9"&gt;
                    &lt;CitationNumber&gt;9.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Littrup&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Duan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Feng&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Z&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;235&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;289&lt;/FirstPage&gt;
                      &lt;LastPage&gt;298&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1148/radiol.2351030747&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;15798173&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289–98.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR10"&gt;
                    &lt;CitationNumber&gt;10.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Inoue&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nakatsuka&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yashiro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Percutaneous cryoablation of lung tumors: feasibility and safety&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Vasc Interv Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;23&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;295&lt;/FirstPage&gt;
                      &lt;LastPage&gt;302&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jvir.2011.11.019&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22265246&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Inoue M, Nakatsuka S, Yashiro H, et al. Percutaneous cryoablation of lung tumors: feasibility and safety. J Vasc Interv Radiol. 2012;23:295–302.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR11"&gt;
                    &lt;CitationNumber&gt;11.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dupuy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zagoria&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Akerley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mayo-Smith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PV&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kavanagh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Safran&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2000&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Percutaneous radiofrequency ablation of malignancies in the lung&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;AJR Am J Roentgenol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;174&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;57&lt;/FirstPage&gt;
                      &lt;LastPage&gt;59&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3c%2Fpt1Sgtw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2214/ajr.174.1.1740057&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;10628454&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol. 2000;174:57–9.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR12"&gt;
                    &lt;CitationNumber&gt;12.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chaudhry&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grechushkin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoshmand&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pena&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Huston&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chaya&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bilfinger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moore&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Characteristic CT findings after percutaneous cryoablation treatment of malignant lung nodules&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Medicine (Baltimore)&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;94&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;e16&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/MD.0000000000001672&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Chaudhry A, Grechushkin V, Hoshmand M, Kim CW, Pena A, Huston B, Chaya Y, Bilfinger T, Moore W. Characteristic CT findings after percutaneous cryoablation treatment of malignant lung nodules. Medicine (Baltimore). 2015;94:e16.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR13"&gt;
                    &lt;CitationNumber&gt;13.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;NH&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hung&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Huang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Diagnosed chest lesion on diffusion-weighted magnetic resonance images using apparent diffusion coefficients&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Xray Sci Technol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;24&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;133&lt;/FirstPage&gt;
                      &lt;LastPage&gt;143&lt;/LastPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;NH L, Hung CM, Liu KY, Chen TB, Huang YH. Diagnosed chest lesion on diffusion-weighted magnetic resonance images using apparent diffusion coefficients. J Xray Sci Technol. 2016;24:133–43.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR14"&gt;
                    &lt;CitationNumber&gt;14.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Souza CA. MRI of the chest: review of imaging strategies. Radiol Bras. 2015;48(V-VI)&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR15"&gt;
                    &lt;CitationNumber&gt;15.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Onishi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matsushita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Murakami&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2004&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;MR appearances of radiofrequency thermal ablation region: histopathologic correlation with dog liver models and an autopsy case&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Acad Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;11&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1180&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1189&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.acra.2004.06.004&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;15530812&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Onishi H, Matsushita M, Murakami T, et al. MR appearances of radiofrequency thermal ablation region: histopathologic correlation with dog liver models and an autopsy case. Acad Radiol. 2004;11:1180–9.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR16"&gt;
                    &lt;CitationNumber&gt;16.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ren&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lv&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Li&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CMR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Li&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Imaging-guided percutaneous cryotherapy for lung tumors: initial experience&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Vasc Interv Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;25&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1456&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1462&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jvir.2014.04.025&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24985720&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Liu S, Ren R, Liu M, Lv Y, Li B, Li CMR. Imaging-guided percutaneous cryotherapy for lung tumors: initial experience. J Vasc Interv Radiol. 2014;25:1456–62.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR17"&gt;
                    &lt;CitationNumber&gt;17.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SN&lt;/Initials&gt;
                        &lt;FamilyName&gt;Goldberg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gazelle&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Compton&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TC&lt;/Initials&gt;
                        &lt;FamilyName&gt;McLoud&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1995&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Radiofrequency tissue ablation in the rabbit lung: efficacy and complications&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Acad Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;2&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;776&lt;/FirstPage&gt;
                      &lt;LastPage&gt;784&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK1c%2FotV2juw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S1076-6332(05)80852-9&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;9419639&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Goldberg SN, Gazelle GS, Compton CC, McLoud TC. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol. 1995;2:776–84.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR18"&gt;
                    &lt;CitationNumber&gt;18.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Z&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;PLoS One&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;BibArticleNumber&gt;e0123065&lt;/BibArticleNumber&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1371/journal.pone.0123065&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25849963&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4388736&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Rong G, Bai W, Dong Z, et al. Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria. PLoS One. 2015;10:e0123065.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR19"&gt;
                    &lt;CitationNumber&gt;19.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LZ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Niu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Li&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;XKC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Percutaneous&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Cryoablation for liver cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Transl Hepatol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;2&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;182&lt;/FirstPage&gt;
                      &lt;LastPage&gt;188&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26355719&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4521246&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Niu LZ, Li JL, Percutaneous XKC. Cryoablation for liver cancer. J Clin Transl Hepatol. 2014;2:182–8.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR20"&gt;
                    &lt;CitationNumber&gt;20.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Heye&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sommer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Miedinger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bremerich&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bieri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Ultrafast 3D balanced steady-state free precession MRI of the lung: assessment of anatomic details in comparison to low-dose CT&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Magn Reson Imaging&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;42&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;602&lt;/FirstPage&gt;
                      &lt;LastPage&gt;609&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1002/jmri.24836&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25545835&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Heye T, Sommer G, Miedinger D, Bremerich J, Bieri O. Ultrafast 3D balanced steady-state free precession MRI of the lung: assessment of anatomic details in comparison to low-dose CT. J Magn Reson Imaging. 2015;42:602–9.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR21"&gt;
                    &lt;CitationNumber&gt;21.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Park&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Park&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Choi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;AJR Am J Roentgenol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;202&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;92&lt;/FirstPage&gt;
                      &lt;LastPage&gt;101&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2214/AJR.12.10212&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24370133&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Park HJ, Kim SH, Jang KM, Lim S, Kang TW, Park HC, Choi D. Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease. AJR Am J Roentgenol. 2014;202:92–101.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR22"&gt;
                    &lt;CitationNumber&gt;22.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;de Baere&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tselikas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Woodrum&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Abtin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Littrup&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Deschamps&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Suh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Aoun&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Callstrom&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Evaluating cryoablation of metastatic lung tumors in patients--safety and efficacy: the ECLIPSE trial--interim analysis at 1 year&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1468&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1474&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/JTO.0000000000000632&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26230972&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;de Baere T, Tselikas L, Woodrum D, Abtin F, Littrup P, Deschamps F, Suh R, Aoun HD, Callstrom M. Evaluating cryoablation of metastatic lung tumors in patients--safety and efficacy: the ECLIPSE trial--interim analysis at 1 year. J Thorac Oncol. 2015;10:1468–74.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR23"&gt;
                    &lt;CitationNumber&gt;23.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Romaneehsen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Anders&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Röhrl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hengstler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schiffer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Neugebauer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Teichmann&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schreiber&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Thelen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2001&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Cryotherapy of malignant tumors: studies with MRI in an animal experiment and comparison with morphological changes&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Rofo&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;173&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;632&lt;/FirstPage&gt;
                      &lt;LastPage&gt;638&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3MvmvVSktQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1055/s-2001-15832&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;11512236&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Romaneehsen B, Anders M, Röhrl B, Hengstler JG, Schiffer I, Neugebauer B, Teichmann E, Schreiber WG, Thelen M. Cryotherapy of malignant tumors: studies with MRI in an animal experiment and comparison with morphological changes. Rofo. 2001;173:632–8.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR24"&gt;
                    &lt;CitationNumber&gt;24.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dupuy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Thermal ablation of tumours: biological mechanisms and advances in therapy&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Rev Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;199&lt;/FirstPage&gt;
                      &lt;LastPage&gt;208&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXivFamtr0%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nrc3672&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24561446&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR25"&gt;
                    &lt;CitationNumber&gt;25.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Suh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wallace&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sheehan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Heinze&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Goldin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2003&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;229&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;821&lt;/FirstPage&gt;
                      &lt;LastPage&gt;829&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1148/radiol.2293021756&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;14657317&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results. Radiology. 2003;229:821–9.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR26"&gt;
                    &lt;CitationNumber&gt;26.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ito&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nakatsuka&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Inoue&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yashiro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oguro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Izumi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kawamura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nomori&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kuribayashi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Computed tomographic appearance of lung tumors treated with percutaneous cryoablation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Vasc Interv Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;23&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1043&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1052&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jvir.2012.04.033&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22840803&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Ito N, Nakatsuka S, Inoue M, Yashiro H, Oguro S, Izumi Y, Kawamura M, Nomori H, Kuribayashi S. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. J Vasc Interv Radiol. 2012;23:1043–52.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR27"&gt;
                    &lt;CitationNumber&gt;27.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Koyama&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ohno&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Seki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nishio&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yoshikawa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matsumoto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maniwa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Itoh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nishimura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sugimura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Value of diffusion-weighted MR imaging using various parameters for assessment and characterization of solitary pulmonary nodules&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;84&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;509&lt;/FirstPage&gt;
                      &lt;LastPage&gt;515&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.ejrad.2014.11.024&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25554007&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Koyama H, Ohno Y, Seki S, Nishio M, Yoshikawa T, Matsumoto S, Maniwa Y, Itoh T, Nishimura Y, Sugimura K. Value of diffusion-weighted MR imaging using various parameters for assessment and characterization of solitary pulmonary nodules. Eur J Radiol. 2015;84:509–15.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR28"&gt;
                    &lt;CitationNumber&gt;28.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ludwig&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Camacho&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kokabi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xing&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The role of diffusion-weighted imaging (DWI) in locoregional therapy outcome prediction and response assessment for hepatocellular carcinoma (HCC): the new era of functional imaging biomarkers&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Diagnostics (Basel)&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;5&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;546&lt;/FirstPage&gt;
                      &lt;LastPage&gt;563&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3390/diagnostics5040546&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Ludwig JM, Camacho JC, Kokabi N, Xing M, Kim HS. The role of diffusion-weighted imaging (DWI) in locoregional therapy outcome prediction and response assessment for hepatocellular carcinoma (HCC): the new era of functional imaging biomarkers. Diagnostics (Basel). 2015;5:546–63.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR29"&gt;
                    &lt;CitationNumber&gt;29.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nielsen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Ø&lt;/Initials&gt;
                        &lt;FamilyName&gt;Østraat&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Graumann&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pedersen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Andersen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Høyer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Borre&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2017&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Computed tomography perfusion, magnetic resonance imaging, and histopathological findings after laparoscopic renal cryoablation: an in vivo pig model&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Technol Cancer Res Treat&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;406&lt;/FirstPage&gt;
                      &lt;LastPage&gt;413&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1177/1533034616657251&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27402631&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Nielsen TK, Østraat Ø, Graumann O, Pedersen BG, Andersen G, Høyer S, Borre M. Computed tomography perfusion, magnetic resonance imaging, and histopathological findings after laparoscopic renal cryoablation: an in vivo pig model. Technol Cancer Res Treat. 2017;16:406–13.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                &lt;/Bibliography&gt;
              &lt;/ArticleBackmatter&gt;
            &lt;/Article&gt;
          &lt;/Issue&gt;
        &lt;/Volume&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-12-04T14:00:21.38674+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Li, Jing&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Qu, Jinrong&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Zhang, Hongkai&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Wang, Yingshu&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Zheng, Lin&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Geng, Xiang&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Zhao, Yan&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Li, Hailiang&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;the Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital&lt;/meta:OrgName&gt;
            &lt;meta:Country&gt;China&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-01&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-12-01T05:37:15&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1186/s40644-017-0131-7&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;3.0T MRI for long-term observation of lung nodules post cryoablation: a pilot study&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;1470-7330&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;BioMed Central&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;Cancer Imaging&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;Cancer Imaging&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH33160" Priority="1" Type="Secondary"&gt;Oncology&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCB11001" Priority="2" Type="Secondary"&gt;Cancer Research&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH29005" Priority="3" Type="Secondary"&gt;Imaging / Radiology&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH29048" Priority="4" Type="Secondary"&gt;Nuclear Medicine&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:VolumeId&gt;17&lt;/meta:VolumeId&gt;
        &lt;meta:IssueId&gt;1&lt;/meta:IssueId&gt;
        &lt;meta:ArticleSequenceNumber&gt;28&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;Higher Education Press&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;Beijing&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;Higher Education Press, co-published with Springer&lt;/PublisherImprintName&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="All"&gt;
        &lt;JournalInfo JournalProductType="NonStandardArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;13238&lt;/JournalID&gt;
          &lt;JournalDOI&gt;10.1007/13238.1674-8018&lt;/JournalDOI&gt;
          &lt;JournalPrintISSN&gt;1674-800X&lt;/JournalPrintISSN&gt;
          &lt;JournalElectronicISSN&gt;1674-8018&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;Protein &amp;amp; Cell&lt;/JournalTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;Protein Cell&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCL" Type="Primary"&gt;Life Sciences&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCL14005" Priority="1" Type="Secondary"&gt;Biochemistry, general&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCL14040" Priority="2" Type="Secondary"&gt;Protein Science&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCL16008" Priority="3" Type="Secondary"&gt;Cell Biology&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCL16010" Priority="4" Type="Secondary"&gt;Stem Cells&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCB12008" Priority="5" Type="Secondary"&gt;Human Genetics&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCL18000" Priority="6" Type="Secondary"&gt;Developmental Biology&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Biomedical and Life Sciences"&gt;SC3&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;Volume OutputMedium="All"&gt;
          &lt;VolumeInfo TocLevels="0" VolumeType="Regular"&gt;
            &lt;VolumeIDStart&gt;8&lt;/VolumeIDStart&gt;
            &lt;VolumeIDEnd&gt;8&lt;/VolumeIDEnd&gt;
            &lt;VolumeIssueCount&gt;12&lt;/VolumeIssueCount&gt;
          &lt;/VolumeInfo&gt;
          &lt;Issue IssueType="Regular" OutputMedium="All"&gt;
            &lt;IssueInfo IssueType="Regular" TocLevels="0"&gt;
              &lt;IssueIDStart&gt;12&lt;/IssueIDStart&gt;
              &lt;IssueIDEnd&gt;12&lt;/IssueIDEnd&gt;
              &lt;IssueArticleCount&gt;5&lt;/IssueArticleCount&gt;
              &lt;IssueHistory&gt;
                &lt;OnlineDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                  &lt;Day&gt;2&lt;/Day&gt;
                &lt;/OnlineDate&gt;
                &lt;CoverDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                &lt;/CoverDate&gt;
                &lt;PricelistYear&gt;2017&lt;/PricelistYear&gt;
              &lt;/IssueHistory&gt;
              &lt;IssueCopyright&gt;
                &lt;CopyrightHolderName&gt;HEP and Springer-Verlag GmbH Germany, part of Springer Nature&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
              &lt;/IssueCopyright&gt;
            &lt;/IssueInfo&gt;
            &lt;Article ID="s13238-017-0379-5" OutputMedium="All"&gt;
              &lt;ArticleInfo ArticleType="ReviewPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
                &lt;ArticleID&gt;379&lt;/ArticleID&gt;
                &lt;ArticleDOI&gt;10.1007/s13238-017-0379-5&lt;/ArticleDOI&gt;
                &lt;ArticleSequenceNumber&gt;2&lt;/ArticleSequenceNumber&gt;
                &lt;ArticleRelatedObject RelatedObjectType="ErratumFrom"&gt;
                  &lt;RelatedObjectDOI&gt;10.1007/s13238-017-0399-1&lt;/RelatedObjectDOI&gt;
                &lt;/ArticleRelatedObject&gt;
                &lt;ArticleTitle Language="En" OutputMedium="All"&gt;Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung&lt;/ArticleTitle&gt;
                &lt;ArticleCategory&gt;Review&lt;/ArticleCategory&gt;
                &lt;ArticleFirstPage&gt;878&lt;/ArticleFirstPage&gt;
                &lt;ArticleLastPage&gt;895&lt;/ArticleLastPage&gt;
                &lt;ArticleHistory&gt;
                  &lt;RegistrationDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;2&lt;/Month&gt;
                    &lt;Day&gt;9&lt;/Day&gt;
                  &lt;/RegistrationDate&gt;
                  &lt;Received&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;1&lt;/Month&gt;
                    &lt;Day&gt;12&lt;/Day&gt;
                  &lt;/Received&gt;
                  &lt;Accepted&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;2&lt;/Month&gt;
                    &lt;Day&gt;2&lt;/Day&gt;
                  &lt;/Accepted&gt;
                  &lt;OnlineDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;3&lt;/Month&gt;
                    &lt;Day&gt;7&lt;/Day&gt;
                  &lt;/OnlineDate&gt;
                &lt;/ArticleHistory&gt;
                &lt;ChangeHistory&gt;
                  &lt;Change Type="Erratum"&gt;
                    &lt;ChangeDate&gt;
                      &lt;Year&gt;2017&lt;/Year&gt;
                      &lt;Month&gt;4&lt;/Month&gt;
                      &lt;Day&gt;6&lt;/Day&gt;
                    &lt;/ChangeDate&gt;
                    &lt;ChangeDetails&gt;
                      &lt;Para&gt;An erratum to this article has been published.&lt;/Para&gt;
                    &lt;/ChangeDetails&gt;
                  &lt;/Change&gt;
                &lt;/ChangeHistory&gt;
                &lt;ArticleCopyright&gt;
                  &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                  &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                  &lt;License SubType="CC BY" Type="OpenAccess" Version="4.0"&gt;
                    &lt;SimplePara&gt;
                      &lt;Emphasis Type="Bold"&gt;Open Access&lt;/Emphasis&gt;This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;http://creativecommons.org/licenses/by/4.0/&lt;/RefSource&gt;
                        &lt;RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/&gt;
                      &lt;/ExternalRef&gt;), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
                    &lt;/SimplePara&gt;
                  &lt;/License&gt;
                &lt;/ArticleCopyright&gt;
                &lt;ArticleGrants Type="OpenChoice"&gt;
                  &lt;MetadataGrant Grant="OpenAccess"/&gt;
                  &lt;AbstractGrant Grant="OpenAccess"/&gt;
                  &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                  &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                  &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                  &lt;ESMGrant Grant="OpenAccess"/&gt;
                &lt;/ArticleGrants&gt;
              &lt;/ArticleInfo&gt;
              &lt;ArticleHeader&gt;
                &lt;AuthorGroup&gt;
                  &lt;Author AffiliationIDS="Aff1 Aff2" ID="Au1"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Hang&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Cheng&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff3" ID="Au2"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Chengyan&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Jin&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au3"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Jing&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Wu&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au4"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Shan&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Zhu&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1 Aff4" CorrespondingAffiliationID="Aff1" ID="Au5"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Yong-Jun&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;yong-jun.liu@sanofi.com&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au6"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Jingtao&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Chen&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;jtchen@jlu.edu.cn&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Affiliation ID="Aff1"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 1760 5735&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.64924.3d&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Institute of Translational Medicine, The First Hospital&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Jilin University&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Changchun&lt;/City&gt;
                      &lt;Postcode&gt;130061&lt;/Postcode&gt;
                      &lt;Country Code="CN"&gt;China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff2"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 1760 5735&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.64924.3d&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Pediatrics, The First Hospital&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Jilin University&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Changchun&lt;/City&gt;
                      &lt;Postcode&gt;130021&lt;/Postcode&gt;
                      &lt;Country Code="CN"&gt;China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff3"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 1760 5735&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.64924.3d&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Thoracic Surgery, The Second Hospital&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Jilin University&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Changchun&lt;/City&gt;
                      &lt;Postcode&gt;130041&lt;/Postcode&gt;
                      &lt;Country Code="CN"&gt;China&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff4"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 0370 7685&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.34474.30&lt;/OrgID&gt;
                    &lt;OrgName&gt;Sanofi Research and Development&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Cambridge&lt;/City&gt;
                      &lt;State&gt;MA&lt;/State&gt;
                      &lt;Postcode&gt;02139&lt;/Postcode&gt;
                      &lt;Country Code="US"&gt;USA&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                &lt;/AuthorGroup&gt;
                &lt;Abstract ID="Abs1" Language="En" OutputMedium="All"&gt;
                  &lt;Heading&gt;Abstract&lt;/Heading&gt;
                  &lt;Para ID="Par1"&gt;The lung is an important open organ and the primary site of respiration. Many life-threatening diseases develop in the lung, e.g., pneumonia, asthma, chronic obstructive pulmonary diseases (COPDs), pulmonary fibrosis, and lung cancer. In the lung, innate immunity serves as the frontline in both anti-irritant response and anti-tumor defense and is also critical for mucosal homeostasis; thus, it plays an important role in containing these pulmonary diseases. Innate lymphoid cells (ILCs), characterized by their strict tissue residence and distinct function in the mucosa, are attracting increased attention in innate immunity. Upon sensing the danger signals from damaged epithelium, ILCs activate, proliferate, and release numerous cytokines with specific local functions; they also participate in mucosal immune-surveillance, immune-regulation, and homeostasis. However, when their functions become uncontrolled, ILCs can enhance pathological states and induce diseases. In this review, we discuss the physiological and pathological functions of ILC subsets 1 to 3 in the lung, and how the pathogenic environment affects the function and plasticity of ILCs.&lt;/Para&gt;
                &lt;/Abstract&gt;
                &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                  &lt;Heading&gt;Keywords&lt;/Heading&gt;
                  &lt;Keyword&gt;lung&lt;/Keyword&gt;
                  &lt;Keyword&gt;innate lymphoid cells&lt;/Keyword&gt;
                  &lt;Keyword&gt;pulmonary diseases&lt;/Keyword&gt;
                  &lt;Keyword&gt;regional immunity&lt;/Keyword&gt;
                &lt;/KeywordGroup&gt;
                &lt;ArticleNote Type="Misc"&gt;
                  &lt;SimplePara&gt;An erratum to this article is available at 
                    &lt;ExternalRef&gt;
                      &lt;RefSource&gt;https://doi.org/10.1007/s13238-017-0399-1&lt;/RefSource&gt;
                      &lt;RefTarget Address="https://doi.org/10.1007/s13238-017-0399-1" TargetType="URL"/&gt;
                    &lt;/ExternalRef&gt;.
                  &lt;/SimplePara&gt;
                &lt;/ArticleNote&gt;
              &lt;/ArticleHeader&gt;
              &lt;Body&gt;
                &lt;Section1 ID="Sec1"&gt;
                  &lt;Heading&gt;Introduction&lt;/Heading&gt;
                  &lt;Para ID="Par2"&gt;Regional immunity greatly differs from the conventional immune organ or system. Because human diseases are tightly connected with regional immunity, researchers have recently begun to focus on the regional immunity of organs such as the lung, intestine, liver, and skin. The lung is an open organ that is involved in gas conduction and exchange. Approximately 8,000 to 9,000 liters of air are breathed into the lung every day. Compared with the gut and the skin, the lung has a wider surface area, up to 90&nbsp;m
                    &lt;Superscript&gt;2&lt;/Superscript&gt;. A single layer of pulmonary epithelial cells covers the alveoli (Kopf et al., 
                    &lt;CitationRef CitationID="CR76"&gt;2015&lt;/CitationRef&gt;). Because of these characteristics, the lung is constantly exposed to environmental stressors, such as pathogens, allergens, and airborne toxins, e.g., cigarette smoke. In the battle between the mucosal immune cells and the invaders, the innate immune cells are the first line of defense, fortifying the trenches. The innate immune cells in the lung mainly comprise lung-resident macrophages, lung-resident dendritic cells (DCs) (Holt et al., 
                    &lt;CitationRef CitationID="CR53"&gt;2008&lt;/CitationRef&gt;; Kopf et al., 
                    &lt;CitationRef CitationID="CR76"&gt;2015&lt;/CitationRef&gt;), and emerging sets of innate lymphoid cells (ILCs) (Spits and Di Santo, 
                    &lt;CitationRef CitationID="CR123"&gt;2011&lt;/CitationRef&gt;; Spits and Cupedo, 
                    &lt;CitationRef CitationID="CR122"&gt;2012&lt;/CitationRef&gt;; Eberl et al., 
                    &lt;CitationRef CitationID="CR31"&gt;2015&lt;/CitationRef&gt;).
                  &lt;/Para&gt;
                  &lt;Para ID="Par3"&gt;ILCs are important tissue-resident innate immune cells. They are promptly activated by danger signals from injured mucosa and produce an array of effective cytokines to repel pathogens and tumor cells, thereby maintaining mucosal integrity. However, if they are excessively activated, they may cause pathologic tissue damage, e.g., asthma, Crohn’s disease, or psoriasis (Buonocore et al., 
                    &lt;CitationRef CitationID="CR12"&gt;2010&lt;/CitationRef&gt;; Spits and Cupedo, 
                    &lt;CitationRef CitationID="CR122"&gt;2012&lt;/CitationRef&gt;; Spits et al., 
                    &lt;CitationRef CitationID="CR124"&gt;2013&lt;/CitationRef&gt;; Karta et al., 
                    &lt;CitationRef CitationID="CR62"&gt;2016&lt;/CitationRef&gt;). Research into ILCs in the lung is only now in its infancy but it is known that there are three groups of ILCs in the lung, namely ILC1s, ILC2s, and ILC3s. Recently Lai et al. reviewed the origin, development, heterogeneity, and interaction of ILCs with other cells in the lung (Lai et al., 
                    &lt;CitationRef CitationID="CR78"&gt;2016&lt;/CitationRef&gt;), however the roles of ILCs in lung pathologies have not been extensively reviewed, especially with respect to ILC1s and ILC3s. With this in mind, here we describe the general characteristics, functions, and phenotypic plasticity of ILCs, focusing especially on the roles of all three groups of ILCs in diseases of the lung.
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec2"&gt;
                  &lt;Heading&gt;CLASSIFICATION AND GENERAL CHARACTERISTICS OF ILCs&lt;/Heading&gt;
                  &lt;Para ID="Par4"&gt;Lymphoid tissue inducer (LTi) cells and NK cells are prototypic ILCs, which require the common γ chain of the interleukin-2 receptor (IL-2Rγ) and transcriptional repressor inhibitor of DNA binding 2 (Id2) for their development (Kelly and Scollay, 
                    &lt;CitationRef CitationID="CR64"&gt;1992&lt;/CitationRef&gt;; Held et al., 
                    &lt;CitationRef CitationID="CR51"&gt;2011&lt;/CitationRef&gt;; Hesslein and Lanier, 
                    &lt;CitationRef CitationID="CR52"&gt;2011&lt;/CitationRef&gt;). Over the last ten years, numerous cells have been identified whose development is also IL-2Rγ and Id2-dependent; these cells are referred to as “innate lymphoid cells” (ILCs). ILCs have three main characteristics: a lymphoid morphology, the absence of rearranged antigen-specific receptors, and a lack of myeloid dendritic cell phenotypical markers; ILCs also do not express antigen receptors or undergo clonal selection (Spits and Cupedo, 
                    &lt;CitationRef CitationID="CR122"&gt;2012&lt;/CitationRef&gt;; Spits et al., 
                    &lt;CitationRef CitationID="CR124"&gt;2013&lt;/CitationRef&gt;). In 2013, Spits et al. classified the ILCs into three groups according to their cytokine secretion ability, mirroring CD4
                    &lt;Superscript&gt;+&lt;/Superscript&gt; T helper (Th) cells: group 1 ILCs (ILC1s), comprising conventional NK cells and ILCs that produce interferon-γ (IFN-γ); group 2 ILCs (ILC2s), which are ILCs that secrete type 2 cytokines, such as IL-5 and IL-13; and group 3 ILCs (ILC3s), that produce IL-17 and/or IL-22 (Spits and Cupedo, 
                    &lt;CitationRef CitationID="CR122"&gt;2012&lt;/CitationRef&gt;; Spits et al., 
                    &lt;CitationRef CitationID="CR124"&gt;2013&lt;/CitationRef&gt;).
                  &lt;/Para&gt;
                  &lt;Para ID="Par5"&gt;ILCs mirror Th cells but also differ from them. Although ILCs and Th cells both arise from a common lymphoid progenitor (CLP), the development of ILCs is unique. It is generally believed that ILCs initially develop in fetal liver, whereas after birth they develop in the bone marrow (Vosshenrich et al., 
                    &lt;CitationRef CitationID="CR138"&gt;2005&lt;/CitationRef&gt;; Sawa et al., 
                    &lt;CitationRef CitationID="CR115"&gt;2010&lt;/CitationRef&gt;; Klose et al., 
                    &lt;CitationRef CitationID="CR74"&gt;2014&lt;/CitationRef&gt;), and are then subsequently recruited into other tissues (Eberl et al., 
                    &lt;CitationRef CitationID="CR31"&gt;2015&lt;/CitationRef&gt;; Gasteiger et al., 
                    &lt;CitationRef CitationID="CR39"&gt;2015&lt;/CitationRef&gt;). Migration into tissues is likely mediated by the co-ordinated action of adhesion molecules and chemokines (Eberl et al., 
                    &lt;CitationRef CitationID="CR31"&gt;2015&lt;/CitationRef&gt;). Interestingly, some researchers found that ILC progenitors seed themselves in tissues in the embryonic and adult phases, and in these tissue micro-environments they undergo development and differentiation (Montaldo et al., 
                    &lt;CitationRef CitationID="CR99"&gt;2014&lt;/CitationRef&gt;; Bando et al., 
                    &lt;CitationRef CitationID="CR3"&gt;2015&lt;/CitationRef&gt;). It should be noted that, in contrast to Th cells, ILCs remain tissue-resident; they are maintained locally in one organ and do not re-enter the circulation or migrate to other organs (Gasteiger et al., 
                    &lt;CitationRef CitationID="CR39"&gt;2015&lt;/CitationRef&gt;; Fan and Rudensky, 
                    &lt;CitationRef CitationID="CR34"&gt;2016&lt;/CitationRef&gt;). Following acute environmental challenges tissue-resident ILCs expand locally and in this way the pool of cells is renewed, although phenotypic transformation can also occur. Hematogenously derived ILC precursors or mature ILCs can also partially supply the local tissue ILC pool (Gasteiger et al., 
                    &lt;CitationRef CitationID="CR39"&gt;2015&lt;/CitationRef&gt;). In addition, ILCs lack recombination-activating gene (RAG), meaning that unlike B and T cells, ILCs can be activated directly (Spits and Cupedo, 
                    &lt;CitationRef CitationID="CR122"&gt;2012&lt;/CitationRef&gt;; Spits et al., 
                    &lt;CitationRef CitationID="CR124"&gt;2013&lt;/CitationRef&gt;). When the mucosa is invaded by pathogens, allergens, or tumor cells, damaged epithelial cells secrete cytokines to directly stimulate ILCs. ILCs then become promptly activated, proliferate, and produce copious amounts of cytokines to repel the invaders and maintain mucosal homeostasis; this response, however, may also lead to pathological damage (Spits and Di Santo, 
                    &lt;CitationRef CitationID="CR123"&gt;2011&lt;/CitationRef&gt;; Scanlon and McKenzie, 
                    &lt;CitationRef CitationID="CR116"&gt;2012&lt;/CitationRef&gt;; Philip and Artis, 
                    &lt;CitationRef CitationID="CR108"&gt;2013&lt;/CitationRef&gt;; Salimi and Ogg, 
                    &lt;CitationRef CitationID="CR113"&gt;2014&lt;/CitationRef&gt;). Thus, ILCs become activated by sensing danger signals from the tissue milieu rather than by antigen presentation with antigen-presenting cells (APCs) (Drake and Kita, 
                    &lt;CitationRef CitationID="CR26"&gt;2014&lt;/CitationRef&gt;; Eberl et al., 
                    &lt;CitationRef CitationID="CR31"&gt;2015&lt;/CitationRef&gt;). Compared with the few days or weeks required by Th cells (Hansen et al., 
                    &lt;CitationRef CitationID="CR50"&gt;1999&lt;/CitationRef&gt;), ILCs can therefore be activated more quickly (Spits and Cupedo, 
                    &lt;CitationRef CitationID="CR122"&gt;2012&lt;/CitationRef&gt;; Fan and Rudensky, 
                    &lt;CitationRef CitationID="CR34"&gt;2016&lt;/CitationRef&gt;) (Table&nbsp;
                    &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;).
                    &lt;Table Float="Yes" ID="Tab1"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Table&nbsp;1&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;Comparison of ILC and Th cell characteristics&lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;tgroup cols="3"&gt;
                        &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                        &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                        &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                        &lt;thead&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"/&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;ILCs&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;TH cells&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/thead&gt;
                        &lt;tbody&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;TF&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;ILC1s: T-bet&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;ILC2s: Gata3&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;ILC3s: RORγt&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Th1: T-bet&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Th2: Gata3&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Th17: RORγt&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Principal effector cytokines&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;ILC1s: IFN-γ&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;ILC2s: IL-3, IL-4, IL-9, IL-13&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;ILC3s: IL-17, IL-22&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Th1: IFN-γ&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Th2: IL-3, IL-4, IL-9, IL-13&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Th17: IL-17, IL-22&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Genesis&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;CLP&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;CLP&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Innate/Adaptive system&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;Innate immune cells&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Adaptive immune cells&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;RAG&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;Absent&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Present&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Response time&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;Hours~days&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Days~weeks&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Activated pathway&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;APC-independent&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Directly activated&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;APC-dependent&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Indirectly activated&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Tissue residency&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;Yes&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;No&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Extension/Activation&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;Tissue&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Lymph node&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Recruitment (Back to circulation)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;Seldom&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Frequently&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Memory-property&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;Antigen non-specific memory-property&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Antigen specific memory-property&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/tbody&gt;
                      &lt;/tgroup&gt;
                      &lt;tfooter&gt;
                        &lt;SimplePara&gt;APC, antigen-presenting cell; CLP, common lymphoid progenitor; ILCs, innate lymphoid cells; SLO, secondary lymph organ; TF, transcription factor&lt;/SimplePara&gt;
                      &lt;/tfooter&gt;
                    &lt;/Table&gt;
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec3"&gt;
                  &lt;Heading&gt;ILC plasticity&lt;/Heading&gt;
                  &lt;Para ID="Par6"&gt;The phenotype of ILCs is not stable; these cells are highly plastic and can change phenotypes under the influence of the environment. IL-2 and IL-12 drive human natural cytotoxicity receptor (NCR)-positive ILC3s (NCR
                    &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s) to transform into ILC1s (Cella et al., 
                    &lt;CitationRef CitationID="CR15"&gt;2010&lt;/CitationRef&gt;; Bernink et al., 
                    &lt;CitationRef CitationID="CR9"&gt;2013&lt;/CitationRef&gt;; Bernink et al., 
                    &lt;CitationRef CitationID="CR10"&gt;2015&lt;/CitationRef&gt;). In response to the tissue environment 
                    &lt;Emphasis Type="Italic"&gt;in vivo&lt;/Emphasis&gt;, ILC3s down-regulate the expression of RORγt (retinoic acid receptor-related orphan receptor γt) and produce IFN-γ (Vonarbourg et al., 
                    &lt;CitationRef CitationID="CR136"&gt;2010a&lt;/CitationRef&gt;). IL-1β and IL-12 induce ILC2s to express T-bet and to produce IFN-γ while down-regulating ST2 and GATA3, and losing the ability to produce IL-5 and IL-13 (Bal et al., 
                    &lt;CitationRef CitationID="CR2"&gt;2016&lt;/CitationRef&gt;; Kim et al., 
                    &lt;CitationRef CitationID="CR69"&gt;2016&lt;/CitationRef&gt;; Lim et al., 
                    &lt;CitationRef CitationID="CR82"&gt;2016&lt;/CitationRef&gt;). IL-23 and IL-1β cause CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt; ILC1s to differentiate into IL-22-producing ILC3s (Bernink et al., 
                    &lt;CitationRef CitationID="CR10"&gt;2015&lt;/CitationRef&gt;). Enhanced GATA3 expression by ILC1s results in their conversion to ILC2s with the capacity to produce greater amounts of type 2 cytokines (Mjosberg et al., 
                    &lt;CitationRef CitationID="CR97"&gt;2012&lt;/CitationRef&gt;; KleinJan et al., 
                    &lt;CitationRef CitationID="CR72"&gt;2014&lt;/CitationRef&gt;). Such plasticity occurs not only between ILC groups, but also between ILC subgroups. For example, mouse NKp46
                    &lt;Superscript&gt;−&lt;/Superscript&gt;RORγt
                    &lt;Superscript&gt;+&lt;/Superscript&gt; LTi-like cells may transform into NKp46
                    &lt;Superscript&gt;+&lt;/Superscript&gt;RORγt
                    &lt;Superscript&gt;+&lt;/Superscript&gt; cells either 
                    &lt;Emphasis Type="Italic"&gt;in vivo&lt;/Emphasis&gt; or 
                    &lt;Emphasis Type="Italic"&gt;in vitro&lt;/Emphasis&gt; (Vonarbourg et al., 
                    &lt;CitationRef CitationID="CR136"&gt;2010a&lt;/CitationRef&gt;; Klose et al., 
                    &lt;CitationRef CitationID="CR73"&gt;2013&lt;/CitationRef&gt;; Rankin et al., 
                    &lt;CitationRef CitationID="CR110"&gt;2013&lt;/CitationRef&gt;; Rankin et al., 
                    &lt;CitationRef CitationID="CR111"&gt;2016&lt;/CitationRef&gt;). Human NKp44
                    &lt;Superscript&gt;−&lt;/Superscript&gt;ILC3s undergo a profound shift toward NKp44
                    &lt;Superscript&gt;+&lt;/Superscript&gt; ILC3s upon culture in the presence of IL-2, IL-1β, and IL-23, and they display pro-inflammatory properties (Bernink et al., 
                    &lt;CitationRef CitationID="CR9"&gt;2013&lt;/CitationRef&gt;; Glatzer et al., 
                    &lt;CitationRef CitationID="CR42"&gt;2013&lt;/CitationRef&gt;). Plasticity is one of the important characteristics of ILCs, and this property is especially important in the lung; the shift of ILC2s to ILC3s and the plasticity within ILC2 subgroups will be discussed below in detail (Table&nbsp;
                    &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt;) (Fig.&nbsp;
                    &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt;).
                    &lt;Table Float="Yes" ID="Tab2"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Table&nbsp;2&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;Characteristics of lung ILCs&lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;tgroup cols="4"&gt;
                        &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                        &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                        &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                        &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                        &lt;thead&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"/&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;ILC1s&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;ILC2s&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;ILC3s&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/thead&gt;
                        &lt;tbody&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Development-dependent TF&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;T-bet&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Gata3, RORα, EST1,&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Bcl11b, G9a, Gfi1&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;RORγt&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Surface marker (Human)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;CD127
                                &lt;Superscript&gt;high&lt;/Superscript&gt;ILC1s:
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Lin
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD127
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD117
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;NKp44
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD25
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD103
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CCR6
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD127
                                &lt;Superscript&gt;low&lt;/Superscript&gt;ILC1s:
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Lin
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD127
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;NKp44
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;NKp46
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD103
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Lin
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD127
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CRTH2
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD117
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD161
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD25
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;ICOS
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;ST2
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;Lin
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD127
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD117
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD161
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD25
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;NKp44
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;NKp46
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;NKp30
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD56
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CCR6
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CXCR5
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Surface marker (Mouse)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;Lin
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD90
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;IL-12R2
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;IL-18Rα
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Lin
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD90
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD127
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;ST2
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Sca-1
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;KLRG1
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD25
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;IL-7RB
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD44
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;IL-9R
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;Lin
                                &lt;Superscript&gt;−&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD90
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD127
                                &lt;Superscript&gt;+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;NKp46
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;NKp30
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CD56
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CCR6
                                &lt;Superscript&gt;−/+&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Active factors&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;IL-12, IL-18&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;IL-25, IL-33, TSLP, PGD
                                &lt;Subscript&gt;2&lt;/Subscript&gt;, TGF-β, Spred1, Arginase 1,
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;TL1A, RAGE, SP-D, IRF4&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;CysLT1, IL-1β&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;IL-1β, IL-23&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Inhibitory factors&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;IFN-γ, IL-27, Lipoxin4&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Corticosteroid, TSA, PGI
                                &lt;Subscript&gt;2&lt;/Subscript&gt;, HES
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Effective cytokines&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;IFN-γ&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;IL-4, IL-5, IL-6, IL-13, IL-9&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;IL-17, IL-22, TNF-α, IL-8, IL-2,&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;GM-CSF, lymphotoxin&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/tbody&gt;
                      &lt;/tgroup&gt;
                      &lt;tfooter&gt;
                        &lt;SimplePara&gt;NCR, natural cytotoxicity receptor; TF, transcription factor; Bcl11b, B cell leukemia/lymphoma 11b; Gfi1, growth&nbsp;factor independence-1; Lin, lineage; G9a, lysine methyltransferase G9a; HES, 
                          &lt;Emphasis Type="Italic"&gt;Heligmosomoides polygyrus&lt;/Emphasis&gt; excretory/secretory products; TSLP, thymic stromal lymphopoietin; PGD
                          &lt;Subscript&gt;2&lt;/Subscript&gt;, prostaglandin D
                          &lt;Subscript&gt;2&lt;/Subscript&gt;; TL1A, tumor necrosis factor like cytokine 1A; RAGE, receptor for advanced glycation end-products; SP-D, surfactant protein D; IRF4, interferon regulatory factor 4; TSA, trichostatin A; PGI
                          &lt;Subscript&gt;2&lt;/Subscript&gt;, prostaglandin I
                          &lt;Subscript&gt;2&lt;/Subscript&gt;; CysLT1, cysteinyl leukotriene receptor 1
                        &lt;/SimplePara&gt;
                      &lt;/tfooter&gt;
                    &lt;/Table&gt;
                    &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Figure&nbsp;1&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;
                            &lt;Emphasis Type="Bold"&gt;ILC plasticity&lt;/Emphasis&gt;. ILCs recruit into the lung and become resident in the mucous epithelium. When the tissue is exposed to danger signals elicited by pathogens, allergens or tumor cells, the epithelium or other innate immune cells produce many cytokines. In response to these cytokines, ILCs may alter their phenotype to respond to the environment. IL-2 and IL-12 drive the transformation of ILC3s to ILC1s. ILC1s convert to ILC3s under the influence of IL-1β and IL-23; ILC2s also transform to ILC1s when cultured with IL-12 and IL-1β. Upon increased GATA3 expression, ILC1s gain ILC2s characteristics; when cultured with TGF-β and IL-6, ILC2s become ILC3-like. Whether ILC3s convert into ILC2s is still unclear. In the ILC2 and ILC3 sub-groups, iILC2 cells give rise to cells with nILC2 phenotype when cultured in the presence of IL-2, IL-7, IL-25, and IL-33 
                            &lt;Emphasis Type="Italic"&gt;in vitro&lt;/Emphasis&gt; or 
                            &lt;Emphasis Type="Italic"&gt;in vivo&lt;/Emphasis&gt;. Under the influence of IL-2, IL-1β, and IL-23, NCR
                            &lt;Superscript&gt;−&lt;/Superscript&gt;ILC3s express NCR
                            &lt;Superscript&gt;+&lt;/Superscript&gt;. The hypothesis that nILC2s convert to iILC2s and NCR
                            &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s convert to NCR
                            &lt;Superscript&gt;−&lt;/Superscript&gt;ILC3s should be confirmed in the future. See text for details
                          &lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;MediaObject ID="MO1"&gt;
                        &lt;ImageObject Color="Color" FileRef="MediaObjects/13238_2017_379_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Figure&gt;
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec4"&gt;
                  &lt;Heading&gt;Identification and characterization of ILC1s&lt;/Heading&gt;
                  &lt;Para ID="Par7"&gt;Compared with the other ILC groups, ILC1s are the least studied. Their characteristics are not yet well defined, and indeed there is even still debate concerning their classification. As of now, the ILCs nomenclature introduced by Spits et al. (
                    &lt;CitationRef CitationID="CR124"&gt;2013&lt;/CitationRef&gt;) is widely accepted, with NK cells and ILC1s belonging to group 1 ILCs. Group 1 ILCs are defined by their ability to produce IFN-γ and inability to produce IL-4, IL-13, IL-22, and IL-17. They require transcription factor T-bet for their development (Spits et al., 
                    &lt;CitationRef CitationID="CR124"&gt;2013&lt;/CitationRef&gt;). NK cells have been reviewed elsewhere, and therefore we will only focus on ILC1s in this review.
                  &lt;/Para&gt;
                  &lt;Para ID="Par8"&gt;The original report concerning mouse ILC1s described them as RORγt
                    &lt;Superscript&gt;−&lt;/Superscript&gt;NKR
                    &lt;Superscript&gt;−&lt;/Superscript&gt;LTi, capable of releasing IFN-γ, and as being potent inducers of experimental colitis (Vonarbourg et al., 
                    &lt;CitationRef CitationID="CR137"&gt;2010b&lt;/CitationRef&gt;). Another group of mouse ILC1s was then described as NKp46
                    &lt;Superscript&gt;+&lt;/Superscript&gt;NKp1.1
                    &lt;Superscript&gt;+&lt;/Superscript&gt;Eomes
                    &lt;Superscript&gt;−&lt;/Superscript&gt;T-bet
                    &lt;Superscript&gt;+&lt;/Superscript&gt;, with the ability to produce IFN-γ (Klose et al., 
                    &lt;CitationRef CitationID="CR74"&gt;2014&lt;/CitationRef&gt;). In humans, ILC1s can be divided into CD127
                    &lt;Superscript&gt;low&lt;/Superscript&gt; ILC1s and CD127
                    &lt;Superscript&gt;high&lt;/Superscript&gt; ILC1s, based on the expression of CD127. CD127
                    &lt;Superscript&gt;low&lt;/Superscript&gt; ILC1s are defined as CD3
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD56
                    &lt;Superscript&gt;+&lt;/Superscript&gt;NKp44
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD103
                    &lt;Superscript&gt;+&lt;/Superscript&gt; and CD3
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD56
                    &lt;Superscript&gt;+&lt;/Superscript&gt;NKp44
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD103
                    &lt;Superscript&gt;−&lt;/Superscript&gt;; the former have an intraepithelial localization (Fuchs et al., 
                    &lt;CitationRef CitationID="CR37"&gt;2013&lt;/CitationRef&gt;). CD127
                    &lt;Superscript&gt;high&lt;/Superscript&gt; ILC1s were first identified in human tonsil and intestine, and they are defined as Lineage (Lin)
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CRTH2
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD117
                    &lt;Superscript&gt;−&lt;/Superscript&gt;NKp44
                    &lt;Superscript&gt;−&lt;/Superscript&gt; (Bernink et al., 
                    &lt;CitationRef CitationID="CR9"&gt;2013&lt;/CitationRef&gt;). Although the markers that define ILC1s in mouse and human are somewhat different, the two are generally defined as lineage negative, T-bet positive, and both are capable of producing IFN-γ.
                  &lt;/Para&gt;
                  &lt;Para ID="Par9"&gt;CD127
                    &lt;Superscript&gt;high&lt;/Superscript&gt; and CD127
                    &lt;Superscript&gt;low&lt;/Superscript&gt; ILC1s have also been identified in the human lung. CD127
                    &lt;Superscript&gt;high&lt;/Superscript&gt; ILC1s are identified as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD117
                    &lt;Superscript&gt;−&lt;/Superscript&gt;NKp44
                    &lt;Superscript&gt;−&lt;/Superscript&gt;; they express T-bet but do not express C-C motif chemokine receptor 6 (CCR6), CD103, or CD25. CD127
                    &lt;Superscript&gt;low&lt;/Superscript&gt; ILC1s are defined as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;−&lt;/Superscript&gt;NKp46
                    &lt;Superscript&gt;+&lt;/Superscript&gt;, and express T-bet. Similar to CD127
                    &lt;Superscript&gt;high&lt;/Superscript&gt; ILC1s in the tonsil and the intestine, most Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;−&lt;/Superscript&gt;NKp46
                    &lt;Superscript&gt;+&lt;/Superscript&gt;NKp44
                    &lt;Superscript&gt;+&lt;/Superscript&gt;cells express CD103 (Carrega et al., 
                    &lt;CitationRef CitationID="CR13"&gt;2015&lt;/CitationRef&gt;). Another group identified non-toxic ILC1s in the human lung was Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD56
                    &lt;Superscript&gt;−&lt;/Superscript&gt;IL12Rβ2
                    &lt;Superscript&gt;+&lt;/Superscript&gt; (De Grove et al., 
                    &lt;CitationRef CitationID="CR20"&gt;2016&lt;/CitationRef&gt;). In mouse lung, ILC1s are defined by the Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD90
                    &lt;Superscript&gt;+&lt;/Superscript&gt;T-bet
                    &lt;Superscript&gt;+&lt;/Superscript&gt; phenotype, and they express IL-12Rβ2 and IL-18Rα; furthermore, IL-12 and IL-18 enhance ILC1 expansion 
                    &lt;Emphasis Type="Italic"&gt;in vivo&lt;/Emphasis&gt;, and they produce copious amounts of IFN-γ (Silver et al., 
                    &lt;CitationRef CitationID="CR118"&gt;2016a&lt;/CitationRef&gt;) (Table&nbsp;
                    &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt;).
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec5"&gt;
                  &lt;Heading&gt;ILC1s in the lung&lt;/Heading&gt;
                  &lt;Section2 ID="Sec6"&gt;
                    &lt;Heading&gt;ILC1s and infection&lt;/Heading&gt;
                    &lt;Para ID="Par10"&gt;ILC1s produce large amounts of IFN-γ and protect the organism against pathogens as first reported in mouse models of intracellular infection, e.g., infections caused by the parasite 
                      &lt;Emphasis Type="Italic"&gt;Toxoplasma gondii&lt;/Emphasis&gt; and by 
                      &lt;Emphasis Type="Italic"&gt;Clostridium difficile&lt;/Emphasis&gt; in the intestine (Klose et al., 
                      &lt;CitationRef CitationID="CR74"&gt;2014&lt;/CitationRef&gt;; Abt et al., 
                      &lt;CitationRef CitationID="CR1"&gt;2015&lt;/CitationRef&gt;). Silver et al. (
                      &lt;CitationRef CitationID="CR118"&gt;2016a&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR119"&gt;b&lt;/CitationRef&gt;) found that during lung infection in mice caused by either influenza A, 
                      &lt;Emphasis Type="Italic"&gt;Haemophilus influenzae&lt;/Emphasis&gt;, respiratory syncytial virus (RSV), or 
                      &lt;Emphasis Type="Italic"&gt;Staphylococcus aureus&lt;/Emphasis&gt;, GATA3 expression in the resident ILC2s was rapidly down-regulated (within two days after infection), and this was accompanied by decreased expression of ST2, CD25 (IL-2Rα), IL-7Rα, inducible costimulator (ICOS), and the stem cell factor receptor c-kit (CD117). Meanwhile, the T-bet
                      &lt;Superscript&gt;+&lt;/Superscript&gt; ILC1 number in the lung increased and the expression of IL-12 and IL-18 receptors (IL-12Rβ2 and IL-18Rα) in ILC1s was up-regulated. The down-regulation of GATA3 expression was negatively correlated with IL-18Rα up-regulation. These results indicate that during infection of the lung, ILC2s may lose their properties and phenotypically convert into ILC1s. To confirm these findings, Silver et al. used a reporter mouse that expressed ST2 labeled with green fluorescent protein (GFP), they found that upon stimulation with IL-12, IL-18, and IL-33, the number of IL-18Rα
                      &lt;Superscript&gt;+&lt;/Superscript&gt; ILC1 cells increased, and 50% of these cells expressed ST2-GFP. Collectively, these data suggest that lung ILC1s are derived from ILC2s that are resident in the lung rather than from ILC1 proliferation.
                    &lt;/Para&gt;
                    &lt;Para ID="Par11"&gt;In the same study, GFP
                      &lt;Superscript&gt;+&lt;/Superscript&gt; ILC2s (GFP-labeled ILC2s) were transferred to 
                      &lt;Emphasis Type="Italic"&gt;Rag2&lt;/Emphasis&gt;
                      &lt;Superscript&gt;−/−&lt;/Superscript&gt;/
                      &lt;Emphasis Type="Italic"&gt;Il2rg&lt;/Emphasis&gt;
                      &lt;Superscript&gt;−/−&lt;/Superscript&gt; mice with mature lymphocyte deficiency, and then the mice were infected with influenza A virus. GFP
                      &lt;Superscript&gt;+&lt;/Superscript&gt; ILC2s infiltrated into the lungs of host mice 7&nbsp;d after infection. GATA3 expression in these cells was significantly down-regulated and accompanied by a striking up-regulation of both IL-18Rα and IL-12Rβ2 expression. Double IHC (immunohistochemistry) revealed that ILCs were localized to the influenza virus-infected airways. IHC combined with hybridization 
                      &lt;Emphasis Type="Italic"&gt;in situ&lt;/Emphasis&gt; revealed that 
                      &lt;Emphasis Type="Italic"&gt;Il-12&lt;/Emphasis&gt; and 
                      &lt;Emphasis Type="Italic"&gt;Il-18&lt;/Emphasis&gt; mRNAs produced by myeloid-derived cells were present near GFP
                      &lt;Superscript&gt;+&lt;/Superscript&gt; ILC2s in the inflamed region. GATA3
                      &lt;Superscript&gt;high&lt;/Superscript&gt;ILCs were predominantly localized in uninfected tissue regions, whereas GATA3
                      &lt;Superscript&gt;low&lt;/Superscript&gt; ILCs were enriched in virus-associated areas (Silver et al., 
                      &lt;CitationRef CitationID="CR118"&gt;2016a&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par12"&gt;In summary, these data demonstrate that during infection, ILC2s migrate to the inflamed regions, where the myeloid-derived pro-inflammatory cytokines IL-12 and IL-18 drive ILC2 conversion into ILC1s, enabling their participation in the anti-pathogen response (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig2"&gt;2&lt;/InternalRef&gt;).
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig2"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Figure&nbsp;2&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;
                              &lt;Emphasis Type="Bold"&gt;ILC1 functions in the lung&lt;/Emphasis&gt;. When pathogens, such as viruses or bacteria, or tumor cells invade the airway epithelium, the myeloid cells receive danger signals from the epithelium and produce IL-12 and IL-18. These pro-inflammatory cytokines down-regulate GATA3 expression of ILC2s and then drive the conversion of ILC2s into ILC1s. IL-12 and IL-18 also enhance the activation and expansion of ILC1s. After activation, ILC1s produce copious amounts of IFN-γ. IFN-γ plays potentially important roles in clearing both pathogens and tumors, and also in the development of chronic obstructive pulmonary disease (COPD). See text for details
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO2"&gt;
                          &lt;ImageObject Color="Color" FileRef="MediaObjects/13238_2017_379_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec7"&gt;
                    &lt;Heading&gt;ILC1s and chronic obstructive pulmonary disease (COPD)&lt;/Heading&gt;
                    &lt;Para ID="Par13"&gt;COPD is widely regarded as a heterogeneous disease associated with increased numbers of alveolar macrophages, T lymphocytes (predominantly Tc1, Th1, and Th17 cells), B lymphocytes, and neutrophils (Barnes, 
                      &lt;CitationRef CitationID="CR5"&gt;2009&lt;/CitationRef&gt;; Kearley et al., 
                      &lt;CitationRef CitationID="CR63"&gt;2015&lt;/CitationRef&gt;). Recently, two groups almost simultaneously reported a relationship between ILC1s and COPD (Bal et al., 
                      &lt;CitationRef CitationID="CR2"&gt;2016&lt;/CitationRef&gt;; Silver et al., 
                      &lt;CitationRef CitationID="CR118"&gt;2016a&lt;/CitationRef&gt;). The percentage of ILC1s is much higher in patients with COPD than in healthy controls, and is accompanied by a lower occurrence of ILC2s, either in the lung or in the circulation (Bal et al., 
                      &lt;CitationRef CitationID="CR2"&gt;2016&lt;/CitationRef&gt;; Silver et al., 
                      &lt;CitationRef CitationID="CR118"&gt;2016a&lt;/CitationRef&gt;). According to the classification of the Global Initiative for Chronic Obstructive Lung Disease (GOLD), ILC1s occur more frequently in severe COPD (GOLD III–IV) than in milder COPD (GOLD I–II). A strong negative correlation exists between the occurrence of ILC1s in the blood and lung function, with a higher proportion of ILC1s associated with worse lung function. The numbers of circulating ILC1s are higher in patients with two or more exacerbations of COPD per year than in patients with one exacerbation per year (Bal et al., 
                      &lt;CitationRef CitationID="CR2"&gt;2016&lt;/CitationRef&gt;; Silver et al., 
                      &lt;CitationRef CitationID="CR118"&gt;2016a&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par14"&gt;The development and exacerbation of COPD are associated with cigarette smoke and viral and bacterial infection. Silver et al. (
                      &lt;CitationRef CitationID="CR118"&gt;2016a&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR119"&gt;b&lt;/CitationRef&gt;) reported that the occurrence of GATA3
                      &lt;Superscript&gt;+&lt;/Superscript&gt; ILC2s declines promptly and that the fraction of T-bet
                      &lt;Superscript&gt;+&lt;/Superscript&gt;IL-18Rα
                      &lt;Superscript&gt;+&lt;/Superscript&gt; ILC1s is increased in response to cigarette smoke or viral and bacterial infections in mouse models (Silver et al., 
                      &lt;CitationRef CitationID="CR119"&gt;2016b&lt;/CitationRef&gt;). When ILC2s from human fetal lung are cultured with IL-2, IL-1β, and IL-12, CRTH2 and c-kit in ILC2s are down-regulated, and the cells produce IFN-γ but not IL-5. These results indicate that ILC2s have the potential to transform into ILC1s when exposed to a type 1 inflammatory environment, such as cigarette smoke or infection, and participate in the development of COPD (Bal et al., 
                      &lt;CitationRef CitationID="CR2"&gt;2016&lt;/CitationRef&gt;) (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig2"&gt;2&lt;/InternalRef&gt;).
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec8"&gt;
                    &lt;Heading&gt;ILC1s and tumors&lt;/Heading&gt;
                    &lt;Para ID="Par15"&gt;Recently, Dadi et al. (
                      &lt;CitationRef CitationID="CR19"&gt;2016&lt;/CitationRef&gt;) discovered that unconventional type 1-like innate lymphoid cells and type 1&nbsp;innate-like&nbsp;T&nbsp;cells play a role in tumor-elicited&nbsp;immune surveillance in murine cancer models (Dadi et al., 
                      &lt;CitationRef CitationID="CR19"&gt;2016&lt;/CitationRef&gt;). This suggests that ILC1s may possess an anti-tumor function; however, no data on the function of ILC1s in lung tumors are available, and future studies should thus be performed to further elucidate this issue.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec9"&gt;
                  &lt;Heading&gt;Identification and characterization of ILC2s&lt;/Heading&gt;
                  &lt;Para ID="Par16"&gt;In 2001, Fort et al. were the first to report that non-T/non-B T 
                    &lt;Emphasis Type="Italic"&gt;cells in Rag2&lt;/Emphasis&gt;
                    &lt;Superscript&gt;−/−&lt;/Superscript&gt;mice could produce IL-5 and IL-13, leading to a type 2 response (Fort et al., 
                    &lt;CitationRef CitationID="CR36"&gt;2001&lt;/CitationRef&gt;). Ten years later, these cells were observed by different researchers and were differently named as nuocytes, natural helper cells, or innate helper type 2 cells (Moro et al., 
                    &lt;CitationRef CitationID="CR103"&gt;2010&lt;/CitationRef&gt;; Neill et al., 
                    &lt;CitationRef CitationID="CR106"&gt;2010&lt;/CitationRef&gt;; Price et al., 
                    &lt;CitationRef CitationID="CR109"&gt;2010&lt;/CitationRef&gt;). These three groups of cells share similar molecular surface markers and function, and finally they were collectively named as group 2 innate lymphoid cells. In addition to Id2 and IL-2Rγ, the development and function of ILC2s depend on GATA3, Notch, and RORα (Halim et al., 
                    &lt;CitationRef CitationID="CR46"&gt;2012b&lt;/CitationRef&gt;; Mjosberg et al., 
                    &lt;CitationRef CitationID="CR97"&gt;2012&lt;/CitationRef&gt;; Gentek et al., 
                    &lt;CitationRef CitationID="CR40"&gt;2013&lt;/CitationRef&gt;). Growth&nbsp;factor independence-1 (Gfi1), B cell leukemia/lymphoma 11b (Bcl11b), lysine methyltransferase G9a, and ETS1 are also essential for the development of ILC2s (Spooner et al., 
                    &lt;CitationRef CitationID="CR125"&gt;2013&lt;/CitationRef&gt;; Walker et al., 
                    &lt;CitationRef CitationID="CR139"&gt;2015&lt;/CitationRef&gt;; Yu et al., 
                    &lt;CitationRef CitationID="CR150"&gt;2015&lt;/CitationRef&gt;; Zook et al., 
                    &lt;CitationRef CitationID="CR152"&gt;2016&lt;/CitationRef&gt;).
                  &lt;/Para&gt;
                  &lt;Para ID="Par17"&gt;ILC2s can be activated by IL-25, IL-33, and thymic stromal lymphopoietin (TSLP), which are produced by epithelial cells and certain immune cells. Other ILC2 activators were later identified, namely, tumor necrosis factor (TNF)-family cytokine TL1A, prostaglandin D
                    &lt;Subscript&gt;2&lt;/Subscript&gt;, cysteinyl leukotriene receptor 1 (CysLT1), arginase 1, receptor for advanced glycation end-products, and surfactant protein D (Barnig et al., 
                    &lt;CitationRef CitationID="CR6"&gt;2013&lt;/CitationRef&gt;; Doherty et al., 
                    &lt;CitationRef CitationID="CR23"&gt;2013&lt;/CitationRef&gt;; Meylan et al., 
                    &lt;CitationRef CitationID="CR95"&gt;2014&lt;/CitationRef&gt;; Yu et al., 
                    &lt;CitationRef CitationID="CR149"&gt;2014&lt;/CitationRef&gt;; Tait Wojno et al., 
                    &lt;CitationRef CitationID="CR128"&gt;2015&lt;/CitationRef&gt;; Taniguchi et al., 
                    &lt;CitationRef CitationID="CR130"&gt;2015&lt;/CitationRef&gt;; Monticelli et al., 
                    &lt;CitationRef CitationID="CR101"&gt;2016&lt;/CitationRef&gt;; Thawer et al., 
                    &lt;CitationRef CitationID="CR132"&gt;2016&lt;/CitationRef&gt;). IL-1β has been considered to be an activator of ILC3s, but a recent study demonstrated that IL-1β may also activate ILC2s (Bal et al., 
                    &lt;CitationRef CitationID="CR2"&gt;2016&lt;/CitationRef&gt;). These cells can also produce amphiregulin to enhance the recovery of the mucosa during viral infection (Monticelli et al., 
                    &lt;CitationRef CitationID="CR100"&gt;2011&lt;/CitationRef&gt;). ILC2 inhibitors were recently identified and include prostaglandin I
                    &lt;Subscript&gt;2&lt;/Subscript&gt;, IFN-γ, IL-27, and lipoxin A4. Because these molecules inhibit ILC2 proliferation and cytokine production (McHedlidze et al., 
                    &lt;CitationRef CitationID="CR90"&gt;2016&lt;/CitationRef&gt;; Moro et al., 
                    &lt;CitationRef CitationID="CR104"&gt;2016&lt;/CitationRef&gt;; Zhou et al., 
                    &lt;CitationRef CitationID="CR151"&gt;2016&lt;/CitationRef&gt;), they may be used to control ILC2-related diseases (See below). Activated ILC2s predominantly produce type 2 cytokines such as IL-5, IL-13, and IL-4, and also IL-9 (Moro, 
                    &lt;CitationRef CitationID="CR102"&gt;2010&lt;/CitationRef&gt;; Mjosberg et al., 
                    &lt;CitationRef CitationID="CR96"&gt;2011&lt;/CitationRef&gt;; Wilhelm et al., 
                    &lt;CitationRef CitationID="CR141"&gt;2011&lt;/CitationRef&gt;; Kim et al., 
                    &lt;CitationRef CitationID="CR67"&gt;2013&lt;/CitationRef&gt;).
                  &lt;/Para&gt;
                  &lt;Para ID="Par18"&gt;In the mouse lung, ILC2s are defined as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD90
                    &lt;Superscript&gt;+&lt;/Superscript&gt;ICOS
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD25
                    &lt;Superscript&gt;+&lt;/Superscript&gt;ST2
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt;. They also express CD44 and IL-17BR, and 20% of nuocytes (ILC2s) express c-kit (CD117) (Monticelli et al., 
                    &lt;CitationRef CitationID="CR100"&gt;2011&lt;/CitationRef&gt;; Barlow et al., 
                    &lt;CitationRef CitationID="CR4"&gt;2012&lt;/CitationRef&gt;; Bartemes et al., 
                    &lt;CitationRef CitationID="CR7"&gt;2012&lt;/CitationRef&gt;). Based on their killer cell lectin-like receptor G1 (KLRG1) expression, mouse lung ILC2s can be divided into two groups: nILC2s, designated as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;ST2
                    &lt;Superscript&gt;+&lt;/Superscript&gt;KLRG1
                    &lt;Superscript&gt;int&lt;/Superscript&gt; cells, and iILC2s, designated as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;ST2
                    &lt;Superscript&gt;−&lt;/Superscript&gt;KLRG1
                    &lt;Superscript&gt;hi&lt;/Superscript&gt; (Huang et al., 
                    &lt;CitationRef CitationID="CR56"&gt;2015&lt;/CitationRef&gt;). ILC2s are also found in the fetal and adult lung, and in the bronchoalveolar lavage fluid (BLF) in human. They are defined as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD161
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CRTH2
                    &lt;Superscript&gt;+&lt;/Superscript&gt; and also express ICOS, CD25 and ST2; they also partially express CD117 (Mjosberg et al., 
                    &lt;CitationRef CitationID="CR96"&gt;2011&lt;/CitationRef&gt;; Monticelli et al., 
                    &lt;CitationRef CitationID="CR100"&gt;2011&lt;/CitationRef&gt;). ILC2s in mouse and human have similar markers and function, although CRHT2 is specific for human since mouse ILC2s do not express this marker (Table&nbsp;
                    &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt;).
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec10"&gt;
                  &lt;Heading&gt;ILC2s in the lung&lt;/Heading&gt;
                  &lt;Para ID="Par19"&gt;ILC2s were the first ILC group identified in lung (Monticelli et al., 
                    &lt;CitationRef CitationID="CR100"&gt;2011&lt;/CitationRef&gt;). ILC2-related diseases in the lung involve pathogen infections (virus and helminth parasites), asthma, pulmonary fibrosis, and eosinophilic pleural effusion in primary spontaneous pneumothorax.
                  &lt;/Para&gt;
                  &lt;Section2 ID="Sec11"&gt;
                    &lt;Heading&gt;ILC2s and viral infection&lt;/Heading&gt;
                    &lt;Para ID="Par20"&gt;During viral infection, ILC2s may exert a dual effect in the lung: on the one hand, ILC2s play a protective role in repelling the virus; on the other hand, if ILC2 function is not tightly controlled, these cells may induce airway hyperactivity (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig3"&gt;3&lt;/InternalRef&gt;).
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig3"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Figure&nbsp;3&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;
                              &lt;Emphasis Type="Bold"&gt;ILC2 functions in the lung&lt;/Emphasis&gt;. Following interaction with pathogens or allergens, the airway epithelium secretes IL-25, IL-33, TSLP, and TGF-β. Upon a molecular cue from the damaged epithelium, activated macrophages and DCs also release IL-33. All of these cytokines activate ILC2s. After activation, ILC2s proliferate and produce copious amounts of IL-4, IL-5, IL-9, IL-13, and amphiregulin. IL-4 stimulates B cells and also activates DCs and enhances Th2 cell maturation and activation. IL-5 and IL-13 stimulate the proliferation and recruitment of eosinophils, which are involved in parasite clearance and airway hyper-responsiveness (AHR). IL-5 also enhances B1 cell self-renewal and antibody production by B cells. ILC2s produce IL-9, and the autocrine effect of IL-9 stimulates secretion of effector cytokines by ILC2s. IL-13 induces smooth muscle contractility and airway remodeling that leads to AHR. Additionally, IL-9 plays an essential role in mast cell differentiation and also can induce mast cells to secrete IL-6; IL-9 can also promote both the proliferation of eosinophils and induce their migration into the lung. IL-13 can also induce collagen deposition and the development of pulmonary fibrosis. Furthermore, IL-13 enhances eosinophil recruitment and alternative macrophage activation. Finally, ILC2s also play an important role in airway remodeling by secreting amphiregulin. See text for details
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO3"&gt;
                          &lt;ImageObject Color="Color" FileRef="MediaObjects/13238_2017_379_Fig3_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                    &lt;Section3 ID="Sec12"&gt;
                      &lt;Heading&gt;Maintenance of epithelial integrity&lt;/Heading&gt;
                      &lt;Para ID="Par21"&gt;During the early phase of respiratory infection caused by influenza A virus subtype H
                        &lt;Subscript&gt;1&lt;/Subscript&gt;N
                        &lt;Subscript&gt;1,&lt;/Subscript&gt; no significant differences were observed between wild-type mice and 
                        &lt;Emphasis Type="Italic"&gt;Rag&lt;/Emphasis&gt;
                        &lt;Superscript&gt;−/−&lt;/Superscript&gt; mice that lack adaptive immunity with respect to the decline in lung function and pathology of the lung. Because ILC2s accumulated in the lung, it was inferred that lung ILC2s play a key role in the regulation of lung innate immunity and tissue homeostasis (Monticelli et al., 
                        &lt;CitationRef CitationID="CR100"&gt;2011&lt;/CitationRef&gt;). Depletion of ILCs led to substantial lung epithelial degeneration and necrosis, as a result of significantly impaired epithelial integrity. Adoptive transfer of ILCs to ILC-depleted mice effectively restored epithelial integrity (Monticelli et al., 
                        &lt;CitationRef CitationID="CR100"&gt;2011&lt;/CitationRef&gt;). In the same study it was found that IL-33/IL-33R signaling was essential for the accumulation of ILC2s in H
                        &lt;Subscript&gt;1&lt;/Subscript&gt;N
                        &lt;Subscript&gt;1&lt;/Subscript&gt; virus infected lungs whereas IL-13 and IL-22 appeared to be dispensable for tissue homeostasis (Monticelli et al., 
                        &lt;CitationRef CitationID="CR100"&gt;2011&lt;/CitationRef&gt;). Data from genome-wide transcriptional profiling has suggested that ILC2s in the lung express wound healing-associated genes at higher levels. 
                        &lt;Emphasis Type="Italic"&gt;In vivo&lt;/Emphasis&gt;, lung ILC2s have the ability to produce high levels of amphiregulin, a molecule that regulates tissue remodeling and repair during acute epithelial injury and asthma (Dolinay et al., 
                        &lt;CitationRef CitationID="CR24"&gt;2006&lt;/CitationRef&gt;; Enomoto et al., 
                        &lt;CitationRef CitationID="CR32"&gt;2009&lt;/CitationRef&gt;; Fukumoto et al., 
                        &lt;CitationRef CitationID="CR38"&gt;2010&lt;/CitationRef&gt;; Monticelli et al., 
                        &lt;CitationRef CitationID="CR100"&gt;2011&lt;/CitationRef&gt;). In summary, lung ILC2s play an important role in maintaining the integrity of the respiratory epithelium and restoring lung function by producing amphiregulin during H
                        &lt;Subscript&gt;1&lt;/Subscript&gt;N
                        &lt;Subscript&gt;1&lt;/Subscript&gt; infection.
                      &lt;/Para&gt;
                    &lt;/Section3&gt;
                    &lt;Section3 ID="Sec13"&gt;
                      &lt;Heading&gt;Induction of lung inflammation and airway hyper-reactivity&lt;/Heading&gt;
                      &lt;Para ID="Par22"&gt;Chang et al. (
                        &lt;CitationRef CitationID="CR16"&gt;2011&lt;/CitationRef&gt;) observed that BALB/c mice infected with H
                        &lt;Subscript&gt;3&lt;/Subscript&gt;N
                        &lt;Subscript&gt;1&lt;/Subscript&gt; virus rapidly develop AHR (airway hyper-responsiveness) that peaked on day 5 of infection. Because the sensitization of Th2 cells and enrollment of adaptive immunity during allergen-induced AHR required 7~14 d to develop (Hansen et al., 
                        &lt;CitationRef CitationID="CR50"&gt;1999&lt;/CitationRef&gt;), based on the speed with which H
                        &lt;Subscript&gt;3&lt;/Subscript&gt;N
                        &lt;Subscript&gt;1&lt;/Subscript&gt; induced AHR, it was hypothesized that this response was mediated by innate immune mechanisms. The authors provided evidence that indeed H
                        &lt;Subscript&gt;3&lt;/Subscript&gt;N
                        &lt;Subscript&gt;1&lt;/Subscript&gt;-induced AHR development did involve the innate immune pathway and did not require T, B, or NKT cells (Chang et al., 
                        &lt;CitationRef CitationID="CR16"&gt;2011&lt;/CitationRef&gt;). Depletion of natural helper cells suppressed the AHR response, and furthermore only the transfer of IL-13-producing ILC2s, but no other IL-13-producing cells (such as mast cells or basophils), was sufficient for the development of H
                        &lt;Subscript&gt;3&lt;/Subscript&gt;N
                        &lt;Subscript&gt;1&lt;/Subscript&gt;-induced AHR. Furthermore, H
                        &lt;Subscript&gt;3&lt;/Subscript&gt;N
                        &lt;Subscript&gt;1&lt;/Subscript&gt;-induced AHR was tightly correlated with the presence of ILC2s, IL-33, and IL-13. IL-33 derived from alveolar macrophages likely plays an essential role in the activation of ILC2s (Chang et al., 
                        &lt;CitationRef CitationID="CR16"&gt;2011&lt;/CitationRef&gt;). These data confirm that ILC2s are essential for the development of AHR during H
                        &lt;Subscript&gt;3&lt;/Subscript&gt;N
                        &lt;Subscript&gt;1&lt;/Subscript&gt; infection.
                      &lt;/Para&gt;
                      &lt;Para ID="Par23"&gt;During RSV infection, the number of IL-13-producing ILC2s triples compared with basal levels, and the IL-13 levels increase simultaneously. This increase contributes to airway hyper-reactivity and airway mucus accumulation in a TSLP-dependent manner (Stier et al., 
                        &lt;CitationRef CitationID="CR126"&gt;2016&lt;/CitationRef&gt;). ILC2s have also been shown to produce IL-13 in order to recruit eosinophils and induce AHR through the IL-33/ST2 pathway during RSV infection (Liu et al., 
                        &lt;CitationRef CitationID="CR84"&gt;2015b&lt;/CitationRef&gt;). Similarly, neonatal rhinovirus induces AHR and mucus metaplasia through IL-25 and ILC2s (Hong et al., 
                        &lt;CitationRef CitationID="CR54"&gt;2014&lt;/CitationRef&gt;).
                      &lt;/Para&gt;
                    &lt;/Section3&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec14"&gt;
                    &lt;Heading&gt;ILC2s and helminth parasites&lt;/Heading&gt;
                    &lt;Para ID="Par24"&gt;Upon infection with helminthic parasites, the host undergoes a strong type 2 response to clear the pathogens (Paul and Zhu, 
                      &lt;CitationRef CitationID="CR107"&gt;2010&lt;/CitationRef&gt;; Maizels et al., 
                      &lt;CitationRef CitationID="CR86"&gt;2012&lt;/CitationRef&gt;). During 
                      &lt;Emphasis Type="Italic"&gt;Strongyloides venezuelensis&lt;/Emphasis&gt; infection of the lung, IL-33 levels increase, activating ILC2s to release the effector cytokines IL-5 and IL-13 that, in turn, can recruit eosinophils to fight the infection. IL-33
                      &lt;Superscript&gt;−/−&lt;/Superscript&gt; mice are unable to recruit eosinophils to the lungs or expel 
                      &lt;Emphasis Type="Italic"&gt;S. venezuelensis&lt;/Emphasis&gt; (Yasuda et al., 
                      &lt;CitationRef CitationID="CR146"&gt;2012&lt;/CitationRef&gt;). During lung inflammation induced by 
                      &lt;Emphasis Type="Italic"&gt;Nippostrongylus brasiliensis&lt;/Emphasis&gt;, epithelial cells produce TSLP and IL-33, synergistically stimulating ILC2s to produce IL-5 and IL-13. Furthermore, IL-9, which is produced by ILC2s in an autocrine manner, stimulates IL-5 and IL-13 production by ILC2s. In IL-9 receptor-deficient mice infected with 
                      &lt;Emphasis Type="Italic"&gt;N. brasiliensis&lt;/Emphasis&gt;, ILC2s numbers are reduced and IL-5, IL-13, and amphiregulin levels are decreased, whereas the numbers of Th2 cells remain unchanged. As a result, helminth clearance is strongly impaired (Turner et al., 
                      &lt;CitationRef CitationID="CR133"&gt;2013&lt;/CitationRef&gt;). The IL-9 signal plays an important role in the activation of ILC2s, especially in the early phase of helminth infection. This process also requires interferon regulatory factor 4 (IRF4) (Turner et al., 
                      &lt;CitationRef CitationID="CR133"&gt;2013&lt;/CitationRef&gt;; Mohapatra et al., 
                      &lt;CitationRef CitationID="CR98"&gt;2016&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par25"&gt;During 
                      &lt;Emphasis Type="Italic"&gt;N. brasiliensis&lt;/Emphasis&gt; infection, the ILC2 subgroup iILC2 can convert into nILC2. 
                      &lt;Emphasis Type="Italic"&gt;N. brasiliensis&lt;/Emphasis&gt;-infected 
                      &lt;Emphasis Type="Italic"&gt;Il17rb&lt;/Emphasis&gt;
                      &lt;Superscript&gt;−/−&lt;/Superscript&gt; mice lack iILC2 cells and, interestingly, nILC2 cell numbers are significantly decreased in these mouse models. This suggests that iILC2s contribute to the nILC2 population during 
                      &lt;Emphasis Type="Italic"&gt;N. brasiliensis&lt;/Emphasis&gt; infection. Researchers simultaneously transferred CD45.1
                      &lt;Superscript&gt;+&lt;/Superscript&gt; nILC2s and CD45.2
                      &lt;Superscript&gt;+&lt;/Superscript&gt; iILC2s into 
                      &lt;Emphasis Type="Italic"&gt;Rag2&lt;/Emphasis&gt;
                      &lt;Superscript&gt;−/−&lt;/Superscript&gt;
                      &lt;Emphasis Type="Italic"&gt;Il2rg&lt;/Emphasis&gt;
                      &lt;Superscript&gt;−/−&lt;/Superscript&gt; mice infected with 
                      &lt;Emphasis Type="Italic"&gt;N. brasiliensis&lt;/Emphasis&gt;, and 14 d later found that all iILC2 cells had developed into nILC2-like cells. iILC2s may thus comprise a transient progenitor population of cells that can transform into nILC2-like cells and be involved in the clearance of 
                      &lt;Emphasis Type="Italic"&gt;N. brasiliensis&lt;/Emphasis&gt; (Huang et al., 
                      &lt;CitationRef CitationID="CR56"&gt;2015&lt;/CitationRef&gt;) (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par26"&gt;Interestingly, another natural mouse parasite, 
                      &lt;Emphasis Type="Italic"&gt;Heligmosomoides polygyrus&lt;/Emphasis&gt;, that causes parasitic infections suppresses inflammatory responses in models of asthma, food allergy, diabetes, and colitis (McSorley and Maizels, 
                      &lt;CitationRef CitationID="CR91"&gt;2012&lt;/CitationRef&gt;). 
                      &lt;Emphasis Type="Italic"&gt;H. polygyrus&lt;/Emphasis&gt; excretory/secretory (HES) products can suppress both Treg (Grainger et al., 
                      &lt;CitationRef CitationID="CR44"&gt;2010&lt;/CitationRef&gt;) and dendritic cells (Massacand et al., 
                      &lt;CitationRef CitationID="CR88"&gt;2009&lt;/CitationRef&gt;). McSorley et al. found that HES products inhibit the allergic reaction in the ovalbumin (OVA)-induced mouse asthma model by suppressing the release of IL-33 and inhibiting the activation of ILC2s (McSorley et al., 
                      &lt;CitationRef CitationID="CR92"&gt;2014&lt;/CitationRef&gt;; McSorley et al., 
                      &lt;CitationRef CitationID="CR93"&gt;2015&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec15"&gt;
                    &lt;Heading&gt;ILC2s and asthma&lt;/Heading&gt;
                    &lt;Para ID="Par27"&gt;Asthma is a heterogeneous disease that occurs worldwide and whose pathology involves chronic airway inflammation. The type 2 response is regarded as a central mechanism for allergic asthma (Deckers et al., 
                      &lt;CitationRef CitationID="CR21"&gt;2013&lt;/CitationRef&gt;; Licona-Limon et al., 
                      &lt;CitationRef CitationID="CR81"&gt;2013&lt;/CitationRef&gt;). Conventionally, Th2 cells have been regarded as the main source of type 2 cytokines, but this notion has now been challenged by the emergence of ILC2 cells.
                    &lt;/Para&gt;
                    &lt;Para ID="Par28"&gt;In mouse asthma models that use ovalbumin (Kim et al., 
                      &lt;CitationRef CitationID="CR66"&gt;2012&lt;/CitationRef&gt;), house dust mite (HDM) (Wilhelm et al., 
                      &lt;CitationRef CitationID="CR141"&gt;2011&lt;/CitationRef&gt;; Halim et al., 
                      &lt;CitationRef CitationID="CR45"&gt;2012a&lt;/CitationRef&gt;; Klein Wolterink et al., 
                      &lt;CitationRef CitationID="CR71"&gt;2012&lt;/CitationRef&gt;), papain (Halim et al., 
                      &lt;CitationRef CitationID="CR45"&gt;2012a&lt;/CitationRef&gt;), and fungal allergens, ILC2s uniformly increase in number and are the major source of IL-5 or/and IL-13, especially in the early phases of the disease. In mouse models that lack adaptive immune cells, i.e., T and B cells, allergens can also induce significant AHR, a high level of type 2 cytokines, and increased numbers of ILC2s in the lung (Bartemes et al., 
                      &lt;CitationRef CitationID="CR7"&gt;2012&lt;/CitationRef&gt;; Halim et al., 
                      &lt;CitationRef CitationID="CR45"&gt;2012a&lt;/CitationRef&gt;). In these allergen-induced asthma models, the pulmonary epithelium, macrophages, and DCs release IL-33; in addition, the pulmonary epithelium also produces IL-25, TSLP, and transforming growth factor-β (TGF-β). All of these cytokines can activate ILC2s (Halim et al., 
                      &lt;CitationRef CitationID="CR45"&gt;2012a&lt;/CitationRef&gt;; Kim et al., 
                      &lt;CitationRef CitationID="CR66"&gt;2012&lt;/CitationRef&gt;; Iijima et al., 
                      &lt;CitationRef CitationID="CR59"&gt;2014&lt;/CitationRef&gt;; Denney et al., 
                      &lt;CitationRef CitationID="CR22"&gt;2015&lt;/CitationRef&gt;). 
                      &lt;Emphasis Type="Italic"&gt;In vitro&lt;/Emphasis&gt;, IL-25 and IL-33 enhance the proliferation of ILC2s and stimulate them to produce IL-4, IL-5, IL-13, and/or IL-9 (Wilhelm et al., 
                      &lt;CitationRef CitationID="CR141"&gt;2011&lt;/CitationRef&gt;; Barlow et al., 
                      &lt;CitationRef CitationID="CR4"&gt;2012&lt;/CitationRef&gt;; Bartemes et al., 
                      &lt;CitationRef CitationID="CR7"&gt;2012&lt;/CitationRef&gt;; Halim et al., 
                      &lt;CitationRef CitationID="CR45"&gt;2012a&lt;/CitationRef&gt;; Kim et al., 
                      &lt;CitationRef CitationID="CR66"&gt;2012&lt;/CitationRef&gt;; Klein Wolterink et al., 
                      &lt;CitationRef CitationID="CR71"&gt;2012&lt;/CitationRef&gt;). This is important because, IL-4 stimulates B cells to produce IgE, IL-5 recruits and activates eosinophils and also enhances B cell antibody production and B1 cell self-renewal, and IL-13 enhances smooth muscle contraction, epithelial mucous production, airway remodeling, and eosinophil recruitment. IL-9 plays an essential role in mast cell differentiation and can also induce mast cells to secrete IL-6; IL-9 promotes both the proliferation of eosinophils and their migration into the lung (Renauld, 
                      &lt;CitationRef CitationID="CR112"&gt;2001&lt;/CitationRef&gt;). Otherwise, the IL-9 production of ILC2s depends on IL-2 secreted by adaptive immune cells. IL-9 also stimulates ILC2s to produce IL-13 and IL-5 (Wilhelm et al., 
                      &lt;CitationRef CitationID="CR141"&gt;2011&lt;/CitationRef&gt;). All of these cytokines play an important role in the development of AHR (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig3"&gt;3&lt;/InternalRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par29"&gt;During AHR development, ILC2s crosstalk with DCs, CD4
                      &lt;Superscript&gt;+&lt;/Superscript&gt; Th2 cells, B cells, and Th9 cells, thereby potentiating the pathology. ILC2s produce IL-13, which directly activates DCs to express CCL17, enhancing CD4
                      &lt;Superscript&gt;+&lt;/Superscript&gt; Th2 cell activation; ILC2s also activate Th2 cells directly by producing IL-4 and OX40L. ILC2s and CD4
                      &lt;Superscript&gt;+&lt;/Superscript&gt; Th2 cells thereby exert a synergistic effect on the development of AHR (Drake et al., 
                      &lt;CitationRef CitationID="CR27"&gt;2014&lt;/CitationRef&gt;; Gold et al., 
                      &lt;CitationRef CitationID="CR43"&gt;2014&lt;/CitationRef&gt;; Halim et al., 
                      &lt;CitationRef CitationID="CR47"&gt;2014&lt;/CitationRef&gt;; Halim et al., 
                      &lt;CitationRef CitationID="CR48"&gt;2015&lt;/CitationRef&gt;; Liu et al., 
                      &lt;CitationRef CitationID="CR83"&gt;2015a&lt;/CitationRef&gt;). Mouse lung ILC2s enhance the proliferation of B1- and B2-type B cells and stimulate their production of IgM, IgG1, IgA, and IgE 
                      &lt;Emphasis Type="Italic"&gt;in vitro&lt;/Emphasis&gt;. Specifically, ILC2-derived IL-5 is critically involved in increased IgM production (Drake et al., 
                      &lt;CitationRef CitationID="CR28"&gt;2016&lt;/CitationRef&gt;). Polarized ILC2s and Th9 cells also stimulate each other in mouse models of asthma in the lung (Ying et al., 
                      &lt;CitationRef CitationID="CR147"&gt;2016&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par30"&gt;Researchers have recently observed that similar to Th2 cells, ILC2s gain memory-like properties upon allergen challenge. ILC2s stimulated by inhalation of either IL-33 or papain persist for a long time; even after resolution of the inflammatory response; in fact, some ILC2s persist for more than 4&nbsp;weeks. Furthermore, ‘allergen-experienced’ ILC2s responded better to unrelated allergen than naïve ILC2s, mediating a more severe allergic inflammation (Martinez-Gonzalez et al., 
                      &lt;CitationRef CitationID="CR87"&gt;2016&lt;/CitationRef&gt;). Allergen-experienced ILC2s are also more responsive and produce higher amounts of the same cytokines than unexperienced ILC2s. Compared with memory lymphocytes, ILC2s are activated by cytokines, while memory lymphocytes are activated by specific antigens, thus the memory-like ILC2s are antigen non-specific. This means that memory-like ILC2s can be activated by unrelated allergens but produce a stronger response than naïve ILC2s. Memory-like ILC2s can also enhance Th2 cell-mediated adaptive type 2 lung inflammation. These two important characteristics may explain the phenomena that some asthma patients react against multiple allergens, while some do not (Martinez-Gonzalez et al., 
                      &lt;CitationRef CitationID="CR87"&gt;2016&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par31"&gt;In comparison with mouse, far fewer studies describing the role of ILC2s in human asthma have been published. The occurrence of ILC2s is more frequent in the blood of subjects with allergic asthma than in healthy individuals and allergic donors. When stimulated with IL-25 or IL-33, peripheral blood mononuclear cells from patients with allergic asthma produced significantly greater amounts of IL-5 and IL-13 than those from patients with allergic rhinitis and those from healthy donors (Bartemes et al., 
                      &lt;CitationRef CitationID="CR8"&gt;2014&lt;/CitationRef&gt;; Jia et al., 
                      &lt;CitationRef CitationID="CR60"&gt;2016&lt;/CitationRef&gt;). Recently, ILC2s were found in the bronchoalvoelar lavage (BAL) and sputum of patients with asthma, and the proportion of IL-5
                      &lt;Superscript&gt;+&lt;/Superscript&gt;IL-13
                      &lt;Superscript&gt;+&lt;/Superscript&gt; ILC2s in the sputum of patients with severe asthma was higher than that in corresponding samples from patients with mild asthma (Smith et al., 
                      &lt;CitationRef CitationID="CR120"&gt;2016&lt;/CitationRef&gt;). ILC2 levels are also increased in the sputum from severe asthmatic children (Nagakumar et al., 
                      &lt;CitationRef CitationID="CR105"&gt;2016&lt;/CitationRef&gt;). Other researchers have also compared the relationship between ILC2s and asthma control status, and the results indicate a positive correlation between IL-13-producing ILC2s and asthma control status (Jia et al., 
                      &lt;CitationRef CitationID="CR60"&gt;2016&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par32"&gt;Based on the above studies of examining ILC2s in human asthma, the number of ILC2s is increased in asthmatic patients’ blood, these ILC2s are activated, and the number of IL-13-producing ILC2s negatively correlates with asthma control status. These results might suggest that level of ILC2s in the blood maybe partially indicate asthma status. However, ILCs are generally tissue-resident cells and the characteristics of ILCs in tissue are very different from ILCs in the circulation since tissue-resident ILCs are affected by the tissue microenvironment, which can cause changes of biomarker profile as well as function. Therefore, the blood ILC profile and function does not absolutely represent ILC2s resident in the lungs of asthmatics; blood ILC2s therefore only partially indicates the status of the disease. In the future, it will be important to study the function of human tissue-resident ILC2s, for example ILC2s from BAL and sputum, and even from lung tissue itself.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec16"&gt;
                    &lt;Heading&gt;ILC2s and pulmonary fibrosis&lt;/Heading&gt;
                    &lt;Para ID="Par33"&gt;Pulmonary fibrosis is a heterogeneous disease that is prevalent worldwide, and that is typically regarded as a chronic progressive disease, with high morbidity and mortality (Hutchinson et al., 
                      &lt;CitationRef CitationID="CR58"&gt;2015&lt;/CitationRef&gt;). The key pathogenic mechanism involves extracellular matrix deposition in the lung. The pro-inflammatory cytokines TGF-β, IL-13, IL-1β, and IL-17A all play an important role in the fibrotic process (Kolb et al., 
                      &lt;CitationRef CitationID="CR75"&gt;2001&lt;/CitationRef&gt;; Wynn, 
                      &lt;CitationRef CitationID="CR143"&gt;2011&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par34"&gt;In the mouse model of pulmonary fibrosis that uses injection of 
                      &lt;Emphasis Type="Italic"&gt;S. mansoni&lt;/Emphasis&gt; eggs, IL-25 has been shown to be the key cytokine in the development of fibrosis. IL-25 induces a dramatic increase in both IL-13 and TGF-β in the lungs. In humans, increased levels of IL-25 and ILC2s are found in the BAL and lung tissue of patients with idiopathic pulmonary fibrosis (Hams et al., 
                      &lt;CitationRef CitationID="CR49"&gt;2014&lt;/CitationRef&gt;). Compared with wild-type mice, pulmonary collagen deposition is impaired in ILC2-deficient mice after 
                      &lt;Emphasis Type="Italic"&gt;S. mansoni&lt;/Emphasis&gt; egg injection (Hams et al., 
                      &lt;CitationRef CitationID="CR49"&gt;2014&lt;/CitationRef&gt;). Furthermore, ILC2s induce pulmonary collagen deposition in an IL-13-dependent manner (Hams et al., 
                      &lt;CitationRef CitationID="CR49"&gt;2014&lt;/CitationRef&gt;). Li et al. (
                      &lt;CitationRef CitationID="CR79"&gt;2014&lt;/CitationRef&gt;) have suggested that the IL-33-ST2 axis is essential for the initiation and progression of pulmonary fibrosis. In this model IL-33 activates M2 macrophages to produce IL-13 and TGF-β1, and then further induces the expansion of ILC2s to produce IL-13, ultimately resulting in the development of pulmonary fibrosis (Li et al., 
                      &lt;CitationRef CitationID="CR79"&gt;2014&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par35"&gt;Dermal and circulating ILC2 counts correlate closely with the occurrence of pulmonary fibrosis in systemic sclerosis patients. This implies that ILC2s may aggravate the pulmonary fibrosis in these patients (Wohlfahrt et al., 
                      &lt;CitationRef CitationID="CR142"&gt;2016&lt;/CitationRef&gt;) (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig3"&gt;3&lt;/InternalRef&gt;).
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec17"&gt;
                    &lt;Heading&gt;ILC2s and eosinophilic pleural effusion (EPE) in primary spontaneous pneumothorax (PSP)&lt;/Heading&gt;
                    &lt;Para ID="Par36"&gt;EPE is defined as&nbsp;&amp;gt;&nbsp;10% eosinophilia in the pleural fluid and is frequently associated with the presence of blood and/or air in the pleural space (Kalomenidis and Light, 
                      &lt;CitationRef CitationID="CR61"&gt;2003&lt;/CitationRef&gt;). PSP is a common complication, with a high rate of recurrence in EPE (Kalomenidis and Light, 
                      &lt;CitationRef CitationID="CR61"&gt;2003&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par37"&gt;The levels of IL-4, IL-5, IL-13, and Eotaxin-3, as well as TSLP and IL-33, have been shown to be increased in the pleural fluid of PSP patients. These cytokines are type 2 immune response-related, and it therefore appears that Th2 cells and ILC2s might play an essential role in this pathology; however, CD4
                      &lt;Superscript&gt;+&lt;/Superscript&gt; and CD8
                      &lt;Superscript&gt;+&lt;/Superscript&gt; T cells are known not to be involved in the pathogenesis of PSP (Kwon et al., 
                      &lt;CitationRef CitationID="CR77"&gt;2013&lt;/CitationRef&gt;). IL-33 directly stimulates ILC2s to produce increased amounts of IL-5, which then recruits eosinophils into the pleural space, resulting in EPE; Th2 cells are not involved in this process. This indicates that the type 2 immune response is associated with the development of EPE in PSP through an ILC2-dependent but Th2-independent manner (Kwon et al., 
                      &lt;CitationRef CitationID="CR77"&gt;2013&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec18"&gt;
                  &lt;Heading&gt;Identification and characterization of ILC3s&lt;/Heading&gt;
                  &lt;Para ID="Par38"&gt;ILC3s can be classified into two main groups according to the host developmental stage when they mature: fetal LTi cells and post-natal (adult) ILC3s. Fetal LTi cells, the prototypical ILC3s, were originally reported two decades ago. In mice, LTi cells are identified as CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD3
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD4
                    &lt;Superscript&gt;+&lt;/Superscript&gt;. Their development is RORγt-dependent, they originate in the fetal liver, and they are found in fetal lymphoid nodes and the intestine (Kelly and Scollay, 
                    &lt;CitationRef CitationID="CR64"&gt;1992&lt;/CitationRef&gt;; Mebius et al., 
                    &lt;CitationRef CitationID="CR94"&gt;1997&lt;/CitationRef&gt;; Yoshida et al., 
                    &lt;CitationRef CitationID="CR148"&gt;1999&lt;/CitationRef&gt;; Eberl et al., 
                    &lt;CitationRef CitationID="CR30"&gt;2004&lt;/CitationRef&gt;; Finke, 
                    &lt;CitationRef CitationID="CR35"&gt;2005&lt;/CitationRef&gt;). In humans, fetal LTi cells were first found in 2009 and recognized as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;RORγt
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD4
                    &lt;Superscript&gt;−&lt;/Superscript&gt;; they play a role similar to that of mouse LTi cells (Cupedo et al., 
                    &lt;CitationRef CitationID="CR18"&gt;2009&lt;/CitationRef&gt;).
                  &lt;/Para&gt;
                  &lt;Para ID="Par39"&gt;In mice, adult ILC3s are defined as CD45
                    &lt;Superscript&gt;+&lt;/Superscript&gt;Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;Thy1
                    &lt;Superscript&gt;+&lt;/Superscript&gt;RORγt
                    &lt;Superscript&gt;+&lt;/Superscript&gt;, and they partially express CCR6 and NKp46 (Sanos et al., 
                    &lt;CitationRef CitationID="CR114"&gt;2009&lt;/CitationRef&gt;; Takatori et al., 
                    &lt;CitationRef CitationID="CR129"&gt;2009&lt;/CitationRef&gt;; Vonarbourg et al., 
                    &lt;CitationRef CitationID="CR137"&gt;2010b&lt;/CitationRef&gt;; Song et al., 
                    &lt;CitationRef CitationID="CR121"&gt;2015&lt;/CitationRef&gt;). RORγt, AHR, GATA3, and T-bet are required for their development (Luci et al., 
                    &lt;CitationRef CitationID="CR85"&gt;2009&lt;/CitationRef&gt;; Klose et al., 
                    &lt;CitationRef CitationID="CR73"&gt;2013&lt;/CitationRef&gt;; Hughes et al., 
                    &lt;CitationRef CitationID="CR57"&gt;2014&lt;/CitationRef&gt;; Serafini et al., 
                    &lt;CitationRef CitationID="CR117"&gt;2014&lt;/CitationRef&gt;). In humans, adult ILC3s are defined as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CRTH2
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD117
                    &lt;Superscript&gt;+&lt;/Superscript&gt;; they also heterogeneously express NKp44, NKp46, CD56, and NKp30 (Crellin et al., 
                    &lt;CitationRef CitationID="CR17"&gt;2010&lt;/CitationRef&gt;; Hoorweg et al., 
                    &lt;CitationRef CitationID="CR55"&gt;2012&lt;/CitationRef&gt;; Glatzer et al., 
                    &lt;CitationRef CitationID="CR42"&gt;2013&lt;/CitationRef&gt;). Upon stimulation with IL-1β and IL-23, ILC3s express IL-17, IL-22, and granulocyte-macrophage colony-stimulating factor (GM-CSF) (Takatori et al., 
                    &lt;CitationRef CitationID="CR129"&gt;2009&lt;/CitationRef&gt;; Crellin et al., 
                    &lt;CitationRef CitationID="CR17"&gt;2010&lt;/CitationRef&gt;; Hoorweg et al., 
                    &lt;CitationRef CitationID="CR55"&gt;2012&lt;/CitationRef&gt;; Song et al., 
                    &lt;CitationRef CitationID="CR121"&gt;2015&lt;/CitationRef&gt;).
                  &lt;/Para&gt;
                  &lt;Para ID="Par40"&gt;Adult ILC3s are the most heterogeneous ILCs. Depending on the level of the expressed NK receptor, e.g., NKp44, NKp46, or NKp30, ILC3s can be divided into NCR
                    &lt;Superscript&gt;−&lt;/Superscript&gt;ILC3s and NCR
                    &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s. ILC3s can also be divided according to the level of expression of CCR6 into CCR6
                    &lt;Superscript&gt;−&lt;/Superscript&gt; ILC3s and CCR6
                    &lt;Superscript&gt;+&lt;/Superscript&gt; ILC3s. Recently, it was shown that NCR engagement enables ILC3s to play a pro-inflammatory role (Glatzer et al., 
                    &lt;CitationRef CitationID="CR42"&gt;2013&lt;/CitationRef&gt;); based on this an increasing numbers of researchers use the NCR status to classify the function of adult ILC3s. Similar markers and functions are found in both mouse and human ILC3s with the exception that mice do not express NKp44 (Killig et al., 
                    &lt;CitationRef CitationID="CR65"&gt;2014&lt;/CitationRef&gt;).
                  &lt;/Para&gt;
                  &lt;Para ID="Par41"&gt;In the mouse lung, ILC3s were initially reported by Centre et al. (2015), who found that 30% of ILCs were ILC3s, defined as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD90
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt;RORγt
                    &lt;Superscript&gt;+&lt;/Superscript&gt;; almost 70% of ILC3s also co-express CCR6. IL-1β and IL-23 have been shown to activate these cells. ILC3s were also identified as a major source of IL-22 produced in response to IL-23 stimulation (Van Maele et al., 
                    &lt;CitationRef CitationID="CR135"&gt;2014&lt;/CitationRef&gt;). In the human lung, ILC3s are identified as Lin
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD127
                    &lt;Superscript&gt;+&lt;/Superscript&gt;CRTH2
                    &lt;Superscript&gt;−&lt;/Superscript&gt;CD117
                    &lt;Superscript&gt;+&lt;/Superscript&gt;, and are NCR
                    &lt;Superscript&gt;−&lt;/Superscript&gt; or NCR
                    &lt;Superscript&gt;+&lt;/Superscript&gt;. NCR
                    &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s produce IL-22, TNF-α, IL-8, IL-2, and GM-CSF upon stimulation (Carrega et al., 
                    &lt;CitationRef CitationID="CR13"&gt;2015&lt;/CitationRef&gt;; De Grove et al., 
                    &lt;CitationRef CitationID="CR20"&gt;2016&lt;/CitationRef&gt;) (Table&nbsp;
                    &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt;).
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec19"&gt;
                  &lt;Heading&gt;ILC3s in the lung&lt;/Heading&gt;
                  &lt;Section2 ID="Sec20"&gt;
                    &lt;Heading&gt;ILC3s and infection&lt;/Heading&gt;
                    &lt;Para ID="Par42"&gt;ILC3s play an essential role in the maintenance of mucosal barrier function because they produce effector cytokines, especially IL-22 and IL-17. IL-22 and IL-17 activate epidermal cells to produce antimicrobial molecules and protect the host from extracellular bacteria and fungi (Liang et al., 
                      &lt;CitationRef CitationID="CR80"&gt;2006&lt;/CitationRef&gt;). IL-22 can also enhance the epithelial production of mucus-associated molecules (McAleer and Kolls, 
                      &lt;CitationRef CitationID="CR89"&gt;2014&lt;/CitationRef&gt;). A protective role of ILC3s against infections in the digestive system has also been reported. During an intestinal infection with 
                      &lt;Emphasis Type="Italic"&gt;Citrobacter rodentium&lt;/Emphasis&gt;, the number of IL-22-producing ILC3s increased in the intestinal lamina propria (Cella et al., 
                      &lt;CitationRef CitationID="CR14"&gt;2009&lt;/CitationRef&gt;; Sanos et al., 
                      &lt;CitationRef CitationID="CR114"&gt;2009&lt;/CitationRef&gt;). Gladiator et al. found that ILC3s can also produce IL-17 that helps eliminate pathogens during fungal infection in mice, especially in the early phase of infection. (Gladiator et al., 
                      &lt;CitationRef CitationID="CR41"&gt;2013&lt;/CitationRef&gt;). In 2014, Van Maele et al. reported the function of ILC3s in the lung. During 
                      &lt;Emphasis Type="Italic"&gt;Streptococcus pneumoniae&lt;/Emphasis&gt; infection, ILC3s rapidly accumulate in the lung tissue to produce IL-22 in a DC- and MyD88-dependent manner (Van Maele et al., 
                      &lt;CitationRef CitationID="CR135"&gt;2014&lt;/CitationRef&gt;). Boosting lung ILC3 numbers might therefore represent an interesting strategy for fighting respiratory bacterial infections.
                    &lt;/Para&gt;
                    &lt;Para ID="Par43"&gt;One study suggested that Toll-like receptor 5 (TLR5) signaling could activate ILCs (CD3
                      &lt;Superscript&gt;−&lt;/Superscript&gt;CD127
                      &lt;Superscript&gt;+&lt;/Superscript&gt;) and enhance the production of IL-17 and IL-22, which are crucial for anti-pathogen defenses in the mucous membrane of the intestine and the lung (Van Maele et al., 
                      &lt;CitationRef CitationID="CR134"&gt;2010&lt;/CitationRef&gt;). This raises the interesting notion that TLR5 may activate ILC3s to reject the pathogen in the lung. Later, Van Maele et al. found that during 
                      &lt;Emphasis Type="Italic"&gt;S. pneumoniae&lt;/Emphasis&gt; infection, the TLR5 agonist flagellin accelerates and over-stimulates lung ILC3s to produce more IL-22 (Van Maele et al., 
                      &lt;CitationRef CitationID="CR135"&gt;2014&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par44"&gt;
                      &lt;Emphasis Type="Italic"&gt;Klebsiella pneumoniae&lt;/Emphasis&gt; is a gram-negative bacterium that is highly resistant to antibiotics and is a common pathogen in pneumonia (Doorduijn et al., 
                      &lt;CitationRef CitationID="CR25"&gt;2016&lt;/CitationRef&gt;). In 2014, Xu et al. found that IL-22-producing NK cells are required for optimal host defense in mouse models of 
                      &lt;Emphasis Type="Italic"&gt;K.&lt;/Emphasis&gt;
                      &lt;Emphasis Type="Italic"&gt;pneumoniae&lt;/Emphasis&gt; infection (Xu et al., 
                      &lt;CitationRef CitationID="CR145"&gt;2014&lt;/CitationRef&gt;). Recently, another group reported that following infection with 
                      &lt;Emphasis Type="Italic"&gt;K.&lt;/Emphasis&gt;
                      &lt;Emphasis Type="Italic"&gt;pneumoniae&lt;/Emphasis&gt; in mice, inflammatory monocytes are immediately recruited to the lungs, where they produce TNF, which then increases the number of IL-17-producing ILC3s. IL-17A-dependent clearance of 
                      &lt;Emphasis Type="Italic"&gt;K.&lt;/Emphasis&gt;
                      &lt;Emphasis Type="Italic"&gt;pneumoniae&lt;/Emphasis&gt; is impaired in monocyte- or TNF-depleted mouse models, whereas IL-17-producing ILC3s enhance monocyte-mediated bacterial clearance. These results indicate that ILC3s and monocytes participate in a positive feedback cycle that&nbsp;promotes&nbsp;the clearance of highly antibiotic-resistant bacterial pathogens from the lung (Xiong et al., 
                      &lt;CitationRef CitationID="CR144"&gt;2016&lt;/CitationRef&gt;) (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig4"&gt;4&lt;/InternalRef&gt;).
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig4"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Figure&nbsp;4&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;
                              &lt;Emphasis Type="Bold"&gt;ILC3 functions in the lung&lt;/Emphasis&gt;. After receiving the danger signals from the airway epithelium upon pathogen and tumor cell invasion, DCs and macrophages release IL-1β and IL-23, which activate ILC3s. Activated ILC3s release IL-17, IL-22, IL-8, IL-2, TNF, and LTα1β2. IL-17 and IL-22 play a dual role: on the one hand, they stimulate the epithelium to produce antimicrobial peptides and proteins, and mucus-associated molecules to clear the pathogen and tumor cells to maintain homeostasis of the mucosa; on the other hand, they may aggravate the development of obesity-related asthma and COPD. IL-22-producing-ILC3s may have anti-asthma effects, whereas IL-17-producing ILC3s may participate in the pathology of asthma, especially in obesity-related asthma. IL-2 and IL-8 recruit neutrophils to the lung. LTα1β2 stimulates mesenchymal stem cells (MSCs) to express ICAM-1 and VCAM-1. These molecules participate in the formation of a tertiary lymphoid organ in the tumor. See text for details
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO4"&gt;
                          &lt;ImageObject Color="Color" FileRef="MediaObjects/13238_2017_379_Fig4_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par45"&gt;iILC2-derived ILC3-like cells also play a role in 
                      &lt;Emphasis Type="Italic"&gt;Candida albicans&lt;/Emphasis&gt; infections. iILC2s express an intermediate amount of RORγt, i.e., one that is significantly different from nILC2s but lower than that in ILC3 cells. A small proportion of freshly isolated iILC2s produces IL-17 upon stimulation with PMA and ionomycin (Huang et al., 
                      &lt;CitationRef CitationID="CR56"&gt;2015&lt;/CitationRef&gt;). When cultured with TGF-β and IL-6, iILC2s become ILC3-like, produce IL-17, and lose the ability to produce IL-13. During 
                      &lt;Emphasis Type="Italic"&gt;C. albicans&lt;/Emphasis&gt; infection, iILC2 cells aid in the clearance of this pathogen. In the lungs of mice infected with 
                      &lt;Emphasis Type="Italic"&gt;C. albicans&lt;/Emphasis&gt;, transferred iILC2 cells become ILC3-like cells after 5 d; these ILC3-like cells produce IL-17 but not IL-13 (Huang et al., 
                      &lt;CitationRef CitationID="CR56"&gt;2015&lt;/CitationRef&gt;). Thus, iILC2 cells can transform into ILC3-like cells 
                      &lt;Emphasis Type="Italic"&gt;in vitro&lt;/Emphasis&gt; and 
                      &lt;Emphasis Type="Italic"&gt;in vivo&lt;/Emphasis&gt;, and gain the ability to protect the host against 
                      &lt;Emphasis Type="Italic"&gt;C. albicans&lt;/Emphasis&gt; (Huang et al., 
                      &lt;CitationRef CitationID="CR56"&gt;2015&lt;/CitationRef&gt;) (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt;).
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec21"&gt;
                    &lt;Heading&gt;ILC3s and asthma&lt;/Heading&gt;
                    &lt;Para ID="Par46"&gt;In addition to ILC2s, ILC3s are also involved in asthma. In an OVA-induced asthma murine model, Taube et al. found that IL-22 expression increased, and the IL-22 was mainly produced by innate lymphoid cells in the lungs, rather than by TH cells. OVA challenged IL-22-deficient mice suffered from much higher AHR. In contrast mice treated with IL-22 before OVA challenge displayed significantly reduced allergic airway inflammation. Based on these data, IL-22-producing ILC3s may participate in reducing allergic asthma pathology (Taube et al., 
                      &lt;CitationRef CitationID="CR131"&gt;2011&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par47"&gt;Obesity is a risk factor associated with asthma, and obese asthma patients respond poorly to typical anti-asthma medications, including corticosteroids (Sutherland et al., 
                      &lt;CitationRef CitationID="CR127"&gt;2009&lt;/CitationRef&gt;); therefore, a distinct immune mechanism must be at play in obese asthmatics. Mice fed a high-fat diet become obese and exhibit AHR through an IL-17A and NKRP3-dependent pathway, and this AHR also occurs in obese 
                      &lt;Emphasis Type="Italic"&gt;Rag1&lt;/Emphasis&gt;
                      &lt;Superscript&gt;−/−&lt;/Superscript&gt; mice (Kim et al., 
                      &lt;CitationRef CitationID="CR68"&gt;2014&lt;/CitationRef&gt;). In this model, the number of CCR6
                      &lt;Superscript&gt;+&lt;/Superscript&gt; IL-17A-producing ILC3s is elevated in the lung and macrophage-derived IL-1 directly causes AHR by stimulating this IL-17-producing ILC3 population (Kim et al., 
                      &lt;CitationRef CitationID="CR68"&gt;2014&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par48"&gt;Everaere et al. found a similar result where, compared with lean mice, the number of ILCs was increased in the lung of obese mice, and this effect was accompanied by eosinophil infiltration. Following an HDM challenge, the counts of ILC2s and ILC3s in the lung further increased, as did IL-33 and IL-1β levels, whereas ILC markers in visceral adipose tissue decreased. In an obese mouse model with ILC depletion, the HDM-induced inflammatory profile of the airway was profoundly decreased, including reduced Th2 and Th17 infiltration (Everaere et al., 
                      &lt;CitationRef CitationID="CR33"&gt;2016&lt;/CitationRef&gt;) (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig4"&gt;4&lt;/InternalRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par49"&gt;In humans, IL-17-producing ILCs are found in BAL fluid samples from asthma patients; their levels are increased in severe asthma patients compared with those in patients with mild asthma or control donors (Kim et al., 
                      &lt;CitationRef CitationID="CR68"&gt;2014&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par50"&gt;These results indicate that IL-22-producing-ILC3s may have an anti-asthma effect, whereas IL-17-producing ILC3s participate in the pathology of asthma, possibly providing a link between obesity and asthma. Further studies should be performed to help illuminate these potential connections.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec22"&gt;
                    &lt;Heading&gt;ILC3s and COPD&lt;/Heading&gt;
                    &lt;Para ID="Par51"&gt;IL-17A plays an essential role in the development of COPD. Since ILC3s have the ability to produce IL-17A it is therefore possible that ILC3s are linked with COPD. De Grove et al. (
                      &lt;CitationRef CitationID="CR20"&gt;2016&lt;/CitationRef&gt;) found that in patients with COPD, the population of NCR
                      &lt;Superscript&gt;−&lt;/Superscript&gt;ILC3s comprises the largest subset of ILCs (De Grove et al., 
                      &lt;CitationRef CitationID="CR20"&gt;2016&lt;/CitationRef&gt;). Bal et al. (
                      &lt;CitationRef CitationID="CR2"&gt;2016&lt;/CitationRef&gt;) also found that NKp44
                      &lt;Superscript&gt;−&lt;/Superscript&gt;ILC3 levels were increased, whereas the numbers of ILC2s and NKp44
                      &lt;Superscript&gt;+&lt;/Superscript&gt; ILC3s were significantly diminished in lung tissue from patients with severe COPD (Bal et al., 
                      &lt;CitationRef CitationID="CR2"&gt;2016&lt;/CitationRef&gt;). This supports our hypothesis that IL-17-producing ILC3s may play a role in COPD; however, the authors suggested that the accumulation of NCR
                      &lt;Superscript&gt;−&lt;/Superscript&gt;ILC3s in COPD could be associated with the protective immunity of the host in response to bacterial respiratory tract infections that occur frequently in patients with COPD. The involvement of ILC3s in COPD therefore requires further study (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig4"&gt;4&lt;/InternalRef&gt;).
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec23"&gt;
                    &lt;Heading&gt;ILC3s and tumors&lt;/Heading&gt;
                    &lt;Para ID="Par52"&gt;A dual effect of ILC3s on tumor immunity was suggested for intestinal tumors. On the one hand, IL-22 produced by ILC3s maintains mucosal integrity and clearance of pathogens and transformed cells. On the other hand, IL-22 activates the STAT3 cascade to enhance tumor generation (Kirchberger et al., 
                      &lt;CitationRef CitationID="CR70"&gt;2013&lt;/CitationRef&gt;). Carrega et al. (
                      &lt;CitationRef CitationID="CR13"&gt;2015&lt;/CitationRef&gt;) observed that NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s were enriched in non-small cell lung cancer (NSCLC) and that the proportion of NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s was positively associated with tumor stage. NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s were present in significantly higher amounts in stage I/II NSCLC tumors than in more tumors from more advanced stages. When stimulated, NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s, which had been freshly isolated from NSCLC tissues, produced IL-22, TNF-α, IL-8, and IL-2, but did not secrete IL-17. IL-22 maintains the integrity of epithelial cells (Dudakov et al., 
                      &lt;CitationRef CitationID="CR29"&gt;2015&lt;/CitationRef&gt;); TNF-α is a pro-inflammatory cytokine that exerts anti-tumor and anti-pathogen effects, and IL-8 and IL-2 enhance leukocyte recruitment and proliferation (Waugh and Wilson, 
                      &lt;CitationRef CitationID="CR140"&gt;2008&lt;/CitationRef&gt;; Boyman and Sprent, 
                      &lt;CitationRef CitationID="CR11"&gt;2012&lt;/CitationRef&gt;). Based on the characteristics of the cytokines produced by NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s, it was concluded that these cells might play a role in anti-tumor defenses (Carrega et al., 
                      &lt;CitationRef CitationID="CR13"&gt;2015&lt;/CitationRef&gt;).
                    &lt;/Para&gt;
                    &lt;Para ID="Par53"&gt;As stated above, LTi is the prototype for ILC3s. LTi cells produce lymphotoxin α, lymphotoxin β, and TNF-α. They also stimulate stromal cells to produce vascular cell adhesion molecule 1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1), which recruit the immune cells and form the fetal lymphoid node and Peyer’s patches (Kelly and Scollay, 
                      &lt;CitationRef CitationID="CR64"&gt;1992&lt;/CitationRef&gt;; Mebius et al., 
                      &lt;CitationRef CitationID="CR94"&gt;1997&lt;/CitationRef&gt;; Yoshida et al., 
                      &lt;CitationRef CitationID="CR148"&gt;1999&lt;/CitationRef&gt;; Eberl et al., 
                      &lt;CitationRef CitationID="CR30"&gt;2004&lt;/CitationRef&gt;; Finke, 
                      &lt;CitationRef CitationID="CR35"&gt;2005&lt;/CitationRef&gt;; Cupedo et al., 
                      &lt;CitationRef CitationID="CR18"&gt;2009&lt;/CitationRef&gt;). Lung cancer-derived NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s express more lymphotoxin mRNA than their tonsil counterparts. Furthermore, lung cancer-derived NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s elicit significant up-regulation of ICAM-1 and VCAM-1 in mesenchymal stem cells in a lymphotoxin α, lymphotoxin β, and TNF-α dependent manner. Additionally, NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s preferentially reside at the edge of lymphoid structures associated with NSCLC, and the percentage of NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s is correlated with the density of tertiary lymphoid structures in the tumor region. These observations suggest that NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s might play a role in the formation and maintenance of these structures as well as lymphoid aggregates in tumor tissue (Carrega et al., 
                      &lt;CitationRef CitationID="CR13"&gt;2015&lt;/CitationRef&gt;). Otherwise, NCR
                      &lt;Superscript&gt;−&lt;/Superscript&gt;ILC3s can gain pro-inflammatory properties by engaging NKp44, as the number of NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3s is increased in the lung tumor region (Fig.&nbsp;
                      &lt;InternalRef RefID="Fig4"&gt;4&lt;/InternalRef&gt;). Whether the conversion of NCR
                      &lt;Superscript&gt;−&lt;/Superscript&gt;ILC3 to NCR
                      &lt;Superscript&gt;+&lt;/Superscript&gt;ILC3 cells contributes to this increased number and how the tumor microenvironment influences this conversion are questions that should be answered in future studies. Additionally, the question of whether IL-22-producing ILC3s enhance or inhibit tumors in the lung remains unresolved and should be studied further.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec24"&gt;
                  &lt;Heading&gt;Conclusions&lt;/Heading&gt;
                  &lt;Para ID="Par54"&gt;ILCs are attracting increasing attention on account of their distinct tissue-resident properties. Although it is known that ILCs are involved in pulmonary infection, asthma, COPD, fibrosis, and tumors in the lung, in-depth studies are still only in their infancy. The mechanisms of ILC activation, proliferation, and regulation in the lung are not clear; how exactly the pathological environment affects ILC function and how ILCs respond to the environment also remain unknown. Elucidation of these mechanisms is therefore an urgent matter, especially in pulmonary diseases. Answers to these questions will hopefully provide new clues for the treatment of these serious human diseases.
&lt;/Para&gt;
                &lt;/Section1&gt;
              &lt;/Body&gt;
              &lt;BodyRef FileRef="BodyRef/PDF/13238_2017_Article_379.pdf" TargetType="OnlinePDF"/&gt;
              &lt;ArticleBackmatter&gt;
                &lt;Acknowledgments&gt;
                  &lt;Heading&gt;ACKNOWLEDGMENTS&lt;/Heading&gt;
                  &lt;SimplePara&gt;This work was supported by the National Natural Science Foundation of China (Grant No. 81571534), and Youth Development Fund of First Hospital of Jilin University (No. JDYY72016041). We are grateful to Ying Sun for critical reading of this manuscript. We sincerely apologize to the authors whose work was not cited in this review due to the space limitations.&lt;/SimplePara&gt;
                  &lt;FormalPara ID="FPar1" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;ABBREVIATIONS&lt;/Heading&gt;
                    &lt;Para ID="Par55"&gt;AHR, airway hyper-responsiveness; APC, antigen-presenting cell; Bcl11b, B cell leukemia/lymphoma 11b; BLF, bronchoalveolar lavage fluid; CCR6, C-C motif chemokine receptor 6; COPD, chronic obstructive pulmonary disease; CysLT1, cysteinyl leukotriene receptor 1; DC, dendritic cell; EPE, eosinophilic pleural effusion; G9a, lysine methyltransferase G9a; GATA3, GATA binding protein 3; GFP, green fluorescent protein; GM-CSF, granulocyte-macrophage colony-stimulating factor; HDM, house dust mite; HES, 
                      &lt;Emphasis Type="Italic"&gt;Heligmosomoides polygyrus&lt;/Emphasis&gt; excretory/secretory products; ICAM-1, intercellular adhesion molecule 1; IFN-γ, interferon-γ; ILCs, innate lymphoid cells; IL-2Rγ, common γ chain of the interleukin-2 receptor; IRF4, interferon regulatory factor 4; Lin, lineage; LTi, lymphoid tissue inducer; NCR, natural cytotoxicity triggering receptor; NK cell, nature killer cell; NSCLC, non-small cell lung cancer; OVA, ovalbumin; PSP, primary spontaneous pneumothorax; RAG, recombination-activating gene; ROR, retinoic acid receptor-related orphan receptor; TGF-β, transforming growth factor-β; Th cells, T helper cells; TLR5, Toll-like receptor 5; TNF, tumor necrosis factor; TSLP, thymic stromal lymphopoietin; VCAM-1, vascular cell adhesion molecule-1
                    &lt;/Para&gt;
                  &lt;/FormalPara&gt;
                  &lt;FormalPara ID="FPar2" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;COMPLIANCE WITH ETHICS GUIDELINES&lt;/Heading&gt;
                    &lt;Para ID="Par56"&gt;Hang Cheng, Chengyan Jin, Jing Wu, Shan Zhu, Yong-Jun Liu, and Jingtao Chen declare that they have no competing interest. This article does not contain any studies with human or animal subjects performed by any of the authors.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Acknowledgments&gt;
                &lt;Bibliography ID="Bib1"&gt;
                  &lt;Heading&gt;REFERENCES&lt;/Heading&gt;
                  &lt;Citation ID="CR1"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Abt&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lewis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Caballero&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xiong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carter&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Susac&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ling&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Leiner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pamer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cell Host Microbe&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;18&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;27&lt;/FirstPage&gt;
                      &lt;LastPage&gt;37&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhtV2lt7nL&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26159718&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4537644&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.chom.2015.06.011&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Abt MC, Lewis BB, Caballero S, Xiong H, Carter RA, Susac B, Ling L, Leiner I, Pamer EG (2015) Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection. Cell Host Microbe 18:27–37&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR2"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bal&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bernink&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nagasawa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Groot&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shikhagaie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Golebski&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Drunen&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lutter&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jonkers&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hombrink&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;636&lt;/FirstPage&gt;
                      &lt;LastPage&gt;645&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xms1Wku7c%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27111145&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3444&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K, van Drunen CM, Lutter R, Jonkers RE, Hombrink P et al (2016) IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol 17:636–645&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR3"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bando&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Locksley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;153&lt;/FirstPage&gt;
                      &lt;LastPage&gt;160&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXitFKltL7F&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25501629&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3057&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Bando JK, Liang HE, Locksley RM (2015) Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine. Nat Immunol 16:153–160&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR4"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barlow&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bellosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hardman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Drynan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cruickshank&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;129&lt;/VolumeID&gt;
                      &lt;IssueID&gt;191–198&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e191&lt;/FirstPage&gt;
                      &lt;LastPage&gt;e194&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jaci.2011.09.041&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXhs1yrsLbK&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, Cruickshank JP, McKenzie AN (2012) Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 129(191–198):e191–e194&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR5"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barnes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The cytokine network in chronic obstructive pulmonary disease&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Respir Cell Mol Biol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;41&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;631&lt;/FirstPage&gt;
                      &lt;LastPage&gt;638&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1MXhsFWisbvE&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19717810&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1165/rcmb.2009-0220TR&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Barnes PJ (2009) The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 41:631–638&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR6"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barnig&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cernadas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dutile&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Perrella&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kazani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ME&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wechsler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Israel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Levy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Sci Transl Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;5&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;174ra126&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1126/scitranslmed.3004812&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXktV2gs7Y%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, Wechsler ME, Israel E, Levy BD (2013) Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 5:174ra126&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR7"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bartemes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Iijima&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kobayashi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kephart&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-33-responsive lineage- CD25&nbsp;+&nbsp;CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;188&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1503&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1513&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XpslKmtw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22198948&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.4049/jimmunol.1102832&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H (2012) IL-33-responsive lineage- CD25&nbsp;+&nbsp;CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 188:1503–1513&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR8"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bartemes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kephart&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fox&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Enhanced innate type 2 immune response in peripheral blood from patients with asthma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;134&lt;/VolumeID&gt;
                      &lt;IssueID&gt;671–678&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e674&lt;/FirstPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Bartemes KR, Kephart GM, Fox SJ, Kita H (2014) Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 134(671–678):e674&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR9"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bernink&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Peters&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Munneke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Velde&lt;/FamilyName&gt;
                        &lt;Particle&gt;te&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Meijer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Weijer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hreggvidsdottir&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Heinsbroek&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Legrand&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Buskens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;221&lt;/FirstPage&gt;
                      &lt;LastPage&gt;229&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhtV2qtrw%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23334791&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.2534&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ et al (2013) Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14:221–229&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR10"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bernink&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Krabbendam&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Germar&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jong&lt;/FamilyName&gt;
                        &lt;Particle&gt;de&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gronke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kofoed-Nielsen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Munneke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hazenberg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Villaudy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Buskens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Interleukin-12 and -23 CONTROL PLASTICITY of CD127(+) Group 1 and Group 3 Innate lymphoid cells in the intestinal lamina propria&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;43&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;146&lt;/FirstPage&gt;
                      &lt;LastPage&gt;160&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhtFKrtLvM&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26187413&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2015.06.019&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, Munneke JM, Hazenberg MD, Villaudy J, Buskens CJ et al (2015) Interleukin-12 and -23 CONTROL PLASTICITY of CD127(+) Group 1 and Group 3 Innate lymphoid cells in the intestinal lamina propria. Immunity 43:146–160&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR11"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Boyman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sprent&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The role of interleukin-2 during homeostasis and activation of the immune system&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Rev Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;12&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;180&lt;/FirstPage&gt;
                      &lt;LastPage&gt;190&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XitlKnsrg%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22343569&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Boyman O, Sprent J (2012) The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12:180–190&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR12"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Buonocore&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ahern&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Uhlig&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;II&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ivanov&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Littman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maloy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Powrie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nature&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;464&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1371&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1375&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXkslartLY%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20393462&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3796764&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nature08949&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:1371–1375&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR13"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carrega&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Loiacono&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carlo&lt;/FamilyName&gt;
                        &lt;Particle&gt;Di&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scaramuccia&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mora&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Conte&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Benelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spaggiari&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cantoni&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Campana&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Commun&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;6&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;8280&lt;/FirstPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhsFGks7%2FK&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26395069&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ncomms9280&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Carrega P, Loiacono F, Di Carlo E, Scaramuccia A, Mora M, Conte R, Benelli R, Spaggiari GM, Cantoni C, Campana S et al (2015) NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat Commun 6:8280&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR14"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cella&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fuchs&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vermi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Facchetti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Otero&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lennerz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Doherty&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mills&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Colonna&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nature&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;457&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;722&lt;/FirstPage&gt;
                      &lt;LastPage&gt;725&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1MXht1eiu7c%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;18978771&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nature07537&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, Colonna M (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457:722–725&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR15"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cella&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Otero&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Colonna&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Proc Natl Acad Sci USA&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;107&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;10961&lt;/FirstPage&gt;
                      &lt;LastPage&gt;10966&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXotVOjsr8%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20534450&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2890739&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1073/pnas.1005641107&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Cella M, Otero K, Colonna M (2010) Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity. Proc Natl Acad Sci USA 107:10961–10966&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR16"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Albacker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Baumgarth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Smith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dekruyff&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Umetsu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;12&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;631&lt;/FirstPage&gt;
                      &lt;LastPage&gt;638&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXmslSrt7w%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21623379&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3417123&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.2045&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12:631–638&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR17"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Crellin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Trifari&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kaplan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cupedo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spits&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Human NKp44+IL-22+&nbsp;cells and LTi-like cells constitute a stable RORC+&nbsp;lineage distinct from conventional natural killer cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;207&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;281&lt;/FirstPage&gt;
                      &lt;LastPage&gt;290&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXitFGqtbk%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20142432&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2822607&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20091509&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Crellin NK, Trifari S, Kaplan CD, Cupedo T, Spits H (2010) Human NKp44+IL-22+&nbsp;cells and LTi-like cells constitute a stable RORC+&nbsp;lineage distinct from conventional natural killer cells. J Exp Med 207:281–290&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR18"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cupedo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Crellin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Papazian&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rombouts&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Weijer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grogan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fibbe&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cornelissen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spits&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+&nbsp;natural killer-like cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;66&lt;/FirstPage&gt;
                      &lt;LastPage&gt;74&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1cXhsVWhu7jO&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19029905&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.1668&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, Fibbe WE, Cornelissen JJ, Spits H (2009) Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+&nbsp;natural killer-like cells. Nat Immunol 10:66–74&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR19"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dadi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chhangawala&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Whitlock&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Franklin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Luo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Toure&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pritykin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Huse&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Leslie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cell&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;164&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;365&lt;/FirstPage&gt;
                      &lt;LastPage&gt;377&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XhsVKitbs%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26806130&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4733424&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.cell.2016.01.002&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Dadi S, Chhangawala S, Whitlock BM, Franklin RA, Luo CT, Oh SA, Toure A, Pritykin Y, Huse M, Leslie CS et al (2016) Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells. Cell 164:365–377&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR20"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grove&lt;/FamilyName&gt;
                        &lt;Particle&gt;De&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Provoost&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Verhamme&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bracke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Joos&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brusselle&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Characterization and quantification of innate lymphoid cell subsets in human lung&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;PLoS ONE&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;11&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;e0145961&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26727464&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4699688&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1371/journal.pone.0145961&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;De Grove KC, Provoost S, Verhamme FM, Bracke KR, Joos GF, Maes T, Brusselle GG (2016) Characterization and quantification of innate lymphoid cell subsets in human lung. PLoS ONE 11:e0145961&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR21"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Deckers&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Branco Madeira&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hammad&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate immune cells in asthma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Trends Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;34&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;540&lt;/FirstPage&gt;
                      &lt;LastPage&gt;547&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhsVClur7J&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24035576&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.it.2013.08.004&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Deckers J, Branco Madeira F, Hammad H (2013) Innate immune cells in asthma. Trends Immunol 34:540–547&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR22"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Denney&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Byrne&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shea&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Buckley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pease&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Herledan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Walker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gregory&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lloyd&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Pulmonary epithelial cell-derived cytokine TGF-beta1 is a critical cofactor for enhanced innate lymphoid cell function&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;43&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;945&lt;/FirstPage&gt;
                      &lt;LastPage&gt;958&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhvVKmtbzL&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26588780&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4658339&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2015.10.012&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Denney L, Byrne AJ, Shea TJ, Buckley JS, Pease JE, Herledan GM, Walker SA, Gregory LG, Lloyd CM (2015) Pulmonary epithelial cell-derived cytokine TGF-beta1 is a critical cofactor for enhanced innate lymphoid cell function. Immunity 43:945–958&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR23"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Doherty&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Khorram&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lund&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mehta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Croft&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Broide&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;132&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;205&lt;/FirstPage&gt;
                      &lt;LastPage&gt;213&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXosVGgsLY%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23688412&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3704056&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jaci.2013.03.048&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH (2013) Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol 132:205–213&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR24"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dolinay&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kaminski&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Felgendreher&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Reynolds&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Watkins&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Karp&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Uhlig&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Choi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2006&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Gene expression profiling of target genes in ventilator-induced lung injury&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Physiol Genom&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;26&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;68&lt;/FirstPage&gt;
                      &lt;LastPage&gt;75&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD28XmsFersLw%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1152/physiolgenomics.00110.2005&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Dolinay T, Kaminski N, Felgendreher M, Kim HP, Reynolds P, Watkins SC, Karp D, Uhlig S, Choi AM (2006) Gene expression profiling of target genes in ventilator-induced lung injury. Physiol Genom 26:68–75&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR25"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Doorduijn&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rooijakkers&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schaik&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bardoel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Complement resistance mechanisms of 
                        &lt;Emphasis Type="Italic"&gt;Klebsiella pneumoniae&lt;/Emphasis&gt;
                      &lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunobiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;221&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1102&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1109&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XhtVOnt7jL&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27364766&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.imbio.2016.06.014&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Doorduijn DJ, Rooijakkers SH, van Schaik W, Bardoel BW (2016) Complement resistance mechanisms of 
                      &lt;Emphasis Type="Italic"&gt;Klebsiella pneumoniae&lt;/Emphasis&gt;. Immunobiology 221:1102–1109
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR26"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Drake&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Group 2 innate lymphoid cells in the lung&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Adv Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;124&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1&lt;/FirstPage&gt;
                      &lt;LastPage&gt;16&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25175771&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4449733&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/B978-0-12-800147-9.00001-7&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Drake LY, Kita H (2014) Group 2 innate lymphoid cells in the lung. Adv Immunol 124:1–16&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR27"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Drake&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Iijima&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Group 2 innate lymphoid cells and CD4+&nbsp;T cells cooperate to mediate type 2 immune response in mice&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Allergy&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;69&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1300&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1307&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXhsFarsb%2FN&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24939388&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4160406&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1111/all.12446&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Drake LY, Iijima K, Kita H (2014) Group 2 innate lymphoid cells and CD4+&nbsp;T cells cooperate to mediate type 2 immune response in mice. Allergy 69:1300–1307&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR28"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Drake&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Iijima&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bartemes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Group 2 innate lymphoid cells promote an early antibody response to a respiratory antigen in mice&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;197&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1335&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1342&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xht1yrtrvO&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27421480&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4976030&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.4049/jimmunol.1502669&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Drake LY, Iijima K, Bartemes K, Kita H (2016) Group 2 innate lymphoid cells promote an early antibody response to a respiratory antigen in mice. J Immunol 197:1335–1342&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR29"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dudakov&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hanash&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brink&lt;/FamilyName&gt;
                        &lt;Particle&gt;van den&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Interleukin-22: immunobiology and pathology&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Annu Rev Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;33&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;747&lt;/FirstPage&gt;
                      &lt;LastPage&gt;785&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhsVSisL7F&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25706098&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4407497&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1146/annurev-immunol-032414-112123&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Dudakov JA, Hanash AM, van den Brink MR (2015) Interleukin-22: immunobiology and pathology. Annu Rev Immunol 33:747–785&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR30"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Eberl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marmon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sunshine&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rennert&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Choi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Littman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2004&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;5&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;64&lt;/FirstPage&gt;
                      &lt;LastPage&gt;73&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD3sXhtVWhtr3N&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;14691482&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni1022&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR (2004) An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 5:64–73&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR31"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Eberl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Colonna&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Santo&lt;/FamilyName&gt;
                        &lt;Particle&gt;Di&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells: a new paradigm in immunology&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Science&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;348&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;aaa6566&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25999512&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;5658207&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1126/science.aaa6566&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXosFakurw%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Eberl G, Colonna M, Di Santo JP, McKenzie AN (2015) Innate lymphoid cells: a new paradigm in immunology. Science 348:aaa6566&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR32"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Enomoto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Orihara&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takamasu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matsuda&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Saito&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Okayama&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;124&lt;/VolumeID&gt;
                      &lt;IssueID&gt;913–920&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e911&lt;/FirstPage&gt;
                      &lt;LastPage&gt;e917&lt;/LastPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Enomoto Y, Orihara K, Takamasu T, Matsuda A, Gon Y, Saito H, Ra C, Okayama Y (2009) Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack. J Allergy Clin Immunol 124(913–920):e911–e917&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR33"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Everaere&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ait-Yahia&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Molendi-Coste&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vorng&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Quemener&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;LeVu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fleury&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bouchaert&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Duez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells contribute to allergic airway disease exacerbation by obesity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;138&lt;/VolumeID&gt;
                      &lt;IssueID&gt;5&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1309&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1318&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xns1elsLc%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27177781&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jaci.2016.03.019&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Everaere L, Ait-Yahia S, Molendi-Coste O, Vorng H, Quemener S, LeVu P, Fleury S, Bouchaert E, Fan Y, Duez C et al (2016) Innate lymphoid cells contribute to allergic airway disease exacerbation by obesity. J Allergy Clin Immunol 138(5):1309–1318&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR34"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rudensky&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Hallmarks of tissue-resident lymphocytes&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cell&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;164&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1198&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1211&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XktFKjs7o%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26967286&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4973889&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.cell.2016.02.048&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Fan X, Rudensky AY (2016) Hallmarks of tissue-resident lymphocytes. Cell 164:1198–1211&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR35"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Finke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Fate and function of lymphoid tissue inducer cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Curr Opin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;144&lt;/FirstPage&gt;
                      &lt;LastPage&gt;150&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD2MXit1Cht7k%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;15766673&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.coi.2005.01.006&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Finke D (2005) Fate and function of lymphoid tissue inducer cells. Curr Opin Immunol 17:144–150&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR36"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fort&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cheung&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Li&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zurawski&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Menon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Clifford&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hunte&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lesley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2001&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;15&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;985&lt;/FirstPage&gt;
                      &lt;LastPage&gt;995&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD38Xhsl2ksA%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;11754819&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S1074-7613(01)00243-6&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R et al (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15:985–995&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR37"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fuchs&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vermi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lonardi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gilfillan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Newberry&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cella&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Colonna&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;38&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;769&lt;/FirstPage&gt;
                      &lt;LastPage&gt;781&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXjtlamu7Y%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23453631&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3634355&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2013.02.010&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M (2013) Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38:769–781&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR38"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fukumoto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Harada&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kawaguchi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Suetsugu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maeyama&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Inoshima&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hamada&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kuwano&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nakanishi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Amphiregulin attenuates bleomycin-induced pneumopathy in mice&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Physiol Lung Cell Mol Physiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;298&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;L131&lt;/FirstPage&gt;
                      &lt;LastPage&gt;L138&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXhvVyrsbw%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19915156&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1152/ajplung.90576.2008&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Fukumoto J, Harada C, Kawaguchi T, Suetsugu S, Maeyama T, Inoshima I, Hamada N, Kuwano K, Nakanishi Y (2010) Amphiregulin attenuates bleomycin-induced pneumopathy in mice. Am J Physiol Lung Cell Mol Physiol 298:L131–L138&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR39"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gasteiger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dikiy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rudensky&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Science&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;350&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;981&lt;/FirstPage&gt;
                      &lt;LastPage&gt;985&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhvVeqsrrM&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26472762&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4720139&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1126/science.aac9593&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Gasteiger G, Fan X, Dikiy S, Lee SY, Rudensky AY (2015) Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350:981–985&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR40"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gentek&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Munneke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Helbig&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Blom&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hazenberg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spits&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Amsen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Modulation of signal strength switches notch from an inducer of T cells to an inducer of ILC2&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Front Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;4&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;334&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24155745&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3804867&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3389/fimmu.2013.00334&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXht1ejsbfI&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Gentek R, Munneke JM, Helbig C, Blom B, Hazenberg MD, Spits H, Amsen D (2013) Modulation of signal strength switches notch from an inducer of T cells to an inducer of ILC2. Front Immunol 4:334&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR41"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gladiator&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wangler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Trautwein-Weidner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;LeibundGut-Landmann&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;190&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;521&lt;/FirstPage&gt;
                      &lt;LastPage&gt;525&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXjtlGqtg%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23255360&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.4049/jimmunol.1202924&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Gladiator A, Wangler N, Trautwein-Weidner K, LeibundGut-Landmann S (2013) Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 190:521–525&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR42"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Glatzer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Killig&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Meisig&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ommert&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Luetke-Eversloh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Babic&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Paclik&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bluthgen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Seidl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Seifarth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;38&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1223&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1235&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXpvVentrw%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23791642&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2013.05.013&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Glatzer T, Killig M, Meisig J, Ommert I, Luetke-Eversloh M, Babic M, Paclik D, Bluthgen N, Seidl R, Seifarth C et al (2013) RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 38:1223–1235&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR43"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gold&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Antignano&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Halim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hirota&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Blanchet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zaph&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takei&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KM&lt;/Initials&gt;
                        &lt;FamilyName&gt;McNagny&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;133&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1142&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1148&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXmtVCgur0%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24679471&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jaci.2014.02.033&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Gold MJ, Antignano F, Halim TY, Hirota JA, Blanchet MR, Zaph C, Takei F, McNagny KM (2014) Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 133:1142–1148&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR44"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grainger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Smith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hewitson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mcsorley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Harcus&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Filbey&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Finney&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Greenwood&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Knox&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wilson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;207&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2331&lt;/FirstPage&gt;
                      &lt;LastPage&gt;2341&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXhsVSktLzM&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20876311&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2964568&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20101074&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Grainger JR, Smith KA, Hewitson JP, Mcsorley HJ, Harcus Y, Filbey KJ, Finney CA, Greenwood EJ, Knox DP, Wilson MS (2010) Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med 207:2331–2341&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR45"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Halim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Krauss&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sun&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takei&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;36&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;451&lt;/FirstPage&gt;
                      &lt;LastPage&gt;463&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XktVaktbk%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22425247&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2011.12.020&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Halim TY, Krauss RH, Sun AC, Takei F (2012a) Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36:451–463&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR46"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Halim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;MacLaren&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Romanish&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gold&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KM&lt;/Initials&gt;
                        &lt;FamilyName&gt;McNagny&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takei&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;37&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;463&lt;/FirstPage&gt;
                      &lt;LastPage&gt;474&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XhtlGjsrzN&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22981535&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2012.06.012&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Halim TY, MacLaren A, Romanish MT, Gold MJ, McNagny KM, Takei F (2012b) Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 37:463–474&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR47"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Halim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Steer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matha&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gold&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Martinez-Gonzalez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KM&lt;/Initials&gt;
                        &lt;FamilyName&gt;McNagny&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takei&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;40&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;425&lt;/FirstPage&gt;
                      &lt;LastPage&gt;435&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXjslahur4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24613091&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4210641&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2014.01.011&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Halim TY, Steer CA, Matha L, Gold MJ, Martinez-Gonzalez I, McNagny KM, McKenzie AN, Takei F (2014) Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40:425–435&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR48"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Halim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hwang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ST&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scanlon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zaghouani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Garbi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fallon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Group 2 innate lymphoid cells license dendritic cells to potentiate memory T2 cell responses&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;57&lt;/FirstPage&gt;
                      &lt;LastPage&gt;64&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26523868&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4685755&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3294&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhslGiu7%2FI&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Halim TY, Hwang YY, Scanlon ST, Zaghouani H, Garbi N, Fallon PG, McKenzie AN (2015) Group 2 innate lymphoid cells license dendritic cells to potentiate memory T2 cell responses. Nat Immunol 17:57–64&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR49"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hams&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ME&lt;/Initials&gt;
                        &lt;FamilyName&gt;Armstrong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barlow&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Saunders&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schwartz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cooke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fahy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Crotty&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hirani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Flynn&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Proc Natl Acad Sci USA&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;111&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;367&lt;/FirstPage&gt;
                      &lt;LastPage&gt;372&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXps1OgsA%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24344271&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1073/pnas.1315854111&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hams E, Armstrong ME, Barlow JL, Saunders SP, Schwartz C, Cooke G, Fahy RJ, Crotty TB, Hirani N, Flynn RJ et al (2014) IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci USA 111:367–372&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR50"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hansen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Berry&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RH&lt;/Initials&gt;
                        &lt;FamilyName&gt;DeKruyff&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Umetsu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1999&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Invest&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;103&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;175&lt;/FirstPage&gt;
                      &lt;LastPage&gt;183&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DyaK1MXltFeqsw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;9916129&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;407883&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1172/JCI5155&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hansen G, Berry G, DeKruyff RH, Umetsu DT (1999) Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 103:175–183&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR51"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Held&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kijima&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Angelov&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bessoles&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The function of natural killer cells: education, reminders and some good memories&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Curr Opin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;23&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;228&lt;/FirstPage&gt;
                      &lt;LastPage&gt;233&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXkt1KisbY%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21159498&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.coi.2010.11.008&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Held W, Kijima M, Angelov G, Bessoles S (2011) The function of natural killer cells: education, reminders and some good memories. Curr Opin Immunol 23:228–233&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR52"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hesslein&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lanier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Transcriptional control of natural killer cell development and function&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Adv Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;109&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;45&lt;/FirstPage&gt;
                      &lt;LastPage&gt;85&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXpsFGksLw%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21569912&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/B978-0-12-387664-5.00002-9&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hesslein DG, Lanier LL (2011) Transcriptional control of natural killer cell development and function. Adv Immunol 109:45–85&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR53"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Holt&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Strickland&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ME&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wikstrom&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jahnsen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2008&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Regulation of immunological homeostasis in the respiratory tract&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Rev Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;8&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;142&lt;/FirstPage&gt;
                      &lt;LastPage&gt;152&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1cXhtVGis7s%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;18204469&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nri2236&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL (2008) Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol 8:142–152&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR54"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bentley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chung&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lei&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Steenrod&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Q&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;US&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sajjan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hershenson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;134&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;429&lt;/FirstPage&gt;
                      &lt;LastPage&gt;439&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXpslClsL4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24910174&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4119851&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jaci.2014.04.020&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hong JY, Bentley JK, Chung Y, Lei J, Steenrod JM, Chen Q, Sajjan US, Hershenson MB (2014) Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. J Allergy Clin Immunol 134:429–439&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR55"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoorweg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Peters&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cornelissen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Aparicio-Domingo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Papazian&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kazemier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mjosberg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spits&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cupedo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Functional differences between human NKp44(-) and NKp44(+) RORC(+) innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Front Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;3&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;72&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22566953&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3342004&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3389/fimmu.2012.00072&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hoorweg K, Peters CP, Cornelissen F, Aparicio-Domingo P, Papazian N, Kazemier G, Mjosberg JM, Spits H, Cupedo T (2012) Functional differences between human NKp44(-) and NKp44(+) RORC(+) innate lymphoid cells. Front Immunol 3:72&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR56"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Huang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Guo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Qiu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hu-Li&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;U&lt;/Initials&gt;
                        &lt;FamilyName&gt;Siebenlist&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Williamson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Urban&lt;/FamilyName&gt;
                        &lt;Suffix&gt;Jr&lt;/Suffix&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Paul&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;161&lt;/FirstPage&gt;
                      &lt;LastPage&gt;169&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXitFKltL%2FN&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25531830&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3078&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Huang Y, Guo L, Qiu J, Chen X, Hu-Li J, Siebenlist U, Williamson PR, Urban JF Jr, Paul WE (2015) IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells. Nat Immunol 16:161–169&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR57"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hughes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Briercheck&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Freud&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Trotta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;McClory&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scoville&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Keller&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Deng&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cole&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Harrison&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cell Rep&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;8&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;150&lt;/FirstPage&gt;
                      &lt;LastPage&gt;162&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXhtVCjur%2FJ&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24953655&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4133146&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.celrep.2014.05.042&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hughes T, Briercheck EL, Freud AG, Trotta R, McClory S, Scoville SD, Keller K, Deng Y, Cole J, Harrison N et al (2014) The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Cell Rep 8:150–162&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR58"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hutchinson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fogarty&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hubbard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKeever&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur Respir J&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;46&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;795&lt;/FirstPage&gt;
                      &lt;LastPage&gt;806&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25976683&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1183/09031936.00185114&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hutchinson J, Fogarty A, Hubbard R, McKeever T (2015) Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J 46:795–806&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR59"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Iijima&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kobayashi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hara&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kephart&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ziegler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;193&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1549&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1559&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXht1KjurbP&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25015831&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4119518&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.4049/jimmunol.1302984&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Iijima K, Kobayashi T, Hara K, Kephart GM, Ziegler SF, McKenzie AN, Kita H (2014) IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure. J Immunol 193:1549–1559&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR60"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jia&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Z&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-13+&nbsp;Type 2 innate lymphoid cells correlate with asthma control status and treatment response&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Respir Cell Mol Biol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;55&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;675&lt;/FirstPage&gt;
                      &lt;LastPage&gt;683&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2sXit12qtbg%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27314535&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1165/rcmb.2016-0099OC&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Jia Y, Fang X, Zhu X, Bai C, Zhu L, Jin M, Wang X, Hu M, Tang R, Chen Z (2016) IL-13+&nbsp;Type 2 innate lymphoid cells correlate with asthma control status and treatment response. Am J Respir Cell Mol Biol 55:675–683&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR61"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kalomenidis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Light&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2003&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Eosinophilic pleural effusions&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Curr Opin Pulm Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;9&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;254&lt;/FirstPage&gt;
                      &lt;LastPage&gt;260&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;12806236&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/00063198-200307000-00002&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kalomenidis I, Light RW (2003) Eosinophilic pleural effusions. Curr Opin Pulm Med 9:254–260&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR62"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Karta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Broide&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Doherty&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Insights into Group 2 innate lymphoid cells in human airway disease&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Curr Allergy Asthma Rep&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;8&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26746844&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;5026503&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s11882-015-0581-6&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XovVShtQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Karta MR, Broide DH, Doherty TA (2016) Insights into Group 2 innate lymphoid cells in human airway disease. Curr Allergy Asthma Rep 16:8&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR63"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kearley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Silver&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sanden&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Z&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Berlin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;White&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mori&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pham&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ward&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Criner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;42&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;566&lt;/FirstPage&gt;
                      &lt;LastPage&gt;579&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXks12jtr0%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25786179&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2015.02.011&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kearley J, Silver JS, Sanden C, Liu Z, Berlin AA, White N, Mori M, Pham TH, Ward CK, Criner GJ et al (2015) Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. Immunity 42:566–579&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR64"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kelly&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scollay&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1992&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Seeding of neonatal lymph nodes by T cells and identification of a novel population of CD3-CD4+&nbsp;cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;22&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;329&lt;/FirstPage&gt;
                      &lt;LastPage&gt;334&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK387msVOjtQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;1347010&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1002/eji.1830220207&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kelly KA, Scollay R (1992) Seeding of neonatal lymph nodes by T cells and identification of a novel population of CD3-CD4+&nbsp;cells. Eur J Immunol 22:329–334&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR65"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Killig&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Glatzer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Romagnani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Recognition strategies of group 3 innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Front Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;5&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;142&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24744763&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3978353&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3389/fimmu.2014.00142&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXht1enu7zI&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Killig M, Glatzer T, Romagnani C (2014) Recognition strategies of group 3 innate lymphoid cells. Front Immunol 5:142&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR66"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Subramanian&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Albacker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matangkasombut&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Savage&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Smith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rottman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;129&lt;/VolumeID&gt;
                      &lt;IssueID&gt;216–227&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e211&lt;/FirstPage&gt;
                      &lt;LastPage&gt;e216&lt;/LastPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, Matangkasombut P, Savage PB, McKenzie AN, Smith DE, Rottman JB et al (2012) Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol 129(216–227):e211–e216&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR67"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Siracusa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Saenz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Noti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Monticelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sonnenberg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hepworth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Voorhees&lt;/FamilyName&gt;
                        &lt;Particle&gt;Van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Comeau&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Artis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Sci Transl Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;5&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;170ra116&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1126/scitranslmed.3005374&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXis1ynsr0%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, Hepworth MR, Van Voorhees AS, Comeau MR, Artis D (2013) TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 5:170ra116&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR68"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pichavant&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shore&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fitzgerald&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Iwakura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Israel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bolger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Faul&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;20&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;54&lt;/FirstPage&gt;
                      &lt;LastPage&gt;61&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhvFentb%2FE&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24336249&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nm.3423&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kim HY, Lee HJ, Chang YJ, Pichavant M, Shore SA, Fitzgerald KA, Iwakura Y, Israel E, Bolger K, Faul J et al (2014) Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 20:54–61&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR69"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kwon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Do&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Han&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Polym J&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;646&lt;/FirstPage&gt;
                      &lt;LastPage&gt;655&lt;/LastPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kim J, Kwon J, Kim M, Do J, Lee D, Han H (2016) IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Polym J 17:646–655&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR70"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kirchberger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Royston&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Boulard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Thornton&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Franchini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Szabady&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Harrison&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Powrie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;210&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;917&lt;/FirstPage&gt;
                      &lt;LastPage&gt;931&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXntlKjsr0%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23589566&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3646494&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20122308&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kirchberger S, Royston DJ, Boulard O, Thornton E, Franchini F, Szabady RL, Harrison O, Powrie F (2013) Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 210:917–931&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR71"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klein Wolterink&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kleinjan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nimwegen&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bergen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bruijn&lt;/FamilyName&gt;
                        &lt;Particle&gt;de&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Levani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hendriks&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;42&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1106&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1116&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22539286&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1002/eji.201142018&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XmtFait7o%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Klein Wolterink RG, Kleinjan A, van Nimwegen M, Bergen I, de Bruijn M, Levani Y, Hendriks RW (2012) Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur J Immunol 42:1106–1116&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR72"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;KleinJan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klein Wolterink&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Levani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bruijn&lt;/FamilyName&gt;
                        &lt;Particle&gt;de&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoogsteden&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nimwegen&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hendriks&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;192&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1385&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1394&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXitFWnu78%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24415780&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.4049/jimmunol.1301888&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;KleinJan A, Klein Wolterink RG, Levani Y, de Bruijn MJ, Hoogsteden HC, van Nimwegen M, Hendriks RW (2014) Enforced expression of Gata3 in T cells and group 2 innate lymphoid cells increases susceptibility to allergic airway inflammation in mice. J Immunol 192:1385–1394&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR73"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klose&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kiss&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schwierzeck&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ebert&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoyler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;d’Hargues&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Goppert&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Croxford&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Waisman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tanriver&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;A T-bet gradient controls the fate and function of CCR6-RORgammat+innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nature&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;494&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;261&lt;/FirstPage&gt;
                      &lt;LastPage&gt;265&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhtFShurk%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23334414&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nature11813&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d’Hargues Y, Goppert N, Croxford AL, Waisman A, Tanriver Y et al (2013) A T-bet gradient controls the fate and function of CCR6-RORgammat+innate lymphoid cells. Nature 494:261–265&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR74"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klose&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Flach&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mohle&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rogell&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoyler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ebert&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fabiunke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pfeifer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sexl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fonseca-Pereira&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cell&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;157&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;340&lt;/FirstPage&gt;
                      &lt;LastPage&gt;356&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXmslalsrw%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24725403&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.cell.2014.03.030&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Klose CS, Flach M, Mohle L, Rogell L, Hoyler T, Ebert K, Fabiunke C, Pfeifer D, Sexl V, Fonseca-Pereira D et al (2014) Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157:340–356&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR75"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kolb&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Margetts&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Anthony&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pitossi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gauldie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2001&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Invest&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;107&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1529&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1536&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD3MXksFeqsLY%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;11413160&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;200196&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1172/JCI12568&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J (2001) Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107:1529–1536&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR76"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kopf&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schneider&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nobs&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The development and function of lung-resident macrophages and dendritic cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;36&lt;/FirstPage&gt;
                      &lt;LastPage&gt;44&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXitFKltLrE&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25521683&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3052&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kopf M, Schneider C, Nobs SP (2015) The development and function of lung-resident macrophages and dendritic cells. Nat Immunol 16:36–44&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR77"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BI&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kwon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Choi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hwang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate type 2 immunity is associated with eosinophilic pleural effusion in primary spontaneous pneumothorax&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Respir Crit Care Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;188&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;577&lt;/FirstPage&gt;
                      &lt;LastPage&gt;585&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhs1Wgt7%2FE&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23815597&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1164/rccm.201302-0295OC&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kwon BI, Hong S, Shin K, Choi EH, Hwang JJ, Lee SH (2013) Innate type 2 immunity is associated with eosinophilic pleural effusion in primary spontaneous pneumothorax. Am J Respir Crit Care Med 188:577–585&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR78"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Q&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The origin and role of innate lymphoid cells in the lung&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Mil Med Res&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;3&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;25&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27547445&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4992280&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1186/s40779-016-0093-2&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lai DM, Shu Q, Fan J (2016) The origin and role of innate lymphoid cells in the lung. Mil Med Res 3:25&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR79"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Li&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Guabiraba&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Besnard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Komai-Koma&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jabir&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Graham&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kurowska-Stolarska&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liew&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;McSharry&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;134&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1422–1432&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e1411&lt;/FirstPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Li D, Guabiraba R, Besnard AG, Komai-Koma M, Jabir MS, Zhang L, Graham GJ, Kurowska-Stolarska M, Liew FY, McSharry C et al (2014) IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol 134(1422–1432):e1411&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR80"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;XY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Luxenberg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Karim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dunussi-Joannopoulos&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Collins&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fouser&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2006&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;203&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2271&lt;/FirstPage&gt;
                      &lt;LastPage&gt;2279&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD28XhtVGls7fF&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16982811&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2118116&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20061308&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271–2279&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR81"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Licona-Limon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Palm&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Flavell&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;TH2, allergy and group 2 innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;536&lt;/FirstPage&gt;
                      &lt;LastPage&gt;542&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXnvVGqt7c%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23685824&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.2617&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Licona-Limon P, Kim LK, Palm NW, Flavell RA (2013) TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 14:536–542&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR82"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AI&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Menegatti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bustamante&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bourhis&lt;/FamilyName&gt;
                        &lt;Particle&gt;Le&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Allez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rogge&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Casanova&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yssel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Santo&lt;/FamilyName&gt;
                        &lt;Particle&gt;Di&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-12 drives functional plasticity of human group 2 innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;213&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;569&lt;/FirstPage&gt;
                      &lt;LastPage&gt;583&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xhtlens7%2FF&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26976630&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4821648&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20151750&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lim AI, Menegatti S, Bustamante J, Le Bourhis L, Allez M, Rogge L, Casanova JL, Yssel H, Di Santo JP (2016) IL-12 drives functional plasticity of human group 2 innate lymphoid cells. J Exp Med 213:569–583&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR83"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hershey&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+&nbsp;Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;194&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;3583&lt;/FirstPage&gt;
                      &lt;LastPage&gt;3593&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXlvVejtL0%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25780046&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4390517&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.4049/jimmunol.1400951&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Liu B, Lee JB, Chen CY, Hershey GK, Wang YH (2015a) Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+&nbsp;Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J Immunol 194:3583–3593&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR84"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Qi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zeng&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Natural helper cells contribute to pulmonary eosinophilia by producing IL-13 via IL-33/ST2 pathway in a murine model of respiratory syncytial virus infection&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int Immunopharmacol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;28&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;337&lt;/FirstPage&gt;
                      &lt;LastPage&gt;343&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXpsVylsrg%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26044350&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.intimp.2015.05.035&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Liu J, Wu J, Qi F, Zeng S, Xu L, Hu H, Wang D, Liu B (2015b) Natural helper cells contribute to pulmonary eosinophilia by producing IL-13 via IL-33/ST2 pathway in a murine model of respiratory syncytial virus infection. Int Immunopharmacol 28:337–343&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR85"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Luci&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Reynders&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;II&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ivanov&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cognet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chiche&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chasson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hardwigsen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Anguiano&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Banchereau&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chaussabel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;75&lt;/FirstPage&gt;
                      &lt;LastPage&gt;82&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1cXhsVWhu7%2FK&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19029904&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.1681&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J, Chaussabel D et al (2009) Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 10:75–82&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR86"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maizels&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hewitson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Smith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Susceptibility and immunity to helminth parasites&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Curr Opin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;24&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;459&lt;/FirstPage&gt;
                      &lt;LastPage&gt;466&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XhtVekur3M&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22795966&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3437973&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.coi.2012.06.003&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Maizels RM, Hewitson JP, Smith KA (2012) Susceptibility and immunity to helminth parasites. Curr Opin Immunol 24:459–466&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR87"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Martinez-Gonzalez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matha&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Steer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ghaedi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Poon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takei&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Allergen-experienced Group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;45&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;198&lt;/FirstPage&gt;
                      &lt;LastPage&gt;208&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XhtFKls7vJ&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27421705&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2016.06.017&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Martinez-Gonzalez I, Matha L, Steer CA, Ghaedi M, Poon GF, Takei F (2016) Allergen-experienced Group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity 45:198–208&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR88"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Massacand&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stettler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Meier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Humphreys&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grencis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marsland&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Harris&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating dendritic cell function&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Proc Natl Acad Sci USA&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;106&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;13968&lt;/FirstPage&gt;
                      &lt;LastPage&gt;13973&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1MXhtFWgt7nO&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19666528&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2729004&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1073/pnas.0906367106&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Massacand JC, Stettler RC, Meier R, Humphreys NE, Grencis RK, Marsland BJ, Harris NL (2009) Helminth products bypass the need for TSLP in Th2 immune responses by directly modulating dendritic cell function. Proc Natl Acad Sci USA 106:13968–13973&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR89"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;McAleer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kolls&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunol Rev&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;260&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;129&lt;/FirstPage&gt;
                      &lt;LastPage&gt;144&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXhtVahtrvM&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24942687&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4066195&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1111/imr.12183&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;McAleer JP, Kolls JK (2014) Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense. Immunol Rev 260:129–144&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR90"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;McHedlidze&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kindermann&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Neves&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Voehringer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Neurath&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wirtz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Mucosal Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;3&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1384&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1394&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/mi.2016.20&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xkt1Gnu7s%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;McHedlidze T, Kindermann M, Neves AT, Voehringer D, Neurath MF, Wirtz S (2016) IL-27 suppresses type 2 immune responses in vivo via direct effects on group 2 innate lymphoid cells. Mucosal Immunol 3:1384–1394&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR91"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;McSorley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maizels&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Helminth infections and host immune regulation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Microbiol Rev&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;25&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;585&lt;/FirstPage&gt;
                      &lt;LastPage&gt;608&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XhvVWjsbzJ&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23034321&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3485755&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1128/CMR.05040-11&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;McSorley HJ, Maizels RM (2012) Helminth infections and host immune regulation. Clin Microbiol Rev 25:585–608&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR92"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;McSorley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Blair&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Smith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maizels&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Mucosal Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;7&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1068&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1078&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXhsl2msrY%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24496315&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4016792&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/mi.2013.123&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;McSorley HJ, Blair NF, Smith KA, McKenzie AN, Maizels RM (2014) Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy. Mucosal Immunol 7:1068–1078&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR93"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;McSorley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Blair&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Robertson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maizels&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Suppression of OVA-alum induced allergy by Heligmosomoides polygyrus products is MyD88-, TRIF-, regulatory T- and B cell-independent, but is associated with reduced innate lymphoid cell activation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Exp Parasitol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;158&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;8&lt;/FirstPage&gt;
                      &lt;LastPage&gt;17&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXjslynsr4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25728231&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.exppara.2015.02.009&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;McSorley HJ, Blair NF, Robertson E, Maizels RM (2015) Suppression of OVA-alum induced allergy by Heligmosomoides polygyrus products is MyD88-, TRIF-, regulatory T- and B cell-independent, but is associated with reduced innate lymphoid cell activation. Exp Parasitol 158:8–17&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR94"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mebius&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rennert&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;IL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Weissman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1997&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Developing lymph nodes collect CD4+CD3- LTbeta+&nbsp;cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;7&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;493&lt;/FirstPage&gt;
                      &lt;LastPage&gt;504&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK1c%2FhsVGqsQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;9354470&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S1074-7613(00)80371-4&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Mebius RE, Rennert P, Weissman IL (1997) Developing lymph nodes collect CD4+CD3- LTbeta+&nbsp;cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7:493–504&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR95"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Meylan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ET&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hawley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barron&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barlow&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Penumetcha&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pelletier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sciume&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Richard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ET&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hayes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gomez-Rodriguez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Mucosal Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;7&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;958&lt;/FirstPage&gt;
                      &lt;LastPage&gt;968&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhvFyltb3M&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24368564&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Meylan F, Hawley ET, Barron L, Barlow JL, Penumetcha P, Pelletier M, Sciume G, Richard AC, Hayes ET, Gomez-Rodriguez J et al (2014) The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells. Mucosal Immunol 7:958–968&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR96"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mjosberg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Trifari&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Crellin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Peters&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Drunen&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Piet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fokkens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cupedo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spits&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;12&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1055&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1062&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21909091&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.2104&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXhtFGntbfL&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12:1055–1062&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR97"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mjosberg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bernink&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Golebski&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Karrich&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Peters&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Blom&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Velde&lt;/FamilyName&gt;
                        &lt;Particle&gt;te&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fokkens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Drunen&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spits&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;37&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;649&lt;/FirstPage&gt;
                      &lt;LastPage&gt;659&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23063330&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2012.08.015&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XhsV2rtr3P&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Mjosberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, te Velde AA, Fokkens WJ, van Drunen CM, Spits H (2012) The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37:649–659&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR98"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mohapatra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dyken&lt;/FamilyName&gt;
                        &lt;Particle&gt;Van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schneider&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nussbaum&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Locksley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Mucosal Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;9&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;275&lt;/FirstPage&gt;
                      &lt;LastPage&gt;286&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XhvFKlsw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26129648&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/mi.2015.59&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Mohapatra A, Van Dyken SJ, Schneider C, Nussbaum JC, Liang HE, Locksley RM (2016) Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis. Mucosal Immunol 9:275–286&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR99"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Montaldo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Teixeira-Alves&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Glatzer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Durek&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;U&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stervbo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hamann&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Babic&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Paclik&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stölzel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gröne&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;41&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;988&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1000&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXitFejsrjK&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25500367&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2014.11.010&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Montaldo E, Teixeira-Alves LG, Glatzer T, Durek P, Stervbo U, Hamann W, Babic M, Paclik D, Stölzel K, Gröne J (2014) Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells. Immunity 41:988–1000&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR100"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Monticelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sonnenberg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Abt&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Alenghat&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ziegler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Doering&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Angelosanto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Laidlaw&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sathaliyawala&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;12&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1045&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1054&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXht1anurbP&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21946417&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3320042&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.2131&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T et al (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12:1045–1054&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR101"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Monticelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Buck&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Flamar&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Saenz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ED&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tait Wojno&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yudanin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Osborne&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hepworth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SV&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tran&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rodewald&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;656&lt;/FirstPage&gt;
                      &lt;LastPage&gt;665&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xltleisb4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27043409&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4873382&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3421&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Monticelli LA, Buck MD, Flamar AL, Saenz SA, Tait Wojno ED, Yudanin NA, Osborne LC, Hepworth MR, Tran SV, Rodewald HR et al (2016) Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat Immunol 17:656–665&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR102"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate production of TH2 cytokines by adipose tissue-associated c-kit+Sca-1+&nbsp;lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nature&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;463&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;540&lt;/FirstPage&gt;
                      &lt;LastPage&gt;544&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1MXhsFyhsL3O&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20023630&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nature08636&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Moro K (2010) Innate production of TH2 cytokines by adipose tissue-associated c-kit+Sca-1+&nbsp;lymphoid cells. Nature 463:540–544&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR103"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yamada&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tanabe&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takeuchi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ikawa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kawamoto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Furusawa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ohtani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fujii&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Koyasu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nature&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;463&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;540&lt;/FirstPage&gt;
                      &lt;LastPage&gt;544&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1MXhsFyhsL3O&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20023630&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nature08636&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463:540–544&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR104"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kabata&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tanabe&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Koga&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takeno&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mochizuki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fukunaga&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Asano&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Betsuyaku&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Koyasu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;76&lt;/FirstPage&gt;
                      &lt;LastPage&gt;86&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhvVygur7O&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26595888&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3309&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Moro K, Kabata H, Tanabe M, Koga S, Takeno N, Mochizuki M, Fukunaga K, Asano K, Betsuyaku T, Koyasu S (2016) Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat Immunol 17:76–86&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR105"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nagakumar&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Denney&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fleming&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bush&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lloyd&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Saglani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Type 2 innate lymphoid cells in induced sputum from children with severe asthma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;137&lt;/VolumeID&gt;
                      &lt;IssueID&gt;624–626&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e626&lt;/FirstPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Nagakumar P, Denney L, Fleming L, Bush A, Lloyd CM, Saglani S (2016) Type 2 innate lymphoid cells in induced sputum from children with severe asthma. J Allergy Clin Immunol 137(624–626):e626&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR106"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Neill&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bellosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Flynn&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Daly&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Langford&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bucks&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kane&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fallon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pannell&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nature&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;464&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1367&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1370&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXivVCiur4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20200518&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2862165&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nature08900&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R et al (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464:1367–1370&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR107"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Paul&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;How are T(H)2-type immune responses initiated and amplified?&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Rev Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;225&lt;/FirstPage&gt;
                      &lt;LastPage&gt;235&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXjvVGltLc%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20336151&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3496776&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nri2735&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Paul WE, Zhu J (2010) How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10:225–235&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR108"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Philip&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Artis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;New friendships and old feuds: relationships between innate lymphoid cells and microbial communities&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunol Cell Biol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;91&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;225&lt;/FirstPage&gt;
                      &lt;LastPage&gt;231&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXktVGqsrc%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23337700&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/icb.2013.2&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Philip NH, Artis D (2013) New friendships and old feuds: relationships between innate lymphoid cells and microbial communities. Immunol Cell Biol 91:225–231&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR109"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Price&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sullivan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Reinhardt&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Eisley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Erle&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Locksley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Systemically dispersed innate IL-13-expressing cells in type 2 immunity&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Proc Natl Acad Sci USA&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;107&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;11489&lt;/FirstPage&gt;
                      &lt;LastPage&gt;11494&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXot1ahurc%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20534524&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2895098&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1073/pnas.1003988107&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107:11489–11494&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR110"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rankin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Groom&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chopin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Herold&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Walker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mielke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carotta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nutt&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Belz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The transcription factor T-bet is essential for the development of NKp46+&nbsp;innate lymphocytes via the Notch pathway&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;389&lt;/FirstPage&gt;
                      &lt;LastPage&gt;395&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXjtlKnsb0%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23455676&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4076532&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.2545&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Rankin LC, Groom JR, Chopin M, Herold MJ, Walker JA, Mielke LA, McKenzie AN, Carotta S, Nutt SL, Belz GT (2013) The transcription factor T-bet is essential for the development of NKp46+&nbsp;innate lymphocytes via the Notch pathway. Nat Immunol 14:389–395&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR111"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rankin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Girard-Madoux&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Seillet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mielke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kerdiles&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fenis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wieduwild&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Putoczki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mondot&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lantz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Complementarity and redundancy of IL-22-producing innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;179&lt;/FirstPage&gt;
                      &lt;LastPage&gt;186&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhvVygur7N&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26595889&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3332&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Rankin LC, Girard-Madoux MJ, Seillet C, Mielke LA, Kerdiles Y, Fenis A, Wieduwild E, Putoczki T, Mondot S, Lantz O et al (2016) Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat Immunol 17:179–186&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR112"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Renauld&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2001&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;New insights into the role of cytokines in asthma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;54&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;577&lt;/FirstPage&gt;
                      &lt;LastPage&gt;589&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3MvivFOitw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;11477111&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;1731485&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1136/jcp.54.8.577&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Renauld JC (2001) New insights into the role of cytokines in asthma. J Clin Pathol 54:577–589&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR113"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Salimi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ogg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells and the skin&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;BMC Dermatol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;18&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25427661&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4289267&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1186/1471-5945-14-18&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXit1Kgsb8%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Salimi M, Ogg G (2014) Innate lymphoid cells and the skin. BMC Dermatol 14:18&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR114"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sanos&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;VL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bui&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mortha&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oberle&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Heners&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Johner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Diefenbach&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+&nbsp;cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;83&lt;/FirstPage&gt;
                      &lt;LastPage&gt;91&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1cXhsVWhu7bO&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19029903&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.1684&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Sanos SL, Bui VL, Mortha A, Oberle K, Heners C, Johner C, Diefenbach A (2009) RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+&nbsp;cells. Nat Immunol 10:83–91&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR115"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sawa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cherrier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lochner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Satohtakayama&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fehling&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Langa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JPD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Santo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Eberl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Lineage relationship analysis of RORγt+&nbsp;innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Science&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;330&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;665&lt;/FirstPage&gt;
                      &lt;LastPage&gt;669&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXhtlaqt7nF&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20929731&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1126/science.1194597&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Sawa S, Cherrier M, Lochner M, Satohtakayama N, Fehling HJ, Langa F, Santo JPD, Eberl G (2010) Lineage relationship analysis of RORγt+&nbsp;innate lymphoid cells. Science 330:665–669&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR116"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ST&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scanlon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Type 2 innate lymphoid cells: new players in asthma and allergy&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Curr Opin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;24&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;707&lt;/FirstPage&gt;
                      &lt;LastPage&gt;712&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XhtlGqu7nI&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22985480&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.coi.2012.08.009&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Scanlon ST, McKenzie AN (2012) Type 2 innate lymphoid cells: new players in asthma and allergy. Curr Opin Immunol 24:707–712&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR117"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Serafini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klein Wolterink&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Satoh-Takayama&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vosshenrich&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hendriks&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Santo&lt;/FamilyName&gt;
                        &lt;Particle&gt;Di&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Gata3 drives development of RORgammat+&nbsp;group 3 innate lymphoid cells&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;211&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;199&lt;/FirstPage&gt;
                      &lt;LastPage&gt;208&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXisFarur8%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24419270&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3920560&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20131038&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Serafini N, Klein Wolterink RG, Satoh-Takayama N, Xu W, Vosshenrich CA, Hendriks RW, Di Santo JP (2014) Gata3 drives development of RORgammat+&nbsp;group 3 innate lymphoid cells. J Exp Med 211:199–208&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR118"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Silver&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kearley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Copenhaver&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sanden&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mori&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pritchard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Berlin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hunter&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bowler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;626&lt;/FirstPage&gt;
                      &lt;LastPage&gt;635&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xms1Wrsr4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27111143&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;5345745&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3443&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Silver JS, Kearley J, Copenhaver AM, Sanden C, Mori M, Yu L, Pritchard GH, Berlin AA, Hunter CA, Bowler R et al (2016a) Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol 17:626–635&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR119"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Silver&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kearley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Copenhaver&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sanden&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mori&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pritchard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Berlin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hunter&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bowler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;17&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;626&lt;/FirstPage&gt;
                      &lt;LastPage&gt;635&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xms1Wrsr4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27111143&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;5345745&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.3443&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Silver JS, Kearley J, Copenhaver AM, Sanden C, Mori M, Yu L, Pritchard GH, Berlin AA, Hunter CA, Bowler R et al (2016b) Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol 17:626–635&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR120"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Smith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kjarsgaard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Huang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oliveria&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PM&lt;/Initials&gt;
                        &lt;FamilyName&gt;O’Byrne&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gauvreau&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Boulet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lemiere&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Martin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;137&lt;/VolumeID&gt;
                      &lt;IssueID&gt;75–86&lt;/IssueID&gt;
                      &lt;FirstPage&gt;e78&lt;/FirstPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria JP, O’Byrne PM, Gauvreau GM, Boulet LP, Lemiere C, Martin J et al (2016) Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol 137(75–86):e78&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR121"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Song&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gilfillan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ML&lt;/Initials&gt;
                        &lt;FamilyName&gt;Robinette&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Newberry&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stappenbeck&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mack&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cella&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Colonna&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Unique and redundant functions of NKp46&nbsp;+&nbsp;ILC3s in models of intestinal inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;212&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1869&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1882&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhslKqsr3M&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26458769&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4612098&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20151403&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Song C, Lee JS, Gilfillan S, Robinette ML, Newberry RD, Stappenbeck TS, Mack M, Cella M, Colonna M (2015) Unique and redundant functions of NKp46&nbsp;+&nbsp;ILC3s in models of intestinal inflammation. J Exp Med 212:1869–1882&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR122"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spits&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cupedo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells: emerging insights in development, lineage relationships, and function&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Annu Rev Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;30&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;647&lt;/FirstPage&gt;
                      &lt;LastPage&gt;675&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XmsVKmurY%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22224763&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1146/annurev-immunol-020711-075053&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Spits H, Cupedo T (2012) Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol 30:647–675&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR123"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spits&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Santo&lt;/FamilyName&gt;
                        &lt;Particle&gt;Di&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;12&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;21&lt;/FirstPage&gt;
                      &lt;LastPage&gt;27&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXhsVOrsLjN&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21113163&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.1962&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Spits H, Di Santo JP (2011) The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 12:21–27&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR124"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spits&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Artis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Colonna&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Diefenbach&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Santo&lt;/FamilyName&gt;
                        &lt;Particle&gt;Di&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Eberl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Koyasu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Locksley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mebius&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphoid cells–a proposal for uniform nomenclature&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Rev Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;13&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;145&lt;/FirstPage&gt;
                      &lt;LastPage&gt;149&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXjslGjtg%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23348417&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/nri3365&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE et al (2013) Innate lymphoid cells–a proposal for uniform nomenclature. Nat Rev Immunol 13:145–149&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR125"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spooner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lesch&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Khan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Abbas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ramirez-Carrozzi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhou&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Soriano&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Eastham-Anderson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Diehl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1229&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1236&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhs1CitLnM&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24141388&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.2743&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Spooner CJ, Lesch J, Yan D, Khan AA, Abbas A, Ramirez-Carrozzi V, Zhou M, Soriano R, Eastham-Anderson J, Diehl L et al (2013) Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1. Nat Immunol 14:1229–1236&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR126"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bloodworth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Toki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Newcomb&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Goleniewska&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Boyd&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Quitalig&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hotard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ML&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moore&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TV&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hartert&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;138&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;814&lt;/FirstPage&gt;
                      &lt;LastPage&gt;824&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XntlSmsbg%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27156176&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;5014571&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jaci.2016.01.050&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Stier MT, Bloodworth MH, Toki S, Newcomb DC, Goleniewska K, Boyd KL, Quitalig M, Hotard AL, Moore ML, Hartert TV et al (2016) Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin. J Allergy Clin Immunol 138:814–824&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR127"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ER&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sutherland&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lehman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Teodorescu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ME&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wechsler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;InstitutionalAuthorName&gt;National Heart, Lung and Blood Institute’s Asthma Clinical Research Network&lt;/InstitutionalAuthorName&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Body mass index and phenotype in subjects with mild-to-moderate persistent asthma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Allergy Clin Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;123&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1328&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1334&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19501235&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2743451&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jaci.2009.04.005&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Sutherland ER, Lehman EB, Teodorescu M, Wechsler ME, National Heart, Lung and Blood Institute’s Asthma Clinical Research Network (2009) Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol 123:1328–1334&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR128"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ED&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tait Wojno&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Monticelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SV&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tran&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Alenghat&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Osborne&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Thome&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Willis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Budelsky&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Farber&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Artis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The prostaglandin D2 receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Mucosal Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;8&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1313&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1323&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXmtVaqsrg%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4598246&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/mi.2015.21&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Tait Wojno ED, Monticelli LA, Tran SV, Alenghat T, Osborne LC, Thome JJ, Willis C, Budelsky A, Farber DL, Artis D (2015) The prostaglandin D2 receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. Mucosal Immunol 8:1313–1323&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR129"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takatori&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kanno&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Watford&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tato&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Weiss&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;II&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ivanov&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Littman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;O’Shea&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;206&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;35&lt;/FirstPage&gt;
                      &lt;LastPage&gt;41&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1MXhtVOhtb0%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19114665&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2626689&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20072713&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, Littman DR, O’Shea JJ (2009) Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206:35–41&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR130"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Taniguchi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Miyahara&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Waseda&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kurimoto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;U&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fujii&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tanimoto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kataoka&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yamamoto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gelfand&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yamamoto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Contrasting roles for the receptor for advanced glycation end-products on structural cells in allergic airway inflammation vs. airway hyperresponsiveness&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Physiol Lung Cell Mol Physiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;309&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;L789&lt;/FirstPage&gt;
                      &lt;LastPage&gt;L800&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XmtlGrurs%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26472810&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Taniguchi A, Miyahara N, Waseda K, Kurimoto E, Fujii U, Tanimoto Y, Kataoka M, Yamamoto Y, Gelfand EW, Yamamoto H et al (2015) Contrasting roles for the receptor for advanced glycation end-products on structural cells in allergic airway inflammation vs. airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol 309:L789–L800&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR131"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Taube&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tertilt&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gyulveszi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dehzad&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kreymborg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schneeweiss&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Michel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Reuter&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Renauld&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Arnold-Schild&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;PLoS ONE&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;6&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;e21799&lt;/FirstPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXhtVeht7zP&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21789181&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3138740&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1371/journal.pone.0021799&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Taube C, Tertilt C, Gyulveszi G, Dehzad N, Kreymborg K, Schneeweiss K, Michel E, Reuter S, Renauld JC, Arnold-Schild D et al (2011) IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS ONE 6:e21799&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR132"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Thawer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Auret&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schnoeller&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chetty&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Smith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Darby&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Roberts&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mackay&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Whitwell&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Timms&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Surfactant protein-D is essential for immunity to helminth infection&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;PLoS Pathog&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;12&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;e1005461&lt;/FirstPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26900854&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4763345&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1371/journal.ppat.1005461&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xht1amt7%2FE&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Thawer S, Auret J, Schnoeller C, Chetty A, Smith K, Darby M, Roberts L, Mackay RM, Whitwell HJ, Timms JF et al (2016) Surfactant protein-D is essential for immunity to helminth infection. PLoS Pathog 12:e1005461&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR133"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Turner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Morrison&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wilhelm&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wilson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ahlfors&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Renauld&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;U&lt;/Initials&gt;
                        &lt;FamilyName&gt;Panzer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Helmby&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stockinger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;210&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2951&lt;/FirstPage&gt;
                      &lt;LastPage&gt;2965&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhvFynurrM&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24249111&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3865473&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20130071&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Turner JE, Morrison PJ, Wilhelm C, Wilson M, Ahlfors H, Renauld JC, Panzer U, Helmby H, Stockinger B (2013) IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med 210:2951–2965&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR134"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maele&lt;/FamilyName&gt;
                        &lt;Particle&gt;Van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carnoy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cayet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Songhet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dumoutier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ferrero&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Janot&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Erard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bertout&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Leger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127&nbsp;+&nbsp;immune cells in spleen and mucosa&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;185&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1177&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1185&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20566828&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3060348&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.4049/jimmunol.1000115&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXotlymtb4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Van Maele L, Carnoy C, Cayet D, Songhet P, Dumoutier L, Ferrero I, Janot L, Erard F, Bertout J, Leger H et al (2010) TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127&nbsp;+&nbsp;immune cells in spleen and mucosa. J Immunol 185:1177–1185&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR135"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maele&lt;/FamilyName&gt;
                        &lt;Particle&gt;Van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carnoy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cayet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ivanov&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Porte&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Deruy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chabalgoity&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Renauld&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Eberl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Benecke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Infect Dis&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;210&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;493&lt;/FirstPage&gt;
                      &lt;LastPage&gt;503&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24577508&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1093/infdis/jiu106&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXht1ygtrvI&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Van Maele L, Carnoy C, Cayet D, Ivanov S, Porte R, Deruy E, Chabalgoity JA, Renauld JC, Eberl G, Benecke AG et al (2014) Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. J Infect Dis 210:493–503&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR136"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vonarbourg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mortha&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;VL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bui&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hernandez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kiss&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoyler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Flach&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bengsch&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Thimme&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Holscher&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Progressive loss of RORγt expression confers distinct functional fates to natural killer cell receptor-expressing RORγt&nbsp;+&nbsp;innate lymphocytes&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;33&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;736&lt;/FirstPage&gt;
                      &lt;LastPage&gt;751&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXhsVCms7%2FI&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21093318&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3042726&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2010.10.017&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M, Bengsch B, Thimme R, Holscher C et al (2010a) Progressive loss of RORγt expression confers distinct functional fates to natural killer cell receptor-expressing RORγt&nbsp;+&nbsp;innate lymphocytes. Immunity 33:736–751&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR137"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vonarbourg&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mortha&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;VL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bui&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hernandez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kiss&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoyler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Flach&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bengsch&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Thimme&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Holscher&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Immunity&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;33&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;736&lt;/FirstPage&gt;
                      &lt;LastPage&gt;751&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3cXhsVCms7%2FI&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21093318&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3042726&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.immuni.2010.10.017&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M, Bengsch B, Thimme R, Holscher C et al (2010b) Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 33:736–751&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR138"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vosshenrich&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ranson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SI&lt;/Initials&gt;
                        &lt;FamilyName&gt;Samson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Corcuff&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Colucci&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rosmaraki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Di&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;174&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1213&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1221&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD2MXlsFyitQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;15661875&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.4049/jimmunol.174.3.1213&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di SJ (2005) Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 174:1213–1221&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR139"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Walker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oliphant&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Englezakis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Clare&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rodewald&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Belz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fallon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AN&lt;/Initials&gt;
                        &lt;FamilyName&gt;McKenzie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Bcl11b is essential for group 2 innate lymphoid cell development&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;212&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;875&lt;/FirstPage&gt;
                      &lt;LastPage&gt;882&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhtVGns73J&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25964370&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4451131&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20142224&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Walker JA, Oliphant CJ, Englezakis A, Yu Y, Clare S, Rodewald HR, Belz G, Liu P, Fallon PG, McKenzie AN (2015) Bcl11b is essential for group 2 innate lymphoid cell development. J Exp Med 212:875–882&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR140"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Waugh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wilson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2008&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The interleukin-8 pathway in cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Cancer Res&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;6735&lt;/FirstPage&gt;
                      &lt;LastPage&gt;6741&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1cXhtlens7vL&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;18980965&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1158/1078-0432.CCR-07-4843&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14:6735–6741&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR141"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wilhelm&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hirota&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stieglitz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Snick&lt;/FamilyName&gt;
                        &lt;Particle&gt;Van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tolaini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lahl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sparwasser&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Helmby&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stockinger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Nat Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;12&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1071&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1077&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXht12iu7jE&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21983833&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3198843&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/ni.2133&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K, Sparwasser T, Helmby H, Stockinger B (2011) An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 12:1071–1077&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR142"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wohlfahrt&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Usherenko&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Englbrecht&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dees&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Weber&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Beyer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gelse&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Distler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schett&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Distler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Ann Rheum Dis&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;75&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;623&lt;/FirstPage&gt;
                      &lt;LastPage&gt;626&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XitFGnurrM&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26338035&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1136/annrheumdis-2015-207388&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Wohlfahrt T, Usherenko S, Englbrecht M, Dees C, Weber S, Beyer C, Gelse K, Distler O, Schett G, Distler JH et al (2016) Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis. Ann Rheum Dis 75:623–626&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR143"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wynn&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Integrating mechanisms of pulmonary fibrosis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;208&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1339&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1350&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3MXovVKhtLs%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21727191&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3136685&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20110551&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Wynn TA (2011) Integrating mechanisms of pulmonary fibrosis. J Exp Med 208:1339–1350&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR144"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xiong&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Keith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Samilo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carter&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;IM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Leiner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pamer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Innate lymphocyte/Ly6C(hi) Monocyte crosstalk promotes 
                        &lt;Emphasis Type="Italic"&gt;Klebsiella pneumoniae&lt;/Emphasis&gt; clearance
                      &lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cell&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;165&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;679&lt;/FirstPage&gt;
                      &lt;LastPage&gt;689&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XltlOku7Y%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27040495&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4842125&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.cell.2016.03.017&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Xiong H, Keith JW, Samilo DW, Carter RA, Leiner IM, Pamer EG (2016) Innate lymphocyte/Ly6C(hi) Monocyte crosstalk promotes 
                      &lt;Emphasis Type="Italic"&gt;Klebsiella pneumoniae&lt;/Emphasis&gt; clearance. Cell 165:679–689
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR145"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ID&lt;/Initials&gt;
                        &lt;FamilyName&gt;Weiss&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Singh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wynn&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wilson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Farber&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Conventional NK cells can produce IL-22 and promote host defense in 
                        &lt;Emphasis Type="Italic"&gt;Klebsiella pneumoniae&lt;/Emphasis&gt; pneumonia
                      &lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;192&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1778&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1786&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXitFWntLw%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24442439&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3995347&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.4049/jimmunol.1300039&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Xu X, Weiss ID, Zhang HH, Singh SP, Wynn TA, Wilson MS, Farber JM (2014) Conventional NK cells can produce IL-22 and promote host defense in 
                      &lt;Emphasis Type="Italic"&gt;Klebsiella pneumoniae&lt;/Emphasis&gt; pneumonia. J Immunol 192:1778–1786
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR146"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yasuda&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Muto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kawagoe&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matsumoto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sasaki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matsushita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Taki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Futatsugi-Yumikura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tsutsui&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ishii&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Proc Natl Acad Sci U S A&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;109&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;3451&lt;/FirstPage&gt;
                      &lt;LastPage&gt;3456&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XksVyhtLY%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22331917&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3295287&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1073/pnas.1201042109&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Yasuda K, Muto T, Kawagoe T, Matsumoto M, Sasaki Y, Matsushita K, Taki Y, Futatsugi-Yumikura S, Tsutsui H, Ishii KJ et al (2012) Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc Natl Acad Sci U S A 109:3451–3456&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR147"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ying&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Z&lt;/Initials&gt;
                        &lt;FamilyName&gt;Su&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Q&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bie&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Synergistically increased ILC2 and Th9 cells in lung tissue jointly promote the pathological process of asthma in mice&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Mol Med Rep&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;13&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;5230&lt;/FirstPage&gt;
                      &lt;LastPage&gt;5240&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XhsVWisLfF&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27109139&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3892/mmr.2016.5174&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Ying X, Su Z, Bie Q, Zhang P, Yang H, Wu Y, Xu Y, Wu J, Zhang M, Wang S et al (2016) Synergistically increased ILC2 and Th9 cells in lung tissue jointly promote the pathological process of asthma in mice. Mol Med Rep 13:5230–5240&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR148"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yoshida&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Honda&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shinkura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Adachi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nishikawa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ikuta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SI&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nishikawa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1999&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;IL-7 receptor alpha&nbsp;+&nbsp;CD3(-) cells in the embryonic intestine induces the organizing center of Peyer’s patches&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;11&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;643&lt;/FirstPage&gt;
                      &lt;LastPage&gt;655&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DyaK1MXjs1Olt7g%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;10330270&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1093/intimm/11.5.643&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Yoshida H, Honda K, Shinkura R, Adachi S, Nishikawa S, Maki K, Ikuta K, Nishikawa SI (1999) IL-7 receptor alpha&nbsp;+&nbsp;CD3(-) cells in the embryonic intestine induces the organizing center of Peyer’s patches. Int Immunol 11:643–655&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR149"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pappu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ramirez-Carrozzi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ota&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Caplazi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Xu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grogan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Mucosal Immunol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;7&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;730&lt;/FirstPage&gt;
                      &lt;LastPage&gt;740&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhslKmsb7L&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24220298&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/mi.2013.92&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Yu X, Pappu R, Ramirez-Carrozzi V, Ota N, Caplazi P, Zhang J, Yan D, Xu M, Lee WP, Grogan JL (2014) TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers. Mucosal Immunol 7:730–740&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR150"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Clare&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brandt&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Burke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;He&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jenkins&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;212&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;865&lt;/FirstPage&gt;
                      &lt;LastPage&gt;874&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXhtVOjtbfO&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25964371&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4451136&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20142318&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Yu Y, Wang C, Clare S, Wang J, Lee SC, Brandt C, Burke S, Lu L, He D, Jenkins NA et al (2015) The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development. J Exp Med 212:865–874&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR151"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhou&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Toki&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zhang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Goleniewksa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Newcomb&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JY&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cephus&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dulek&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bloodworth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Polosuhkin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Respir Crit Care Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;193&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;31&lt;/FirstPage&gt;
                      &lt;LastPage&gt;42&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XhtFOqtr%2FE&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26378386&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4731613&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1164/rccm.201410-1793OC&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Zhou W, Toki S, Zhang J, Goleniewksa K, Newcomb DC, Cephus JY, Dulek DE, Bloodworth MH, Stier MT, Polosuhkin V et al (2016) Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses. Am J Respir Crit Care Med 193:31–42&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR152"&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zook&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ramirez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;X&lt;/Initials&gt;
                        &lt;FamilyName&gt;Guo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Voort&lt;/FamilyName&gt;
                        &lt;Particle&gt;van der&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sigvardsson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Svensson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YX&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The ETS1 transcription factor is required for the development and cytokine-induced expansion of ILC2&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Exp Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;213&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;687&lt;/FirstPage&gt;
                      &lt;LastPage&gt;696&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XhsV2nsLnO&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27069114&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4854726&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1084/jem.20150851&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Zook EC, Ramirez K, Guo X, van der Voort G, Sigvardsson M, Svensson EC, Fu YX, Kee BL (2016) The ETS1 transcription factor is required for the development and cytokine-induced expansion of ILC2. J Exp Med 213:687–696&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                &lt;/Bibliography&gt;
              &lt;/ArticleBackmatter&gt;
            &lt;/Article&gt;
          &lt;/Issue&gt;
        &lt;/Volume&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-12-04T13:24:13.087125+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Cheng, Hang&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Jin, Chengyan&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Wu, Jing&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Zhu, Shan&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Liu, Yong-Jun&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Chen, Jingtao&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution geo="125.3245000,43.8868410,0"&gt;
            &lt;meta:OrgName&gt;Jilin University&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;125.3245000,43.8868410,0#Jilin University&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;China&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="125.3245000,43.8868410,0"&gt;
            &lt;meta:OrgName&gt;Jilin University&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;125.3245000,43.8868410,0#Jilin University&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;China&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="125.3245000,43.8868410,0"&gt;
            &lt;meta:OrgName&gt;Jilin University&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;125.3245000,43.8868410,0#Jilin University&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;China&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;Sanofi Research and Development&lt;/meta:OrgName&gt;
            &lt;meta:Country&gt;United States&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-01&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-12-03T05:08:10&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1007/s13238-017-0379-5&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;1674-8018&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;Springer&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;Protein &amp;amp; Cell&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;Protein &amp;amp; Cell&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCL" Type="Primary"&gt;Life Sciences&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCL14005" Priority="1" Type="Secondary"&gt;Biochemistry, general&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCL14040" Priority="2" Type="Secondary"&gt;Protein Science&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCL16008" Priority="3" Type="Secondary"&gt;Cell Biology&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCL16010" Priority="4" Type="Secondary"&gt;Stem Cells&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCB12008" Priority="5" Type="Secondary"&gt;Human Genetics&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCL18000" Priority="6" Type="Secondary"&gt;Developmental Biology&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:VolumeId&gt;8&lt;/meta:VolumeId&gt;
        &lt;meta:IssueId&gt;12&lt;/meta:IssueId&gt;
        &lt;meta:ArticleSequenceNumber&gt;2&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;Springer Berlin Heidelberg&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;Berlin/Heidelberg&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;Springer&lt;/PublisherImprintName&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="All"&gt;
        &lt;JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;428&lt;/JournalID&gt;
          &lt;JournalDOI&gt;10.1007/428.1432-2307&lt;/JournalDOI&gt;
          &lt;JournalPrintISSN&gt;0945-6317&lt;/JournalPrintISSN&gt;
          &lt;JournalElectronicISSN&gt;1432-2307&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;Virchows Archiv&lt;/JournalTitle&gt;
          &lt;JournalSubTitle&gt;European Journal of Pathology&lt;/JournalSubTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;Virchows Arch&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH4800X" Priority="1" Type="Secondary"&gt;Pathology&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Medicine"&gt;SC11&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;Volume OutputMedium="All"&gt;
          &lt;VolumeInfo TocLevels="0" VolumeType="Regular"&gt;
            &lt;VolumeIDStart&gt;471&lt;/VolumeIDStart&gt;
            &lt;VolumeIDEnd&gt;471&lt;/VolumeIDEnd&gt;
            &lt;VolumeIssueCount&gt;6&lt;/VolumeIssueCount&gt;
          &lt;/VolumeInfo&gt;
          &lt;Issue IssueType="Regular" OutputMedium="All"&gt;
            &lt;IssueInfo IssueType="Regular" TocLevels="0"&gt;
              &lt;IssueIDStart&gt;6&lt;/IssueIDStart&gt;
              &lt;IssueIDEnd&gt;6&lt;/IssueIDEnd&gt;
              &lt;IssueArticleCount&gt;17&lt;/IssueArticleCount&gt;
              &lt;IssueHistory&gt;
                &lt;OnlineDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                  &lt;Day&gt;1&lt;/Day&gt;
                &lt;/OnlineDate&gt;
                &lt;PrintDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                  &lt;Day&gt;1&lt;/Day&gt;
                &lt;/PrintDate&gt;
                &lt;CoverDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                &lt;/CoverDate&gt;
                &lt;PricelistYear&gt;2017&lt;/PricelistYear&gt;
              &lt;/IssueHistory&gt;
              &lt;IssueCopyright&gt;
                &lt;CopyrightHolderName&gt;Springer-Verlag GmbH Germany, part of Springer Nature&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
              &lt;/IssueCopyright&gt;
            &lt;/IssueInfo&gt;
            &lt;Article ID="s00428-017-2177-0" OutputMedium="All"&gt;
              &lt;ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
                &lt;ArticleID&gt;2177&lt;/ArticleID&gt;
                &lt;ArticleDOI&gt;10.1007/s00428-017-2177-0&lt;/ArticleDOI&gt;
                &lt;ArticleSequenceNumber&gt;4&lt;/ArticleSequenceNumber&gt;
                &lt;ArticleTitle Language="En"&gt;Distinctive pathological and clinical features of lung carcinoids with high proliferation index&lt;/ArticleTitle&gt;
                &lt;ArticleCategory&gt;Original Article&lt;/ArticleCategory&gt;
                &lt;ArticleFirstPage&gt;713&lt;/ArticleFirstPage&gt;
                &lt;ArticleLastPage&gt;720&lt;/ArticleLastPage&gt;
                &lt;ArticleHistory&gt;
                  &lt;RegistrationDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;6&lt;/Month&gt;
                    &lt;Day&gt;9&lt;/Day&gt;
                  &lt;/RegistrationDate&gt;
                  &lt;Received&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;5&lt;/Month&gt;
                    &lt;Day&gt;2&lt;/Day&gt;
                  &lt;/Received&gt;
                  &lt;Revised&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;5&lt;/Month&gt;
                    &lt;Day&gt;25&lt;/Day&gt;
                  &lt;/Revised&gt;
                  &lt;Accepted&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;6&lt;/Month&gt;
                    &lt;Day&gt;8&lt;/Day&gt;
                  &lt;/Accepted&gt;
                  &lt;OnlineDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;6&lt;/Month&gt;
                    &lt;Day&gt;19&lt;/Day&gt;
                  &lt;/OnlineDate&gt;
                &lt;/ArticleHistory&gt;
                &lt;ArticleFundingInformation&gt;
                  &lt;Fund&gt;
                    &lt;FunderName FundRefID="http://dx.doi.org/10.13039/501100005010"&gt;Associazione Italiana per la Ricerca sul Cancro&lt;/FunderName&gt;
                    &lt;GrantNumber Type="FundRef"&gt;MFAG13310&lt;/GrantNumber&gt;
                    &lt;GrantNumber GrantRecipient="Au8" Type="FundRef"&gt;IG19238&lt;/GrantNumber&gt;
                  &lt;/Fund&gt;
                  &lt;Fund&gt;
                    &lt;FunderName FundRefID="http://dx.doi.org/10.13039/501100003407"&gt;Ministero dell’Istruzione, dell’Università e della Ricerca&lt;/FunderName&gt;
                    &lt;GrantNumber Type="FundRef"&gt;2015HAJH8E&lt;/GrantNumber&gt;
                  &lt;/Fund&gt;
                &lt;/ArticleFundingInformation&gt;
                &lt;ArticleCopyright&gt;
                  &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                  &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                  &lt;License SubType="CC BY" Type="OpenAccess" Version="4.0"&gt;
                    &lt;SimplePara&gt;
                      &lt;Emphasis Type="Bold"&gt;Open Access&lt;/Emphasis&gt; This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
                    &lt;/SimplePara&gt;
                  &lt;/License&gt;
                &lt;/ArticleCopyright&gt;
                &lt;ArticleGrants Type="OpenChoice"&gt;
                  &lt;MetadataGrant Grant="OpenAccess"/&gt;
                  &lt;AbstractGrant Grant="OpenAccess"/&gt;
                  &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                  &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                  &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                  &lt;ESMGrant Grant="OpenAccess"/&gt;
                &lt;/ArticleGrants&gt;
              &lt;/ArticleInfo&gt;
              &lt;ArticleHeader&gt;
                &lt;AuthorGroup&gt;
                  &lt;Author AffiliationIDS="Aff1 Aff2" CorrespondingAffiliationID="Aff1" ID="Au1" ORCID="http://orcid.org/0000-0003-2024-6131"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Caterina&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Marchiò&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Phone&gt;+39-0116334127&lt;/Phone&gt;
                      &lt;Email&gt;caterina.marchio@unito.it&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff3" ID="Au2"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Gaia&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Gatti&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff2" ID="Au3"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Federica&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Massa&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1 Aff2" ID="Au4"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Luca&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Bertero&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff4" ID="Au5"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Pierluigi&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Filosso&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff5 Aff6" ID="Au6"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Giuseppe&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Pelosi&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1 Aff2" ID="Au7"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Paola&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Cassoni&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff3 Aff7" ID="Au8"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Marco&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Volante&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff2 Aff7" ID="Au9"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Mauro&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Papotti&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Affiliation ID="Aff1"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0001 2336 6580&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.7605.4&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Medical Sciences&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;University of Turin&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;Via Giuseppe Verdi, 8&lt;/Street&gt;
                      &lt;Postcode&gt;10124&lt;/Postcode&gt;
                      &lt;City&gt;Turin&lt;/City&gt;
                      &lt;Country Code="IT"&gt;Italy&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff2"&gt;
                    &lt;OrgName&gt;Pathology Division, AOU Città della Salute e della Scienza di Torino&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;Via Santena 7&lt;/Street&gt;
                      &lt;Postcode&gt;10126&lt;/Postcode&gt;
                      &lt;City&gt;Turin&lt;/City&gt;
                      &lt;Country Code="IT"&gt;Italy&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff3"&gt;
                    &lt;OrgDivision&gt;Pathology Division&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;San Luigi Hospital&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;Regione Gonzole 10&lt;/Street&gt;
                      &lt;Postcode&gt;10043&lt;/Postcode&gt;
                      &lt;City&gt;Orbassano&lt;/City&gt;
                      &lt;Country Code="IT"&gt;Italy&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff4"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0001 2336 6580&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.7605.4&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Surgical Sciences&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;University of Turin&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;Via Giuseppe Verdi, 8&lt;/Street&gt;
                      &lt;Postcode&gt;10124&lt;/Postcode&gt;
                      &lt;City&gt;Turin&lt;/City&gt;
                      &lt;Country Code="IT"&gt;Italy&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff5"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0004 1757 2822&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.4708.b&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Oncology and Hemato-Oncology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Università degli Studi di Milano&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;Via Festa del Perdono, 7&lt;/Street&gt;
                      &lt;Postcode&gt;I-20122&lt;/Postcode&gt;
                      &lt;City&gt;Milan&lt;/City&gt;
                      &lt;Country Code="IT"&gt;Italy&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff6"&gt;
                    &lt;OrgName&gt;Inter-hospital Pathology Division, Science &amp;amp; Technology Park, IRCCS MultiMedica Group&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Milan&lt;/City&gt;
                      &lt;Country Code="IT"&gt;Italy&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff7"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0001 2336 6580&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.7605.4&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Oncology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;University of Turin&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;Via Giuseppe Verdi, 8&lt;/Street&gt;
                      &lt;Postcode&gt;10124&lt;/Postcode&gt;
                      &lt;City&gt;Turin&lt;/City&gt;
                      &lt;Country Code="IT"&gt;Italy&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                &lt;/AuthorGroup&gt;
                &lt;Abstract ID="Abs1" Language="En" OutputMedium="All"&gt;
                  &lt;Heading&gt;Abstract&lt;/Heading&gt;
                  &lt;Para ID="Par1"&gt;Typical (TCs) and atypical carcinoids (ACs) are defined based on morphological criteria, and no grading system is currently accepted to further stratify these entities. The 2015 WHO classification restricts the Ki-67 role to biopsy or cytology samples, rather than for prognostic prediction. We aimed to investigate whether values and patterns of Ki-67 alone would allow for a clinically meaningful stratification of lung carcinoids, regardless of histological typing. Ki-67 proliferation index and pattern (homogeneous versus heterogeneous expression) were assessed in a cohort of 171 TCs and 68 ACs. Cases were subdivided into three Ki-67 ranges (&amp;lt;4/4–9/≥10%). Correlations with clinicopathological data, univariate and multivariate survival analyses were performed. The majority of cases (61.5%) belonged to the &amp;lt;4% Ki-67 range; 25.1 and 13.4% had a proliferation index of 4–9% and ≥10%, respectively. The &amp;lt;4% Ki-67 subgroup was significantly enriched for TCs (83%, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001); ACs were more frequent in the subgroup showing Ki-67&nbsp;≥&nbsp;10% (75%, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001). A heterogeneous Ki-67 pattern was preferentially seen in carcinoids with a Ki-67 ≥10% (38%, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.02). Mean Ki-67 values ≥4 and ≥10% identified categories of poor prognosis both in terms of disease-free and overall survival (
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.003 and &amp;lt;0.0001). At multivariate analysis, the two thresholds did not retain statistical significance; however, a Ki-67&nbsp;≥&nbsp;10% identified a subgroup of dismal prognosis even within ACs (
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.03) at univariate analysis. Here, we describe a subgroup of lung carcinoids showing brisk proliferation activity within the necrosis and/or mitotic count-based categories. These patients were associated with specific clinicopathological characteristics, to some extent regardless of histological subtyping.
                  &lt;/Para&gt;
                &lt;/Abstract&gt;
                &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                  &lt;Heading&gt;Keywords&lt;/Heading&gt;
                  &lt;Keyword&gt;Carcinoid&lt;/Keyword&gt;
                  &lt;Keyword&gt;Lung&lt;/Keyword&gt;
                  &lt;Keyword&gt;WHO classification&lt;/Keyword&gt;
                  &lt;Keyword&gt;Ki-67&lt;/Keyword&gt;
                  &lt;Keyword&gt;Heterogeneity&lt;/Keyword&gt;
                  &lt;Keyword&gt;Prognosis&lt;/Keyword&gt;
                &lt;/KeywordGroup&gt;
              &lt;/ArticleHeader&gt;
              &lt;Body&gt;
                &lt;Section1 ID="Sec1"&gt;
                  &lt;Heading&gt;Introduction&lt;/Heading&gt;
                  &lt;Para ID="Par2"&gt;Carcinoid tumours of the lung are rare primary lesions accounting for 0.2% (atypical carcinoids, AC) to 2% (typical carcinoids, TC) of resected lung cancers. According to the 2015 WHO classification [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;], they make up the morphologically defined group of neuroendocrine tumour (NETs) based upon cytological traits, mitotic count and necrosis. Lung NETs comprise low- to intermediate-grade forms (TCs and ACs, respectively), clearly segregated from high-grade malignancies, namely large cell NE carcinomas and small cell carcinomas. Carcinoid tumours, however, translate into a broad clinicopathologic spectrum characterized by highly variable outcomes, which are currently best stratified according to the 2015 WHO classification and 8th edition TNM staging [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]. Surgery is the best treatment modality choice for both TCs and ACs [
                    &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;], with TCs usually exhibiting long life expectancy with 5- and 10-year survival rate by far over 90% [
                    &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;]. Conversely, ACs exhibit a more aggressive clinical course and a 5-year survival rate ranging from 56 to 87%, which is lower in node positive patients, suggesting that this subgroup could benefit from some adjuvant treatment [
                    &lt;CitationRef AdditionalCitationIDS="CR5 CR6 CR7" CitationID="CR4"&gt;4&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par3"&gt;In pulmonary NETs, whether biopsy samples or surgical specimens, no grading system is currently accepted for further stratifying single tumour entities beyond the pure tumour histological typing. Indeed, the grading system proposed for gastroenteropancreatic (GEP) NETs does not apply to thoracic NETs, nor Ki-67 plays a role in tumour classification. In the 2015 WHO classification, the Ki-67 prognostic role is not established and is considered valuable in biopsy or cytology samples only [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]. As a matter of fact, several groups have confirmed the significant prognostic value of Ki-67 in lung NETs [
                    &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;], with a 4–5% cut-off being the most widely employed for the sake of reproducibility and reliability [
                    &lt;CitationRef CitationID="CR10"&gt;10&lt;/CitationRef&gt;] compared to mitotic count and necrosis, especially when dealing with biopsy specimens [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par4"&gt;However, in multivariate survival analysis, Ki-67 seems to add little value to histological typing [
                    &lt;CitationRef CitationID="CR13"&gt;13&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;] when a 4–5% cut-off is adopted, but results from several studies are still inconclusive. In order to integrate rather than to replace the histological classification with the information stemming from Ki-67 index determination, Rindi and co-workers have proposed an accurate and innovative grading system for pulmonary NETs (G1 to G3) where mitotic count, necrosis and Ki-67 index were jointly combined on the basis of lung-specific cut-off values [
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;]. At the histological level, only TCs by morphology turned out G1, while ACs and the LCNEC/SCLC group crossed G1 to G3 and G2 to G3 categories, respectively, confirming the inherent heterogeneity in behaviour of intermediate- to high-grade lung NETs [
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par5"&gt;In the GEP area, NET-G3 retaining a well-differentiated morphology but showing proliferation rates consistent with NE carcinomas, either in the whole tumour or in focal areas only, have recently been recognized [
                    &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR17"&gt;17&lt;/CitationRef&gt;]. These tumours are associated to genetic alterations of well-differentiated tumours, but with a clinical behaviour intermediate between G2 NETs and more conventional NE carcinomas [
                    &lt;CitationRef AdditionalCitationIDS="CR19" CitationID="CR18"&gt;18&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR20"&gt;20&lt;/CitationRef&gt;]. This phenomenon would identify secondary high-grade NE tumours evolving from pre-existing lower grade carcinoids, as recently demonstrated in the thymus [
                    &lt;CitationRef CitationID="CR21"&gt;21&lt;/CitationRef&gt;]. In the lung, LCNECs with carcinoid-like appearance have been identified [
                    &lt;CitationRef CitationID="CR22"&gt;22&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR23"&gt;23&lt;/CitationRef&gt;], but little is known about the clinical impact of carcinoid tumours, as defined by current diagnostic guidelines, showing high Ki-67 indices.
                  &lt;/Para&gt;
                  &lt;Para ID="Par6"&gt;Based on these premises, in this study, we sought to investigate the prevalence of carcinoid tumours showing brisk proliferation activity and to define whether values and patterns of Ki-67 labelling alone would allow for a clinically meaningful stratification of a large cohort of lung carcinoids, regardless of the histological type. This could be propaedeutic to the identification of low- to intermediate-grade NETs in the lung that may have the potential to evolve to a higher grade disease, thus sustaining the paradigm shift to secondary high-grade NETs even in the lung.&lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec2"&gt;
                  &lt;Heading&gt;Materials and methods&lt;/Heading&gt;
                  &lt;Section2 ID="Sec3"&gt;
                    &lt;Heading&gt;Cohort and Ki-67 scoring&lt;/Heading&gt;
                    &lt;Para ID="Par7"&gt;The pathology files of the AOU Città della Salute e della Scienza di Torino and San Luigi Hospital were interrogated for a diagnosis of carcinoid tumour on surgical specimen, and a total of 239 consecutive specimens were retrieved. All original H&amp;amp;E slides were reviewed by four of the authors (CM, GG, MV, MP) to confirm the diagnostic categorization, including re-evaluation of the mitotic count and Ki-67 index, the latter on newly stained slides (if unavailable or suboptimal). The cohort comprised 171 TCs and 68 ACs, defined according to the WHO 2015 criteria [
                      &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]. The study has been approved by the local ethical committee (Department of Oncology at San Luigi Hospital, number 17975, October 14th 2015). Discordant cases were discussed at a multi-headed microscope to reach agreement. We manually scored Ki-67 labelling index by counting at least 1000 cells. We also recorded whether the pattern of Ki-67 labelling was homogeneous throughout tumour samples or whether hotspot areas could be clearly identified (heterogeneous Ki-67 pattern). Whenever hotspot areas were detected, the highest recorded value was taken into account to perform statistical correlative analyses. Hotspot areas were defined as 
                      &lt;Emphasis Type="Italic"&gt;foci&lt;/Emphasis&gt; of tumour cells selected at low magnification (40×) based on an overcrowding of positive nuclei that led to a much higher count than the mean Ki-67 index evaluated on the overall tumour cell population. No specific cut-offs were adopted to identify hotspots. This definition allowed to identify areas of heterogeneous proliferation even within the context of TCs, where a proliferation count as low as 1 to 4% is usually encountered.
                    &lt;/Para&gt;
                    &lt;Para ID="Par8"&gt;A dedicated database was constructed where clinicopathological features were annotated, including follow-up data.&lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec4"&gt;
                    &lt;Heading&gt;Statistical analysis&lt;/Heading&gt;
                    &lt;Para ID="Par9"&gt;Cases were subdivided according to three different Ki-67 ranges (&amp;lt;4, 4–9, ≥10%) and correlation with histopathological features; pattern of Ki-67 and follow-up data were performed by Chi square test. The 4% threshold for Ki-67 is one of the most frequently adopted in literature [
                      &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;, 
                      &lt;CitationRef AdditionalCitationIDS="CR25" CitationID="CR24"&gt;24&lt;/CitationRef&gt;–
                      &lt;CitationRef CitationID="CR26"&gt;26&lt;/CitationRef&gt;], while the ≥10% cut-off was chosen based on the mean Ki-67 value of 9% observed in this series of AC (otherwise belonging to the 10–20% range mentioned for carcinoids in the current WHO classification [
                      &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]). A 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.05 value was considered statistically significant. Univariate time to progression and overall survival analyses were performed with the Kaplan-Meier method, and the log-rank test was employed to compare survival curves. Cox proportional hazards regression model was also used in multivariate survival analysis.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec5"&gt;
                  &lt;Heading&gt;Results&lt;/Heading&gt;
                  &lt;Section2 ID="Sec6"&gt;
                    &lt;Heading&gt;Clinicopathological features&lt;/Heading&gt;
                    &lt;Para ID="Par10"&gt;TCs and ACs showed a mean Ki-67 value of 2.8 and 9%, respectively, ranging from 1 to 18% for TCs and 1 to 43% for ACs (Fig. 
                      &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt;). Of note, four cases of ACs (1.7% of the total, 5.9% of the ACs) displayed a mean proliferation index of ≥25%.
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Atypical carcinoids showing different Ki-67 patterns (homogenous versus heterogeneous). ACs with organoid and trabecular growth patterns (
                              &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt; and 
                              &lt;Emphasis Type="Bold"&gt;c&lt;/Emphasis&gt;: H&amp;amp;E 40×, inset 100×) showing a homogenously (
                              &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt;: 40×) and heterogeneously (
                              &lt;Emphasis Type="Bold"&gt;d&lt;/Emphasis&gt;: 40×) increased Ki-67 index, in both cases up to 12%
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO1"&gt;
                          &lt;ImageObject Color="Color" FileRef="MediaObjects/428_2017_2177_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par11"&gt;Stratification of the tumour cohort according to 4 and 10% Ki-67 cut-off thresholds is shown in Table 
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;. The large majority of cases (147/239, 61.5%) pertained to the lowest Ki-67 range (&amp;lt;4%), 60 cases (25.1%) had a proliferation index between 4 and 9%, and a minor subgroup (32/239, 13.4%) displayed a Ki-67 labelling index of ≥10%.
                      &lt;Table Float="Yes" ID="Tab1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Clinicopathological features stratified according to different classes of proliferation, as defined by Ki-67 cut-offs of 4 and 10%&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup align="left" cols="6"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                          &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                          &lt;colspec align="left" colname="c6" colnum="6"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c2" namest="c1"&gt;
                                &lt;SimplePara&gt;Parameter&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Ki-67&nbsp;&amp;lt;&nbsp;4% (#147)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Ki-67&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;4–9% (#60)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Ki-67&nbsp;≥&nbsp;10% (#32)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt; value
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Sex&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;M&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;66&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;18&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;16&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6" morerows="1"&gt;
                                &lt;SimplePara&gt;0.08&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;F&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;81&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;42&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;16&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Age&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Median&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;56&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;55&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;64&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0.45&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Histological type&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;TC&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;122&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;41&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;8&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6" morerows="1"&gt;
                                &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;AC&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;25&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;19&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;24&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;pT&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;pT1–2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;133&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;56&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;26&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6" morerows="1"&gt;
                                &lt;SimplePara&gt;0.35&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;pT3–4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;14&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;pN&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;pN0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;113&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;49&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;21&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6" morerows="1"&gt;
                                &lt;SimplePara&gt;0.21&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;pN+&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;28&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;10&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;10&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Ki-67 pattern&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Homogeneous&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;80&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;32&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;18&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6" morerows="1"&gt;
                                &lt;SimplePara&gt;0.02&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Heterogeneous&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;13&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;8&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;11&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Vascular invasion&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Present&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;34&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;17&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;17&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6" morerows="1"&gt;
                                &lt;SimplePara&gt;0.001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Absent&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;101&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;33&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;11&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Pleura&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;PL0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;100&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;28&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;20&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6" morerows="1"&gt;
                                &lt;SimplePara&gt;0.001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;PL+&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Patient status&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;NED/DOC&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;127&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;51&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;20&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6" morerows="1"&gt;
                                &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;AWD/DOD&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;11&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;10&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"&gt;
                                &lt;SimplePara&gt;Survival data&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Median TTP (months)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Undefined&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Undefined&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;101&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0.0052&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;Median OS (months)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;244&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Undefined&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;122&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Emphasis Type="Italic"&gt;M&lt;/Emphasis&gt; male, 
                            &lt;Emphasis Type="Italic"&gt;F&lt;/Emphasis&gt; female, 
                            &lt;Emphasis Type="Italic"&gt;TC&lt;/Emphasis&gt; typical carcinoid, 
                            &lt;Emphasis Type="Italic"&gt;AC&lt;/Emphasis&gt; atypical carcinoid, 
                            &lt;Emphasis Type="Italic"&gt;NED&lt;/Emphasis&gt; no evidence of disease, 
                            &lt;Emphasis Type="Italic"&gt;DOC&lt;/Emphasis&gt; died of other unrelated causes, 
                            &lt;Emphasis Type="Italic"&gt;AWD&lt;/Emphasis&gt; alive with disease, 
                            &lt;Emphasis Type="Italic"&gt;DOD&lt;/Emphasis&gt; died of disease, 
                            &lt;Emphasis Type="Italic"&gt;OS&lt;/Emphasis&gt; overall survival, 
                            &lt;Emphasis Type="Italic"&gt;TTP&lt;/Emphasis&gt; time to progression
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par12"&gt;The low Ki-67 subgroup (&amp;lt;4%) was significantly enriched for TCs (122/147, 83%, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001, Table 
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;), whereas ACs were more frequently found in the subgroup showing a mean Ki-67 of ≥10% (24/32, 75%, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001, Table 
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;). Nevertheless, eight cases with a Ki-67 higher than 10% were classified as TC, according to the morphological criteria. A homogeneous Ki-67 labelling pattern was a significant feature of the low (&amp;lt;4%) Ki-67 subgroup (80/93, 86%, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.02, Table 
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;, Fig. 
                      &lt;InternalRef RefID="Fig2"&gt;2&lt;/InternalRef&gt;) as well as of the intermediate (4–9%) Ki-67 subgroup (32/40, 80%, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.02, Table 
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;), whereas a heterogeneous Ki-67 pattern was preferentially seen in the subgroup of carcinoids with a proliferation index of ≥10% (11/29 assessable cases, 38%, 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.02, Table 
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;, Figs. 
                      &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt; and 
                      &lt;InternalRef RefID="Fig2"&gt;2&lt;/InternalRef&gt;).
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig2"&gt;
                        &lt;!--SingleCol--&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 2&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Relative prevalence of Ki-67 pattern (homogeneous versus heterogeneous distribution) in lung carcinoids. A homogeneous Ki-67 labelling pattern was significantly more represented in the low (&amp;lt;4%) Ki-67 subgroup (86%, 
                              &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.02, Chi square test) and in the intermediate (4–9%) Ki-67 subgroup (80%, 
                              &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.02, Chi square test), whereas a heterogeneous Ki-67 pattern was preferentially seen in the subgroup of carcinoids with a proliferation index of ≥10% (38%, 
                              &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.02, Chi square test)
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO2"&gt;
                          &lt;ImageObject Color="Color" FileRef="MediaObjects/428_2017_2177_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                    &lt;Para ID="Par13"&gt;Vascular invasion and pleural involvement were relatively more represented in the carcinoid subgroup with Ki-67&nbsp;≥&nbsp;10%, and the differences among subgroups were statistically significant (
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.001, Table 
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;).
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec7"&gt;
                    &lt;Heading&gt;Patient outcome&lt;/Heading&gt;
                    &lt;Section3 ID="Sec8"&gt;
                      &lt;Heading&gt;Univariate analyses&lt;/Heading&gt;
                      &lt;Para ID="Par14"&gt;Patients with a TC diagnosis had an excellent disease-free and overall survival, which was significantly better compared to patients affected by ACs (
                        &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001, Tables 
                        &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt; and 
                        &lt;InternalRef RefID="Tab3"&gt;3&lt;/InternalRef&gt;, Fig. 
                        &lt;InternalRef RefID="Fig3"&gt;3&lt;/InternalRef&gt;).
                        &lt;Table Float="Yes" ID="Tab2"&gt;
                          &lt;Caption Language="En"&gt;
                            &lt;CaptionNumber&gt;Table 2&lt;/CaptionNumber&gt;
                            &lt;CaptionContent&gt;
                              &lt;SimplePara&gt;Univariate and multivariate time to progression survival analysis&lt;/SimplePara&gt;
                            &lt;/CaptionContent&gt;
                          &lt;/Caption&gt;
                          &lt;tgroup align="left" cols="7"&gt;
                            &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                            &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                            &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                            &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                            &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                            &lt;colspec align="left" colname="c6" colnum="6"/&gt;
                            &lt;colspec align="left" colname="c7" colnum="7"/&gt;
                            &lt;thead&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1" morerows="2"&gt;
                                  &lt;SimplePara&gt;Parameter&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry nameend="c5" namest="c2"&gt;
                                  &lt;SimplePara&gt;Carcinoids—time to progression survival (#219)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry nameend="c7" namest="c6"&gt;
                                  &lt;SimplePara&gt;ACs—time to progression survival (#58)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry nameend="c3" namest="c2"&gt;
                                  &lt;SimplePara&gt;Univariate&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry nameend="c5" namest="c4"&gt;
                                  &lt;SimplePara&gt;Multivariate&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry nameend="c7" namest="c6"&gt;
                                  &lt;SimplePara&gt;Univariate&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;HR (CI)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;
                                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                  &lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;HR (CI)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;
                                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                  &lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;HR (CI)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;
                                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                  &lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                            &lt;/thead&gt;
                            &lt;tbody&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Sex (M vs F)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;4.015 (1.697–9.785)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.002&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;0.12 (0.03–0.44)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;3.424 (1.243–9.430)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.017&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Age (above vs below median)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;1.570 (0.664–3.712)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.3&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;0.450 (0.155–1.310)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.14&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Histological type (AC vs TC)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;55.87 (18.13–172.2)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;22.90 (4.628–113.34)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Rindi’s grade (2 vs 1)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;50.01 (11.53–217.0)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;0.261 (0.066–1035)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.22&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.193 (0.445–3.199)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.72&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Size (above vs below mean)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;1.438 (0.570–3.628)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.59&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.170 (0.406–3.366)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.7&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Clinical stage (all others vs IA/B)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;2.001 (0.792–5050)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.14&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.703 (0.615–4.716)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.3&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Nodal status (N+ vs N0)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;7093 (2327–21.61)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.0006&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;3.374 (0.684–13.63)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.036&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.921 (0.764–5.232)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.2&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Vascular invasion (VI+ vs VI−)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;4.709 (1.684–13.16)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.003&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.634 (0.559–4.776)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.36&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;KI-67 (≥4 vs &amp;lt;4)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;3.994 (1.58–10.0)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.003&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;3.374 (0.684–16.63)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.13&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.252 (0.450–3.475)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.66&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Ki-67 (≥10%)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;17.121 (4.32–68.56)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;0.767 (0.198–2.95)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.7&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.772 (0.610–5.108)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.28&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Necrosis (present vs absent)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;369 (65.42–2082)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;2.186 (0.622–7.678)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.2&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;2.656 (0.925–7.625)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.07&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                            &lt;/tbody&gt;
                          &lt;/tgroup&gt;
                        &lt;/Table&gt;
                        &lt;Table Float="Yes" ID="Tab3"&gt;
                          &lt;Caption Language="En"&gt;
                            &lt;CaptionNumber&gt;Table 3&lt;/CaptionNumber&gt;
                            &lt;CaptionContent&gt;
                              &lt;SimplePara&gt;Univariate and multivariate overall survival analysis&lt;/SimplePara&gt;
                            &lt;/CaptionContent&gt;
                          &lt;/Caption&gt;
                          &lt;tgroup align="left" cols="7"&gt;
                            &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                            &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                            &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                            &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                            &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                            &lt;colspec align="left" colname="c6" colnum="6"/&gt;
                            &lt;colspec align="left" colname="c7" colnum="7"/&gt;
                            &lt;thead&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1" morerows="2"&gt;
                                  &lt;SimplePara&gt;Parameter&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry nameend="c5" namest="c2"&gt;
                                  &lt;SimplePara&gt;Carcinoids—overall survival (#219)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;ACs—overall survival (#58)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"/&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry nameend="c3" namest="c2"&gt;
                                  &lt;SimplePara&gt;Univariate&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry nameend="c5" namest="c4"&gt;
                                  &lt;SimplePara&gt;Multivariate&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry nameend="c7" namest="c6"&gt;
                                  &lt;SimplePara&gt;Univariate&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;HR (CI)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;
                                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                  &lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;HR (CI)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;
                                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                  &lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;HR (CI)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;
                                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;
                                  &lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                            &lt;/thead&gt;
                            &lt;tbody&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Sex (M vs F)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;3.429 (1.345–8.740)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.01&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;0.526 (0.218–1.271)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.15&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;2.477 (0.853–7.187)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.09&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Age (above vs below median)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;1.617 (0.665–4.08)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.28&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.336 (0.435–4.097)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.6&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Histoloigc type (AC vs TC)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;39.63 (12.37–127.9)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;3.029 (0.923–9.939)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.06&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Rindi’s grade (2 vs 1)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;40.14 (8.760–183.9)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;0.383 (0.111–1.441)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.15&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.325 (0.461–3.828)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.6&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Size (above vs below mean)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;7.437 (0.539–3.823)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.52&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.22 (0.389–3.828)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.7&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Clinical stage (all others vs IA/B)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;1.324 (0.486–3.605)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.3&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.401 (0.450–4.355)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.6&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Nodal status (N+ vs N0)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;5.109 (1.503–16.70)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.007&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;2.930 (1.161–7.546)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.02&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;2.206 (0.733–6.642)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.16&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Vascular invasion (VI+ vs VI−)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;7.646 (2.531–23.10)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;–&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;4.128 (1.251–13.63)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.02&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;KI-67 (≥4 vs &amp;lt;4)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;4.31 (1.624–11.45)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;0.003&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;2.879 (0.837–9.904)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.09&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;1.451 (0.49–4.29)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.5&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Ki-67 (≥10%)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;36.79 (8.868–152)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;1.949 (0.629–6.036)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.24&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;3.53 (1.128–11.08)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.03&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                              &lt;row&gt;
                                &lt;entry colname="c1"&gt;
                                  &lt;SimplePara&gt;Necrosis (present vs absent)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c2"&gt;
                                  &lt;SimplePara&gt;281 (46.50–1698)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c3"&gt;
                                  &lt;SimplePara&gt;&amp;lt;0.0001&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c4"&gt;
                                  &lt;SimplePara&gt;2.004 (0.627–6.411)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c5"&gt;
                                  &lt;SimplePara&gt;0.24&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c6"&gt;
                                  &lt;SimplePara&gt;3.094 (0.977–9.793)&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                                &lt;entry colname="c7"&gt;
                                  &lt;SimplePara&gt;0.05&lt;/SimplePara&gt;
                                &lt;/entry&gt;
                              &lt;/row&gt;
                            &lt;/tbody&gt;
                          &lt;/tgroup&gt;
                        &lt;/Table&gt;
                        &lt;Figure Category="Standard" Float="Yes" ID="Fig3"&gt;
                          &lt;!--SingleCol--&gt;
                          &lt;Caption Language="En"&gt;
                            &lt;CaptionNumber&gt;Fig. 3&lt;/CaptionNumber&gt;
                            &lt;CaptionContent&gt;
                              &lt;SimplePara&gt;Kaplan-Meier survival curves in lung carcinoids segregated according to histological type (
                                &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt;) and Ki-67&nbsp;&amp;gt;&nbsp;4% (
                                &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt;). 
                                &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt; Patients with a TC diagnosis had an excellent overall survival, which was significantly better compared to patients affected by ACs (
                                &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001). 
                                &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt; The 4% cut-off on the whole tumour cohort effectively split patients into worse categories for tumours displaying Ki-67 higher than 4% (
                                &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.003)
                              &lt;/SimplePara&gt;
                            &lt;/CaptionContent&gt;
                          &lt;/Caption&gt;
                          &lt;MediaObject ID="MO3"&gt;
                            &lt;ImageObject Color="Color" FileRef="MediaObjects/428_2017_2177_Fig3_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                          &lt;/MediaObject&gt;
                        &lt;/Figure&gt;
                      &lt;/Para&gt;
                      &lt;Para ID="Par15"&gt;When investigating Ki-67, we first dichotomized cases according to a 4% cut-off on the whole tumour cohort finding that it effectively split patients into worse categories in terms of both disease-free and overall survival for tumours displaying Ki-67 higher than 4% (
                        &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.003, Tables 
                        &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt; and 
                        &lt;InternalRef RefID="Tab3"&gt;3&lt;/InternalRef&gt;; Fig. 
                        &lt;InternalRef RefID="Fig3"&gt;3&lt;/InternalRef&gt;). The same held true when stratifying cases by using the 10% cut-off threshold, with two different prognostic populations for both time to progression and overall survival (
                        &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001, Tables 
                        &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt; and 
                        &lt;InternalRef RefID="Tab3"&gt;3&lt;/InternalRef&gt;). In addition, when the whole tumour cohort was stratified into three groups according to the 4 and 10% cut-off thresholds, we observed that outcome of patients with tumours pertaining to the three relevant Ki-67 categories (&amp;lt;4, 4–9, ≥10%) was different in terms of both overall survival and time to progression (
                        &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.0052 and &amp;lt;0.0001, respectively; Table 
                        &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt; and Fig. 
                        &lt;InternalRef RefID="Fig4"&gt;4&lt;/InternalRef&gt;), with cases displaying a Ki-67&nbsp;≥&nbsp;10% running a poorer survival. Of note, the difference in terms of outcome between the categories of &amp;lt;4% and 4–9% was not significantly different for either overall survival or time to progression (
                        &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.40 and 
                        &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.32, respectively). Importantly, the ≥10% cut-off was capable of significantly predicting patients’ outcome in terms of overall survival (
                        &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.03, Fig. 
                        &lt;InternalRef RefID="Fig4"&gt;4&lt;/InternalRef&gt;) even in the sole AC subgroup (accounting for the largest number of tumours with a relatively higher Ki-67).
                        &lt;Figure Category="Standard" Float="Yes" ID="Fig4"&gt;
                          &lt;!--SingleCol--&gt;
                          &lt;Caption Language="En"&gt;
                            &lt;CaptionNumber&gt;Fig. 4&lt;/CaptionNumber&gt;
                            &lt;CaptionContent&gt;
                              &lt;SimplePara&gt;Kaplan-Meier survival curves in lung carcinoids segregated according to distinct Ki-67 thresholds (4 and 10%). Analysis of patients’ outcome in terms of overall survival (
                                &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt;) and time to progression (
                                &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt;) in the whole cohort of lung carcinoids stratified according to 4 and 10% cut-offs. Of note, the difference in terms of outcome between the categories of &amp;lt;4 and 4–9% was not statistically significant for either overall survival or time to progression (
                                &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.40 and 
                                &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.32, respectively). 
                                &lt;Emphasis Type="Bold"&gt;c&lt;/Emphasis&gt; Subgroup analysis restricted to atypical carcinoids segregated according to the 10% cut-off, which significantly predicted the ultimate outcome of patients (
                                &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.03) even in the sole AC&nbsp;histological type
                              &lt;/SimplePara&gt;
                            &lt;/CaptionContent&gt;
                          &lt;/Caption&gt;
                          &lt;MediaObject ID="MO4"&gt;
                            &lt;ImageObject Color="Color" FileRef="MediaObjects/428_2017_2177_Fig4_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                          &lt;/MediaObject&gt;
                        &lt;/Figure&gt;
                      &lt;/Para&gt;
                      &lt;Para ID="Par16"&gt;Finally, male sex, G2 Rindi’s grade, presence of vascular invasion or necrosis, and positive nodal status were significantly associated with adverse prognosis at both time to progression and overall survival.&lt;/Para&gt;
                    &lt;/Section3&gt;
                    &lt;Section3 ID="Sec9"&gt;
                      &lt;Heading&gt;Multivariate analysis&lt;/Heading&gt;
                      &lt;Para ID="Par17"&gt;Male sex, nodal status and histological typing were independent prognostic factors at multivariate analysis, whereas the two Ki-67 cut-off thresholds of ≥4 and ≥10% did not retain statistical significance upon multivariate analysis (Tables 
                        &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt; and 
                        &lt;InternalRef RefID="Tab3"&gt;3&lt;/InternalRef&gt;). The subgroup of ACs was not powered enough to perform a multivariate analysis.
                      &lt;/Para&gt;
                    &lt;/Section3&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec10"&gt;
                  &lt;Heading&gt;Discussion&lt;/Heading&gt;
                  &lt;Para ID="Par18"&gt;In this study, we showed that up to 13% of lung carcinoids display a Ki-67 proliferation index of ≥10% and that 6% of ACs may show Ki-67 values around 25%. Most importantly, a 10% cut-off for Ki-67 labelling index provided a clinically meaningful stratification of carcinoid tumours of the lung even within the subgroup of ACs, thereby providing evidence that proliferation index assessed by Ki-67 would add useful prognostic information to histological subtyping.&lt;/Para&gt;
                  &lt;Para ID="Par19"&gt;It is currently a matter of debate whether the 2015 WHO classification [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;] is adequate enough to encompass the spectrum of lung NETs. This classification has substantially confirmed the four categories already crystallized in the two previous editions: it is solely based on histological parameters [
                    &lt;CitationRef CitationID="CR27"&gt;27&lt;/CitationRef&gt;], and the threshold of 10&nbsp;mitoses/2&nbsp;mm
                    &lt;Superscript&gt;2&lt;/Superscript&gt; is the criterion used to take pulmonary carcinoids apart from NE carcinomas [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]. Here, we show that the rare group of carcinoid tumours is biologically heterogeneous, including a subgroup of lesions with a relatively high proliferative potential as highlighted by the Ki-67 index. From a classification standpoint, the even rarer AC category is monolithic (necrosis and/or 2 to 10&nbsp;mitoses/2mm
                    &lt;Superscript&gt;2&lt;/Superscript&gt;), even if a cut-off of six mitoses has been proposed, but not envisaged, to separate tumours with different life expectation [
                    &lt;CitationRef CitationID="CR28"&gt;28&lt;/CitationRef&gt;]. The only diagnostic alternative is the category of high-grade neuroendocrine carcinomas, either LCNECs or SCLCs, which is however ruled out upon mitotic count. Interestingly, even LCNECs may show morphologic [
                    &lt;CitationRef CitationID="CR22"&gt;22&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR23"&gt;23&lt;/CitationRef&gt;] and molecular [
                    &lt;CitationRef CitationID="CR23"&gt;23&lt;/CitationRef&gt;] features rather akin to ACs, supporting the view of a grey-zone in lung NETs where a biological continuum could probably be more effective than categorical criteria for classification purposes. Most importantly, the optimal treatment options for ACs after surgery, particularly in the metastatic setting, are highly debated and variably including close follow-up, systemic therapies different from or comprising platinum or even biological drugs (somatostatin analogues or m-TOR inhibitors).
                  &lt;/Para&gt;
                  &lt;Para ID="Par20"&gt;Based on this evidence, we reasoned that rather than forcing the four-tier histological classification, an approach based on proliferation activity could be beneficial to best depict the clinical variety within carcinoid tumours, thereby integrating a purely histological classification. At present, over 2000 lung NET cases have been published having Ki-67 investigated as part of the morphological and phenotypical description [
                    &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;], and most of these studies recognize the usefulness of Ki-67 index reporting. A multicentre study on almost 400 cases proposed a grading system for lung NETs incorporating the Ki-67 index alongside mitotic count and necrosis evaluation [
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par21"&gt;In our study, we wanted to ascertain whether Ki-67 alone, not engaged in a grading system, would allow a prognostic classification within the category of carcinoid tumours with the specific aim of identifying a niche of carcinoid tumours (defined according to the official parameters) having a proliferation index above the expected values. Our results clearly show a prognostic separation in terms of both overall survival and time to progression when cut-offs of 4 and 10% are adopted. Our analysis also revealed that the tumours with either &amp;lt;4 or 4–9% proliferation indices showed comparable survival rates, thus suggesting the 10% as a more suitable cut-off to identify lung carcinoids with a clinically meaningful brisk proliferation activity.&lt;/Para&gt;
                  &lt;Para ID="Par22"&gt;The adoption of Rindi’s grade (grade 2 versus 1) showed a significant correlation with outcome in univariate but not in multivariate analysis. Although also the Ki-67 thresholds here analysed did not reach statistical significance in multivariate analysis, it is interesting to note that the 10% cut-off was able to tease out a category of tumours harbouring dismal prognosis even within the restricted category of ACs, whereas Rindi’s grade did not hold significant prognostic information in this subset of patients.&lt;/Para&gt;
                  &lt;Para ID="Par23"&gt;Importantly, a heterogeneous Ki-67 proliferation pattern was significantly more common in the category of cases displaying a Ki-67 labelling index ≥10%. This is in line with recent reports suggesting that intra-tumour heterogeneity holds per se a negative prognostic impact, as shown across several distinct diseases [
                    &lt;CitationRef CitationID="CR29"&gt;29&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par24"&gt;We documented in our study that a non-negligible number of life-threatening ACs showed quite unexpected high Ki-67 indices, which overlapped with those reported for LCNECs [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;], even if not fulfilling the relevant mitotic count for this tumour category. Although Ki-67 levels and mitoses do not entirely reflect the same cell cycle-associated event, it is known that pancreatic NETs with discrepant Ki-67 and mitotic indices bear different impacts on tumour grading [
                    &lt;CitationRef CitationID="CR30"&gt;30&lt;/CitationRef&gt;]. Moreover, we speculate that these ACs with high Ki-67 index could harbour a potential of transition towards LCNECs with similar molecular profiles, either synchronously or metachronously, as recently demonstrated in thymus ACs [
                    &lt;CitationRef CitationID="CR21"&gt;21&lt;/CitationRef&gt;]. Furthermore, a recent study by Simbolo et al. [
                    &lt;CitationRef CitationID="CR31"&gt;31&lt;/CitationRef&gt;] has also shown that rare lung LCNECs resembling carcinoids harbour 
                    &lt;Emphasis Type="Italic"&gt;MEN1&lt;/Emphasis&gt; mutations—the most frequent alteration in ACs—along with 
                    &lt;Emphasis Type="Italic"&gt;TERT&lt;/Emphasis&gt;, 
                    &lt;Emphasis Type="Italic"&gt;SDHA&lt;/Emphasis&gt;, 
                    &lt;Emphasis Type="Italic"&gt;RICTOR&lt;/Emphasis&gt;, 
                    &lt;Emphasis Type="Italic"&gt;PIK3CA&lt;/Emphasis&gt;, 
                    &lt;Emphasis Type="Italic"&gt;MYCL&lt;/Emphasis&gt; and 
                    &lt;Emphasis Type="Italic"&gt;SRC&lt;/Emphasis&gt; gains are shared with high-grade carcinomas. This is in line with a paradigm shift, even in the lung, that envisages the development of secondary high-grade NETs from pre-existing lower grade NETs, as demonstrated in the thymus [
                    &lt;CitationRef CitationID="CR21"&gt;21&lt;/CitationRef&gt;]. Regrettably, the numerosity of outlier tumour carcinoids, i.e. either highly proliferating or harbouring genetic features of aggressive disease (
                    &lt;Emphasis Type="Italic"&gt;TP53&lt;/Emphasis&gt; mutations, hypermutated profile), was too limited in the recent study reported by Simbolo et al. [
                    &lt;CitationRef CitationID="CR31"&gt;31&lt;/CitationRef&gt;] to draw any informative conclusions. In this scenario, it becomes clear that a thorough genomic characterization focused on a large cohort of highly proliferating carcinoid tumours in strict comparison with LCNECs and SCLCs is eagerly awaited.
                  &lt;/Para&gt;
                  &lt;Para ID="Par25"&gt;In conclusion, although the histological subtyping still represents the cornerstone in lung carcinoid classification, the inter- and intra-tumour heterogeneity of proliferation indices together with different clinical behaviour within the same histological subgroups suggest that the current morphology-based system could be suboptimal for an effective prognostic stratification and therapy planning. Herein, we indicate that a subgroup of ACs showed brisk Ki-67 indices within the spectrum of allowed mitotic count. These patients were associated with specific clinical and pathological characteristics, to some extent regardless of histological subtyping. Preliminary data obtained by our group in thymus ACs on synchronous and metachronous lesions suggest that a progression capability of these lesions may stem form a markedly heterogeneous intra-tumour distribution of Ki-67 labelling indices. The correct identification of these tumours is clinically warranted. A thorough molecular characterization of this specific high proliferative index carcinoid subgroup may uncover the determinants of their biology and/or progression capacity, as well as identify biomarkers of potential therapeutic usefulness.&lt;/Para&gt;
                &lt;/Section1&gt;
              &lt;/Body&gt;
              &lt;BodyRef FileRef="BodyRef/PDF/428_2017_Article_2177.pdf" TargetType="OnlinePDF"/&gt;
              &lt;ArticleBackmatter&gt;
                &lt;Acknowledgments&gt;
                  &lt;Heading&gt;Acknowledgements&lt;/Heading&gt;
                  &lt;SimplePara&gt;This work was supported by AIRC, Associazione Italiana per la Ricerca sul Cancro (MFAG13310 to CM and IG19238 to MV), and by the Italian Ministry of Education, University and Research (PRIN 2015HAJH8E to CM). We would like to thank Mrs. Chiara Musuraca and Mr. Marco Cupo for the assistance in Ki-67 data analysis.&lt;/SimplePara&gt;
                &lt;/Acknowledgments&gt;
                &lt;Ethics&gt;
                  &lt;Heading&gt;Compliance with ethical standards&lt;/Heading&gt;
                  &lt;SimplePara&gt;The study has been approved by the local ethical committee (Department of Oncology at San Luigi Hospital, number 17975, October 14th 2015).&lt;/SimplePara&gt;
                  &lt;SimplePara&gt;The funders (see Acknowledgements) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no potential conflicts of interest to declare.&lt;/SimplePara&gt;
                &lt;/Ethics&gt;
                &lt;Bibliography ID="Bib1"&gt;
                  &lt;Heading&gt;References&lt;/Heading&gt;
                  &lt;Citation ID="CR1"&gt;
                    &lt;CitationNumber&gt;1.&lt;/CitationNumber&gt;
                    &lt;BibBook&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Travis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brambilla&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Burke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marx&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nicholson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;BookTitle&gt;WHO classification of tumours of the lung, pleura, thymus and heart&lt;/BookTitle&gt;
                      &lt;EditionNumber&gt;4&lt;/EditionNumber&gt;
                      &lt;PublisherName&gt;IARC Press&lt;/PublisherName&gt;
                      &lt;PublisherLocation&gt;Lyon&lt;/PublisherLocation&gt;
                    &lt;/BibBook&gt;
                    &lt;BibUnstructured&gt;Travis WD, Brambilla E, Burke A, Marx A, Nicholson A (2015) WHO classification of tumours of the lung, pleura, thymus and heart, 4th edn. IARC Press, Lyon&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR2"&gt;
                    &lt;CitationNumber&gt;2.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, Travis WD, participants Ecc (2015) Pulmonary neuroendocrine (carcinoid) tumors: European neuroendocrine tumor society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids. Ann Oncol 26 (8):1604–1620. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1093/annonc/mdv041&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1093/annonc/mdv041" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR3"&gt;
                    &lt;CitationNumber&gt;3.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Travis WD (2010) Advances in neuroendocrine lung tumors. Ann Oncol 21 Suppl 7:vii65-71. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1093/annonc/mdq380&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1093/annonc/mdq380" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR4"&gt;
                    &lt;CitationNumber&gt;4.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Asamura&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kameya&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Matsuno&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Noguchi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tada&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ishikawa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Yokose&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SX&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jiang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Inoue&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nakagawa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tajima&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nagai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2006&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Neuroendocrine neoplasms of the lung: a prognostic spectrum&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;24&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;70&lt;/FirstPage&gt;
                      &lt;LastPage&gt;76&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1200/JCO.2005.04.1202&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.2005.04.1202&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16382115&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Asamura H, Kameya T, Matsuno Y, Noguchi M, Tada H, Ishikawa Y, Yokose T, Jiang SX, Inoue T, Nakagawa K, Tajima K, Nagai K (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24(1):70–76. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1200/JCO.2005.04.1202&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1200/JCO.2005.04.1202" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR5"&gt;
                    &lt;CitationNumber&gt;5.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maurizi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ibrahim&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Andreetti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;D'Andrilli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ciccone&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pomes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Menna&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pellegrini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Venuta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rendina&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Long-term results after resection of bronchial carcinoid tumour: evaluation of survival and prognostic factors&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Interact Cardiovasc Thorac Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;19&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;239&lt;/FirstPage&gt;
                      &lt;LastPage&gt;244&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1093/icvts/ivu109&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1093/icvts/ivu109&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24737788&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Maurizi G, Ibrahim M, Andreetti C, D'Andrilli A, Ciccone AM, Pomes LM, Menna C, Pellegrini M, Venuta F, Rendina EA (2014) Long-term results after resection of bronchial carcinoid tumour: evaluation of survival and prognostic factors. Interact Cardiovasc Thorac Surg 19(2):239–244. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1093/icvts/ivu109&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1093/icvts/ivu109" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR6"&gt;
                    &lt;CitationNumber&gt;6.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mezzetti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Raveglia&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Panigalli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Giuliani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lo Giudice&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Meda&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Conforti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2003&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Ann Thorac Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;76&lt;/VolumeID&gt;
                      &lt;IssueID&gt;6&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1838&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1842&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1016/S0003-4975(03)01194-9&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S0003-4975(03)01194-9&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;14667595&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Mezzetti M, Raveglia F, Panigalli T, Giuliani L, Lo Giudice F, Meda S, Conforti S (2003) Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification. Ann Thorac Surg 76(6):1838–1842. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1016/S0003-4975(03)01194-9&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1016/S0003-4975(03)01194-9" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR7"&gt;
                    &lt;CitationNumber&gt;7.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Filosso&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rena&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Guerrera&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moreno Casado&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sagan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Raveglia&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brunelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Welter&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gust&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pompili&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Casadio&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bora&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Alvarez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zaluska&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Baisi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Roesel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Thomas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EN-WS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Committee&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Groupdagger&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Cardiothorac Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;48&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;55&lt;/FirstPage&gt;
                      &lt;LastPage&gt;64&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1093/ejcts/ezu404&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1093/ejcts/ezu404&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25406425&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Filosso PL, Rena O, Guerrera F, Moreno Casado P, Sagan D, Raveglia F, Brunelli A, Welter S, Gust L, Pompili C, Casadio C, Bora G, Alvarez A, Zaluska W, Baisi A, Roesel C, Thomas PA, Committee EN-WS (2015) Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Groupdagger. Eur J Cardiothorac Surg 48(1):55–64. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1093/ejcts/ezu404&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1093/ejcts/ezu404" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR8"&gt;
                    &lt;CitationNumber&gt;8.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Filosso&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ruffini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gangi&lt;/FamilyName&gt;
                        &lt;Particle&gt;Di&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Guerrera&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bora&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ciccone&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Galassi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Solidoro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lyberis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oliaro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sandri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Cardiothorac Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;45&lt;/VolumeID&gt;
                      &lt;IssueID&gt;3&lt;/IssueID&gt;
                      &lt;FirstPage&gt;521&lt;/FirstPage&gt;
                      &lt;LastPage&gt;526&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1093/ejcts/ezt442&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1093/ejcts/ezt442&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24092506&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;BibComments&gt;discussion 526&lt;/BibComments&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Filosso PL, Ruffini E, Di Gangi S, Guerrera F, Bora G, Ciccone G, Galassi C, Solidoro P, Lyberis P, Oliaro A, Sandri A (2014) Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience. Eur J Cardiothorac Surg 45(3):521–526; discussion 526. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1093/ejcts/ezt442&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1093/ejcts/ezt442" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR9"&gt;
                    &lt;CitationNumber&gt;9.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pelosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rindi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Travis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Papotti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Thorac Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;9&lt;/VolumeID&gt;
                      &lt;IssueID&gt;3&lt;/IssueID&gt;
                      &lt;FirstPage&gt;273&lt;/FirstPage&gt;
                      &lt;LastPage&gt;284&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1097/JTO.0000000000000092&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXisF2htb4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/JTO.0000000000000092&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24518085&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Pelosi G, Rindi G, Travis WD, Papotti M (2014) Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice. J Thorac Oncol 9(3):273–284. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1097/JTO.0000000000000092&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1097/JTO.0000000000000092" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR10"&gt;
                    &lt;CitationNumber&gt;10.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;InstitutionalAuthorName&gt;Warth A, Fink L, Fisseler-Eckhoff A, Jonigk D, Keller M, Ott G, Rieker RJ, Sinn P, Soder S, Soltermann A, Willenbrock K, Weichert W, Pulmonary Pathology Working Group of the German Society of P&lt;/InstitutionalAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Virchows Arch&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;462&lt;/VolumeID&gt;
                      &lt;IssueID&gt;5&lt;/IssueID&gt;
                      &lt;FirstPage&gt;507&lt;/FirstPage&gt;
                      &lt;LastPage&gt;513&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1007/s00428-013-1408-2&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00428-013-1408-2&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Warth A, Fink L, Fisseler-Eckhoff A, Jonigk D, Keller M, Ott G, Rieker RJ, Sinn P, Soder S, Soltermann A, Willenbrock K, Weichert W, Pulmonary Pathology Working Group of the German Society of P (2013) Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids. Virchows Arch 462(5):507–513. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1007/s00428-013-1408-2&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1007/s00428-013-1408-2" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR11"&gt;
                    &lt;CitationNumber&gt;11.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fabbri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cossa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sonzogni&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Papotti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Righi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gatti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maisonneuve&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Valeri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;U&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pastorino&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pelosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2017&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Virchows Arch&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;470&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;153&lt;/FirstPage&gt;
                      &lt;LastPage&gt;164&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1007/s00428-016-2062-2&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2sXkvFeltg%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00428-016-2062-2&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;28054150&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Fabbri A, Cossa M, Sonzogni A, Papotti M, Righi L, Gatti G, Maisonneuve P, Valeri B, Pastorino U, Pelosi G (2017) Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied. Virchows Arch 470(2):153–164. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1007/s00428-016-2062-2&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1007/s00428-016-2062-2" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR12"&gt;
                    &lt;CitationNumber&gt;12.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pelosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rodriguez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Viale&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rosai&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Surg Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;29&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;179&lt;/FirstPage&gt;
                      &lt;LastPage&gt;187&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1097/01.pas.0000149690.75462.29&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/01.pas.0000149690.75462.29&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;15644774&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Pelosi G, Rodriguez J, Viale G, Rosai J (2005) Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am J Surg Pathol 29(2):179–187. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1097/01.pas.0000149690.75462.29&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1097/01.pas.0000149690.75462.29" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR13"&gt;
                    &lt;CitationNumber&gt;13.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Swarts&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rudelius&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Claessen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cleutjens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Seidl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Volante&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ramaekers&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Speel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2017&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Histopathology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;70&lt;/VolumeID&gt;
                      &lt;IssueID&gt;3&lt;/IssueID&gt;
                      &lt;FirstPage&gt;412&lt;/FirstPage&gt;
                      &lt;LastPage&gt;422&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1111/his.13096&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1111/his.13096&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27701763&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Swarts DR, Rudelius M, Claessen SM, Cleutjens JP, Seidl S, Volante M, Ramaekers FC, Speel EJ (2017) Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids. Histopathology 70(3):412–422. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1111/his.13096&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1111/his.13096" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR14"&gt;
                    &lt;CitationNumber&gt;14.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Walts&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ines&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marchevsky&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Mod Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;25&lt;/VolumeID&gt;
                      &lt;IssueID&gt;9&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1258&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1264&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1038/modpathol.2012.81&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1038/modpathol.2012.81&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22575865&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Walts AE, Ines D, Marchevsky AM (2012) Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors. Mod Pathol 25(9):1258–1264. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1038/modpathol.2012.81&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1038/modpathol.2012.81" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR15"&gt;
                    &lt;CitationNumber&gt;15.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rindi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klersy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Inzani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fellegara&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ampollini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ardizzoni&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Campanini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carbognani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pas&lt;/FamilyName&gt;
                        &lt;Particle&gt;De&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Galetta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Granone&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Righi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rusca&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spaggiari&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tiseo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Viale&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Volante&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Papotti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pelosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Grading the neuroendocrine tumors of the lung: an evidence-based proposal&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Endocr Relat Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;21&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1&lt;/FirstPage&gt;
                      &lt;LastPage&gt;16&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1530/ERC-13-0246&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BC2c3otlSltQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1530/ERC-13-0246&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24344249&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Rindi G, Klersy C, Inzani F, Fellegara G, Ampollini L, Ardizzoni A, Campanini N, Carbognani P, De Pas TM, Galetta D, Granone PL, Righi L, Rusca M, Spaggiari L, Tiseo M, Viale G, Volante M, Papotti M, Pelosi G (2014) Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer 21(1):1–16. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1530/ERC-13-0246&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1530/ERC-13-0246" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR16"&gt;
                    &lt;CitationNumber&gt;16.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Untch&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Reidy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;O'Reilly&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dhall&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jih&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Basturk&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Allen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klimstra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from Poorly differentiated neuroendocrine carcinomas&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Cancer Res&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;22&lt;/VolumeID&gt;
                      &lt;IssueID&gt;4&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1011&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1017&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1158/1078-0432.CCR-15-0548&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XivFGmsb8%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1158/1078-0432.CCR-15-0548&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26482044&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Tang LH, Untch BR, Reidy DL, O'Reilly E, Dhall D, Jih L, Basturk O, Allen PJ, Klimstra DS (2016) Well-differentiated neuroendocrine tumors with a morphologically apparent high-grade component: a pathway distinct from Poorly differentiated neuroendocrine carcinomas. Clin Cancer Res 22(4):1011–1017. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1158/1078-0432.CCR-15-0548&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1158/1078-0432.CCR-15-0548" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR17"&gt;
                    &lt;CitationNumber&gt;17.&lt;/CitationNumber&gt;
                    &lt;BibBook&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bosman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carneiro&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hruban&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ND&lt;/Initials&gt;
                        &lt;FamilyName&gt;Theise&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;BookTitle&gt;WHO classification of tumours of the digestive system&lt;/BookTitle&gt;
                      &lt;PublisherName&gt;IARC Press&lt;/PublisherName&gt;
                      &lt;PublisherLocation&gt;Lyon&lt;/PublisherLocation&gt;
                    &lt;/BibBook&gt;
                    &lt;BibUnstructured&gt;Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system. IARC Press, Lyon&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR18"&gt;
                    &lt;CitationNumber&gt;18.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Milione&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maisonneuve&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spada&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pellegrinelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spaggiari&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Albarello&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pisa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barberis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vanoli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Buzzoni&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pusceddu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Concas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sessa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Solcia&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Capella&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fazio&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rosa&lt;/FamilyName&gt;
                        &lt;Particle&gt;La&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2017&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The clinicopathologic heterogeneity of grade 3 gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different prognostic categories&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Neuroendocrinology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;104&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;85&lt;/FirstPage&gt;
                      &lt;LastPage&gt;93&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1159/000445165&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XhvVSjurjP&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1159/000445165&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26943788&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Milione M, Maisonneuve P, Spada F, Pellegrinelli A, Spaggiari P, Albarello L, Pisa E, Barberis M, Vanoli A, Buzzoni R, Pusceddu S, Concas L, Sessa F, Solcia E, Capella C, Fazio N, La Rosa S (2017) The clinicopathologic heterogeneity of grade 3 gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different prognostic categories. Neuroendocrinology 104(1):85–93. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1159/000445165&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1159/000445165" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR19"&gt;
                    &lt;CitationNumber&gt;19.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Raj&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Valentino&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Capanu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Basturk&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Untch&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Allen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klimstra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Reidy-Lagunes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2017&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Treatment response and outcomes of grade 3 pancreatic neuroendocrine neoplasms based on morphology: well differentiated versus poorly differentiated&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Pancreas&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;46&lt;/VolumeID&gt;
                      &lt;IssueID&gt;3&lt;/IssueID&gt;
                      &lt;FirstPage&gt;296&lt;/FirstPage&gt;
                      &lt;LastPage&gt;301&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1097/MPA.0000000000000735&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/MPA.0000000000000735&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27759713&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Raj N, Valentino E, Capanu M, Tang LH, Basturk O, Untch BR, Allen PJ, Klimstra DS, Reidy-Lagunes D (2017) Treatment response and outcomes of grade 3 pancreatic neuroendocrine neoplasms based on morphology: well differentiated versus poorly differentiated. Pancreas 46(3):296–301. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1097/MPA.0000000000000735&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1097/MPA.0000000000000735" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR20"&gt;
                    &lt;CitationNumber&gt;20.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Basturk&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sue&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klimstra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Surg Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;40&lt;/VolumeID&gt;
                      &lt;IssueID&gt;9&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1192&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1202&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1097/PAS.0000000000000662&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/PAS.0000000000000662&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27259015&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4988129&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Tang LH, Basturk O, Sue JJ, Klimstra DS (2016) A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas. Am J Surg Pathol 40(9):1192–1202. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1097/PAS.0000000000000662&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1097/PAS.0000000000000662" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR21"&gt;
                    &lt;CitationNumber&gt;21.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Fabbri A, Cossa M, Sonzogni A, Bidoli P, Canova S, Abbate MI, Calabrese F, Nannini N, Lunardi F, Rossi G, La Rosa S, Capella C, Tamborini E, Perrone F, Busico A, Capone I, Valeri B, Pastorino U, Crtinovis D, Albini A, Pelosi G (2017) Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift. Virchows Arch in press&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR22"&gt;
                    &lt;CitationNumber&gt;22.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Quinn&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chaturvedi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nonaka&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;High-grade neuroendocrine carcinoma of the lung with carcinoid morphology: a study of 12 cases&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Surg Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;41&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;263&lt;/FirstPage&gt;
                      &lt;LastPage&gt;270&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1097/PAS.0000000000000767&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/PAS.0000000000000767&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Quinn AM, Chaturvedi A, Nonaka D (2016) High-grade neuroendocrine carcinoma of the lung with carcinoid morphology: a study of 12 cases. Am J Surg Pathol 41(2):263–270. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1097/PAS.0000000000000767&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1097/PAS.0000000000000767" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR23"&gt;
                    &lt;CitationNumber&gt;23.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rekhtman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pietanza&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hellmann&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Naidoo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Arora&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Won&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Halpenny&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tian&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Litvak&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Paik&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Drilon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Socci&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Poirier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Berger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moreira&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Travis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rudin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ladanyi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2016&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Cancer Res&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;22&lt;/VolumeID&gt;
                      &lt;IssueID&gt;14&lt;/IssueID&gt;
                      &lt;FirstPage&gt;3618&lt;/FirstPage&gt;
                      &lt;LastPage&gt;3629&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1158/1078-0432.CCR-15-2946&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28Xht1Sitr3O&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1158/1078-0432.CCR-15-2946&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26960398&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4995776&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Rekhtman N, Pietanza MC, Hellmann MD, Naidoo J, Arora A, Won H, Halpenny DF, Wang H, Tian SK, Litvak AM, Paik PK, Drilon AE, Socci N, Poirier JT, Shen R, Berger MF, Moreira AL, Travis WD, Rudin CM, Ladanyi M (2016) Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets. Clin Cancer Res 22(14):3618–3629. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1158/1078-0432.CCR-15-2946&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1158/1078-0432.CCR-15-2946" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR24"&gt;
                    &lt;CitationNumber&gt;24.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Costes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marty-Ane&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Picot&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Serre&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pujol&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mary&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Baldet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1995&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Hum Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;26&lt;/VolumeID&gt;
                      &lt;IssueID&gt;7&lt;/IssueID&gt;
                      &lt;FirstPage&gt;740&lt;/FirstPage&gt;
                      &lt;LastPage&gt;745&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1016/0046-8177(95)90221-X&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK2MzlsFWitw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/0046-8177(95)90221-X&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;7628845&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Costes V, Marty-Ane C, Picot MC, Serre I, Pujol JL, Mary H, Baldet P (1995) Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study. Hum Pathol 26(7):740–745. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1016/0046-8177(95)90221-X&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1016/0046-8177(95)90221-X" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR25"&gt;
                    &lt;CitationNumber&gt;25.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pelosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pasini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fraggetta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;U&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pastorino&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Iannucci&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Maisonneuve&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Arrigoni&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Manzoni&lt;/FamilyName&gt;
                        &lt;Particle&gt;De&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bresaola&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Viale&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2003&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Lung Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;42&lt;/VolumeID&gt;
                      &lt;IssueID&gt;2&lt;/IssueID&gt;
                      &lt;FirstPage&gt;203&lt;/FirstPage&gt;
                      &lt;LastPage&gt;213&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S0169-5002(03)00294-0&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;14568688&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Pelosi G, Pasini F, Fraggetta F, Pastorino U, Iannucci A, Maisonneuve P, Arrigoni G, De Manzoni G, Bresaola E, Viale G (2003) Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 42(2):203–213&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR26"&gt;
                    &lt;CitationNumber&gt;26.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rugge&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fassan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Clemente&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rizzardi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Giacomelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pennelli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mescoli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Segat&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rea&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2008&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Cancer Res&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;IssueID&gt;1&lt;/IssueID&gt;
                      &lt;FirstPage&gt;149&lt;/FirstPage&gt;
                      &lt;LastPage&gt;154&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1158/1078-0432.CCR-07-1631&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1cXoslCr&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1158/1078-0432.CCR-07-1631&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;18172265&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Rugge M, Fassan M, Clemente R, Rizzardi G, Giacomelli L, Pennelli G, Mescoli C, Segat D, Rea F (2008) Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients. Clin Cancer Res 14(1):149–154. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1158/1078-0432.CCR-07-1631&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1158/1078-0432.CCR-07-1631" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR27"&gt;
                    &lt;CitationNumber&gt;27.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pelosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fabbri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cossa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sonzogni&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Valeri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Righi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Papotti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Semin Diagn Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;32&lt;/VolumeID&gt;
                      &lt;IssueID&gt;6&lt;/IssueID&gt;
                      &lt;FirstPage&gt;469&lt;/FirstPage&gt;
                      &lt;LastPage&gt;479&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1053/j.semdp.2015.10.009&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1053/j.semdp.2015.10.009&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26561395&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Pelosi G, Fabbri A, Cossa M, Sonzogni A, Valeri B, Righi L, Papotti M (2015) What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? Semin Diagn Pathol 32(6):469–479. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1053/j.semdp.2015.10.009&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1053/j.semdp.2015.10.009" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR28"&gt;
                    &lt;CitationNumber&gt;28.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Beasley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Thunnissen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brambilla&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hasleton&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Steele&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hammar&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TV&lt;/Initials&gt;
                        &lt;FamilyName&gt;Colby&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sheppard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shimosato&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MN&lt;/Initials&gt;
                        &lt;FamilyName&gt;Koss&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Falk&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Travis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2000&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Pulmonary atypical carcinoid: predictors of survival in 106 cases&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Hum Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;31&lt;/VolumeID&gt;
                      &lt;IssueID&gt;10&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1255&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1265&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1053/hupa.2000.19294&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3M%2FksF2kuw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1053/hupa.2000.19294&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;11070119&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Beasley MB, Thunnissen FB, Brambilla E, Hasleton P, Steele R, Hammar SP, Colby TV, Sheppard M, Shimosato Y, Koss MN, Falk R, Travis WD (2000) Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol 31(10):1255–1265. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1053/hupa.2000.19294&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1053/hupa.2000.19294" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR29"&gt;
                    &lt;CitationNumber&gt;29.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;Morris LG, Riaz N, Desrichard A, Senbabaoglu Y, Hakimi AA, Makarov V, Reis-Filho JS, Chan TA (2016) Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival. Oncotarget 7 (9):10051-10063. Doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.18632/oncotarget.7067&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.18632/oncotarget.7067" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR30"&gt;
                    &lt;CitationNumber&gt;30.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CM&lt;/Initials&gt;
                        &lt;FamilyName&gt;McCall&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Shi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cornish&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Klimstra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Basturk&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mun&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ellison&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wolfgang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Choti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schulick&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Edil&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hruban&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Surg Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;37&lt;/VolumeID&gt;
                      &lt;IssueID&gt;11&lt;/IssueID&gt;
                      &lt;FirstPage&gt;1671&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1677&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1097/PAS.0000000000000089&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/PAS.0000000000000089&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24121170&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3891823&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;McCall CM, Shi C, Cornish TC, Klimstra DS, Tang LH, Basturk O, Mun LJ, Ellison TA, Wolfgang CL, Choti MA, Schulick RD, Edil BH, Hruban RH (2013) Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am J Surg Pathol 37(11):1671–1677. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1097/PAS.0000000000000089&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1097/PAS.0000000000000089" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR31"&gt;
                    &lt;CitationNumber&gt;31.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Simbolo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mafficini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KO&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sikora&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fassan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barbi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Corbo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mastracci&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rusev&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grillo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vicentini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ferrara&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pilotto&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Davini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pelosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lawlor&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chilosi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tortora&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bria&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fontanini&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Volante&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scarpa&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2017&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Pathol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;241&lt;/VolumeID&gt;
                      &lt;IssueID&gt;4&lt;/IssueID&gt;
                      &lt;FirstPage&gt;488&lt;/FirstPage&gt;
                      &lt;LastPage&gt;500&lt;/LastPage&gt;
                      &lt;BibArticleDOI&gt;10.1002/path.4853&lt;/BibArticleDOI&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2sXislKrtrk%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1002/path.4853&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;27873319&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Simbolo M, Mafficini A, Sikora KO, Fassan M, Barbi S, Corbo V, Mastracci L, Rusev B, Grillo F, Vicentini C, Ferrara R, Pilotto S, Davini F, Pelosi G, Lawlor RT, Chilosi M, Tortora G, Bria E, Fontanini G, Volante M, Scarpa A (2017) Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D. J Pathol 241(4):488–500. doi:
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;10.1002/path.4853&lt;/RefSource&gt;
                        &lt;RefTarget Address="10.1002/path.4853" TargetType="DOI"/&gt;
                      &lt;/ExternalRef&gt;
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                &lt;/Bibliography&gt;
              &lt;/ArticleBackmatter&gt;
            &lt;/Article&gt;
          &lt;/Issue&gt;
        &lt;/Volume&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-12-04T12:58:49.809598+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Marchiò, Caterina&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Gatti, Gaia&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Massa, Federica&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Bertero, Luca&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Filosso, Pierluigi&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Pelosi, Giuseppe&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Cassoni, Paola&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Volante, Marco&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Papotti, Mauro&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution geo="7.578284,45.062322,0"&gt;
            &lt;meta:OrgName&gt;University of Turin&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;7.578284,45.062322,0#University of Turin&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Italy&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;Pathology Division, AOU Città della Salute e della Scienza di Torino&lt;/meta:OrgName&gt;
            &lt;meta:Country&gt;Italy&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="7.5374276,45.0074539,0"&gt;
            &lt;meta:OrgName&gt;San Luigi Hospital&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;7.5374276,45.0074539,0#San Luigi Hospital&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Italy&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="7.578284,45.062322,0"&gt;
            &lt;meta:OrgName&gt;University of Turin&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;7.578284,45.062322,0#University of Turin&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Italy&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="9.194020,45.460444,0"&gt;
            &lt;meta:OrgName&gt;Università degli Studi di Milano&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;9.194020,45.460444,0#Università degli Studi di Milano&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Italy&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;Inter-hospital Pathology Division, Science &amp;amp; Technology Park, IRCCS MultiMedica Group&lt;/meta:OrgName&gt;
            &lt;meta:Country&gt;Italy&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="7.578284,45.062322,0"&gt;
            &lt;meta:OrgName&gt;University of Turin&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;7.578284,45.062322,0#University of Turin&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Italy&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-01&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-12-02T06:08:21&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1007/s00428-017-2177-0&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;Distinctive pathological and clinical features of lung carcinoids with high proliferation index&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;1432-2307&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;Springer&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;Virchows Archiv&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;Virchows Archiv&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH4800X" Priority="1" Type="Secondary"&gt;Pathology&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:VolumeId&gt;471&lt;/meta:VolumeId&gt;
        &lt;meta:IssueId&gt;6&lt;/meta:IssueId&gt;
        &lt;meta:ArticleSequenceNumber&gt;4&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;Springer Berlin Heidelberg&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;Berlin/Heidelberg&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;Springer&lt;/PublisherImprintName&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="All"&gt;
        &lt;JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;15010&lt;/JournalID&gt;
          &lt;JournalDOI&gt;10.1007/15010.1439-0973&lt;/JournalDOI&gt;
          &lt;JournalPrintISSN&gt;0300-8126&lt;/JournalPrintISSN&gt;
          &lt;JournalElectronicISSN&gt;1439-0973&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;Infection&lt;/JournalTitle&gt;
          &lt;JournalSubTitle&gt;A Journal of Infectious Diseases&lt;/JournalSubTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;Infection&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH33096" Priority="1" Type="Secondary"&gt;Infectious Diseases&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH24003" Priority="2" Type="Secondary"&gt;General Practice / Family Medicine&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH33002" Priority="3" Type="Secondary"&gt;Internal Medicine&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Medicine"&gt;SC11&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;Volume OutputMedium="All"&gt;
          &lt;VolumeInfo TocLevels="0" VolumeType="Regular"&gt;
            &lt;VolumeIDStart&gt;45&lt;/VolumeIDStart&gt;
            &lt;VolumeIDEnd&gt;45&lt;/VolumeIDEnd&gt;
            &lt;VolumeIssueCount&gt;6&lt;/VolumeIssueCount&gt;
          &lt;/VolumeInfo&gt;
          &lt;Issue IssueType="Regular" OutputMedium="All"&gt;
            &lt;IssueInfo IssueType="Regular" TocLevels="0"&gt;
              &lt;IssueIDStart&gt;6&lt;/IssueIDStart&gt;
              &lt;IssueIDEnd&gt;6&lt;/IssueIDEnd&gt;
              &lt;IssueArticleCount&gt;26&lt;/IssueArticleCount&gt;
              &lt;IssueHistory&gt;
                &lt;OnlineDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;20&lt;/Day&gt;
                &lt;/OnlineDate&gt;
                &lt;PrintDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;20&lt;/Day&gt;
                &lt;/PrintDate&gt;
                &lt;CoverDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                &lt;/CoverDate&gt;
                &lt;PricelistYear&gt;2017&lt;/PricelistYear&gt;
              &lt;/IssueHistory&gt;
              &lt;IssueCopyright&gt;
                &lt;CopyrightHolderName&gt;Springer-Verlag GmbH Germany, part of Springer Nature&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
              &lt;/IssueCopyright&gt;
            &lt;/IssueInfo&gt;
            &lt;Article ID="s15010-017-1072-6" OutputMedium="All"&gt;
              &lt;ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
                &lt;ArticleID&gt;1072&lt;/ArticleID&gt;
                &lt;ArticleDOI&gt;10.1007/s15010-017-1072-6&lt;/ArticleDOI&gt;
                &lt;ArticleSequenceNumber&gt;13&lt;/ArticleSequenceNumber&gt;
                &lt;ArticleTitle Language="En" OutputMedium="All"&gt;Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience&lt;/ArticleTitle&gt;
                &lt;ArticleCategory&gt;Original Paper&lt;/ArticleCategory&gt;
                &lt;ArticleFirstPage&gt;867&lt;/ArticleFirstPage&gt;
                &lt;ArticleLastPage&gt;875&lt;/ArticleLastPage&gt;
                &lt;ArticleHistory&gt;
                  &lt;RegistrationDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;9&lt;/Month&gt;
                    &lt;Day&gt;16&lt;/Day&gt;
                  &lt;/RegistrationDate&gt;
                  &lt;Received&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;8&lt;/Month&gt;
                    &lt;Day&gt;10&lt;/Day&gt;
                  &lt;/Received&gt;
                  &lt;Accepted&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;9&lt;/Month&gt;
                    &lt;Day&gt;16&lt;/Day&gt;
                  &lt;/Accepted&gt;
                  &lt;OnlineDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;9&lt;/Month&gt;
                    &lt;Day&gt;27&lt;/Day&gt;
                  &lt;/OnlineDate&gt;
                &lt;/ArticleHistory&gt;
                &lt;ArticleFundingInformation&gt;
                  &lt;Fund&gt;
                    &lt;FunderName FundRefID="http://dx.doi.org/10.13039/501100002428"&gt;Austrian Science Fund&lt;/FunderName&gt;
                    &lt;GrantNumber GrantRecipient="Au1" Type="FundRef"&gt;W1253-B24&lt;/GrantNumber&gt;
                    &lt;GrantNumber GrantRecipient="Au10" Type="FundRef"&gt;W1253-B24&lt;/GrantNumber&gt;
                    &lt;GrantNumber GrantRecipient="Au9" Type="FundRef"&gt;W1253-B24&lt;/GrantNumber&gt;
                  &lt;/Fund&gt;
                  &lt;Fund&gt;
                    &lt;FunderName FundRefID="http://dx.doi.org/10.13039/501100006012"&gt;Christian Doppler Forschungsgesellschaft&lt;/FunderName&gt;
                    &lt;GrantNumber GrantRecipient="Au1" Type="FundRef"&gt;CD-Laboratory fo Fungal Infections&lt;/GrantNumber&gt;
                  &lt;/Fund&gt;
                &lt;/ArticleFundingInformation&gt;
                &lt;ArticleCopyright&gt;
                  &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                  &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                  &lt;License SubType="CC BY" Type="OpenAccess" Version="4.0"&gt;
                    &lt;SimplePara&gt;
                      &lt;Emphasis Type="Bold"&gt;Open Access&lt;/Emphasis&gt;This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;http://creativecommons.org/licenses/by/4.0/&lt;/RefSource&gt;
                        &lt;RefTarget Address="http://creativecommons.org/licenses/by/4.0/" TargetType="URL"/&gt;
                      &lt;/ExternalRef&gt;), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
                    &lt;/SimplePara&gt;
                  &lt;/License&gt;
                &lt;/ArticleCopyright&gt;
                &lt;ArticleGrants Type="OpenChoice"&gt;
                  &lt;MetadataGrant Grant="OpenAccess"/&gt;
                  &lt;AbstractGrant Grant="OpenAccess"/&gt;
                  &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                  &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                  &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                  &lt;ESMGrant Grant="OpenAccess"/&gt;
                &lt;/ArticleGrants&gt;
              &lt;/ArticleInfo&gt;
              &lt;ArticleHeader&gt;
                &lt;AuthorGroup&gt;
                  &lt;Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au1" ORCID="http://orcid.org/0000-0002-2946-7785"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Cornelia&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Lass-Flörl&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Phone&gt;+43 (0)512 9003-70700&lt;/Phone&gt;
                      &lt;Email&gt;cornelia.lass-floerl@i-med.ac.at&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au2"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Maria&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Aigner&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff3" ID="Au3"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;David&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Nachbaur&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff4" ID="Au4"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Stephan&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Eschertzhuber&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff5" ID="Au5"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Brigitte&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Bucher&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff5" ID="Au6"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Christian&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Geltner&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff6" ID="Au7"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Romuald&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Bellmann&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au8"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Michaela&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Lackner&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au9"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Dorothea&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Orth-Höller&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au10"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Reinhard&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Würzner&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff7" ID="Au11"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Günter&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Weiss&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff2" CorrespondingAffiliationID="Aff2" ID="Au12"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Bernhard&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Glodny&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Phone&gt;+43 (0)512 504-80918&lt;/Phone&gt;
                      &lt;Email&gt;bernhard.glodny@i-med.ac.at&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Affiliation ID="Aff1"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0000 8853 2677&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.5361.1&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Division of Hygiene and Medical Microbiology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Medical University of Innsbruck&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;Schöpfstraße 41/III&lt;/Street&gt;
                      &lt;Postcode&gt;6020&lt;/Postcode&gt;
                      &lt;City&gt;Innsbruck&lt;/City&gt;
                      &lt;State&gt;Tirol&lt;/State&gt;
                      &lt;Country Code="AT"&gt;Austria&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff2"&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.410706.4&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Radiology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;University Hospital Innsbruck&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Innsbruck&lt;/City&gt;
                      &lt;Country Code="AT"&gt;Austria&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff3"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0000 8853 2677&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.5361.1&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Division of Haematology and Oncology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Medical University of Innsbruck&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Innsbruck&lt;/City&gt;
                      &lt;Country Code="AT"&gt;Austria&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff4"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0000 8853 2677&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.5361.1&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Transplant Intensive Care Unit, Department of Anesthesia and Critical Care, Centre of Operative Medicine&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Medical University of Innsbruck&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Innsbruck&lt;/City&gt;
                      &lt;Country Code="AT"&gt;Austria&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff5"&gt;
                    &lt;OrgDivision&gt;Department of Pulmonology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Hospital Natters&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Natters&lt;/City&gt;
                      &lt;Country Code="AT"&gt;Austria&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff6"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0000 8853 2677&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.5361.1&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Division of Intensive Care and Emergency Medicine, Department of Internal Medicine I&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Medical University of Innsbruck&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Innsbruck&lt;/City&gt;
                      &lt;Country Code="AT"&gt;Austria&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff7"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000 0000 8853 2677&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.5361.1&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Internal Medicine II&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Medical University of Innsbruck&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;City&gt;Innsbruck&lt;/City&gt;
                      &lt;Country Code="AT"&gt;Austria&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                &lt;/AuthorGroup&gt;
                &lt;Abstract ID="Abs1" Language="En" OutputMedium="All"&gt;
                  &lt;Heading&gt;Abstract&lt;/Heading&gt;
                  &lt;AbstractSection ID="ASec1"&gt;
                    &lt;Heading&gt;Background&lt;/Heading&gt;
                    &lt;Para ID="Par1"&gt;Invasive fungal diseases (IFD) are an important cause of morbidity and mortality in immunocompromised patients, and early diagnosis and management are a challenge. We evaluated the clinical utility of computed tomography (CT)-guided percutaneous lung biopsies in diagnosing IFD.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec2"&gt;
                    &lt;Heading&gt;Methods&lt;/Heading&gt;
                    &lt;Para ID="Par2"&gt;Between 2003 and 2014, we analyzed 2671 CT-guided lung biopsies, from which 157 were IFD associated; we aimed to determine microbiological-based diagnostic accuracy of calcofluor white staining (CFWS), culture, 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; antigen detection (GM), broad-range fungal PCR, and 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR per sample.
                    &lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec3"&gt;
                    &lt;Heading&gt;Results&lt;/Heading&gt;
                    &lt;Para ID="Par3"&gt;127 (81%) specimens were microscopically positive for any fungal elements, 30 (19%) negative. 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; and non-
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; like hyphae were obtained in 85 (67%) and 42 (33%) specimens, respectively. CFWS positivity was defined as proof of infection. Sensitivity, specificity, and positive (PPV) and negative predictive (NPV) values for CT scan were 100, 44, 80, and 100%, for 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR 89, 58, 88, and 58%, for broad-range fungal PCR 90, 83, 95, and 90%, and for GM 94, 83, 95, and 90%. The most common CT features were patchy opacifications with central necrosis (78%) or cavern defects (50%), less common were air bronchograms (39%) or ground glass halos (39%), and all other features were rare. The overall pneumothorax rate subsequent to biopsy was 19%, but in only 2% of all cases the placement of a chest tube was indicated. One case of fatal air embolism occurred.
                    &lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec4"&gt;
                    &lt;Heading&gt;Conclusions&lt;/Heading&gt;
                    &lt;Para ID="Par4"&gt;CT-guided lung biopsies have high diagnostic accuracy in terms of microscopic examination, and complication rates are low. Molecular-based and antigen tests applied on fungal hyphae-positive specimens showed comparable results.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                &lt;/Abstract&gt;
                &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                  &lt;Heading&gt;Keywords&lt;/Heading&gt;
                  &lt;Keyword&gt;
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;
                  &lt;/Keyword&gt;
                  &lt;Keyword&gt;Mucormycoses&lt;/Keyword&gt;
                  &lt;Keyword&gt;Fungal infection&lt;/Keyword&gt;
                  &lt;Keyword&gt;Invasive fungal disease&lt;/Keyword&gt;
                  &lt;Keyword&gt;Computed tomography-guided lung biopsy&lt;/Keyword&gt;
                &lt;/KeywordGroup&gt;
              &lt;/ArticleHeader&gt;
              &lt;Body&gt;
                &lt;Section1 ID="Sec1"&gt;
                  &lt;Heading&gt;Introduction&lt;/Heading&gt;
                  &lt;Para ID="Par5"&gt;Invasive fungal diseases (IFD) are a major cause of morbidity and mortality in immunocompromised patients [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;]. Case fatality rates range from 30 to 80% in neutropenic patients and result at least partly from difficulties in obtaining a reliable diagnosis at an early stage of disease. The diagnostic workup may consist of imaging techniques, culture, serology, and molecular-based methods. Culture-based methods are often delayed and may have low sensitivity [
                    &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;], because the materials used are not picked up from the proper site of ongoing, progressive infection yielding necrotic tissue. In most instances, an antimycotic treatment had already been started, so that the viability of the pathogens is hampered. Galactomannan detection in body fluids is more sensitive than culture for diagnosis of invasive aspergillosis (IA), but sensitivity is variable (17–100%) [
                    &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;]. Only moderate data are available for 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR [
                    &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;] and β-
                    &lt;Emphasis Type="SmallCaps"&gt;d&lt;/Emphasis&gt;-glucan (Fungitell, Associates of Cape Cod) [
                    &lt;CitationRef CitationID="CR4"&gt;4&lt;/CitationRef&gt;] in diagnosing IFD, from blood and broncho-alveolar lavages (BAL). Imaging has a crucial role in the diagnosis and management of patients with suspected IFD who are immunocompromised [
                    &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;]. The preferred method of choice is a computed tomography (CT) scan, as chest radiography might show normal or non-specific findings in neutropenic patients with IFD [
                    &lt;CitationRef CitationID="CR5"&gt;5&lt;/CitationRef&gt;]. Although the halo sign and air crescent sign are characteristic, they are not diagnostic of IA. Infections due to other angioinvasive fungi, such as Mucorales, 
                    &lt;Emphasis Type="Italic"&gt;Fusarium&lt;/Emphasis&gt; spp. as well as 
                    &lt;Emphasis Type="Italic"&gt;Nocardia&lt;/Emphasis&gt; spp. may cause radiological features described for IA [
                    &lt;CitationRef CitationID="CR6"&gt;6&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR7"&gt;7&lt;/CitationRef&gt;]. However, the identification of the causative organism is highly warranted for a targeted treatment, especially if patients fail to respond to standard anti-mold therapy. Mucorales are resistant to the newer antifungal drugs such as voriconazole and echinocandins [
                    &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;] and therefore the choice of first-line treatment is (liposomal) amphotericin B; 
                    &lt;Emphasis Type="Italic"&gt;A. terreus&lt;/Emphasis&gt;, by contrast, is amphotericin B resistant; both fungal pathogens are frequently involved in pulmonary infections in our patient cohort [
                    &lt;CitationRef AdditionalCitationIDS="CR10" CitationID="CR9"&gt;9&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;]. Hence, our center needs a powerful diagnostic strategy with the performance of CT-guided lung biopsies displaying a standard of care. Here, we aimed to investigate the value of CT-guided lung biopsies in diagnosing IFDs in immunocompromised patients and best practice specimen handling, applying Calcofluor White staining (CFWS), culture, 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; antigen detection (GM), broad-range fungal PCR, and 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR in lung specimens obtained during 2003–2014.
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec2"&gt;
                  &lt;Heading&gt;Materials and methods&lt;/Heading&gt;
                  &lt;Section2 ID="Sec3"&gt;
                    &lt;Heading&gt;Patients&lt;/Heading&gt;
                    &lt;Para ID="Par6"&gt;We attended to 2671 patients undergoing lung biopsy for any diagnostic reason, including cancer, infectious diseases, and others between 2003 and 2014. Of them, 179 patients were evaluated with fever and a CT scan compatible with filamentous fungal lung infections according to EORTC/MSG criteria [
                      &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;]. Of these patients, 168 eligible patients underwent CT-guided lung biopsies because they either did not improve during standard antifungal therapy or the proof of diagnosis was important for further medical procedures. From this cohort, 11 samples were excluded for various reasons such as lack of triple diagnostic tests performed (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;6), PCR inhibition (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;2), or lack of detailed clinical data (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;3). Thus, data were evaluated of 157 patients, with the majority having underlying hematological malignancies (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;85), solid organ transplantations (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;40), solid cancer (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;19) or otherwise severe immunocompromised conditions (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;13). Lung biopsy specimens were investigated for the presence of fungal pathogens.
                    &lt;/Para&gt;
                    &lt;Para ID="Par7"&gt;Patients received standard of care treatment, including antibiotics and antifungals, and those with hematological malignancies and or allogeneic/autologous stem cell transplantations and or lung transplantation received standard prophylaxis with fluconazole, and/or posaconazole, and/or micafungin if indicated [
                      &lt;CitationRef CitationID="CR13"&gt;13&lt;/CitationRef&gt;]. CT scans were performed as part of the diagnostic workup and were reviewed by a senior radiologist for evidence of fungal infection, which included the presence and distribution of nodule(s) and/or consolidations with or without ground-glass opacities, a halo sign, and an air crescent sign and cavitation. Various CT scanners of different vendors and protocols with various slice thickness with or without intravenous contrast enhancement were used over the time. In all patients, the whole chest was scanned continuously utilizing a multidetector spiral CT technique, including a high-resolution mode with at least 1.0&nbsp;mm or even sub-millimeter slice thickness.
                    &lt;/Para&gt;
                    &lt;Para ID="Par8"&gt;Patients who were hemodynamically unstable or in whom platelet counts could not be maintained over 60&nbsp;×&nbsp;10
                      &lt;Superscript&gt;9&lt;/Superscript&gt;/l were excluded. Thrombocytopenic patients received platelet transfusions before the procedure, at the discretion of the clinical team, and a prothrombin time of at least 50% (normal range 70–130%) was requested. Patients suspected to suffer from IFDs were on empirical antifungal therapy at the time of taking lung biopsies.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec4"&gt;
                    &lt;Heading&gt;CT-guided percutaneous lung biopsies&lt;/Heading&gt;
                    &lt;Para ID="Par9"&gt;Lung biopsies were performed by different radiologists, exclusively using CT. Two CT devices, equipped with the Smart-Step technique, were deployed for this purpose (Lightspeed 16 or VCT 64, GE Healthcare) [
                      &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;]. Decisions for patient management were made on a case-by-case basis by the radiologists, based on size and location of the pulmonary lesion. After the intervention, patients were routinely monitored and initially chest radiographs and after 2007 low-dose CTs of the entire chest thorax [
                      &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;] were obtained during follow-up to exclude complications, particularly pneumothorax.
                    &lt;/Para&gt;
                    &lt;Para ID="Par10"&gt;CT-guided percutaneous biopsies were performed with an automated biopsy gun with a detachable coaxial cutting needle system (Bard
                      &lt;Superscript&gt;®&lt;/Superscript&gt;) as described by Lucidarme et al. [
                      &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;]. In our study, an outer coaxial needle with 18-gauge diameter and an inner biopsy needle with 17-gauge diameter were chosen with a local anesthesia with 1% lidocaine, either without or, in most cases, with general anesthesia. On average, 8.5&nbsp;±&nbsp;3.3 samples were taken, with a length of either 1.5 or 2.2&nbsp;cm. Clinical specimens were collected at the Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, and samples were aseptically divided into three fractions for microscopy, culture, PCR, and GM testing.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec5"&gt;
                    &lt;Heading&gt;Fungal microbiology&lt;/Heading&gt;
                    &lt;Para ID="Par11"&gt;Biopsy specimens, transferred to 2&nbsp;ml normal saline were minced and homogenized aseptically. Afterward, samples were vortexed, kept at room temperature for 30&nbsp;min, and centrifuged. All specimens, consisting of supernatants and homogenized tissues, were investigated for fungi by application of the Fungi-Fluor™ (Calcofluor White staining solution, Polysciences, USA; CFWS staining). Samples which showed 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;-like hyphae were tested for GM and 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR [
                      &lt;CitationRef CitationID="CR17"&gt;17&lt;/CitationRef&gt;, 
                      &lt;CitationRef CitationID="CR18"&gt;18&lt;/CitationRef&gt;] positivity. GM (BioRad, Austria) was performed according to the instructions of the company and a 0.5 cutoff was used to define the positivity for GM. Samples which showed non-
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;-like hyphae by CFWS and which remained negative in GM and 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR were evaluated by a broad-range PCR using internally transcribed spacer region (ITS) [
                      &lt;CitationRef CitationID="CR19"&gt;19&lt;/CitationRef&gt;]. In parallel, all samples were cultured in Sabouraud Dextrose Broth at 37&nbsp;°C for 14&nbsp;days. For controls, 24 CT-guided lung biopsies not associated with any IFD were evaluated applying all microbiological assays. Figure&nbsp;
                      &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt; shows a flow diagram of the sequence of diagnostic tests applied.
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig.&nbsp;1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Flow diagram of the sequence of diagnostic test applied&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO1"&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/15010_2017_1072_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec6"&gt;
                    &lt;Heading&gt;Criteria for fungal diagnosis&lt;/Heading&gt;
                    &lt;Para ID="Par12"&gt;Proven pulmonary IA was defined as positive tissue biopsy showing typical septate, acute branching hyphae (CFWS) with positive GM and 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR tests and with or without positive cultures for 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;. Proven pulmonary IFD (non-
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; fungal infection) was defined as positive tissue biopsy showing unseptate or sparsely septate, broad, and irregular hyphae with positive panfungal PCR tests and with or without positive culture for any suitable fungus. Samples with negative results were reported as sterile; samples showing technical difficulties were excluded from the analysis (
                      &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;&nbsp;=&nbsp;11).
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec7"&gt;
                    &lt;Heading&gt;Statistical analysis&lt;/Heading&gt;
                    &lt;Para ID="Par13"&gt;The primary purpose of the study was to evaluate the feasibility of lung biopsies in diagnosing fungal infections in immunocompromised patients. The secondary purposes were to determine the outcome in terms of diagnostic yield and to determine the complications related to the procedure. The Society of Interventional Radiology clinical practice guidelines of 2003 were used to classify minor and major complications [
                      &lt;CitationRef CitationID="CR20"&gt;20&lt;/CitationRef&gt;]. Statistical analysis included a 
                      &lt;Emphasis Type="Italic"&gt;t&lt;/Emphasis&gt; test for assessing the difference in continuous values between the two groups (i.e. patients with 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; infections and patients with non-
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; filamentous fungal infections); a Chi square test was used to assess the difference in categorical values between the two groups. A 
                      &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt; value&nbsp;&amp;lt;&nbsp;0.05 was considered to be statistically significant.
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec8"&gt;
                  &lt;Heading&gt;Results&lt;/Heading&gt;
                  &lt;Para ID="Par14"&gt;Using CFWS, 127 (81%) samples were positive for any fungal elements, 30 (19%) remained negative. 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus-&lt;/Emphasis&gt; and non-
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;-like hyphae were obtained in 85 (67%) and 42 (33%) specimens, respectively (Table&nbsp;
                    &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt; and Fig.&nbsp;
                    &lt;InternalRef RefID="Fig2"&gt;2&lt;/InternalRef&gt;). Fungal species identification done by micromorphology or molecular-based methods yielded 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; spp., Mucoraceae and others (Table&nbsp;
                    &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt;); cultures were positive in only 62 samples investigated. Control specimens remained culture, 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR, broad-range PCR, and GM antigen test negative in all cases. CFWS positivity, which reflects proof of an infection according to EORTC criteria (golden standard), was defined as the standard of comparison; sensitivity, specificity, and positive (PPV) and negative predictive (NPV) values for CT scan, 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR, broad-range PCR, and GM from lung biopsy specimens are outlined in Table&nbsp;
                    &lt;InternalRef RefID="Tab3"&gt;3&lt;/InternalRef&gt;. Antifungal therapy at time of biopsy consisted of voriconazole and/or echinocandins in 55% of patients suffering from non-
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; infections, hence displaying lack of activity against fungal pathogens identified. Over the years, a shift from 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; to non-
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; infections took place and, based on antifungal treatment strategies applied, it is obvious that anti-mold prophylaxis successfully prevents IA, as only five cases were detected during 2011 and 2014. In comparison, 80 IA cases were detected between 2003 and 2010, respectively, see Table&nbsp;
                    &lt;InternalRef RefID="Tab4"&gt;4&lt;/InternalRef&gt;.
                    &lt;Table Float="Yes" ID="Tab1"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Table&nbsp;1&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;Characteristics of 127 patients with invasive pulmonary fungal infections microscopically diagnosed by immunofluorescence staining of lung biopsies in 2000–2015&lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;tgroup cols="4"&gt;
                        &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                        &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                        &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                        &lt;colspec align="char" char="." colname="c4" colnum="4"/&gt;
                        &lt;thead&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1" morerows="1"&gt;
                              &lt;SimplePara&gt;Characteristics&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" nameend="c3" namest="c2"&gt;
                              &lt;SimplePara&gt;No. of patients (%)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4" morerows="1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt; value
                                &lt;Superscript&gt;a&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Aspergillus-&lt;/Emphasis&gt;like hyphae
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Non-
                                &lt;Emphasis Type="Italic"&gt;Aspergillus-&lt;/Emphasis&gt;like hyphae
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/thead&gt;
                        &lt;tbody&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Patients&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;85 (67)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;42 (33)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"/&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Female gender&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;18 (50)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;7 (54)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c4"&gt;
                              &lt;SimplePara&gt;0.86&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Mean of age in years&nbsp;±&nbsp;SD&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;63&nbsp;±&nbsp;4&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;59&nbsp;±&nbsp;7&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c4"&gt;
                              &lt;SimplePara&gt;0.09&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" nameend="c3" namest="c1"&gt;
                              &lt;SimplePara&gt;Underlying diseases
                                &lt;Superscript&gt;b&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c4"&gt;
                              &lt;SimplePara&gt;0.11&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;&nbsp;Hematological malignancies&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;41 (32)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;30 (24)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"/&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;&nbsp;Solid organ transplantations&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;36 (28)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;2 (2)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"/&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;&nbsp;Solid tumors&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;5 (4)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;7 (6)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"/&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;&nbsp;Others&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;3 (2)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;3 (2)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"/&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" nameend="c3" namest="c1"&gt;
                              &lt;SimplePara&gt;Antifungal therapy at the time of biopsy intervention&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c4"&gt;
                              &lt;SimplePara&gt;0.27&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;&nbsp;Voriconazole&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;43 (34)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;6 (46)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"/&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;&nbsp;Echinocandins
                                &lt;Superscript&gt;c&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;21 (17)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;11 (9)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"/&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;&nbsp;Lipid-amphotericin B&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;18 (14)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;5 (4)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"/&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;&nbsp;Posaconazole&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;3 (2)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;12 (9)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"/&gt;
                          &lt;/row&gt;
                        &lt;/tbody&gt;
                      &lt;/tgroup&gt;
                      &lt;tfooter&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;a&lt;/Superscript&gt; Fisher’s exact test, Student’s test, Chi squared test
                        &lt;/SimplePara&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;b&lt;/Superscript&gt; Including patients suffering from acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic syndrome, lymphoma, and lung transplantations
                        &lt;/SimplePara&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;c&lt;/Superscript&gt; Including micafungin and caspofungin
                        &lt;/SimplePara&gt;
                      &lt;/tfooter&gt;
                    &lt;/Table&gt;
                    &lt;Figure Category="Standard" Float="Yes" ID="Fig2"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Fig.&nbsp;2&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;X-ray and computer tomographic images of a 52-year-old immunocompromised patient after heart transplantation suffering from pulmonary aspergillosis (
                            &lt;Emphasis Type="Italic"&gt;Aspergillus terreus).&lt;/Emphasis&gt;
                            &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt; Several lesions on both lungs on X-ray with two of the lesions 
                            &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt; showing an air crescent sign (sagittal reconstruction). The lesion located in the lower lobe developed a ground-glass halo later on, and no pleural effusion is seen
                          &lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;MediaObject ID="MO2"&gt;
                        &lt;ImageObject Color="Color" FileRef="MediaObjects/15010_2017_1072_Fig2_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Figure&gt;
                    &lt;Table Float="Yes" ID="Tab2"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Table&nbsp;2&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;Genus and species identification from 127 fungal-positive lung biopsies obtained by CT-guided procedures&lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;tgroup cols="2"&gt;
                        &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                        &lt;colspec align="char" char="(" colname="c2" colnum="2"/&gt;
                        &lt;thead&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Species&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;No. of patients (%)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/thead&gt;
                        &lt;tbody&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Aspergillus fumigatus&lt;/Emphasis&gt; complex
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;35 (27.5)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Aspergillus terreus&lt;/Emphasis&gt; complex
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;44 (34.6)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Aspergillus flavus&lt;/Emphasis&gt; complex
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;2 (1.5)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;other 
                                &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; species
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;4 (3.1)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Mucor&lt;/Emphasis&gt; sp.
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;11 (8.6)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Rhizomucor&lt;/Emphasis&gt; sp.
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;9 (7.0)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Rhizopus&lt;/Emphasis&gt; sp.
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;5 (3.9)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Lichtheimia corymbifera&lt;/Emphasis&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;6 (4.7)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Cunninghamella&lt;/Emphasis&gt; sp.
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;4 (3.1)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Scedosporium&lt;/Emphasis&gt; sp.
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;2 (1.5)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Penicillium&lt;/Emphasis&gt; sp.
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;3 (2.3)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Trichosporon&lt;/Emphasis&gt; sp.
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="(" colname="c2"&gt;
                              &lt;SimplePara&gt;2 (1.5)&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/tbody&gt;
                      &lt;/tgroup&gt;
                      &lt;tfooter&gt;
                        &lt;SimplePara&gt;Genus and species identification was obtained by culture and micromorphology typing or by applying PCR targeting the ITS techniques&lt;/SimplePara&gt;
                      &lt;/tfooter&gt;
                    &lt;/Table&gt;
                    &lt;Table Float="Yes" ID="Tab3"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Table&nbsp;3&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;Performance of various diagnostic assays in relation to fungal-positive lung biopsies obtained from invasive CT-guided interventions&lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;tgroup cols="5"&gt;
                        &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                        &lt;colspec align="char" char="." colname="c2" colnum="2"/&gt;
                        &lt;colspec align="char" char="." colname="c3" colnum="3"/&gt;
                        &lt;colspec align="char" char="." colname="c4" colnum="4"/&gt;
                        &lt;colspec align="char" char="." colname="c5" colnum="5"/&gt;
                        &lt;thead&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Test assays&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;% Sensitivity&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;% Specificity&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;% PPV&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c5"&gt;
                              &lt;SimplePara&gt;% NPV&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/thead&gt;
                        &lt;tbody&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;CT scan&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c2"&gt;
                              &lt;SimplePara&gt;100&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c3"&gt;
                              &lt;SimplePara&gt;44&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c4"&gt;
                              &lt;SimplePara&gt;80&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c5"&gt;
                              &lt;SimplePara&gt;100&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR
                                &lt;Superscript&gt;a&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c2"&gt;
                              &lt;SimplePara&gt;89&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c3"&gt;
                              &lt;SimplePara&gt;58&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c4"&gt;
                              &lt;SimplePara&gt;88&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c5"&gt;
                              &lt;SimplePara&gt;58&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Broad-range fungal PCR
                                &lt;Superscript&gt;b&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c2"&gt;
                              &lt;SimplePara&gt;90&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c3"&gt;
                              &lt;SimplePara&gt;83&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c4"&gt;
                              &lt;SimplePara&gt;95&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c5"&gt;
                              &lt;SimplePara&gt;90&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;GM
                                &lt;Superscript&gt;c&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c2"&gt;
                              &lt;SimplePara&gt;94&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c3"&gt;
                              &lt;SimplePara&gt;83&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c4"&gt;
                              &lt;SimplePara&gt;95&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="char" char="." colname="c5"&gt;
                              &lt;SimplePara&gt;90&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/tbody&gt;
                      &lt;/tgroup&gt;
                      &lt;tfooter&gt;
                        &lt;SimplePara&gt;
                          &lt;Emphasis Type="Italic"&gt;PPV&lt;/Emphasis&gt; positive predictive value, 
                          &lt;Emphasis Type="Italic"&gt;NPV&lt;/Emphasis&gt; negative predictive value
                        &lt;/SimplePara&gt;
                        &lt;SimplePara&gt;CT-guided lung samples resulted from 127 patients and 24 control (negative) patients&lt;/SimplePara&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;a&lt;/Superscript&gt; Over the last 12&nbsp;years, we used various 
                          &lt;Emphasis Type="Italic"&gt;Aspergillus-&lt;/Emphasis&gt;specific PCR assays targeting the 18S ribosomal RNA
                        &lt;/SimplePara&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;b&lt;/Superscript&gt; We applied a broad-range PCR using the internal transcribed spacer region
                        &lt;/SimplePara&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;c&lt;/Superscript&gt; GM testing defined a cutoff value of 0.5
                        &lt;/SimplePara&gt;
                      &lt;/tfooter&gt;
                    &lt;/Table&gt;
                    &lt;Table Float="Yes" ID="Tab4"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Table&nbsp;4&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;Fungal pathogens identified, treatment modalities, and diagnostic tests applied over the last 12&nbsp;years in immunosuppressed patients&lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;tgroup cols="4"&gt;
                        &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                        &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                        &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                        &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                        &lt;thead&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Time period&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;2003–2006&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;2007–2010&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;2011–2014&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/thead&gt;
                        &lt;tbody&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Number of patients with proven lung infections&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;55
                                &lt;Superscript&gt;a&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;43&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;29&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" nameend="c4" namest="c1"&gt;
                              &lt;SimplePara&gt;Fungal pathogens identified&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; species
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;42&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;38&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;A. terreus&lt;/Emphasis&gt; complex
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;24&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;19&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;A. fumigatus&lt;/Emphasis&gt; complex
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;18&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;16&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;A. flavus&lt;/Emphasis&gt; complex
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;&nbsp;&nbsp;Other species&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Mucorales&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;12&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;18&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Others&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;6&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Main antifungal treatment strategies applied&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;Empirical and pre-emptive treatment
                                &lt;Superscript&gt;b&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;Empirical and pre-emptive treatment
                                &lt;Superscript&gt;c&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;Anti-mold prophylaxis
                                &lt;Superscript&gt;d&lt;/Superscript&gt;
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                          &lt;row&gt;
                            &lt;entry align="left" colname="c1"&gt;
                              &lt;SimplePara&gt;Laboratory blood screening tests performed&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c2"&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;-specific PCR
                              &lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c3"&gt;
                              &lt;SimplePara&gt;GM&lt;/SimplePara&gt;
                              &lt;SimplePara&gt;
                                &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;-specific PCR
                              &lt;/SimplePara&gt;
                              &lt;SimplePara&gt;Panfungal PCR&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                            &lt;entry align="left" colname="c4"&gt;
                              &lt;SimplePara&gt;None&lt;/SimplePara&gt;
                            &lt;/entry&gt;
                          &lt;/row&gt;
                        &lt;/tbody&gt;
                      &lt;/tgroup&gt;
                      &lt;tfooter&gt;
                        &lt;SimplePara&gt;
                          &lt;Emphasis Type="Italic"&gt;GM&lt;/Emphasis&gt; galactomannan testing, 
                          &lt;Emphasis Type="Italic"&gt;PCR&lt;/Emphasis&gt; polymerase chain reaction
                        &lt;/SimplePara&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;a&lt;/Superscript&gt; Data obtained from few patients have been reported earlier in 2007 [
                          &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;]
                        &lt;/SimplePara&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;b&lt;/Superscript&gt; Mainly, empirical treatment was undertaken applying amphotericin B or caspofungin
                        &lt;/SimplePara&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;c&lt;/Superscript&gt; Due to the extensive performance of polymerase chain reaction assays (various protocols) and GM blood screenings, pre-emptive treatment strategies with voriconazole and/or caspofungin were applied
                        &lt;/SimplePara&gt;
                        &lt;SimplePara&gt;
                          &lt;Superscript&gt;d&lt;/Superscript&gt; Antifungal mold prophylaxis with micafungin and posaconazole was administered to patients at risk
                        &lt;/SimplePara&gt;
                      &lt;/tfooter&gt;
                    &lt;/Table&gt;
                  &lt;/Para&gt;
                  &lt;Para ID="Par15"&gt;Patients with mycosis were younger than patients without mycosis (50.3&nbsp;±&nbsp;19.3 versus 62&nbsp;±&nbsp;14&nbsp;years, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001). Mycotic lesions were located in the upper lobes of the lungs in 59% of the cases, 33% in the lower lobes, and 8% in the middle lobe or lingula. The most common CT features of the lesions at the time of biopsy were patchy opacifications with central necrosis (78%) or cavern defects (50%), and less common were air bronchograms (39%), or ground-glass opacity halos (39%), see Figs.&nbsp;
                    &lt;InternalRef RefID="Fig3"&gt;3&lt;/InternalRef&gt; and 
                    &lt;InternalRef RefID="Fig4"&gt;4&lt;/InternalRef&gt;. Extensive alveolar space opacities were present in 41% of cases, in combination with patchy opacities in 15%, and without patchy opacities in 26%. Tree in bud phenomenon was rare (13%), as well as other features. The typical air crescent sign was found in only 32% of patients; this low percentage of the air crescent sign is probably because the decision to perform a lung biopsy is made only after a certain delay, so that the early sign fails to be detected.
                    &lt;Figure Category="Standard" Float="Yes" ID="Fig3"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Fig.&nbsp;3&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;Chest computer tomographic scan of a 21-year-old patient suffering from acute lymphatic leukemia and mucormycosis. 
                            &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt;, A cavern is seen in the right lower lobe of the lung adjacent to the hilum, accompanied by more peripheral small nodules and tree in bud phenomenon, but also in the other lobes of the lung as well, representing a mucormycosis. 
                            &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt;, The right lower lobe was removed surgically and the patient recovered fully
                          &lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;MediaObject ID="MO3"&gt;
                        &lt;ImageObject Color="Color" FileRef="MediaObjects/15010_2017_1072_Fig3_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Figure&gt;
                    &lt;Figure Category="Standard" Float="Yes" ID="Fig4"&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Fig.&nbsp;4&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;Chest computer tomographic lung scan of a 42-year-old patient during aplasia following therapy for acute lymphatic leukemia and suffering from proven mucormycosis. 
                            &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt;, Air space opacification with positive bronchopneumogram in the right upper and 
                            &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt;, lower lobe accompanied by parapneumonic effusions on both lung sides
                          &lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;MediaObject ID="MO4"&gt;
                        &lt;ImageObject Color="Color" FileRef="MediaObjects/15010_2017_1072_Fig4_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Figure&gt;
                  &lt;/Para&gt;
                  &lt;Para ID="Par16"&gt;Mycotic lesions showed significantly lower densities than non-mycotic lesions; they were larger and located more peripherally in the lung (
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001 each). The minimal distance between the lesion and the parietal pleura was significantly shorter in mycoses as compared to other lesions (5.1&nbsp;±&nbsp;9.3 vs. 14.4&nbsp;±&nbsp;16.6&nbsp;mm), and the width of the contact area between parietal pleura and the lesion was larger (33.9&nbsp;±&nbsp;61.2 vs. 19.5&nbsp;±&nbsp;35.6&nbsp;mm; 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;lt;&nbsp;0.0001 each). The overall pneumothorax rate was 16%, but in only 2% of all cases the placement of a chest tube was indicated. In 77% of the cases a visible bleeding occurred after the biopsy, and the size of the hematoma averaged between 25.9&nbsp;±&nbsp;34.2 and 14.4&nbsp;×&nbsp;16.2&nbsp;mm; in two cases, the procedure had to be discontinued due to serious bleeding, one self-limiting and the other treated by bronchoscopic treatment. One case of fatal air embolism occurred [
                    &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par17"&gt;Patients with proven fungal infections had a slightly higher number of biopsies taken than patients without mycosis (8.5&nbsp;±&nbsp;3.3&nbsp;versus 7.7&nbsp;±&nbsp;3.3, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;=&nbsp;0.029). Biopsy numbers in patients suffering from IFDs and major complications was 8.5&nbsp;±&nbsp;0.7 and those with minor complications 6.5&nbsp;±&nbsp;2.8 (
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;gt;&nbsp;0.05). However, both were lower than in mycosis patients without complications (8.9&nbsp;±&nbsp;3.3, 
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;gt;&nbsp;0.05). The number of biopsies taken in IFD patients with any complication was 7&nbsp;±&nbsp;2.6 and slightly lower when compared to the remaining population investigated. The differences between the numbers of biopsies taken in patients with minor or major complications were the same when compared with the number in the normal population (
                    &lt;Emphasis Type="Italic"&gt;p&lt;/Emphasis&gt;&nbsp;&amp;gt;&nbsp;0.05 each).
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec9"&gt;
                  &lt;Heading&gt;Discussion&lt;/Heading&gt;
                  &lt;Para ID="Par18"&gt;CT-guided percutaneous lung biopsies performed in immunocompromised patients over the last 12&nbsp;years was associated with a tolerable risk and was an effective diagnostic tool. 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; as the leading mold in previous years was replaced by non-
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; pathogens likewise as a consequence of effective 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; targeting drugs used for mold prophylaxis to prevent IFD.
                  &lt;/Para&gt;
                  &lt;Para ID="Par19"&gt;Although pulmonary infections may be diagnosed by the performance of broncho-alveolar lavages (BALs) as well as GM antigen testing, CT-guided lung biopsies increase the diagnostic yield and accuracy [
                    &lt;CitationRef CitationID="CR21"&gt;21&lt;/CitationRef&gt;], allowing to specify the underlying pathogen and to rule out contamination or noninfectious causes [
                    &lt;CitationRef CitationID="CR22"&gt;22&lt;/CitationRef&gt;]. The sensitivity of the culture and microscopy in diagnosing IA are about 50% in high-risk patients with hematological disease [
                    &lt;CitationRef CitationID="CR23"&gt;23&lt;/CitationRef&gt;], GM detection seems to be more sensitive [
                    &lt;CitationRef CitationID="CR24"&gt;24&lt;/CitationRef&gt;], but sensitivity is variable and decreases tremendously in patients receiving anti-mold prophylaxis [
                    &lt;CitationRef AdditionalCitationIDS="CR26" CitationID="CR25"&gt;25&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR27"&gt;27&lt;/CitationRef&gt;]. These facts limit their unrestricted use, especially from a clinical point of view when pathogen specification is highly warranted for further medical interventions.
                  &lt;/Para&gt;
                  &lt;Para ID="Par20"&gt;The detection of fungi in tissue or other sterile specimens provides definitive diagnosis of IFD, independent of host factors or clinical features. Speed is crucial and CFWS allows a differentiation between infections caused by septate molds (
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; spp.) or non-septate molds of the order Mucorales (members of the families 
                    &lt;Emphasis Type="Italic"&gt;Mucoraceae, Cunninghamellaceae, Saksenaeaceae, Mortierellaceae, and Syncephalastraceae&lt;/Emphasis&gt;), or others within 30&nbsp;min, which is crucial for the choice of proper antifungal treatment [
                    &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR28"&gt;28&lt;/CitationRef&gt;]. Direct microscopy is especially important for the diagnosis of non-septate fungi, because these fungi are poorly recovered by culture [
                    &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;] and first-line treatment consists of polyene therapy. For IA, the recommended drug of choice is voriconazole, which lacks activity against Mucorales. At the time of diagnosis, 55% of our patients with proven mucormycosis received non-Mucorales-active drugs as primary therapy. At our institution, infections due to 
                    &lt;Emphasis Type="Italic"&gt;A. terreus&lt;/Emphasis&gt; were prevalent within the last few years; however, the timely use of voriconazole and the widespread use of micafungin and/or posaconazole as prophylaxis decreased IA in general including 
                    &lt;Emphasis Type="Italic"&gt;A. terreus&lt;/Emphasis&gt; infections; see Table&nbsp;
                    &lt;InternalRef RefID="Tab4"&gt;4&lt;/InternalRef&gt;. Nowadays, 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; has been more and more replaced by Mucorales or other fungal pathogens. We speculate that this epidemiological situation is due to the extensive application of 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;-active drugs mainly as prophylaxis. In 2014, there was no single case of proven IA in patients with underlying hematological malignancies, yet infections due to rare fungal pathogens albeit in a low frequency were detected. These fungal pathogens are challenging, as the best treatment options are not yet known. 
                    &lt;Emphasis Type="Italic"&gt;Fusarium&lt;/Emphasis&gt; spp. and 
                    &lt;Emphasis Type="Italic"&gt;Scedosporium&lt;/Emphasis&gt; spp. may not be distinguishable from 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; spp. by hyphal morphology in tissue, but may require different management [
                    &lt;CitationRef CitationID="CR28"&gt;28&lt;/CitationRef&gt;]. The proper identification of the fungal genus is therefore highly warranted. The application of 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR, broad-range fungal PCR, and GM detection, or any combination of the above, resulted in an improved, fast, and powerful fungal specification in CFWS-positive samples. 100% specificity and sensitivity was achieved by using these tests in combination (data not shown). The culture technique was less helpful, as 68% of specimens remained negative.
                  &lt;/Para&gt;
                  &lt;Para ID="Par21"&gt;In our study, 127 immunocompromised patients were highly suspicious for IFD due to pathological CT findings; CT-guided biopsies confirmed the diagnosis in 81%. CT scan sensitivity, specificity, NPV, and PPV were 100, 44, 100, and 80%, respectively. So far, CT findings related to fungal infections have been reported in association with other pathogens such as 
                    &lt;Emphasis Type="Italic"&gt;Herpes simplex&lt;/Emphasis&gt;, 
                    &lt;Emphasis Type="Italic"&gt;Cytomegalovirus&lt;/Emphasis&gt;, and 
                    &lt;Emphasis Type="Italic"&gt;Mycobacterium tuberculosis&lt;/Emphasis&gt; [
                    &lt;CitationRef CitationID="CR29"&gt;29&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR30"&gt;30&lt;/CitationRef&gt;]. In our study, CT-guided biopsy revealed negative results for fungi in 30 (19%) patients. In 12 cases, other clinical diagnoses, such as lung carcinoma, leukemic infiltrates, or tuberculosis, were confirmed by pathological examinations. In three cases, however, fungal infection was considered despite negative CFWS. The clinical course and response to antifungal therapy confirmed mycosis being eventually present. Overall, the rate of false-negative results might be low upon examination of biopsy specimens. McCabe reported two cases (13%) which were undetected by an open lung biopsy; similar numbers were found by Cheson et al. [
                    &lt;CitationRef CitationID="CR31"&gt;31&lt;/CitationRef&gt;]. False-negative results may be explained by sampling errors or biopsies obtained in marginal zones of tissue reorganization and necrosis [
                    &lt;CitationRef CitationID="CR22"&gt;22&lt;/CitationRef&gt;]. Therefore, multiple specimens should be taken from different representative regions of the lesions in cases of suspicion of mycosis. A contrast medium-enhancing region should be considered for biopsy, as well as adjacent transition zones to normal parenchyma and to the necrotic zone.
                  &lt;/Para&gt;
                  &lt;Para ID="Par22"&gt;In a retrospective study reviewing the clinical outcome of 17 patients, Nosari et al. [
                    &lt;CitationRef CitationID="CR32"&gt;32&lt;/CitationRef&gt;] showed CT-guided lung biopsies not to be associated with major side effects. Pneumothorax, pulmonary hemorrhage, and fungal dissemination through surgical procedures have previously been reported; however, it is concluded that this radiological intervention is safe [
                    &lt;CitationRef CitationID="CR22"&gt;22&lt;/CitationRef&gt;, 
                    &lt;CitationRef AdditionalCitationIDS="CR33" CitationID="CR32"&gt;32&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR34"&gt;34&lt;/CitationRef&gt;]. Complications may be associated with the size of the lesions and their localization [
                    &lt;CitationRef CitationID="CR21"&gt;21&lt;/CitationRef&gt;]. Unimpaired hemostasis is of utmost importance. In our series, only two bleeding complications with formal consequences occurred. In the first case, the bleeding was self-limiting after a few minutes, while in the second case bronchoscopic intervention was necessary. The risk for severe hemoptyses (8% in our series) may be reduced by using the ipsilateral dependent position. Moreover, we hypothesize that fatal cases of air embolisms have been prevented by using this position [
                    &lt;CitationRef CitationID="CR19"&gt;19&lt;/CitationRef&gt;]. The risk of complications is probably enhanced in patients with severe coagulopathy or with profound thrombocytopenia and in patients on mechanical ventilation. The higher number of biopsies taken in patients with proven fungal infections may be explained by a greater suspicion of IFD being present of the performing radiologist. The more the number of human specimens available, the higher is the diagnostic output. The cause for the slightly lower number of biopsies taken in patients suffering from proven fungal infections with any complication is probably because biopsy procedures are presumably abandoned if difficulties occur.
                  &lt;/Para&gt;
                  &lt;Para ID="Par23"&gt;So far, only an accurate diagnosis permits a targeted therapy, an adequate secondary prophylaxis if needed, and facilitates the decision whether a surgical treatment is indicated or not. CFWS allowed a fast diagnosis and the differentiation between septate and unseptate hyphae, whereas the clinical and CT findings for pulmonary aspergillosis and mucormycosis are similar, respectively [
                    &lt;CitationRef CitationID="CR35"&gt;35&lt;/CitationRef&gt;]. The differences in the frequency of opacities, cavities, halo sign, and air crescent are insignificant between these infections. So far, Chamilos et al. [
                    &lt;CitationRef CitationID="CR36"&gt;36&lt;/CitationRef&gt;] found that the presence of multiple nodules and pleura effusion at the initial CT scan was an independent predictor of pulmonary mucormycoses. Due to the limited number of such cases, we were not able to detect differences between these entities.
                  &lt;/Para&gt;
                  &lt;Para ID="Par24"&gt;Our study has several limitations, as we conducted a single-center study, and the nature of data collection was retrospective. In addition, over time molecular-based techniques changed depending on the samples obtained and studies performed. 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR was applied in specimens displaying 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;-like hyphae, and the panfungal PCR in cases of non-
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt;-like hyphae being present. There was no head to head comparison of both methods in the presence of positive fungal elements, and the usage of CFWS has been stable over the years.
                  &lt;/Para&gt;
                  &lt;Para ID="Par25"&gt;In view of our experience, we propose CT-guided percutaneous biopsies in patients suspected of IFD not responding to standard therapy. The application of CFWS was superior in detecting fungal elements and in distinguishing between septate and non-septate hyphae; the combination of GM, 
                    &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; PCR, and broad fungal PCR resulted in fast and reliable fungus identification. The complication rates were acceptable and comparable to those of previous studies and may outweigh by far the benefits of an accurate diagnosis and a guided specific therapy.
                  &lt;/Para&gt;
                &lt;/Section1&gt;
              &lt;/Body&gt;
              &lt;BodyRef FileRef="BodyRef/PDF/15010_2017_Article_1072.pdf" TargetType="OnlinePDF"/&gt;
              &lt;ArticleBackmatter&gt;
                &lt;Acknowledgments&gt;
                  &lt;Heading&gt;Acknowledgements&lt;/Heading&gt;
                  &lt;SimplePara&gt;Open access funding provided by University of Innsbruck and Medical University of Innsbruck. This work was supported by the W1253-B24 doctoral program HOROS and the CD Laboratory for Fungal Infections.&lt;/SimplePara&gt;
                &lt;/Acknowledgments&gt;
                &lt;Ethics&gt;
                  &lt;Heading&gt;Compliance with ethical standards&lt;/Heading&gt;
                  &lt;FormalPara ID="FPar1" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Conflict of interest&lt;/Heading&gt;
                    &lt;Para ID="Par26"&gt;The authors declare that they have no conflict of interest.&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Ethics&gt;
                &lt;Bibliography ID="Bib1"&gt;
                  &lt;Heading&gt;References&lt;/Heading&gt;
                  &lt;Citation ID="CR1"&gt;
                    &lt;CitationNumber&gt;1.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Denning&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1998&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Invasive aspergillosis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Infect Dis&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;26&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;781&lt;/FirstPage&gt;
                      &lt;LastPage&gt;805&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK1c3isFKnsA%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1086/513943&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;9564455&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26:781–805.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR2"&gt;
                    &lt;CitationNumber&gt;2.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schelenz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barnes&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Barton&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cleverley&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lucas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kibbler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Lancet Infect Dis&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;15&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;461&lt;/FirstPage&gt;
                      &lt;LastPage&gt;474&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S1473-3099(15)70006-X&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25771341&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Schelenz S, Barnes RA, Barton RC, Cleverley JR, Lucas SB, Kibbler CC, et al. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis. 2015;15:461–74.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR3"&gt;
                    &lt;CitationNumber&gt;3.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Arvanitis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ziakas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;IM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zacharioudakis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;FN&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zervou&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Caliendo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mylonakis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Microbiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;52&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;3731&lt;/FirstPage&gt;
                      &lt;LastPage&gt;3742&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXhvFyitbbP&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1128/JCM.01365-14&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25122854&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4187770&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Arvanitis M, Ziakas PD, Zacharioudakis IM, Zervou FN, Caliendo AM, Mylonakis E. PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance. J Clin Microbiol. 2014;52:3731–42.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR4"&gt;
                    &lt;CitationNumber&gt;4.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;Y&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YQ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Guo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Qin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Diagnosis of invasive fungal disease using serum (1-3)-β-
                        &lt;Emphasis Type="SmallCaps"&gt;d&lt;/Emphasis&gt;-glucan: a bivariate meta-analysis
                      &lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Intern Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;50&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2783&lt;/FirstPage&gt;
                      &lt;LastPage&gt;2791&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC38XhsVynsLfK&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2169/internalmedicine.50.6175&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22082890&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lu Y, Chen YQ, Guo YL, Qin SM, Wu C, Wang K. Diagnosis of invasive fungal disease using serum (1-3)-β-
                      &lt;Emphasis Type="SmallCaps"&gt;d&lt;/Emphasis&gt;-glucan: a bivariate meta-analysis. Intern Med. 2011;50:2783–91.
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR5"&gt;
                    &lt;CitationNumber&gt;5.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Caillot&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Casasnovas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bernard&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Couaillier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Durand&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cuisenier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;1997&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;15&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;139&lt;/FirstPage&gt;
                      &lt;LastPage&gt;147&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK2s7kvFehtQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.1997.15.1.139&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;8996135&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 1997;15:139–47.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR6"&gt;
                    &lt;CitationNumber&gt;6.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Horger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Einsele&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;U&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schumacher&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wehrmann&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hebart&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lengerke&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Invasive pulmonary aspergillosis: frequency and meaning of the “hypodense sign” on unenhanced CT&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Br J Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;78&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;697&lt;/FirstPage&gt;
                      &lt;LastPage&gt;703&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD2Mzoslejsg%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1259/bjr/49174919&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16046420&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Horger M, Einsele H, Schumacher U, Wehrmann M, Hebart H, Lengerke C, et al. Invasive pulmonary aspergillosis: frequency and meaning of the “hypodense sign” on unenhanced CT. Br J Radiol. 2005;78:697–703.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR7"&gt;
                    &lt;CitationNumber&gt;7.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hruban&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Meziane&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zerhouni&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wheeler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dumler&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hutchins&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1987&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Comput Assist Tomogr&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;11&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;534&lt;/FirstPage&gt;
                      &lt;LastPage&gt;536&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaL2s7psFKguw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/00004728-198705000-00033&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;3571603&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hruban R, Meziane M, Zerhouni E, Wheeler P, Dumler J, Hutchins G. Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. J Comput Assist Tomogr. 1987;11:534–6.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR8"&gt;
                    &lt;CitationNumber&gt;8.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;OA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cornely&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Arikan-Akdagli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dannaoui&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Groll&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lagrou&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chakrabarti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Microbiol Infect&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;20&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;5&lt;/FirstPage&gt;
                      &lt;LastPage&gt;26&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXkt12isbs%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1111/1469-0691.12371&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24479848&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014;20:5–26.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR9"&gt;
                    &lt;CitationNumber&gt;9.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lass-Flörl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Resch&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nachbaur&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mayr&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gastl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Auberger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2007&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Infect Dis&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;45&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;e101&lt;/FirstPage&gt;
                      &lt;LastPage&gt;e104&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1086/521245&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;17806041&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lass-Flörl C, Resch G, Nachbaur D, Mayr A, Gastl G, Auberger J, et al. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis. 2007;45:e101–4.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR10"&gt;
                    &lt;CitationNumber&gt;10.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lass-Flörl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Griff&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mayr&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Petzer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gastl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bonatti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Epidemiology and outcome of infections due to 
                        &lt;Emphasis Type="Italic"&gt;Aspergillus terreus&lt;/Emphasis&gt;: 10-year single centre experience
                      &lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Br J Haematol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;131&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;201&lt;/FirstPage&gt;
                      &lt;LastPage&gt;207&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1111/j.1365-2141.2005.05763.x&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16197450&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lass-Flörl C, Griff K, Mayr A, Petzer A, Gastl G, Bonatti H, et al. Epidemiology and outcome of infections due to 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus terreus&lt;/Emphasis&gt;: 10-year single centre experience. Br J Haematol. 2005;131:201–7.
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR11"&gt;
                    &lt;CitationNumber&gt;11.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nachbaur&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Angelova&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Orth-Höller&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ditlbacher&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lackner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Auberger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Haematol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;94&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;258&lt;/FirstPage&gt;
                      &lt;LastPage&gt;264&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2MXjtlSksb4%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1111/ejh.12426&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25082655&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Nachbaur D, Angelova O, Orth-Höller D, Ditlbacher A, Lackner M, Auberger J, et al. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study. Eur J Haematol. 2015;94:258–64.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR12"&gt;
                    &lt;CitationNumber&gt;12.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pauw&lt;/FamilyName&gt;
                        &lt;Particle&gt;De&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Walsh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Donnelly&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stevens&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Edwards&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Calandra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2008&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Infect Dis&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;46&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1813&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1821&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1086/588660&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;18462102&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;2671227&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR13"&gt;
                    &lt;CitationNumber&gt;13.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;OA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cornely&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Böhme&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Buchheidt&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Einsele&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Heinz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Karthaus&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Haematologica&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;94&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;113&lt;/FirstPage&gt;
                      &lt;LastPage&gt;122&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.3324/haematol.11665&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19066334&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Cornely OA, Böhme A, Buchheidt D, Einsele H, Heinz WJ, Karthaus M, et al. Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica. 2009;94:113–22.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR14"&gt;
                    &lt;CitationNumber&gt;14.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Glodny&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schönherr&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Freund&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Haslauer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Petersen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Loizides&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2017&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Measures to prevent air embolism in transthoracic, biopsy of the lung&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Ajr Am J Roentgenol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;208&lt;/VolumeID&gt;
                      &lt;IssueID&gt;5&lt;/IssueID&gt;
                      &lt;FirstPage&gt;W184&lt;/FirstPage&gt;
                      &lt;LastPage&gt;W191&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2214/AJR.16.16048&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;28301208&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Glodny B, Schönherr E, Freund MC, Haslauer M, Petersen J, Loizides A, et al. Measures to prevent air embolism in transthoracic, biopsy of the lung. Ajr Am J Roentgenol. 2017;208(5):W184–91.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR15"&gt;
                    &lt;CitationNumber&gt;15.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Freund&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Petersen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Goder&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bunse&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wiedermann&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Glodny&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Systemic air embolism during percutaneous core needle biopsy of the lung: frequency and risk factors&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;BMC Pulm Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;12&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2&lt;/FirstPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1186/1471-2466-12-2&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22309812&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3608336&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Freund MC, Petersen J, Goder KC, Bunse T, Wiedermann F, Glodny B. Systemic air embolism during percutaneous core needle biopsy of the lung: frequency and risk factors. BMC Pulm Med. 2012;12:2.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR16"&gt;
                    &lt;CitationNumber&gt;16.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;O&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lucidarme&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Howarth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Finet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grenier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1998&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Intrapulmonary lesions: percutaneous automated biopsy with a detachable, 18-gauge, coaxial cutting needle&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;207&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;759&lt;/FirstPage&gt;
                      &lt;LastPage&gt;765&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK1c3nt1yhsw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1148/radiology.207.3.9609901&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;9609901&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lucidarme O, Howarth N, Finet JF, Grenier PA. Intrapulmonary lesions: percutaneous automated biopsy with a detachable, 18-gauge, coaxial cutting needle. Radiology. 1998;207:759–65.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR17"&gt;
                    &lt;CitationNumber&gt;17.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lass-Flörl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gunsilius&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gastl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bonatti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Freund&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gschwendtner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2004&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Microbiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;42&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;4154&lt;/FirstPage&gt;
                      &lt;LastPage&gt;4157&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1128/JCM.42.9.4154-4157.2004&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;15365004&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;516315&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lass-Flörl C, Gunsilius E, Gastl G, Bonatti H, Freund MC, Gschwendtner A, et al. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol. 2004;42:4154–7.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR18"&gt;
                    &lt;CitationNumber&gt;18.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lass-Flörl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Follett&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moody&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Denning&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Detection of 
                        &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; in lung and other tissue samples using the MycAssay 
                        &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; real-time PCR kit
                      &lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Can J Microbiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;57&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;765&lt;/FirstPage&gt;
                      &lt;LastPage&gt;768&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1139/w11-064&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21861765&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lass-Flörl C, Follett SA, Moody A, Denning DW. Detection of 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; in lung and other tissue samples using the MycAssay 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; real-time PCR kit. Can J Microbiol. 2011;57:765–8.
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR19"&gt;
                    &lt;CitationNumber&gt;19.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lass-Flörl&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;W&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mutschlechner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Aigner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grif&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Girschikofsky&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Microbiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;51&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;863&lt;/FirstPage&gt;
                      &lt;LastPage&gt;868&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1128/JCM.02965-12&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23269732&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3592065&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Lass-Flörl C, Mutschlechner W, Aigner M, Grif K, Marth C, Girschikofsky M, et al. Utility of PCR in diagnosis of invasive fungal infections: real-life data from a multicenter study. J Clin Microbiol. 2013;51:863–8.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR20"&gt;
                    &lt;CitationNumber&gt;20.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;D&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sacks&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TE&lt;/Initials&gt;
                        &lt;FamilyName&gt;McClenny&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cardella&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lewis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2003&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Society of Interventional Radiology clinical practice guidelines&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Vasc Interv Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;199&lt;/FirstPage&gt;
                      &lt;LastPage&gt;202&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/01.RVI.0000094584.83406.3e&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:199–202.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR21"&gt;
                    &lt;CitationNumber&gt;21.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bazelaire&lt;/FamilyName&gt;
                        &lt;Particle&gt;de&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Coffin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cohen-Zarade&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Margerie-Mellon&lt;/FamilyName&gt;
                        &lt;Particle&gt;de&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scemama&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sabatier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;CT-guided biopsies in lung infections in patients with haematological malignancies&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Diagn Interv Imaging&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;94&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;202&lt;/FirstPage&gt;
                      &lt;LastPage&gt;215&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.diii.2012.12.008&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23352879&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;de Bazelaire C, Coffin A, Cohen-Zarade S, de Margerie-Mellon C, Scemama A, Sabatier F, et al. CT-guided biopsies in lung infections in patients with haematological malignancies. Diagn Interv Imaging. 2013;94:202–15.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR22"&gt;
                    &lt;CitationNumber&gt;22.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sharma&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kumar&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Singh&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Seth&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mishra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mahapatra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Feasibility and outcome of CT-guided lung biopsy in patients with hematological diseases and suspected fungal pneumonia&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Infect Dev Ctries&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;7&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;748&lt;/FirstPage&gt;
                      &lt;LastPage&gt;752&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24129628&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Sharma SK, Kumar S, Singh AK, Seth T, Mishra P, Mahapatra M, et al. Feasibility and outcome of CT-guided lung biopsy in patients with hematological diseases and suspected fungal pneumonia. J Infect Dev Ctries. 2013;7:748–52.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR23"&gt;
                    &lt;CitationNumber&gt;23.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Arvanitis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Anagnostou&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fuchs&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Caliendo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mylonakis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Molecular and nonmolecular diagnostic methods for invasive fungal infections&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Microbiol Rev&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;27&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;490&lt;/FirstPage&gt;
                      &lt;LastPage&gt;529&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXhs1WmtrnF&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1128/CMR.00091-13&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24982319&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4135902&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Arvanitis M, Anagnostou T, Fuchs BB, Caliendo AM, Mylonakis E. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27:490–529.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR24"&gt;
                    &lt;CitationNumber&gt;24.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Guinea&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jensen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Peláez&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gijón&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Alonso&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rivera&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2008&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of 
                        &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; spp
                      &lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Med Mycol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;46&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;575&lt;/FirstPage&gt;
                      &lt;LastPage&gt;579&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BD1cXhtVygt7vI&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1080/13693780801978968&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19180751&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Guinea J, Jensen J, Peláez T, Gijón P, Alonso R, Rivera M, et al. Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of 
                      &lt;Emphasis Type="Italic"&gt;Aspergillus&lt;/Emphasis&gt; spp. Med Mycol. 2008;46:575–9.
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR25"&gt;
                    &lt;CitationNumber&gt;25.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Leeflang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Debets-Ossenkopp&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Visser&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scholten&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hooft&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bijlmer&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2008&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Galactomannan detection for invasive aspergillosis in immunocompromised patients&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cochrane Database Syst Rev&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;4&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;CD007394&lt;/FirstPage&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev. 2008;4:CD007394.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR26"&gt;
                    &lt;CitationNumber&gt;26.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Arvanitis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Anagnostou&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mylonakis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: a diagnostic meta-analysis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Infect Dis&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;61&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1263&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1272&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC28XhvFaku7rO&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1093/cid/civ555&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;26157047&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Arvanitis M, Anagnostou T, Mylonakis E. Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: a diagnostic meta-analysis. Clin Infect Dis. 2015;61:1263–72.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR27"&gt;
                    &lt;CitationNumber&gt;27.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RF&lt;/Initials&gt;
                        &lt;FamilyName&gt;Duarte&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sánchez-Ortega&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cuesta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Arnan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Patiño&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fernández De Sevilla&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Infect Dis&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;59&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1696&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1702&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2sXhsF2ntb7P&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1093/cid/ciu673&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25165088&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Duarte RF, Sánchez-Ortega I, Cuesta I, Arnan M, Patiño B, Fernández De Sevilla A, et al. Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis. Clin Infect Dis. 2014;59:1696–702.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR28"&gt;
                    &lt;CitationNumber&gt;28.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tortorano&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Richardson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Roilides&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Diepeningen&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Caira&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Munoz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2014&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: 
                        &lt;Emphasis Type="Italic"&gt;Fusarium&lt;/Emphasis&gt; spp., 
                        &lt;Emphasis Type="Italic"&gt;Scedosporium&lt;/Emphasis&gt; spp. and others
                      &lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Microbiol Infect&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;20&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;27&lt;/FirstPage&gt;
                      &lt;LastPage&gt;46&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC2cXkt12isbg%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1111/1469-0691.12465&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24548001&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: 
                      &lt;Emphasis Type="Italic"&gt;Fusarium&lt;/Emphasis&gt; spp., 
                      &lt;Emphasis Type="Italic"&gt;Scedosporium&lt;/Emphasis&gt; spp. and others. Clin Microbiol Infect. 2014;20:27–46.
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR29"&gt;
                    &lt;CitationNumber&gt;29.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gaeta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Volta&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Stroscio&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Romeo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;I&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pandolfo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1992&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;CT “halo sign” in pulmonary tuberculoma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Comput Assist Tomogr&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;827&lt;/FirstPage&gt;
                      &lt;LastPage&gt;828&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK38zpsFagsg%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1097/00004728-199209000-00029&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;1522281&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Gaeta M, Volta S, Stroscio S, Romeo P, Pandolfo I. CT “halo sign” in pulmonary tuberculoma. J Comput Assist Tomogr. 1992;16:827–8.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR30"&gt;
                    &lt;CitationNumber&gt;30.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Horger&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hebart&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Schimmel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vogel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brodoefel&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oechsle&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2006&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Disseminated mucormycosis in haematological patients: cT and MRI findings with pathological correlation&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Br J Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;79&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;e88&lt;/FirstPage&gt;
                      &lt;LastPage&gt;e95&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD28rhs1Witw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1259/bjr/16038097&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16940368&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Horger M, Hebart H, Schimmel H, Vogel M, Brodoefel H, Oechsle K, et al. Disseminated mucormycosis in haematological patients: cT and MRI findings with pathological correlation. Br J Radiol. 2006;79:e88–95.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR31"&gt;
                    &lt;CitationNumber&gt;31.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;BD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cheson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Samlowski&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tang&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Spruance&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1985&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Value of open-lung biopsy in 87 immunocompromised patients with pulmonary infiltrates&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;55&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;453&lt;/FirstPage&gt;
                      &lt;LastPage&gt;459&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaL2M%2FnsVShtA%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1002/1097-0142(19850115)55:2&amp;lt;453::AID-CNCR2820550228&amp;gt;3.0.CO;2-Q&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;2981147&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Cheson BD, Samlowski WE, Tang TT, Spruance SL. Value of open-lung biopsy in 87 immunocompromised patients with pulmonary infiltrates. Cancer. 1985;55:453–9.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR32"&gt;
                    &lt;CitationNumber&gt;32.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nosari&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Anghilieri&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Carrafiello&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Guffanti&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;L&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marbello&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Montillo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2003&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Haematologica&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;88&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1405&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1409&lt;/LastPage&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;14687995&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Nosari A, Anghilieri M, Carrafiello G, Guffanti C, Marbello L, Montillo M, et al. Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies. Haematologica. 2003;88:1405–9.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR33"&gt;
                    &lt;CitationNumber&gt;33.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takeshita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;K&lt;/Initials&gt;
                        &lt;FamilyName&gt;Masago&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kato&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hata&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kaji&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fujita&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;CT-guided fine-needle aspiration and core needle biopsies of pulmonary lesions: a single-center experience with 750 biopsies in Japan&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;AJR Am J Roentgenol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;204&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;29&lt;/FirstPage&gt;
                      &lt;LastPage&gt;34&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2214/AJR.14.13151&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25539234&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Takeshita J, Masago K, Kato R, Hata A, Kaji R, Fujita S, et al. CT-guided fine-needle aspiration and core needle biopsies of pulmonary lesions: a single-center experience with 750 biopsies in Japan. AJR Am J Roentgenol. 2015;204:29–34.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR34"&gt;
                    &lt;CitationNumber&gt;34.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hsu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kuschner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Paik&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bower&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Vazquez Guillamet&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kothary&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The diagnostic yield of CT-guided percutaneous lung biopsy in solid organ transplant recipients&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Transplant&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;26&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;615&lt;/FirstPage&gt;
                      &lt;LastPage&gt;621&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1111/j.1399-0012.2011.01582.x&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23050274&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3473075&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Hsu JL, Kuschner WG, Paik J, Bower N, Vazquez Guillamet MC, Kothary N. The diagnostic yield of CT-guided percutaneous lung biopsy in solid organ transplant recipients. Clin Transplant. 2012;26:615–21.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR35"&gt;
                    &lt;CitationNumber&gt;35.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Almyroudis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Sutton&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Linden&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Rinaldi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fung&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kusne&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2006&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Am J Transplant&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;6&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2365&lt;/FirstPage&gt;
                      &lt;LastPage&gt;2375&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD28rksFCkug%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1111/j.1600-6143.2006.01496.x&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16925570&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6:2365–75.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR36"&gt;
                    &lt;CitationNumber&gt;36.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chamilos&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marom&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lewis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lionakis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kontoyiannis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Clin Infect Dis&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;41&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;60&lt;/FirstPage&gt;
                      &lt;LastPage&gt;66&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1086/430710&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;15937764&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis. 2005;41:60–6.&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                &lt;/Bibliography&gt;
              &lt;/ArticleBackmatter&gt;
            &lt;/Article&gt;
          &lt;/Issue&gt;
        &lt;/Volume&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-11-21T15:48:43.255635+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Lass-Flörl, Cornelia&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Aigner, Maria&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Nachbaur, David&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Eschertzhuber, Stephan&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Bucher, Brigitte&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Geltner, Christian&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Bellmann, Romuald&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Lackner, Michaela&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Orth-Höller, Dorothea&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Würzner, Reinhard&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Weiss, Günter&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Glodny, Bernhard&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution geo="11.394700,47.262692,0"&gt;
            &lt;meta:OrgName&gt;Medical University of Innsbruck&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;11.394700,47.262692,0#Medical University of Innsbruck&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Austria&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="11.4041024,47.2692124"&gt;
            &lt;meta:OrgName&gt;University Hospital Innsbruck&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;11.4041024,47.2692124#University Hospital Innsbruck&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Austria&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="11.394700,47.262692,0"&gt;
            &lt;meta:OrgName&gt;Medical University of Innsbruck&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;11.394700,47.262692,0#Medical University of Innsbruck&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Austria&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="11.394700,47.262692,0"&gt;
            &lt;meta:OrgName&gt;Medical University of Innsbruck&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;11.394700,47.262692,0#Medical University of Innsbruck&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Austria&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="11.3735600,47.2340520,0"&gt;
            &lt;meta:OrgName&gt;Hospital Natters&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;11.3735600,47.2340520,0#Hospital Natters&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Austria&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="11.394700,47.262692,0"&gt;
            &lt;meta:OrgName&gt;Medical University of Innsbruck&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;11.394700,47.262692,0#Medical University of Innsbruck&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Austria&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
          &lt;meta:Institution geo="11.394700,47.262692,0"&gt;
            &lt;meta:OrgName&gt;Medical University of Innsbruck&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;11.394700,47.262692,0#Medical University of Innsbruck&lt;/meta:GeoOrg&gt;
            &lt;meta:Country&gt;Austria&lt;/meta:Country&gt;
          &lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-01&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-11-21T06:02:10&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1007/s15010-017-1072-6&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;1439-0973&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;Springer&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;Infection&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;Infection&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH33096" Priority="1" Type="Secondary"&gt;Infectious Diseases&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH24003" Priority="2" Type="Secondary"&gt;General Practice / Family Medicine&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH33002" Priority="3" Type="Secondary"&gt;Internal Medicine&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:VolumeId&gt;45&lt;/meta:VolumeId&gt;
        &lt;meta:IssueId&gt;6&lt;/meta:IssueId&gt;
        &lt;meta:ArticleSequenceNumber&gt;13&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
    &lt;Publisher xml:lang="en"&gt;
      &lt;PublisherInfo&gt;
        &lt;PublisherName&gt;Springer Berlin Heidelberg&lt;/PublisherName&gt;
        &lt;PublisherLocation&gt;Berlin/Heidelberg&lt;/PublisherLocation&gt;
        &lt;PublisherImprintName&gt;Springer&lt;/PublisherImprintName&gt;
      &lt;/PublisherInfo&gt;
      &lt;Journal OutputMedium="All"&gt;
        &lt;JournalInfo JournalProductType="NonStandardArchiveJournal" NumberingStyle="Unnumbered"&gt;
          &lt;JournalID&gt;247&lt;/JournalID&gt;
          &lt;JournalDOI&gt;10.1007/247.1432-1998&lt;/JournalDOI&gt;
          &lt;JournalPrintISSN&gt;0301-0449&lt;/JournalPrintISSN&gt;
          &lt;JournalElectronicISSN&gt;1432-1998&lt;/JournalElectronicISSN&gt;
          &lt;JournalTitle&gt;Pediatric Radiology&lt;/JournalTitle&gt;
          &lt;JournalAbbreviatedTitle&gt;Pediatr Radiol&lt;/JournalAbbreviatedTitle&gt;
          &lt;JournalSubjectGroup&gt;
            &lt;JournalSubject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH29005" Priority="1" Type="Secondary"&gt;Imaging / Radiology&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH49006" Priority="2" Type="Secondary"&gt;Pediatrics&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH2903X" Priority="3" Type="Secondary"&gt;Neuroradiology&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH29048" Priority="4" Type="Secondary"&gt;Nuclear Medicine&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH29064" Priority="5" Type="Secondary"&gt;Ultrasound&lt;/JournalSubject&gt;
            &lt;JournalSubject Code="SCH33160" Priority="6" Type="Secondary"&gt;Oncology&lt;/JournalSubject&gt;
            &lt;SubjectCollection Code="Medicine"&gt;SC11&lt;/SubjectCollection&gt;
          &lt;/JournalSubjectGroup&gt;
        &lt;/JournalInfo&gt;
        &lt;Volume OutputMedium="All"&gt;
          &lt;VolumeInfo TocLevels="0" VolumeType="Regular"&gt;
            &lt;VolumeIDStart&gt;47&lt;/VolumeIDStart&gt;
            &lt;VolumeIDEnd&gt;47&lt;/VolumeIDEnd&gt;
            &lt;VolumeIssueCount&gt;13&lt;/VolumeIssueCount&gt;
          &lt;/VolumeInfo&gt;
          &lt;Issue IssueType="Regular" OutputMedium="All"&gt;
            &lt;IssueInfo IssueType="Regular" TocLevels="0"&gt;
              &lt;IssueIDStart&gt;13&lt;/IssueIDStart&gt;
              &lt;IssueIDEnd&gt;13&lt;/IssueIDEnd&gt;
              &lt;IssueArticleCount&gt;23&lt;/IssueArticleCount&gt;
              &lt;IssueHistory&gt;
                &lt;OnlineDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;17&lt;/Day&gt;
                &lt;/OnlineDate&gt;
                &lt;PrintDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;11&lt;/Month&gt;
                  &lt;Day&gt;17&lt;/Day&gt;
                &lt;/PrintDate&gt;
                &lt;CoverDate&gt;
                  &lt;Year&gt;2017&lt;/Year&gt;
                  &lt;Month&gt;12&lt;/Month&gt;
                &lt;/CoverDate&gt;
                &lt;PricelistYear&gt;2017&lt;/PricelistYear&gt;
              &lt;/IssueHistory&gt;
              &lt;IssueCopyright&gt;
                &lt;CopyrightHolderName&gt;Springer-Verlag GmbH Germany, part of Springer Nature&lt;/CopyrightHolderName&gt;
                &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
              &lt;/IssueCopyright&gt;
            &lt;/IssueInfo&gt;
            &lt;Article ID="s00247-017-3946-2" OutputMedium="All"&gt;
              &lt;ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0"&gt;
                &lt;ArticleID&gt;3946&lt;/ArticleID&gt;
                &lt;ArticleDOI&gt;10.1007/s00247-017-3946-2&lt;/ArticleDOI&gt;
                &lt;ArticleSequenceNumber&gt;8&lt;/ArticleSequenceNumber&gt;
                &lt;ArticleTitle Language="En"&gt;Frequency and characteristics of pulmonary nodules in children at computed tomography&lt;/ArticleTitle&gt;
                &lt;ArticleCategory&gt;Original Article&lt;/ArticleCategory&gt;
                &lt;ArticleFirstPage&gt;1751&lt;/ArticleFirstPage&gt;
                &lt;ArticleLastPage&gt;1758&lt;/ArticleLastPage&gt;
                &lt;ArticleHistory&gt;
                  &lt;RegistrationDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;7&lt;/Month&gt;
                    &lt;Day&gt;11&lt;/Day&gt;
                  &lt;/RegistrationDate&gt;
                  &lt;Received&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;5&lt;/Month&gt;
                    &lt;Day&gt;8&lt;/Day&gt;
                  &lt;/Received&gt;
                  &lt;Revised&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;6&lt;/Month&gt;
                    &lt;Day&gt;28&lt;/Day&gt;
                  &lt;/Revised&gt;
                  &lt;Accepted&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;7&lt;/Month&gt;
                    &lt;Day&gt;10&lt;/Day&gt;
                  &lt;/Accepted&gt;
                  &lt;OnlineDate&gt;
                    &lt;Year&gt;2017&lt;/Year&gt;
                    &lt;Month&gt;9&lt;/Month&gt;
                    &lt;Day&gt;4&lt;/Day&gt;
                  &lt;/OnlineDate&gt;
                &lt;/ArticleHistory&gt;
                &lt;ArticleFundingInformation&gt;
                  &lt;Fund&gt;
                    &lt;FunderName&gt;University Medical Center Utrecht&lt;/FunderName&gt;
                  &lt;/Fund&gt;
                &lt;/ArticleFundingInformation&gt;
                &lt;ArticleCopyright&gt;
                  &lt;CopyrightHolderName&gt;The Author(s)&lt;/CopyrightHolderName&gt;
                  &lt;CopyrightYear&gt;2017&lt;/CopyrightYear&gt;
                  &lt;License SubType="CC BY" Type="OpenAccess" Version="4.0"&gt;
                    &lt;SimplePara&gt;
                      &lt;Emphasis Type="Bold"&gt;Open Access&lt;/Emphasis&gt; This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
                    &lt;/SimplePara&gt;
                  &lt;/License&gt;
                &lt;/ArticleCopyright&gt;
                &lt;ArticleGrants Type="OpenChoice"&gt;
                  &lt;MetadataGrant Grant="OpenAccess"/&gt;
                  &lt;AbstractGrant Grant="OpenAccess"/&gt;
                  &lt;BodyPDFGrant Grant="OpenAccess"/&gt;
                  &lt;BodyHTMLGrant Grant="OpenAccess"/&gt;
                  &lt;BibliographyGrant Grant="OpenAccess"/&gt;
                  &lt;ESMGrant Grant="OpenAccess"/&gt;
                &lt;/ArticleGrants&gt;
              &lt;/ArticleInfo&gt;
              &lt;ArticleHeader&gt;
                &lt;AuthorGroup&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au1" ORCID="http://orcid.org/0000-0001-6165-0902"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Atia&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Samim&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1" ID="Au2"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Annemieke&lt;/GivenName&gt;
                      &lt;GivenName&gt;S.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Littooij&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                    &lt;Contact&gt;
                      &lt;Email&gt;a.s.littooij-2@umcutrecht.nl&lt;/Email&gt;
                    &lt;/Contact&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff2" ID="Au3"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Marry&lt;/GivenName&gt;
                      &lt;GivenName&gt;M.&lt;/GivenName&gt;
                      &lt;Particle&gt;van den&lt;/Particle&gt;
                      &lt;FamilyName&gt;Heuvel-Eibrink&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au4"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Frank&lt;/GivenName&gt;
                      &lt;GivenName&gt;J.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Wessels&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au5"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Rutger&lt;/GivenName&gt;
                      &lt;GivenName&gt;A.&lt;/GivenName&gt;
                      &lt;GivenName&gt;J.&lt;/GivenName&gt;
                      &lt;FamilyName&gt;Nievelstein&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Author AffiliationIDS="Aff1" ID="Au6"&gt;
                    &lt;AuthorName DisplayOrder="Western"&gt;
                      &lt;GivenName&gt;Pim&lt;/GivenName&gt;
                      &lt;GivenName&gt;A.&lt;/GivenName&gt;
                      &lt;Particle&gt;de&lt;/Particle&gt;
                      &lt;FamilyName&gt;Jong&lt;/FamilyName&gt;
                    &lt;/AuthorName&gt;
                  &lt;/Author&gt;
                  &lt;Affiliation ID="Aff1"&gt;
                    &lt;OrgID Level="Institution" Type="ISNI"&gt;0000000090126352&lt;/OrgID&gt;
                    &lt;OrgID Level="Institution" Type="GRID"&gt;grid.7692.a&lt;/OrgID&gt;
                    &lt;OrgDivision&gt;Department of Radiology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;University Medical Centre Utrecht/Wilhelmina Children’s Hospital&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;HP E01.132, Heidelberglaan 100&lt;/Street&gt;
                      &lt;Postcode&gt;3584 CX&lt;/Postcode&gt;
                      &lt;City&gt;Utrecht&lt;/City&gt;
                      &lt;Country Code="NL"&gt;The Netherlands&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                  &lt;Affiliation ID="Aff2"&gt;
                    &lt;OrgDivision&gt;Department of Pediatric Oncology&lt;/OrgDivision&gt;
                    &lt;OrgName&gt;Princess Máxima Centre for Pediatric Oncology&lt;/OrgName&gt;
                    &lt;OrgAddress&gt;
                      &lt;Street&gt;Lundlaan 6&lt;/Street&gt;
                      &lt;Postcode&gt;3584 EA&lt;/Postcode&gt;
                      &lt;City&gt;Utrecht&lt;/City&gt;
                      &lt;Country Code="NL"&gt;The Netherlands&lt;/Country&gt;
                    &lt;/OrgAddress&gt;
                  &lt;/Affiliation&gt;
                &lt;/AuthorGroup&gt;
                &lt;Abstract ID="Abs1" Language="En" OutputMedium="All"&gt;
                  &lt;Heading&gt;Abstract&lt;/Heading&gt;
                  &lt;AbstractSection ID="ASec1"&gt;
                    &lt;Heading&gt;Background&lt;/Heading&gt;
                    &lt;Para ID="Par1"&gt;Normative data on pulmonary nodules in children without malignancy are limited. Knowledge of the frequency and characteristics of pulmonary nodules in healthy children can influence care decisions in children with malignant disease.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec2"&gt;
                    &lt;Heading&gt;Objective&lt;/Heading&gt;
                    &lt;Para ID="Par2"&gt;To provide normative data concerning the frequency and characteristics of pulmonary nodules on computed tomography (CT) in young children.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec3"&gt;
                    &lt;Heading&gt;Materials and methods&lt;/Heading&gt;
                    &lt;Para ID="Par3"&gt;All children ages 1&nbsp;year–12&nbsp;years who underwent chest CT after high-energy trauma were retrospectively investigated. Exclusion criteria were a history of malignancy, thick image slices, motion artefacts and extensive post-traumatic pulmonary changes. Two radiologists were asked to independently identify all nodules and to characterize each nodule with respect to location, size, perifissural location and calcification. Discrepancies were adjudicated by a third reader, who set the reference standard in this study. Interobserver agreement in detection and characterization was assessed using the kappa coefficient (κ).&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec4"&gt;
                    &lt;Heading&gt;Results&lt;/Heading&gt;
                    &lt;Para ID="Par4"&gt;Identified were 120 patients, of whom 72 (75% male; median age: 8.0 years [interquartile range: 4–11]) were included. A total of 59 pulmonary nodules were present in 27 patients (38%; 95% confidence interval: 26–49%; range: 1–5 nodules per patient, with a mean diameter of 3.2 mm [standard deviation: 0.9 mm]). For nodule detection, the per-patient interobserver agreement was substantial (
                      &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.78) and per-lobe agreement was moderate (
                      &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.40). For characterization, there was fair to substantial agreement (
                      &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.36–0.74).
                    &lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                  &lt;AbstractSection ID="ASec5"&gt;
                    &lt;Heading&gt;Conclusion&lt;/Heading&gt;
                    &lt;Para ID="Par5"&gt;Small pulmonary nodules on chest CT are a common finding in otherwise healthy children, but detection and characterization have only moderate interobserver agreement.&lt;/Para&gt;
                  &lt;/AbstractSection&gt;
                &lt;/Abstract&gt;
                &lt;KeywordGroup Language="En" OutputMedium="All" Source="Author"&gt;
                  &lt;Heading&gt;Keywords&lt;/Heading&gt;
                  &lt;Keyword&gt;Child&lt;/Keyword&gt;
                  &lt;Keyword&gt;Detection rate&lt;/Keyword&gt;
                  &lt;Keyword&gt;Lungs&lt;/Keyword&gt;
                  &lt;Keyword&gt;Multidetector computed tomography&lt;/Keyword&gt;
                  &lt;Keyword&gt;Observer variability&lt;/Keyword&gt;
                  &lt;Keyword&gt;Pulmonary nodule&lt;/Keyword&gt;
                &lt;/KeywordGroup&gt;
              &lt;/ArticleHeader&gt;
              &lt;Body&gt;
                &lt;Section1 ID="Sec1"&gt;
                  &lt;Heading&gt;Introduction&lt;/Heading&gt;
                  &lt;Para ID="Par6"&gt;A pulmonary nodule in a child with known malignancy can be an important sign of metastatic stage. However, the prevalence and characteristics of nodules in children without malignancy are unclear. Knowledge of these normal values can influence future care decisions in children presenting with a malignancy.&lt;/Para&gt;
                  &lt;Para ID="Par7"&gt;In children, tumours that most frequently disseminate to the lungs are Wilms tumour (nephroblastoma), osteosarcoma and Ewing sarcoma [
                    &lt;CitationRef CitationID="CR1"&gt;1&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR2"&gt;2&lt;/CitationRef&gt;]. According to the latest International Society of Paediatric Oncology (SIOP) protocol for renal tumours, a computed tomography (CT) scan of the chest is now mandatory to assess lung metastases [
                    &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;]. While current CT imaging is highly sensitive in detecting small pulmonary nodules, specificity for metastatic disease is low [
                    &lt;CitationRef CitationID="CR4"&gt;4&lt;/CitationRef&gt;]. In fact, 32% to 65% of the metastasis-suspect nodules on CT in children with various malignancies were proven to be benign at biopsy [
                    &lt;CitationRef AdditionalCitationIDS="CR6 CR7" CitationID="CR5"&gt;5&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR8"&gt;8&lt;/CitationRef&gt;]. To prevent unnecessary upstaging due to false-positive diagnosis, correct recognition of benign nodules is important. Despite various attempts in previous literature, it remains difficult to identify CT features that can reliably predict the nature of pulmonary nodules in children with malignancy [
                    &lt;CitationRef AdditionalCitationIDS="CR6 CR7 CR8" CitationID="CR5"&gt;5&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR9"&gt;9&lt;/CitationRef&gt;]. From studies in adults, some clear clues of benignity have been proposed: Calcified nodules in non-bone-forming tumours would be consistent with granulomas and triangular perifissural nodules with benign intrapulmonary lymph nodes [
                    &lt;CitationRef CitationID="CR4"&gt;4&lt;/CitationRef&gt;]. With regard to the SIOP protocol, international consensus has been reached that cases with nodules ≥3&nbsp;mm depleted of clear benign characteristics are regarded as malignant.
                  &lt;/Para&gt;
                  &lt;Para ID="Par8"&gt;However, in healthy children, the occurrence of pulmonary nodules without the characteristics associated with benignity is unknown. If nodules ≥3&nbsp;mm are prevalent in healthy children, there would be a considerable possibility of upstaging in children presenting with Wilms tumour. Furthermore, whether perifissural nodules occur in children has yet to be determined. Another important issue is the inevitable interobserver variability in detecting, measuring and interpreting small pulmonary nodules on CT [
                    &lt;CitationRef CitationID="CR10"&gt;10&lt;/CitationRef&gt;]. Given poor patient compliance, high respiratory rates and limited temporal resolution at chest CT, it is questionable how capable we are at detecting such small lesions.
                  &lt;/Para&gt;
                  &lt;Para ID="Par9"&gt;Only limited literature is available on the prevalence of pulmonary nodules in healthy children. The prevalence of such nodules remains uncertain, as previous studies in children up to the age of 18&nbsp;years reveal a wide variance, i.e. 33% and 75% [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;]. In view of the new SIOP protocol, the prevalence in the younger age groups is particularly relevant, as nearly all cases of Wilms tumour present before the age of 15&nbsp;years (median: 3.5&nbsp;years) [
                    &lt;CitationRef CitationID="CR13"&gt;13&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par10"&gt;By providing the a priori probability of identifying a lung nodule in a child without malignant disease, we aim to improve the estimation of risk of pulmonary metastatic disease. The purpose of this study is to determine the frequency and characteristics of pulmonary nodules and to evaluate interobserver agreement for detecting and characterizing pulmonary nodules in otherwise healthy young children who received a CT scan following trauma.&lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec2"&gt;
                  &lt;Heading&gt;Materials and methods&lt;/Heading&gt;
                  &lt;Para ID="Par11"&gt;Institutional Review Board (IRB 15–445) approval was obtained. For this retrospective study, formal consent was not required. All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.&lt;/Para&gt;
                  &lt;Para ID="Par12"&gt;We examined a cohort of consecutive trauma patients as a representation of the healthy paediatric population. All potentially eligible patients from the age of 1&nbsp;year to 12&nbsp;years who underwent chest CT as part of their trauma evaluation in a single centre between March 2007 and July 2015 were retrospectively identified. Exclusion criteria were a history of malignancy, scans with ≥1.25-mm slice thickness, diagnostic relevant artefacts and extensive post-traumatic pulmonary changes. Tuberculosis and histoplasmosis are not endemic in our region.&lt;/Para&gt;
                  &lt;Para ID="Par13"&gt;CT examinations were obtained with 16-, 64- and 128-row multidetector CT scanners (Mx8000 IDT 16, Brilliance 16P with 0.75&nbsp;mm collimation; Brilliance 64, Brilliance iCT with 0.625&nbsp;mm collimation; Philips Medical Systems, Cleveland, OH, USA). All patients received 2&nbsp;ml/kg contrast medium according to our trauma protocol. Exposure settings (range: 35–190 mAs and 80–120 kVp) were adjusted to patient size. Thin slice images (1.0-mm maximum thickness at 1.0-mm maximum intervals) were reconstructed, stored in a 512×512 data matrix and displayed with lung parenchyma setting (window level: −500, window width: 1,500).&lt;/Para&gt;
                  &lt;Para ID="Par14"&gt;Two radiologists independently reviewed images of the chest CT of all patients, whilst being aware the study concerned trauma patients. Reader 1 (P.A.d.J.) has &amp;gt;10&nbsp;years of experience in paediatric and thoracic imaging and reader 2 (F.J.W.) has 5&nbsp;years of experience in general radiology. Axial thin slice images were available for review, as well as maximum intensity projection (MIP) in all planes to increase sensitivity. The readers recorded the presence of each nodule together with its lobar location (right upper lobe, right middle lobe, right lower lobe, left upper lobe [lingula included] and left lower lobe) and characteristics (nodule size, perifissural [yes/no] and calcification [yes/no]). Nodule size was measured along the long axis diameter at the axial thin slices without the use of MIP. Bone window was used to assess calcification. In case of discrepancy between the two readers, a 3rd reader with &amp;gt;10&nbsp;years of experience as a paediatric radiologist adjudicated by accepting or rejecting the discrepancies in potential nodules or characteristics and provided a reference standard for our study.&lt;/Para&gt;
                  &lt;Para ID="Par15"&gt;Pulmonary nodules were defined as more or less round well-circumscribed opacities in the lung measuring up to 3&nbsp;cm [
                    &lt;CitationRef CitationID="CR4"&gt;4&lt;/CitationRef&gt;]. De Hoop et al. [
                    &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;] proposed a classification for perifissural nodules, including the characteristic morphological features of intrapulmonary lymph nodes (Fig. 
                    &lt;InternalRef RefID="Fig1"&gt;1&lt;/InternalRef&gt;). Typically, perifissural nodules appear attached to fissures, have a homogenous solid appearance and a lentiform, oval or triangular shape with smooth margins. However, atypical perifissural nodules also occur; therefore, we chose to dichotomize between perifissural yes (typical and atypical perifissural) and no (non–perifissural nodules).
                    &lt;Figure Category="Standard" Float="Yes" ID="Fig1"&gt;
                      &lt;!--SingleCol--&gt;
                      &lt;Caption Language="En"&gt;
                        &lt;CaptionNumber&gt;Fig. 1&lt;/CaptionNumber&gt;
                        &lt;CaptionContent&gt;
                          &lt;SimplePara&gt;The role of fissure attachment and shape in the classification of perifissural nodules. Reprinted with permission: de Hoop B, den Ginneken B, Gietema H et al., Radiology (2012), © Radiological Society of North America. Fissure-attached nodules with a lentiform, oval or triangular shape are shown in the top pane. Nodules with a lentiform, oval or triangular shape, but not attached to a (visible) fissure 
                            &lt;Emphasis Type="Italic"&gt;or&lt;/Emphasis&gt; fissure attached, convex on one side and rounded on the other are shown in the middle pane. Fissure-(un)attached nodules with a spherical or irregular shape that did not appear to be influenced by the fissure are shown in the bottom pane
                          &lt;/SimplePara&gt;
                        &lt;/CaptionContent&gt;
                      &lt;/Caption&gt;
                      &lt;MediaObject ID="MO1"&gt;
                        &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/247_2017_3946_Fig1_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                      &lt;/MediaObject&gt;
                    &lt;/Figure&gt;
                  &lt;/Para&gt;
                  &lt;Para ID="Par16"&gt;Numerical variables were summarized, using either mean with standard deviation (SD) or median with interquartile range (IQR), depending on the distribution. All 95% confidence intervals (CI) were calculated using binomial distribution. The interobserver agreement of the detection of pulmonary nodules was assessed in patient-based and lobe-based analyses, which meant that a patient or lobe was marked as positive if the observer found at least one nodule in the patient or lobe. Agreement for characterization was calculated for each individual nodule. Agreement was calculated with the percent agreement and unweighted Cohen’s kappa (κ) statistic, with κ&amp;lt;0 classified as poor, 0.00–0.20 as slight, 0.21–0.40 as fair, 0.41–0.60 as moderate, 0.61–0.80 as substantial and 0.81–1.00 as almost perfect agreement [
                    &lt;CitationRef CitationID="CR15"&gt;15&lt;/CitationRef&gt;]. Nodule frequency is the percentage of patients with at least one nodule among the study sample. We performed logistic regression with nodule presence as the outcome and age as the determinant. Due to the relatively long sampling period, we used logistic regression to explore the effect of the year of the scan on the presence of nodules and linear regression for number of nodules detected and size of the smallest nodule detected. The nodules were put into size categories of smaller nodules (&amp;lt;3&nbsp;mm) and larger nodules (≥3&nbsp;mm), based on SIOP’s threshold size for pulmonary metastasis. Multiple nodules were defined as ≥4 nodules per patient. All statistical analyses were performed using SPPS version 21 (SPSS Inc., Chicago, IL, USA). Statistical significance level was set at 
                    &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt;&amp;lt;0.05.
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec3"&gt;
                  &lt;Heading&gt;Results&lt;/Heading&gt;
                  &lt;Section2 ID="Sec4"&gt;
                    &lt;Heading&gt;Patients&lt;/Heading&gt;
                    &lt;Para ID="Par17"&gt;We identified 120 children who underwent chest CT as part of their trauma evaluation. Inclusion and exclusion criteria are illustrated in the flow diagram in Fig. 
                      &lt;InternalRef RefID="Fig2"&gt;2&lt;/InternalRef&gt;. The most frequent reason for exclusion was extensive post-traumatic pleuropulmonary changes (
                      &lt;Emphasis Type="Italic"&gt;n=&lt;/Emphasis&gt;42), such as aspiration, pneumothorax, pulmonary haemorrhage, contusion and laceration. In five patients, no thin slices were available and one patient was excluded due to a history of lymphoma. This resulted in a study sample of 72 patients (54 males) with a median age of 8.0 (IQR: 4–11) years and CT scans with a median slice thickness of 0.9&nbsp;mm (range: 0.8–1.0&nbsp;mm) at 0.5– to 0.8–mm intervals.
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig2"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 2&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Flow diagram of patient selection. * 95% confidence interval 26–49%, stratification of included patients into subgroups with or without nodules according to the consensus reading&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO2"&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/247_2017_3946_Fig2_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec5"&gt;
                    &lt;Heading&gt;Interobserver agreement&lt;/Heading&gt;
                    &lt;Para ID="Par18"&gt;Reader 1 and reader 2 detected 43 and 44 potential nodules, respectively. However, only 22 potential nodules were detected by both readers and the remaining 43 potential nodules were detected by only one reader. Regarding nodule detection, interobserver agreement on a per-patient-basis was substantial (
                      &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.78), (Table 
                      &lt;InternalRef RefID="Tab1"&gt;1&lt;/InternalRef&gt;). In contrast, agreement on a per-lobe basis was moderate (
                      &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.40). Regarding characterization, agreement was substantial (
                      &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.74) for size category, fair (
                      &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.36) for perifissural location and moderate (
                      &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.46) for calcification. The consensus reader rejected 6 of the 43 discrepancies in potential nodules, which resulted in a total of 59 nodules that were considered valid. In 18 children with one or more nodules ≥3–5&nbsp;mm, the nodule was detected by one reader but missed by the other. In two children with one or more nodules ≥5&nbsp;mm, the nodule was detected by one reader and missed by the other.
                      &lt;Table Float="Yes" ID="Tab1"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 1&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Interobserver agreement using percent agreement and Cohen’s kappa (κ) statistics (95% confidence intervals [CI])&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup align="left" cols="7"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                          &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                          &lt;colspec align="left" colname="c6" colnum="6"/&gt;
                          &lt;colspec align="left" colname="c7" colnum="7"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1" morerows="1"/&gt;
                              &lt;entry nameend="c3" namest="c2"&gt;
                                &lt;SimplePara&gt;Reader 1 vs. reader 2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c5" namest="c4"&gt;
                                &lt;SimplePara&gt;Reader 1 vs. consensus reader&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c7" namest="c6"&gt;
                                &lt;SimplePara&gt;Reader 2 vs. consensus reader&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;% agreement&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;κ (CI)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;% agreement&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;κ (CI)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;% agreement&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;κ (CI)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c7" namest="c1"&gt;
                                &lt;SimplePara&gt;Nodule detection&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Patient-based&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;90%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(65/72)
                                  &lt;Superscript&gt;a&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.78&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.77–0.80)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;94%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(68/72)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0.88&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.86–0.89)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;96%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(69/72)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.91&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.90–0.92)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Lobe-based&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;89%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(319/360)
                                  &lt;Superscript&gt;b&lt;/Superscript&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.40&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.25–0.55)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;99% (357/360)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0.82&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.73–0.91)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;99% (356/360)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.75&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.64–0.86)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry nameend="c7" namest="c1"&gt;
                                &lt;SimplePara&gt;Characteristics&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Size category&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;91%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(20/22)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.74&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.67–0.82)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;93%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(38/41)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0.76&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.71–0.80)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;100%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(40/40)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;1.00&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(1.00–1.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Perifissural location&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;68%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(15/22)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.36&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.29–0.44)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;95%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(39/41)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0.90&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.88–0.92)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;88%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(35/40)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.70&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.66–0.74)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt; Calcification&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;91%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(20/22)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0.46&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.33–0.60)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;100%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(41/41)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;1.00&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(1.00–1.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;95%&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(38/40)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0.48&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(0.38–0.58)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Superscript&gt;a&lt;/Superscript&gt;In 21 patients, both observers detected a nodule, in 44 patients both observers did not find any nodule and in 7 patients one of the observers detected a nodule
                          &lt;/SimplePara&gt;
                          &lt;SimplePara&gt;
                            &lt;Superscript&gt;b&lt;/Superscript&gt;In 17 lobes, both observers detected a nodule; in 302 lobes, neither detected a nodule and in 41 lobes, one of the observers detected a nodule
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec6"&gt;
                    &lt;Heading&gt;Nodule frequency&lt;/Heading&gt;
                    &lt;Para ID="Par19"&gt;According to the reference standard, at least one nodule was identified in 38% (27/72) (95% CI: 26–49%) of the children (Table 
                      &lt;InternalRef RefID="Tab2"&gt;2&lt;/InternalRef&gt;). A total of 59 pulmonary nodules were found among 27 patients. In the patients with nodules, up to 5 nodules per patient were present, with an average of 2.2 nodules (59/27) per patient and most patients (11/27) with 1 nodule. Logistic regression analysis of nodule frequency per year of age gave an odds ratio of 1.089 (not significant, 95% CI: 0.945–1.255). Table 
                      &lt;InternalRef RefID="Tab3"&gt;3&lt;/InternalRef&gt; shows the absolute probabilities of finding a nodule per age group. Although the year of the scan had no significant effect on the presence of nodules (
                      &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt;=0.09) or on the size of the smallest nodule detected (
                      &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt;=0.90), it seems that the number of nodules detected significantly increased each year (
                      &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt;=0.01).
                      &lt;Table Float="Yes" ID="Tab2"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 2&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Pulmonary nodules in children on chest CT by age&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup align="left" cols="8"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                          &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                          &lt;colspec align="left" colname="c6" colnum="6"/&gt;
                          &lt;colspec align="left" colname="c7" colnum="7"/&gt;
                          &lt;colspec align="left" colname="c8" colnum="8"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Age (y)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;
                                  &lt;Emphasis Type="Italic"&gt;n&lt;/Emphasis&gt;
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;Number of patients with nodule(s)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;Number of nodules&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;Maximum number of nodules per patient&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;Mean size&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;(range), mm&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;Calcified nodules&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;Perifissural nodules&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3.3 (3–4)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"/&gt;
                              &lt;entry colname="c7"/&gt;
                              &lt;entry colname="c8"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;8&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3.3 (2–6)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"/&gt;
                              &lt;entry colname="c7"/&gt;
                              &lt;entry colname="c8"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3.0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;4.0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;7&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;2.0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;8&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;14&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;2.9 (2–4)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;10&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;9&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3.5 (2–6)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;10&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;1&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3.3 (3–4)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;11&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;7&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;8&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3.3 (2–5)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;0&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;11&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;13&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3.2 (2–5)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;7&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Total&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;72&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;27 (38%
                                  &lt;Superscript&gt;a&lt;/Superscript&gt;)
                                &lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;59&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;3.2 (2–6)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;4 (7%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;39 (66%)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                        &lt;tfooter&gt;
                          &lt;SimplePara&gt;
                            &lt;Superscript&gt;a&lt;/Superscript&gt;95% confidence interval 26–49%
                          &lt;/SimplePara&gt;
                        &lt;/tfooter&gt;
                      &lt;/Table&gt;
                      &lt;Table Float="Yes" ID="Tab3"&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Table 3&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;The probability (95% confidence interval [CI]) of finding nodules in a child in whom the largest nodule is ≥3&nbsp;mm or ≥5&nbsp;mm&lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;tgroup align="left" cols="9"&gt;
                          &lt;colspec align="left" colname="c1" colnum="1"/&gt;
                          &lt;colspec align="left" colname="c2" colnum="2"/&gt;
                          &lt;colspec align="left" colname="c3" colnum="3"/&gt;
                          &lt;colspec align="left" colname="c4" colnum="4"/&gt;
                          &lt;colspec align="left" colname="c5" colnum="5"/&gt;
                          &lt;colspec align="left" colname="c6" colnum="6"/&gt;
                          &lt;colspec align="left" colname="c7" colnum="7"/&gt;
                          &lt;colspec align="left" colname="c8" colnum="8"/&gt;
                          &lt;colspec align="left" colname="c9" colnum="9"/&gt;
                          &lt;thead&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;Age in years&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c3" namest="c2"&gt;
                                &lt;SimplePara&gt;Any nodule&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;probability (CI)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c5" namest="c4"&gt;
                                &lt;SimplePara&gt;&amp;gt;1 nodule&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;probability (CI)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c7" namest="c6"&gt;
                                &lt;SimplePara&gt;Any nodule ≥3&nbsp;mm&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;probability (CI)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry nameend="c9" namest="c8"&gt;
                                &lt;SimplePara&gt;Any nodule ≥5&nbsp;mm&lt;/SimplePara&gt;
                                &lt;SimplePara&gt;probability (CI)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/thead&gt;
                          &lt;tbody&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥1–2&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.67&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.13–1.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.33&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.00–0.87)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;1.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥2–3&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                              &lt;entry colname="c4"/&gt;
                              &lt;entry colname="c5"/&gt;
                              &lt;entry colname="c6"/&gt;
                              &lt;entry colname="c7"/&gt;
                              &lt;entry colname="c8"/&gt;
                              &lt;entry colname="c9"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥3–4&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.50&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.15–0.85)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.25&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.00–0.55)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0.75&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;(0.33–1.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥4–5&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"/&gt;
                              &lt;entry colname="c4"/&gt;
                              &lt;entry colname="c5"/&gt;
                              &lt;entry colname="c6"/&gt;
                              &lt;entry colname="c7"/&gt;
                              &lt;entry colname="c8"/&gt;
                              &lt;entry colname="c9"/&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥5–6&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.20&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.00–0.55)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;1.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥6–7&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.17&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.00–0.47)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;1.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥7–8&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.67&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.13–1.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥8–9&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.36&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.11–0.61)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.21&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.00–0.43)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0.80&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;(0.45–1.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥9–10&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.50&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.01–0.99)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.25&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.00–0.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;1.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.50&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;(0.00–1.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥10–11&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.33&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.00–0.87)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.33&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.00–0.87)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;1.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥11–12&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.57&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.21–0.94)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.57&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.21–0.94)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;1.00&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;-&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.25&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;(0.00–0.67)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                            &lt;row&gt;
                              &lt;entry colname="c1"&gt;
                                &lt;SimplePara&gt;≥12–13&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c2"&gt;
                                &lt;SimplePara&gt;0.45&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c3"&gt;
                                &lt;SimplePara&gt;(0.16–0.75)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c4"&gt;
                                &lt;SimplePara&gt;0.36&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c5"&gt;
                                &lt;SimplePara&gt;(0.08–0.65)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c6"&gt;
                                &lt;SimplePara&gt;0.80&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c7"&gt;
                                &lt;SimplePara&gt;(0.45–1.00)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c8"&gt;
                                &lt;SimplePara&gt;0.20&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                              &lt;entry colname="c9"&gt;
                                &lt;SimplePara&gt;(0.00–0.55)&lt;/SimplePara&gt;
                              &lt;/entry&gt;
                            &lt;/row&gt;
                          &lt;/tbody&gt;
                        &lt;/tgroup&gt;
                      &lt;/Table&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                  &lt;Section2 ID="Sec7"&gt;
                    &lt;Heading&gt;Nodule characteristics&lt;/Heading&gt;
                    &lt;Para ID="Par20"&gt;The mean nodule size was 3.2&nbsp;mm (SD: 0.9&nbsp;mm) and the largest nodule measured 6&nbsp;mm. Of the 59 nodules, 81% (48/59) were ≥3&nbsp;mm, only 7% (4/59) contained calcification and 66% (39/59) were perifissural nodules (Fig. 
                      &lt;InternalRef RefID="Fig3"&gt;3&lt;/InternalRef&gt;). Of the 27 children who presented with nodules, 81% (22/27) presented with larger nodules (≥3&nbsp;mm), 19% (5/27) with multiple nodules (≥4 nodules), and 44% (12/27) with nodules that were neither calcified nor perifissural. Of the 16 children who had more than one nodule, 63% (10/16) had bilaterally distributed nodules. Nodules occurred with greatest frequency in the right lower lobe (31%, 18/59), followed by the right upper lobe (24%, 14/59), left lower lobe (19%, 11/59), right middle lobe (17%, 10/59) and the left upper lobe (10%, 6/59).
                      &lt;Figure Category="Standard" Float="Yes" ID="Fig3"&gt;
                        &lt;!--SingleCol--&gt;
                        &lt;Caption Language="En"&gt;
                          &lt;CaptionNumber&gt;Fig. 3&lt;/CaptionNumber&gt;
                          &lt;CaptionContent&gt;
                            &lt;SimplePara&gt;Axial 0.9-mm-thick CT images show examples from the perifissural nodule classification [
                              &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;]. 
                              &lt;Emphasis Type="Bold"&gt;a&lt;/Emphasis&gt; A 3-mm typical perifissural nodule (
                              &lt;Emphasis Type="Italic"&gt;arrow;&lt;/Emphasis&gt; fissure attached, homogenous, smooth margins and triangular shape) in an 8-year-old boy. 
                              &lt;Emphasis Type="Bold"&gt;b&lt;/Emphasis&gt; A 5-mm atypical perifissural nodule (
                              &lt;Emphasis Type="Italic"&gt;arrow;&lt;/Emphasis&gt; fissure attached, homogenous, smooth margins and convex on one side, rounded on the other) in an 11-year-old boy. 
                              &lt;Emphasis Type="Bold"&gt;c&lt;/Emphasis&gt; A 5-mm non–perifissural nodule (
                              &lt;Emphasis Type="Italic"&gt;arrow;&lt;/Emphasis&gt; fissure attached, inhomogenous, blurred margins and spherical shape) in a 12-year-old boy
                            &lt;/SimplePara&gt;
                          &lt;/CaptionContent&gt;
                        &lt;/Caption&gt;
                        &lt;MediaObject ID="MO3"&gt;
                          &lt;ImageObject Color="BlackWhite" FileRef="MediaObjects/247_2017_3946_Fig3_HTML.gif" Format="GIF" Rendition="HTML" Type="LinedrawHalftone"/&gt;
                        &lt;/MediaObject&gt;
                      &lt;/Figure&gt;
                    &lt;/Para&gt;
                  &lt;/Section2&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec8"&gt;
                  &lt;Heading&gt;Discussion&lt;/Heading&gt;
                  &lt;Para ID="Par21"&gt;The most important findings of this study are that small pulmonary nodules are common in otherwise healthy young children, but that they can be difficult to detect. Perifissural nodules and nodules without clearly benign characteristics do occur in otherwise young healthy children. These findings can be relevant as background information for managing young children with cancer.&lt;/Para&gt;
                  &lt;Para ID="Par22"&gt;A study by Alves et al. [
                    &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;], investigating children with pectus excavatum/carinatum, found a remarkable high nodule prevalence (75%), ranging up to 21 nodules per patient, despite excluding all nodules that resembled intrapulmonary lymph nodes. This may be related to the subtropical region that is endemic for tuberculosis, histoplasmosis and paracoccidioidomycosis. Meanwhile, a study by Renne et al. [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;] in a paediatric trauma setting reported a prevalence of 33%, ranging up to 4 nodules per patient. Our results reveal a nodule frequency (38%; 95% CI:26–49%) and range (up to 5 nodules per patient) consistent with Renne et al. [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;]. In the patients with nodules, the average nodule-per-patient rate (2.2) falls in between the rates of Alves et al. (3.4) [
                    &lt;CitationRef CitationID="CR12"&gt;12&lt;/CitationRef&gt;] and Renne et al. (1.5) [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;]. Hence, we confirm previous reports, suggesting that small pulmonary nodules on CT are indeed a common finding in young children without malignancy.
                  &lt;/Para&gt;
                  &lt;Para ID="Par23"&gt;Renne et al. [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;] found that multiple nodules (≥4 nodules) were present in a small subset (5%) of patients, which was also the case in our study (19%). Furthermore, with perifissural nodules a frequent finding in our cohort of children (66%, 39/59 nodules), it is clear that perifissural nodules are not solely limited to adults. In adults, the portion of perifissural nodules has been reported to be 23% to 28% [
                    &lt;CitationRef CitationID="CR14"&gt;14&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR16"&gt;16&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR17"&gt;17&lt;/CitationRef&gt;]. Whether perifissural nodules are indeed benign in adults or children who present with a malignancy has not been investigated to our knowledge.
                  &lt;/Para&gt;
                  &lt;Para ID="Par24"&gt;Our results show that, with a moderate (
                    &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.40) interobserver agreement on a per-lobe basis, it is difficult to detect small pulmonary nodules at chest CT. This corresponds to our experience in adults, although the literature on nodules &amp;lt;4&nbsp;mm is limited as nodules of this size are often regarded as benign in adults [
                    &lt;CitationRef CitationID="CR4"&gt;4&lt;/CitationRef&gt;]. Regarding detection, Scholten et al. [
                    &lt;CitationRef CitationID="CR18"&gt;18&lt;/CitationRef&gt;] reported an almost perfect (
                    &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.89–0.95) agreement for larger nodules (mean: 11.5, SD: 3.8&nbsp;mm), while Kilburn-Toppin et al. [
                    &lt;CitationRef CitationID="CR19"&gt;19&lt;/CitationRef&gt;] found moderate (
                    &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.42–0.50) agreement for smaller (mostly &amp;lt;4&nbsp;mm) nodules. Focusing on children with Wilms tumour, Wilimas et al. [
                    &lt;CitationRef CitationID="CR20"&gt;20&lt;/CitationRef&gt;] found substantial interobserver variability (
                    &lt;Emphasis Type="Italic"&gt;P&lt;/Emphasis&gt;&amp;lt;0.01) in nodule detection: Of the 78 cases, 41 were rated positive by only one reader, 18 by two readers and 19 by all three readers. Overall, this underscores the fact that detecting small pulmonary nodules on CT is challenging. We found substantial agreement (
                    &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.74) regarding agreement for size category. Little variability in size category is important because this 1-mm margin between a 2-mm and 3-mm lesion determines whether stage IV therapy is indicated in children with Wilms tumour [
                    &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;]. The low agreement on perifissural yes/no (
                    &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.36) indicates how difficult it is to classify such small nodules. As for calcification (
                    &lt;Emphasis Type="Italic"&gt;κ&lt;/Emphasis&gt;=0.46), the readers only disagreed on 2 of the 22 nodules. We found that the small sizes of the nodules (2–3&nbsp;mm) and only partially increased density made it difficult to differentiate between real calcification and artefact due to respiratory motion or beam hardening.
                  &lt;/Para&gt;
                  &lt;Para ID="Par25"&gt;Our study can have clinical implications for the assessment and management of pulmonary nodules on CT. We provided normative data that adds to our understanding of incidental nodules in otherwise healthy children. Normative data is important to be able to correctly judge the probability of pulmonary nodules being metastases in children presenting with a malignancy.&lt;/Para&gt;
                  &lt;Para ID="Par26"&gt;The prognostic significance of small pulmonary nodules on CT in children with Wilms tumour has been studied by comparing the treatment as localized disease vs. the treatment as metastatic disease on event-free survival and overall survival [
                    &lt;CitationRef CitationID="CR21"&gt;21&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR22"&gt;22&lt;/CitationRef&gt;]. In one study, more intense stage IV treatment showed no significant improvement of the 3-year event-free survival, while the other study showed a significant improvement of the 5-year event-free survival, which might suggest the nodules were metastases. Nevertheless, both studies found no significant improvement in overall survival, which may imply the dissolvement of small lesions by regular chemotherapeutic regimens, or a misinterpretation of benign nodules as metastases [
                    &lt;CitationRef CitationID="CR10"&gt;10&lt;/CitationRef&gt;]. This is important, as children diagnosed with Wilms tumour and metastasis-suspect lung nodules will receive more intense stage IV treatment, including doxorubicin with or without chest radiotherapy [
                    &lt;CitationRef CitationID="CR3"&gt;3&lt;/CitationRef&gt;]. Our study shows that multiple nodules (≥4 nodules), larger nodules and nodules without clear benign characteristics (non–calcified, non–perifissural nodules) also occur in children without malignancy. As a result, there may be a considerable risk of incorrect upstaging, unnecessarily subjecting children with Wilms tumour to the dangers of more intense therapies, such as doxorubicin-related cardiotoxicity or radiation-induced second malignancies [
                    &lt;CitationRef AdditionalCitationIDS="CR24" CitationID="CR23"&gt;23&lt;/CitationRef&gt;–
                    &lt;CitationRef CitationID="CR25"&gt;25&lt;/CitationRef&gt;]. Hence, we feel that further discussion is needed on whether additional testing or follow-up is warranted before initiating more intense treatment in children with Wilms tumours presenting with a few small pulmonary nodules.
                  &lt;/Para&gt;
                  &lt;Para ID="Par27"&gt;The uncertainty in diagnosis has to be stressed, as our study confirms substantial interobserver variability in detecting small pulmonary nodules and in individual interpretation of nodules. Great care has to be taken with managing patients in the setting of low validity tests. Further investigation of computer-aided detection as a first, concurrent or second reader may be worthwhile to increase detection rates,. Thus far, computer-aided detection in children has only proven to be helpful for nodules ≥4&nbsp;mm, but those systems are rapidly improving [
                    &lt;CitationRef CitationID="CR26"&gt;26&lt;/CitationRef&gt;].
                  &lt;/Para&gt;
                  &lt;Para ID="Par28"&gt;Some limitations of our study may be considered. First, our relatively small sample size may have impaired the precision and statistical certainty of our results. Still, the outcome for nodule frequency was comparable to that of previous literature [
                    &lt;CitationRef CitationID="CR11"&gt;11&lt;/CitationRef&gt;]. Second, we have to acknowledge that kappa calculation is difficult. Kappa calculation for nodule-based agreement was not possible because agreement on negative cases would have been zero. Therefore, we presented our data on a patient and lobe basis. Nevertheless, even lobe-based agreement does not necessarily mean that both observers found identical nodules in the concerning lobe. Third, unenhanced chest CT is standard for metastasis screening in children. We cannot exclude that contrast injection altered detection rates or size measurements in our study [
                    &lt;CitationRef CitationID="CR27"&gt;27&lt;/CitationRef&gt;]. Fourth, the relatively long sampling period might have introduced heterogeneity to the results. The significant increase in nodule number each year may be the result of newer equipment, e.g., new multi-detector CT scanners with improved spatial and temporal resolution and techniques. Another limitation of our retrospective cohort study is the lack of a gold standard. Follow-up or histological confirmation of these coincidentally found nodules is not feasible due to ethical and practical reasons [
                    &lt;CitationRef CitationID="CR28"&gt;28&lt;/CitationRef&gt;]. Although the probability of the nodules being malignant in our study is rather small [
                    &lt;CitationRef CitationID="CR29"&gt;29&lt;/CitationRef&gt;], it is not possible to rule out malignant disease. Lastly, we want to discuss potential bias in the selection of patients. Since the majority of patients were male, potential gender bias may be considered. Ethnic background was not determined in our study but may be relevant for further studies. Although some nodules might be related to recent infections or trauma, we don’t think this substantially influenced our results. There is no real evidence that the occurrence of small subcentrimetric nodules as found in our study may be an early result of chest trauma. Miller et al. [
                    &lt;CitationRef CitationID="CR30"&gt;30&lt;/CitationRef&gt;] noted that lacerations may appear as opacified nodules due to formed blood clots in the weeks after trauma. On the other hand, most scans in our study were made within an hour after the trauma. More frequently, the occurrence of patchy ground glass opacities surrounding contusions or cavitary lesions (traumatic pulmonary pseudocysts or post-traumatic pneumatocele) have been described [
                    &lt;CitationRef CitationID="CR31"&gt;31&lt;/CitationRef&gt;, 
                    &lt;CitationRef CitationID="CR32"&gt;32&lt;/CitationRef&gt;]. However, all patients with extensive posttraumatic changes have been excluded in our study.
                  &lt;/Para&gt;
                &lt;/Section1&gt;
                &lt;Section1 ID="Sec9"&gt;
                  &lt;Heading&gt;Conclusion&lt;/Heading&gt;
                  &lt;Para ID="Par29"&gt;Small pulmonary nodules are a frequent finding in otherwise healthy children undergoing chest CT in a trauma setting. However, we demonstrated that multiple larger nodules without clear benign characteristics also occur in children without malignancy, with moderate interobserver agreement in nodule detection of nodules. These findings can influence the discussion on how to manage young children with cancer.&lt;/Para&gt;
                &lt;/Section1&gt;
              &lt;/Body&gt;
              &lt;BodyRef FileRef="BodyRef/PDF/247_2017_Article_3946.pdf" TargetType="OnlinePDF"/&gt;
              &lt;ArticleBackmatter&gt;
                &lt;Ethics&gt;
                  &lt;Heading&gt;Compliance with ethical standards&lt;/Heading&gt;
                  &lt;FormalPara ID="FPar1" RenderingStyle="Style1"&gt;
                    &lt;Heading&gt;Conflicts of interest&lt;/Heading&gt;
                    &lt;Para ID="Par30"&gt;None&lt;/Para&gt;
                  &lt;/FormalPara&gt;
                &lt;/Ethics&gt;
                &lt;Bibliography ID="Bib1"&gt;
                  &lt;Heading&gt;References&lt;/Heading&gt;
                  &lt;Citation ID="CR1"&gt;
                    &lt;CitationNumber&gt;1.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Eggli&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Newman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1993&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Nodules, masses, and pseudomasses in the pediatric lung&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiol Clin N Am&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;31&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;651&lt;/FirstPage&gt;
                      &lt;LastPage&gt;666&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK3s3mvVyluw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;8497596&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Eggli KD, Newman B (1993) Nodules, masses, and pseudomasses in the pediatric lung. Radiol Clin N Am 31:651–666&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR2"&gt;
                    &lt;CitationNumber&gt;2.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Cohen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;RO&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kaschula&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1992&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Primary pulmonary tumors in childhood: a review of 31 years’ experience and the literature&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Pediatr Pulmonol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;222&lt;/FirstPage&gt;
                      &lt;LastPage&gt;232&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK3s7jtlOjsw%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1002/ppul.1950140405&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;1336597&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Cohen MC, Kaschula RO (1992) Primary pulmonary tumors in childhood: a review of 31 years’ experience and the literature. Pediatr Pulmonol 14:222–232&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR3"&gt;
                    &lt;CitationNumber&gt;3.&lt;/CitationNumber&gt;
                    &lt;BibUnstructured&gt;The International Society of Paediatric Oncology (SIOP) and Renal Tumor Study Group (RTSG) UMBRELLA (2016) Guidelines for standardized diagnostics, integrated research and standard therapy (Version 1.1 August 2016). 
                      &lt;ExternalRef&gt;
                        &lt;RefSource&gt;http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00011208&lt;/RefSource&gt;
                        &lt;RefTarget Address="http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00011208" TargetType="URL"/&gt;
                      &lt;/ExternalRef&gt;.
                    &lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR4"&gt;
                    &lt;CitationNumber&gt;4.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;MacMahon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JHM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Austin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;G&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gamsu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2005&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner society&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;237&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;395&lt;/FirstPage&gt;
                      &lt;LastPage&gt;400&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1148/radiol.2372041887&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16244247&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;MacMahon H, Austin JHM, Gamsu G et al (2005) Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner society. Radiology 237:395–400&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR5"&gt;
                    &lt;CitationNumber&gt;5.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MB&lt;/Initials&gt;
                        &lt;FamilyName&gt;McCarville&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lederman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;VM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Santana&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2006&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Distinguishing benign from malignant pulmonary nodules with helical chest CT in children with malignant solid tumors&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;239&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;514&lt;/FirstPage&gt;
                      &lt;LastPage&gt;520&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1148/radiol.2392050631&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16641356&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;McCarville MB, Lederman HM, Santana VM et al (2006) Distinguishing benign from malignant pulmonary nodules with helical chest CT in children with malignant solid tumors. Radiology 239:514–520&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR6"&gt;
                    &lt;CitationNumber&gt;6.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Silva&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Amaral&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;R&lt;/Initials&gt;
                        &lt;FamilyName&gt;Moineddin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;CT characteristics of lung nodules present at diagnosis of extrapulmonary malignancy in children&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;AJR Am J Roentgenol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;194&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;772&lt;/FirstPage&gt;
                      &lt;LastPage&gt;778&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2214/AJR.09.2490&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20173158&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Silva CT, Amaral JG, Moineddin R et al (2010) CT characteristics of lung nodules present at diagnosis of extrapulmonary malignancy in children. AJR Am J Roentgenol 194:772–778&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR7"&gt;
                    &lt;CitationNumber&gt;7.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Absalon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MB&lt;/Initials&gt;
                        &lt;FamilyName&gt;McCarville&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Liu&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2008&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft-tissue sarcoma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Pediatr Blood Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;50&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1147&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1153&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1002/pbc.21454&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;18300316&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Absalon MJ, McCarville MB, Liu T et al (2008) Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft-tissue sarcoma. Pediatr Blood Cancer 50:1147–1153&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR8"&gt;
                    &lt;CitationNumber&gt;8.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brader&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Abramson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Price&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Do characteristics of pulmonary nodules on computed tomography in children with known osteosarcoma help distinguish whether the nodules are malignant or benign?&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Pediatr Surg&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;46&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;729&lt;/FirstPage&gt;
                      &lt;LastPage&gt;735&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.jpedsurg.2010.11.027&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21496545&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4443702&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Brader P, Abramson SJ, Price AP et al (2011) Do characteristics of pulmonary nodules on computed tomography in children with known osteosarcoma help distinguish whether the nodules are malignant or benign? J Pediatr Surg 46:729–735&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR9"&gt;
                    &lt;CitationNumber&gt;9.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grampp&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bankier&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zoubek&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2000&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Spiral CT of the lung in children with malignant extra-thoracic tumors: distribution of benign vs malignant pulmonary nodules&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;10&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1318&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1322&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3M%2Flt1Shug%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s003300000359&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;10939499&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Grampp S, Bankier AA, Zoubek A et al (2000) Spiral CT of the lung in children with malignant extra-thoracic tumors: distribution of benign vs malignant pulmonary nodules. Eur Radiol 10:1318–1322&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR10"&gt;
                    &lt;CitationNumber&gt;10.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ØE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Olsen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Why measure tumours?&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Pediatr Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;45&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;35&lt;/FirstPage&gt;
                      &lt;LastPage&gt;41&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00247-014-3148-0&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25552390&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;4281379&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Olsen ØE (2015) Why measure tumours? Pediatr Radiol 45:35–41&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR11"&gt;
                    &lt;CitationNumber&gt;11.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;J&lt;/Initials&gt;
                        &lt;FamilyName&gt;Renne&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Linderkamp&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wacker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Prevalence and configuration of pulmonary nodules on multi-row CT in children without malignant diseases&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;25&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2651&lt;/FirstPage&gt;
                      &lt;LastPage&gt;2656&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00330-015-3675-6&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25735514&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Renne J, Linderkamp C, Wacker F et al (2015) Prevalence and configuration of pulmonary nodules on multi-row CT in children without malignant diseases. Eur Radiol 25:2651–2656&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR12"&gt;
                    &lt;CitationNumber&gt;12.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Alves&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;E&lt;/Initials&gt;
                        &lt;FamilyName&gt;Marchiori&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;KL&lt;/Initials&gt;
                        &lt;FamilyName&gt;Irion&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Mediastinal lymph nodes and pulmonary nodules in children: MDCT findings in a cohort of healthy subjects&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;AJR Am J Roentgenol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;204&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;35&lt;/FirstPage&gt;
                      &lt;LastPage&gt;37&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2214/AJR.14.12773&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25539235&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Alves GR, Marchiori E, Irion KL et al (2015) Mediastinal lymph nodes and pulmonary nodules in children: MDCT findings in a cohort of healthy subjects. AJR Am J Roentgenol 204:35–37&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR13"&gt;
                    &lt;CitationNumber&gt;13.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;N&lt;/Initials&gt;
                        &lt;FamilyName&gt;Breslow&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Olshan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JB&lt;/Initials&gt;
                        &lt;FamilyName&gt;Beckwith&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Green&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1993&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Epidemiology of Wilms tumor&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Med Pediatr Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;21&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;172&lt;/FirstPage&gt;
                      &lt;LastPage&gt;181&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK3s7ovVOltA%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1002/mpo.2950210305&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;7680412&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Breslow N, Olshan A, Beckwith JB, Green DM (1993) Epidemiology of Wilms tumor. Med Pediatr Oncol 21:172–181&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR14"&gt;
                    &lt;CitationNumber&gt;14.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Hoop&lt;/FamilyName&gt;
                        &lt;Particle&gt;de&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ginneken&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gietema&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Prokop&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;265&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;611&lt;/FirstPage&gt;
                      &lt;LastPage&gt;616&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1148/radiol.12112351&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22929331&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;de Hoop B, van Ginneken B, Gietema H, Prokop M (2012) Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. Radiology 265:611–616&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR15"&gt;
                    &lt;CitationNumber&gt;15.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Landis&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;GG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Koch&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;1977&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The measurement of observer agreement for categorical data&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Biometrics&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;33&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;159&lt;/FirstPage&gt;
                      &lt;LastPage&gt;174&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaE2s7jsFWqtA%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2307/2529310&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;843571&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR16"&gt;
                    &lt;CitationNumber&gt;16.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MI&lt;/Initials&gt;
                        &lt;FamilyName&gt;Ahn&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;TG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gleeson&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;IH&lt;/Initials&gt;
                        &lt;FamilyName&gt;Chan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2010&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Perifissural nodules seen at CT screening for lung cancer&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiology&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;254&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;949&lt;/FirstPage&gt;
                      &lt;LastPage&gt;956&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1148/radiol.09090031&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;20177105&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Ahn MI, Gleeson TG, Chan IH et al (2010) Perifissural nodules seen at CT screening for lung cancer. Radiology 254:949–956&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR17"&gt;
                    &lt;CitationNumber&gt;17.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;McWilliams&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tammemagi&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mayo&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Probability of cancer in pulmonary nodules detected on first screening CT&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;N Engl J Med&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;369&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;910&lt;/FirstPage&gt;
                      &lt;LastPage&gt;919&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:CAS:528:DC%2BC3sXhsVegsbzE&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1056/NEJMoa1214726&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;24004118&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3951177&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;McWilliams A, Tammemagi MC, Mayo JR et al (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 369:910–919&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR18"&gt;
                    &lt;CitationNumber&gt;18.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;ET&lt;/Initials&gt;
                        &lt;FamilyName&gt;Scholten&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WP&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mali&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Prokop&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Non-solid lung nodules on low-dose computed tomography: comparison of detection rate between 3 visualization techniques&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Cancer Imaging&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;13&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;150&lt;/FirstPage&gt;
                      &lt;LastPage&gt;154&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1102/1470-7330.2013.0016&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23598304&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Scholten ET, Mali WP, Prokop M et al (2013) Non-solid lung nodules on low-dose computed tomography: comparison of detection rate between 3 visualization techniques. Cancer Imaging 13:150–154&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR19"&gt;
                    &lt;CitationNumber&gt;19.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;F&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kilburn-Toppin&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;OJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Arthurs&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AD&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tasker&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Set&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2013&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Detection of pulmonary nodules at paediatric CT: maximum intensity projections and axial source images are complementary&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Pediatr Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;43&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;820&lt;/FirstPage&gt;
                      &lt;LastPage&gt;826&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00247-012-2597-6&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;23344916&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kilburn-Toppin F, Arthurs OJ, Tasker AD, Set PA (2013) Detection of pulmonary nodules at paediatric CT: maximum intensity projections and axial source images are complementary. Pediatr Radiol 43:820–826&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR20"&gt;
                    &lt;CitationNumber&gt;20.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wilimas&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kaste&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;WM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kauffman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;1997&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Use of chest computed tomography in the staging of pediatric Wilms’ tumor: Interobserver variability and prognostic significance&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;15&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;2631&lt;/FirstPage&gt;
                      &lt;LastPage&gt;2635&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK2szlvVOgug%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.1997.15.7.2631&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;9215834&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Wilimas JA, Kaste SC, Kauffman WM et al (1997) Use of chest computed tomography in the staging of pediatric Wilms’ tumor: Interobserver variability and prognostic significance. J Clin Oncol 15:2631–2635&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR21"&gt;
                    &lt;CitationNumber&gt;21.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Smets&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;H&lt;/Initials&gt;
                        &lt;FamilyName&gt;Tinteren&lt;/FamilyName&gt;
                        &lt;Particle&gt;van&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Bergeron&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The contribution of chest CT-scan at diagnosis in children with unilateral Wilms’ tumour. Results of the SIOP 2001 study&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur J Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;48&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1060&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1065&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.ejca.2011.05.025&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;21703848&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Smets AM, van Tinteren H, Bergeron C et al (2012) The contribution of chest CT-scan at diagnosis in children with unilateral Wilms’ tumour. Results of the SIOP 2001 study. Eur J Cancer 48:1060–1065&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR22"&gt;
                    &lt;CitationNumber&gt;22.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grundy&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Green&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Dirks&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Clinical significance of pulmonary nodules detected by CT and not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and 5: a report from the Children’s Oncology Group&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Pediatr Blood Cancer&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;59&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;631&lt;/FirstPage&gt;
                      &lt;LastPage&gt;635&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1002/pbc.24123&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22422736&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3397278&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Grundy PE, Green DM, Dirks AC et al (2012) Clinical significance of pulmonary nodules detected by CT and not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and 5: a report from the Children’s Oncology Group. Pediatr Blood Cancer 59:631–635&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR23"&gt;
                    &lt;CitationNumber&gt;23.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;DM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Green&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;YA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Grigoriev&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B&lt;/Initials&gt;
                        &lt;FamilyName&gt;Nan&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2001&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Congestive heart failure after treatment for Wilms’ tumor: a report from the National Wilms’ tumor study group&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;19&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1926&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1934&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3M3js1ylsg%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.2001.19.7.1926&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;11283124&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Green DM, Grigoriev YA, Nan B et al (2001) Congestive heart failure after treatment for Wilms’ tumor: a report from the National Wilms’ tumor study group. J Clin Oncol 19:1926–1934&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR24"&gt;
                    &lt;CitationNumber&gt;24.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;NE&lt;/Initials&gt;
                        &lt;FamilyName&gt;Breslow&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JR&lt;/Initials&gt;
                        &lt;FamilyName&gt;Takashima&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Whitton&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;1995&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Second malignant neoplasms following treatment for Wilm’s tumor: a report from the National Wilms’ tumor study group&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;J Clin Oncol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;13&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1851&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1859&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DyaK2MzmtlCltQ%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1200/JCO.1995.13.8.1851&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;7636528&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Breslow NE, Takashima JR, Whitton JA et al (1995) Second malignant neoplasms following treatment for Wilm’s tumor: a report from the National Wilms’ tumor study group. J Clin Oncol 13:1851–1859&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR25"&gt;
                    &lt;CitationNumber&gt;25.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Paulino&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;B-C&lt;/Initials&gt;
                        &lt;FamilyName&gt;Wen&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CK&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brown&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2000&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Late effects in children treated with radiation therapy for Wilms’ tumor&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Int J Radiat Oncol Biol Phys&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;46&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1239&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1246&lt;/LastPage&gt;
                      &lt;Occurrence Type="COI"&gt;
                        &lt;Handle&gt;1:STN:280:DC%2BD3c7ptFOktg%3D%3D&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/S0360-3016(99)00534-9&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;10725637&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Paulino AC, Wen B-C, Brown CK et al (2000) Late effects in children treated with radiation therapy for Wilms’ tumor. Int J Radiat Oncol Biol Phys 46:1239–1246&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR26"&gt;
                    &lt;CitationNumber&gt;26.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;EJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Helm&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;CT&lt;/Initials&gt;
                        &lt;FamilyName&gt;Silva&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HC&lt;/Initials&gt;
                        &lt;FamilyName&gt;Roberts&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2009&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Computer-aided detection for the identification of pulmonary nodules in pediatric oncology patients: initial experience&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Pediatr Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;39&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;685&lt;/FirstPage&gt;
                      &lt;LastPage&gt;693&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00247-009-1259-9&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;19418048&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Helm EJ, Silva CT, Roberts HC et al (2009) Computer-aided detection for the identification of pulmonary nodules in pediatric oncology patients: initial experience. Pediatr Radiol 39:685–693&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR27"&gt;
                    &lt;CitationNumber&gt;27.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;PA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Jong&lt;/FamilyName&gt;
                        &lt;Particle&gt;de&lt;/Particle&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;T&lt;/Initials&gt;
                        &lt;FamilyName&gt;Leiner&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JW&lt;/Initials&gt;
                        &lt;FamilyName&gt;Lammers&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;HA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Gietema&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Can low-dose unenhanced chest CT be used for follow-up of lung nodules?&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;AJR Am J Roentgenol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;199&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;777&lt;/FirstPage&gt;
                      &lt;LastPage&gt;780&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.2214/AJR.11.7577&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22997367&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;de Jong PA, Leiner T, Lammers JW, Gietema HA (2012) Can low-dose unenhanced chest CT be used for follow-up of lung nodules? AJR Am J Roentgenol 199:777–780&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR28"&gt;
                    &lt;CitationNumber&gt;28.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;M&lt;/Initials&gt;
                        &lt;FamilyName&gt;Montaudon&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;V&lt;/Initials&gt;
                        &lt;FamilyName&gt;Latrabe&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Pariente&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2004&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Factors influencing accuracy of CT-guided percutaneous biopsies of pulmonary lesions&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Eur Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;14&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;1234&lt;/FirstPage&gt;
                      &lt;LastPage&gt;1240&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00330-004-2250-3&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;14963689&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Montaudon M, Latrabe V, Pariente A et al (2004) Factors influencing accuracy of CT-guided percutaneous biopsies of pulmonary lesions. Eur Radiol 14:1234–1240&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR29"&gt;
                    &lt;CitationNumber&gt;29.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SJ&lt;/Initials&gt;
                        &lt;FamilyName&gt;Westra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;AS&lt;/Initials&gt;
                        &lt;FamilyName&gt;Brody&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;MG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Mahani&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Etal/&gt;
                      &lt;Year&gt;2015&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;The incidental pulmonary nodule in a child: part 1: recommendations from the SPR thoracic imaging committee regarding characterization, significance and follow-up&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Pediatr Radiol&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;45&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;628&lt;/FirstPage&gt;
                      &lt;LastPage&gt;633&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s00247-014-3267-7&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;25655369&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Westra SJ, Brody AS, Mahani MG et al (2015) The incidental pulmonary nodule in a child: part 1: recommendations from the SPR thoracic imaging committee regarding characterization, significance and follow-up. Pediatr Radiol 45:628–633&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR30"&gt;
                    &lt;CitationNumber&gt;30.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;LA&lt;/Initials&gt;
                        &lt;FamilyName&gt;Miller&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2006&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Chest wall, lung, and pleural space trauma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Radiol Clin N Am&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;44&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;213&lt;/FirstPage&gt;
                      &lt;LastPage&gt;224&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1016/j.rcl.2005.10.006&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;16500204&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;BibComments&gt;viii&lt;/BibComments&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Miller LA (2006) Chest wall, lung, and pleural space trauma. Radiol Clin N Am 44:213–224 viii&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR31"&gt;
                    &lt;CitationNumber&gt;31.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;A&lt;/Initials&gt;
                        &lt;FamilyName&gt;Oikonomou&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;P&lt;/Initials&gt;
                        &lt;FamilyName&gt;Prassopoulos&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2011&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;CT imaging of blunt chest trauma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Insights Imaging&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;2&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;281&lt;/FirstPage&gt;
                      &lt;LastPage&gt;295&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1007/s13244-011-0072-9&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PID"&gt;
                        &lt;Handle&gt;22347953&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                      &lt;Occurrence Type="PMCID"&gt;
                        &lt;Handle&gt;3259405&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Oikonomou A, Prassopoulos P (2011) CT imaging of blunt chest trauma. Insights Imaging 2:281–295&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                  &lt;Citation ID="CR32"&gt;
                    &lt;CitationNumber&gt;32.&lt;/CitationNumber&gt;
                    &lt;BibArticle&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;SEM&lt;/Initials&gt;
                        &lt;FamilyName&gt;Kolderman&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;S&lt;/Initials&gt;
                        &lt;FamilyName&gt;Fahrenholz&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;BibAuthorName&gt;
                        &lt;Initials&gt;JG&lt;/Initials&gt;
                        &lt;FamilyName&gt;Zijlstra&lt;/FamilyName&gt;
                      &lt;/BibAuthorName&gt;
                      &lt;Year&gt;2012&lt;/Year&gt;
                      &lt;ArticleTitle Language="En"&gt;Pulmonary cavities after high energy trauma&lt;/ArticleTitle&gt;
                      &lt;JournalTitle&gt;Neth J Crit Care&lt;/JournalTitle&gt;
                      &lt;VolumeID&gt;16&lt;/VolumeID&gt;
                      &lt;FirstPage&gt;226&lt;/FirstPage&gt;
                      &lt;LastPage&gt;228&lt;/LastPage&gt;
                      &lt;Occurrence Type="DOI"&gt;
                        &lt;Handle&gt;10.1186/CC11219&lt;/Handle&gt;
                      &lt;/Occurrence&gt;
                    &lt;/BibArticle&gt;
                    &lt;BibUnstructured&gt;Kolderman SEM, Fahrenholz S, Zijlstra JG (2012) Pulmonary cavities after high energy trauma. Neth J Crit Care 16:226–228&lt;/BibUnstructured&gt;
                  &lt;/Citation&gt;
                &lt;/Bibliography&gt;
              &lt;/ArticleBackmatter&gt;
            &lt;/Article&gt;
          &lt;/Issue&gt;
        &lt;/Volume&gt;
      &lt;/Journal&gt;
      &lt;meta:Info xmlns:meta="http://www.springer.com/app/meta"&gt;
        &lt;meta:DateLoaded&gt;2017-11-18T15:36:39.167234+01:00&lt;/meta:DateLoaded&gt;
        &lt;meta:Authors&gt;
          &lt;meta:Author&gt;Samim, Atia&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Littooij, Annemieke S.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Heuvel-Eibrink, Marry M.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Wessels, Frank J.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Nievelstein, Rutger A. J.&lt;/meta:Author&gt;
          &lt;meta:Author&gt;Jong, Pim A.&lt;/meta:Author&gt;
        &lt;/meta:Authors&gt;
        &lt;meta:Institutions&gt;
          &lt;meta:Institution geo="5.122748,52.091262,0"&gt;
            &lt;meta:OrgName&gt;University Medical Centre Utrecht/Wilhelmina Children’s Hospital&lt;/meta:OrgName&gt;
            &lt;meta:GeoOrg type="code"&gt;5.122748,52.091262,0#University Medical Centre Utrecht/Wilhelmina Children’s Hospital&lt;/meta:GeoOrg&gt;
            &lt;meta:Country/&gt;&lt;/meta:Institution&gt;
          &lt;meta:Institution&gt;
            &lt;meta:OrgName&gt;Princess Máxima Centre for Pediatric Oncology&lt;/meta:OrgName&gt;
          &lt;/meta:Institution&gt;
        &lt;/meta:Institutions&gt;
        &lt;meta:Date&gt;2017-12-01&lt;/meta:Date&gt;
        &lt;meta:DateDelivered&gt;2017-11-18T06:07:54&lt;/meta:DateDelivered&gt;
        &lt;meta:Type&gt;Article&lt;/meta:Type&gt;
        &lt;meta:DOI&gt;10.1007/s00247-017-3946-2&lt;/meta:DOI&gt;
        &lt;meta:Title&gt;Frequency and characteristics of pulmonary nodules in children at computed tomography&lt;/meta:Title&gt;
        &lt;meta:ISXN&gt;1432-1998&lt;/meta:ISXN&gt;
        &lt;meta:PubName&gt;Springer&lt;/meta:PubName&gt;
        &lt;meta:Journal&gt;Pediatric Radiology&lt;/meta:Journal&gt;
        &lt;meta:Publication&gt;Pediatric Radiology&lt;/meta:Publication&gt;
        &lt;meta:PublicationType&gt;Journal&lt;/meta:PublicationType&gt;
        &lt;meta:SubjectGroup&gt;
          &lt;meta:Subject Code="SCH" Type="Primary"&gt;Medicine &amp;amp; Public Health&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH29005" Priority="1" Type="Secondary"&gt;Imaging / Radiology&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH49006" Priority="2" Type="Secondary"&gt;Pediatrics&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH2903X" Priority="3" Type="Secondary"&gt;Neuroradiology&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH29048" Priority="4" Type="Secondary"&gt;Nuclear Medicine&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH29064" Priority="5" Type="Secondary"&gt;Ultrasound&lt;/meta:Subject&gt;
          &lt;meta:Subject Code="SCH33160" Priority="6" Type="Secondary"&gt;Oncology&lt;/meta:Subject&gt;
        &lt;/meta:SubjectGroup&gt;
        &lt;meta:VolumeId&gt;47&lt;/meta:VolumeId&gt;
        &lt;meta:IssueId&gt;13&lt;/meta:IssueId&gt;
        &lt;meta:ArticleSequenceNumber&gt;8&lt;/meta:ArticleSequenceNumber&gt;
      &lt;/meta:Info&gt;
    &lt;/Publisher&gt;
  &lt;/records&gt;
  &lt;facets&gt;
    &lt;facet name="subject"&gt;
      &lt;facet-value count="1311"&gt;Medicine &amp;amp; Public Health&lt;/facet-value&gt;
      &lt;facet-value count="843"&gt;Oncology&lt;/facet-value&gt;
      &lt;facet-value count="753"&gt;Biomedicine&lt;/facet-value&gt;
      &lt;facet-value count="705"&gt;Cancer Research&lt;/facet-value&gt;
      &lt;facet-value count="478"&gt;Medicine/Public Health, general&lt;/facet-value&gt;
      &lt;facet-value count="410"&gt;Surgical Oncology&lt;/facet-value&gt;
      &lt;facet-value count="293"&gt;Pneumology/Respiratory System&lt;/facet-value&gt;
      &lt;facet-value count="282"&gt;Health Promotion and Disease Prevention&lt;/facet-value&gt;
      &lt;facet-value count="281"&gt;Biomedicine general&lt;/facet-value&gt;
      &lt;facet-value count="221"&gt;Internal Medicine&lt;/facet-value&gt;
      &lt;facet-value count="185"&gt;Biomedicine, general&lt;/facet-value&gt;
      &lt;facet-value count="150"&gt;Radiotherapy&lt;/facet-value&gt;
      &lt;facet-value count="148"&gt;Imaging / Radiology&lt;/facet-value&gt;
      &lt;facet-value count="132"&gt;Intensive / Critical Care Medicine&lt;/facet-value&gt;
      &lt;facet-value count="119"&gt;Pharmacology/Toxicology&lt;/facet-value&gt;
      &lt;facet-value count="115"&gt;Thoracic Surgery&lt;/facet-value&gt;
      &lt;facet-value count="114"&gt;Public Health&lt;/facet-value&gt;
      &lt;facet-value count="102"&gt;Life Sciences&lt;/facet-value&gt;
      &lt;facet-value count="95"&gt;Cell Biology&lt;/facet-value&gt;
      &lt;facet-value count="88"&gt;Pathology&lt;/facet-value&gt;
    &lt;/facet&gt;
    &lt;facet name="pub"&gt;
      &lt;facet-value count="297"&gt;BMC Cancer&lt;/facet-value&gt;
      &lt;facet-value count="140"&gt;Radiation Oncology&lt;/facet-value&gt;
      &lt;facet-value count="136"&gt;Respiratory Research&lt;/facet-value&gt;
      &lt;facet-value count="108"&gt;World Journal of Surgical Oncology&lt;/facet-value&gt;
      &lt;facet-value count="75"&gt;BMC Pulmonary Medicine&lt;/facet-value&gt;
      &lt;facet-value count="75"&gt;Molecular Cancer&lt;/facet-value&gt;
      &lt;facet-value count="73"&gt;Journal of Cardiothoracic Surgery&lt;/facet-value&gt;
      &lt;facet-value count="59"&gt;Journal of Experimental &amp;amp; Clinical Cancer Research&lt;/facet-value&gt;
      &lt;facet-value count="54"&gt;Journal of Translational Medicine&lt;/facet-value&gt;
      &lt;facet-value count="51"&gt;Diagnostic Pathology&lt;/facet-value&gt;
      &lt;facet-value count="40"&gt;Cancer Cell International&lt;/facet-value&gt;
      &lt;facet-value count="38"&gt;SpringerPlus&lt;/facet-value&gt;
      &lt;facet-value count="32"&gt;Particle and Fibre Toxicology&lt;/facet-value&gt;
      &lt;facet-value count="31"&gt;Multidisciplinary Respiratory Medicine&lt;/facet-value&gt;
      &lt;facet-value count="30"&gt;Journal of Medical Case Reports&lt;/facet-value&gt;
      &lt;facet-value count="28"&gt;BMC Research Notes&lt;/facet-value&gt;
      &lt;facet-value count="28"&gt;Chinese Journal of Cancer&lt;/facet-value&gt;
      &lt;facet-value count="25"&gt;Cancer Chemotherapy and Pharmacology&lt;/facet-value&gt;
      &lt;facet-value count="22"&gt;BMC Complementary and Alternative Medicine&lt;/facet-value&gt;
      &lt;facet-value count="19"&gt;Surgical Case Reports&lt;/facet-value&gt;
    &lt;/facet&gt;
    &lt;facet name="year"&gt;
      &lt;facet-value count="407"&gt;2017&lt;/facet-value&gt;
      &lt;facet-value count="412"&gt;2016&lt;/facet-value&gt;
      &lt;facet-value count="371"&gt;2015&lt;/facet-value&gt;
      &lt;facet-value count="382"&gt;2014&lt;/facet-value&gt;
      &lt;facet-value count="306"&gt;2013&lt;/facet-value&gt;
      &lt;facet-value count="208"&gt;2012&lt;/facet-value&gt;
      &lt;facet-value count="83"&gt;2011&lt;/facet-value&gt;
      &lt;facet-value count="18"&gt;2010&lt;/facet-value&gt;
      &lt;facet-value count="11"&gt;2009&lt;/facet-value&gt;
      &lt;facet-value count="9"&gt;2008&lt;/facet-value&gt;
      &lt;facet-value count="7"&gt;2007&lt;/facet-value&gt;
      &lt;facet-value count="2"&gt;2006&lt;/facet-value&gt;
      &lt;facet-value count="15"&gt;2005&lt;/facet-value&gt;
      &lt;facet-value count="5"&gt;2004&lt;/facet-value&gt;
      &lt;facet-value count="10"&gt;2003&lt;/facet-value&gt;
      &lt;facet-value count="4"&gt;2002&lt;/facet-value&gt;
      &lt;facet-value count="4"&gt;2001&lt;/facet-value&gt;
      &lt;facet-value count="4"&gt;2000&lt;/facet-value&gt;
    &lt;/facet&gt;
    &lt;facet name="type"&gt;
      &lt;facet-value count="2257"&gt;Journal&lt;/facet-value&gt;
      &lt;facet-value count="1"&gt;Book&lt;/facet-value&gt;
    &lt;/facet&gt;
    &lt;facet name="country"&gt;
      &lt;facet-value count="528"&gt;United States&lt;/facet-value&gt;
      &lt;facet-value count="465"&gt;China&lt;/facet-value&gt;
      &lt;facet-value count="299"&gt;Japan&lt;/facet-value&gt;
      &lt;facet-value count="244"/&gt;
      &lt;facet-value count="180"&gt;Germany&lt;/facet-value&gt;
      &lt;facet-value count="126"&gt;United Kingdom&lt;/facet-value&gt;
      &lt;facet-value count="113"&gt;Italy&lt;/facet-value&gt;
      &lt;facet-value count="107"&gt;South Korea&lt;/facet-value&gt;
      &lt;facet-value count="93"&gt;Canada&lt;/facet-value&gt;
      &lt;facet-value count="78"&gt;France&lt;/facet-value&gt;
      &lt;facet-value count="65"&gt;Taiwan&lt;/facet-value&gt;
      &lt;facet-value count="60"&gt;Australia&lt;/facet-value&gt;
      &lt;facet-value count="55"&gt;Spain&lt;/facet-value&gt;
      &lt;facet-value count="45"&gt;Poland&lt;/facet-value&gt;
      &lt;facet-value count="45"&gt;Switzerland&lt;/facet-value&gt;
      &lt;facet-value count="34"&gt;Denmark&lt;/facet-value&gt;
      &lt;facet-value count="34"&gt;Sweden&lt;/facet-value&gt;
      &lt;facet-value count="32"&gt;Belgium&lt;/facet-value&gt;
      &lt;facet-value count="29"&gt;Greece&lt;/facet-value&gt;
      &lt;facet-value count="26"&gt;Austria&lt;/facet-value&gt;
    &lt;/facet&gt;
    &lt;facet name="keyword"&gt;
      &lt;facet-value count="702"&gt;Lung cancer&lt;/facet-value&gt;
      &lt;facet-value count="309"&gt;Non-small cell lung cancer&lt;/facet-value&gt;
      &lt;facet-value count="154"&gt;Lung&lt;/facet-value&gt;
      &lt;facet-value count="86"&gt;Lung adenocarcinoma&lt;/facet-value&gt;
      &lt;facet-value count="81"&gt;Prognosis&lt;/facet-value&gt;
      &lt;facet-value count="64"&gt;Non-small-cell lung cancer&lt;/facet-value&gt;
      &lt;facet-value count="47"&gt;Chemotherapy&lt;/facet-value&gt;
      &lt;facet-value count="46"&gt;Apoptosis&lt;/facet-value&gt;
      &lt;facet-value count="46"&gt;Metastasis&lt;/facet-value&gt;
      &lt;facet-value count="44"&gt;Meta-analysis&lt;/facet-value&gt;
      &lt;facet-value count="42"&gt;Survival&lt;/facet-value&gt;
      &lt;facet-value count="41"&gt;Biomarker&lt;/facet-value&gt;
      &lt;facet-value count="41"&gt;Interstitial lung disease&lt;/facet-value&gt;
      &lt;facet-value count="40"&gt;Inflammation&lt;/facet-value&gt;
      &lt;facet-value count="38"&gt;Acute lung injury&lt;/facet-value&gt;
      &lt;facet-value count="38"&gt;Lung function&lt;/facet-value&gt;
      &lt;facet-value count="38"&gt;Surgery&lt;/facet-value&gt;
      &lt;facet-value count="33"&gt;Adenocarcinoma&lt;/facet-value&gt;
      &lt;facet-value count="33"&gt;EGFR&lt;/facet-value&gt;
      &lt;facet-value count="33"&gt;Immunohistochemistry&lt;/facet-value&gt;
    &lt;/facet&gt;
  &lt;/facets&gt;
&lt;/response&gt;
</pre></div>        <h4>Response Code</h4>       <div class="block response_code"><pre>200</pre></div>        <h4>Response Headers</h4>       <div class="block response_headers"><pre class="prettyprint">date: Tue, 05 Dec 2017 04:10:47 GMT
content-encoding: gzip
server: openresty/1.11.2.5
x-aspnet-version: 4.0.30319
x-powered-by: ASP.NET
transfer-encoding: chunked
content-type: text/xml; charset=utf-8
access-control-allow-origin: *
cache-control: private
access-control-allow-credentials: true
connection: keep-alive
servernumber: 19
</pre></div>      </div>   </div> </li></ul> </li></ul> </li><li class="resource" id="resource_Integro">   <div class="apidocs-heading operation-heading">     <h2>       <a data-name="Integro" href="https://dev.springer.com/documentation#/Integro">Springer Integro API</a>     </h2>   </div>   <ul class="endpoints" id="Integro_endpoint_list" style=""><li class="endpoint">   <ul class="operations" id="Integro_endpoint_operations"><li class="get operation" data-operation-id="12">   <div class="apidocs-heading" style="background-color:#BABBAD">     <div class="apidocs-bubble">       <div class="action">         <a class="toggle">Springer Integro Service</a>       </div>     </div>     <div class="path-and-method">       <span class="path"><a>/{journalId}</a></span>       <span class="http_method"><a>GET</a></span>     </div>     <ul class="options" style="display:none">       <li>         <a>/{journalId}</a>       </li>     </ul>   </div>   <div class="content" data-operation-id="12" style="display:none">          <h4>Description</h4>     <p></p><p>Provides journal-level metadata for Springer Journals (using JournalID, which can be found in the Web address of Journal pages on SpringerLink; see http://link.springer.com/search?facet-content-type=%22Journal%22).</p><p></p>               <form accept-charset="UTF-8" data-method="GET" data-host="http://integro.nkb3.org/v1/journaltitlesheet" data-path="/{journalId}" action="https://dev.springer.com/documentation#" class="sandbox" method="post">       <div style="margin:0;padding:0;display:inline"></div>       <table class="fullwidth">         <thead>           <tr>             <th>Parameter</th>             <th>Value</th>             <th>Description</th>           </tr>         </thead>         <tbody id="Integro_12_GET_params"><tr class="zebra">   <td class="">api_key</td>   <td>     <input data-threescale-name="user_keys" data-guid="13" data-param-type="query" minlength="0" name="api_key" data-original-name="api_key" type="text" value="">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Your API access key     </div>   </td> </tr><tr class="zebra">   <td class="">journalId</td>   <td>     <input data-guid="14" data-param-type="path" minlength="0" name="journalId" data-original-name="journalId" type="text" value="">       <div class="apidocs-description">                </div>   </td>   <td>     <div class="apidocs-description">       Journal Id      </div>   </td> </tr></tbody>       </table>       <div class="submit-bar">                    <button class="submit" name="commit" type="button">           <span>Send Request</span>         </button>                  <a href="https://dev.springer.com/documentation#" data-guid="12" class="hide-response" style="display:none;">HIDE RESPONSE</a>       </div>     </form>     <div class="response" data-guid="12" style="display:none">        <h4 class="request_heading">Request</h4>       <div class="block request_url"><pre class="prettyprint"></pre></div>        <h4 class="response_body_heading">Response Body</h4>       <div class="block response_body"><pre class="prettyprint"></pre></div>        <h4>Response Code</h4>       <div class="block response_code"><pre></pre></div>        <h4>Response Headers</h4>       <div class="block response_headers"><pre class="prettyprint"></pre></div>      </div>   </div> </li></ul> </li></ul> </li></ul>
</div>
<div class="apidocs-param-tips apidocs-signin-message" style="display:none;">
  <p><a href="https://dev.springer.com/documentation#">Sign in</a> to your account for quick access to useful values.</p>
</div>
<div class="apidocs-param-tips apidocs-nothere-message" style="display:none;">
  <p>
  Please view ActiveDocs from your API Admin Portal <br>
  <strong>OR</strong> <br>
  <a class="big-button" href="http://www.3scale.net/"><small>CREATE YOUR</small> <br> Free Account</a>
  </p>
</div><div class="apidocs-param-tips app_keys" style="display:none;">     <p class="apidocs-tip-description">First application key from the latest five applications</p>     <ul>            </ul> </div><div class="apidocs-param-tips app_ids" style="display:none;">     <p class="apidocs-tip-description">Latest 5 applications (across all accounts and services)</p>     <ul>            </ul> </div><div class="apidocs-param-tips user_keys" style="top: 272px; left: 305px; display: none;">     <p class="apidocs-tip-description">First user key from latest 5 applications</p>     <ul>              <li data-value="b9ab99a51faec6511d70c08f878cfc61"><strong>Student's App - Basic Springer APIs</strong> <span>b9ab99a51faec6511d70c08f878cfc61</span></li>            </ul> </div><div class="apidocs-param-tips client_ids" style="display:none;">     <p class="apidocs-tip-description"></p>     <ul>            </ul> </div><div class="apidocs-param-tips client_secrets" style="display:none;">     <p class="apidocs-tip-description"></p>     <ul>            </ul> </div></div>
<script>
  $(function(){
    

     ThreeScale.APIDocs.init([]);
  });
</script>


<section style="width: 15%;margin-left:80px;float:left;">
<a href="http://dev.springer.com/privacypolicy" target="blank">Privacy Policy</a> 
  </section>

          </div>
        </div>
      
    </main>

    <footer role="contentinfo">
      <div class="container">
        <ul class="list-inline pull-right">
          <li>© 2017 Springer,</li>
          <li><a class="powered-by" href="http://3scale.net/">Powered by 3scale</a></li>
        </ul>
      </div>
    </footer>

    <!-- JS and analytics only. -->
    <script src="./Springer API_files/bootstrap.min.js"></script>
    

  

<div id="cboxOverlay" style="display: none;"></div><div id="colorbox" class="" style="display: none; padding-bottom: 0px; padding-right: 0px;"><div id="cboxWrapper"><div><div id="cboxTopLeft" style="float: left;"></div><div id="cboxTopCenter" style="float: left;"></div><div id="cboxTopRight" style="float: left;"></div></div><div style="clear: left;"><div id="cboxMiddleLeft" style="float: left;"></div><div id="cboxContent" style="float: left;"><div id="cboxLoadedContent" style="width: 0px; height: 0px; overflow: hidden; float: left;"></div><div id="cboxLoadingOverlay" style="float: left;"></div><div id="cboxLoadingGraphic" style="float: left;"></div><div id="cboxTitle" style="float: left;"></div><div id="cboxCurrent" style="float: left;"></div><div id="cboxNext" style="float: left;"></div><div id="cboxPrevious" style="float: left;"></div><div id="cboxSlideshow" style="float: left;"></div><div id="cboxClose" style="float: left;"></div></div><div id="cboxMiddleRight" style="float: left;"></div></div><div style="clear: left;"><div id="cboxBottomLeft" style="float: left;"></div><div id="cboxBottomCenter" style="float: left;"></div><div id="cboxBottomRight" style="float: left;"></div></div></div><div style="position: absolute; width: 9999px; visibility: hidden; display: none;"></div></div></body></html>